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ABSTRACT 
 A series of synthetic methods have been developed based upon iridium-catalyzed 
borylation of aromatic and heteroaromatic C-H bonds. A general, one-pot method for 
alkylation of arenes with the site-selectivity controlled by steric effects as opposed to 
electronic effects via Ir-catalyzed C-H borylation followed by Pd- or Ni-catalyzed 
coupling with allylic, benzylic or unactivated alkyl electrophiles has been developed. 
Simple palladium catalysts enable the coupling of aryl boronate esters formed from 
iridium-catalyzed C-H borylation to be coupled with various allylic halides, allylic 
carboxylates and benzylic halides. Nickel catalysts bearing diamine or phenanthroline- 
based ligands have been used to couple these aryl boronate esters with primary and 
secondary, unactivated alkyl halides. Meta-selective alkylation of a broad scope of arenes 
with various electronic properties and functional groups, including aryl halides, esters, 
amides, ethers and ketones, has been demonstrated with good yield. This methodology 
has also been used to perform a one-pot total synthesis of elemicin, a natural product with 
potential biological activity, and a formal synthesis of an HIV drug candidate. 
In another study, a new approach to Suzuki-Miyaura coupling of potentially 
unstable organoboronates was developed. Biaryls in which one or more of the aryl rings 
are heteroarenes or fluorinated arenes are found widely in medicinal chemistry and 
materials science, but are challenging to prepare by Suzuki-Miyaura coupling because of 
the instability of the corresponding boronic acids. A strategy to prepare and use in situ or 
as isolated material for cross coupling the pinacolboronate esters of unstable boronic 
acids has been developed. These pinacol boronates are synthesized using iridium-
catalyzed C-H borylation, a direct and mild method for borylation, and are stable 
iii 
indefinitely in isolated form on the benchtop. The corresponding boronic acids require 
cold, anaerobic storage. These boronate esters can also be used in situ for Suzuki 
coupling with aryl halides with easily accessible palladium catalysts in a one-pot 
procedure. Mechanistic studies revealed the features of the pinacolboronates that enable 
these cross couplings to occur in high yields. Protodeborylation of the pinacol boronate is 
slow, and the transmetallation of the pinacol boronate with an intermediate palladium 
hydroxide complex occurs rapidly without generation of the boronic acid. This C-H 
borylation and cross coupling sequence can be conducted on small or large scale and does 
not require the use of a glovebox. Because of the importance of these substructures, this 
methodology should find many applications. 
In a third study focused on iridium-catalyzed C-H borylation, a method for site-
selective borylation of nitrogen-containing heterocycles was developed. Selective 
methods for the functionalization of indoles and other nitrogen heterocycles would 
provide access to the core structures of many natural products and pharmaceuticals. 
Although there are many methods and strategies for the synthesis of substituted indoles 
or functionalization of the azole ring, strategies for the selective functionalization of the 
benzo-fused portion of the indole skeleton, particularly the 7-position, are less common. 
We report a one-pot, iridium-catalyzed, silyl-directed C−H borylation of indoles at the 7-
position. This process occurs in high yield with a variety of substituted indoles, and 
conversions of the 7-borylindole products to 7-aryl-, 7-cinnamyl-, and 7-haloindoles are 
demonstrated. The Ir-catalyzed, silyl-directed C−H borylation also occurs with several 
other nitrogen heterocycles, including carbazole, phenothiazines, and tetrahydroquinoline. 
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The utility of this methodology is highlighted by the one-pot synthesis of a member of 
the pyrrolophenanthridone class of alkaloid natural products. 
In another set of studies, a new approach to the use of high-throughput, 
multidimensional screening of transition metal catalysts and organic substrates was 
developed. Although high-throughput methods for catalyst discovery that would mirror 
related approaches for the discovery of medicinally active compounds have been the 
focus of much attention over the past fifteen years, these methods have not been 
sufficiently general or accessible to typical synthetic laboratories to be adopted widely. A 
method to evaluate a broad range of catalysts for potential coupling reactions using 
simple laboratory equipment has been developed. Specifically, an array of catalysts and 
ligands with a diverse mixture of substrates was screened, and then mass spectrometry 
was utilized to identify coupling products that by design exceed the mass of any single 
substrate. Using this method, we have discovered a copper catalyzed alkyne 
hydroamination reaction and two nickel-catalyzed hydroarylation reactions, all displaying 
excellent functional group tolerance. 
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Chapter 1. Overview of Methods for the Control of Site-Selectivity in Transition 
Metal-Catalyzed Functionalization of Aromatic and Heteroaromatic C-H Bonds 
 
1.1 Introduction 
The synthesis of organic molecules relies upon the transformation of inherently 
reactive functional groups, such as carbonyl groups, halogens, or alcohols, into the 
desired structural features of a target molecule. The development of new methodology, or 
new ways to transform these functional groups, in synthetic organic chemistry has the 
potential to address many crucial challenges in medicine, energy production and 
materials science. New synthetic methodology can present approaches for the synthesis 
of fundamentally new molecules, or new methods can enable a more direct to construct a 
desired compound, generally by enabling the synthesis in higher yield, fewer synthetic 
operations, higher levels of site-, chemo- or stereoselectivity, or with generation of fewer 
wasteful byproducts.1-3 One promising area that has sought to address these challenges of 
more efficient and streamlines synthesis is transition metal-catalyzed C-H 
functionalization reactions. While C-H bonds are generally not considered to be reactive 
functional groups, their ubiquity in many types of molecules makes them an attractive 
target for synthetic manipulation. Synthetic methods involving C-H functionalization 
convert C-H bonds into C-C, C-N, C-O or other types of C-heteroatom bonds. While 
there are many approaches to C-H functionalization, many of the most useful methods 
rely upon transition metal catalysts. The most attractive aspect of C-H functionalization 
in the context of complex molecule synthesis is the potential for these methods to 
decrease the length or efficiency of synthetic sequences. In addition, the ability to 
introduce a diverse set of functionality by direct C-H functionalization can allow for 
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rapid synthesis of a diverse set of structures from a simple starting material, which is 
often desirable in the context of medicinal chemistry.  
Because arenes and heteroarenes constitute important structures in molecules with 
a variety of functions, methods for the functionalization of arenes and heteroarenes, and 
more specifically of aromatic and heteroaromatic C-H bonds, have tremendous potential 
to improve approaches to the synthesis of various complex molecules. Arenes and 
heteroarenes form core scaffolds in pharmaceutical agents, natural products with various 
types of biological activity, and functional polymeric materials (Scheme 1). 
 
Scheme 1. Pharmaceutical agents, natural products and functional polymers with arenes 
and heteroarenes as core structures 
One of the oldest and most commonly utilized methods for the functionalization 
of arenes is electrophilic aromatic substitution. Electrophilic aromatic substitution, or 
Friedel-Crafts reactions, involves the reaction of a nucleophilic arene with an alkyl halide 
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or acyl halide to form an alkylated or acylated arene product. The site-selectivity of these 
transformations is controlled by the electronic properties of the arene (Scheme 2). In 
general, electron-donating substituents lead to functionalization at the ortho/para 
positions. Electron-withdrawing substituents direct functionalization to the meta position 
of the aromatic ring. Another strategy to control the site-selectivity of arene 
functionalization is through Pd- or Ni-catalyzed cross-coupling reactions. In these 
reactions, an aromatic halide or pseudohalide is coupled with an organometallic reagent, 
such as a Mg, Zn, Sn, B or Si compound. While these reactions have proven to be 
invaluable in organic synthesis and have become some of the most highly utilized 
methods for the formation of C-C and C-X bonds, prefunctionalization of both the 
electrophilic and nucleophilic coupling partners is required. 
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Scheme 2. Friedel-Crafts and transition metal-catalyzed cross-coupling approaches to 
arene functionalization 
1.2 Transition Metal-Catalyzed Functionalization of Aromatic C-H Bonds  
Another potential strategy to address the challenge of arene and heteroarenes 
functionalization is through the use of transition metal catalysts. Two primary challenges 
exist in developing effective catalysts for C-H functionalization of aromatic C-H bonds. 
The first challenge is catalyst activity. Because C-H bonds are generally inert, catalysts 
must be specifically designed to both cleave the C-H bond and to convert the C-H bond 
into a C-C or C-heteroatom bond. To this end, many studies have described the discovery 
and development of transition metal complexes that activate aromatic, heteroaromatic 
and aliphatic C-H bonds.4-7 The second challenge is to control the site-selectivity of C-H 
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functionalization. Because C-H bonds are ubiquitous in organic structures, to be 
synthetically useful, a catalyst must be able to differentiate between the many C-H bonds 
in a molecule and only functionalize a single C-H bond to provide optimal catalytic 
activity and selectivity. Several of the strategies for the control of site-selectivity for 
transition metal-catalyzed aromatic C-H activation will be discussed (vide infra). These 
strategies can be placed into the following three categories: 
1) Site-selectivity control by the electronic properties of the arene 
2) Site-selectivity control by a substituent of the arene acting as a directing group 
3) Site-selectivity controlled by the steric properties of the arene 
In addition to C-H functionalization of arene C-H bonds, many synthetic methods for 
the site-selective functionalization of heteroaromatic C-H bonds have also been 
developed. Because heteroaromatic structures are particularly important in 
pharmaceuticals and medicinal chemistry, these methods have the potential to find 
widespread practical utility. In addition, for many classes of heteroarenes, the presence of 
a heteroatom(s) in an aromatic molecule often provides new opportunities for the control 
of site-selectivity in transition metal-catalyzed C-H functionalization (vide infra).  
1.2.1 Functionalization of Aromatic C-H Bonds by Electrophilic Metal Species 
One approach to the control of the site-selectivity of transition-metal catalyzed 
functionalization of aromatic C-H bonds is through the use of electrophilic metal 
species.8 The site-selectivity of this type of transformation is similar to that of 
conventional electrophilic aromatic substitution with alkyl or acyl halides in conjunction 
with a Lewis acid. Metallation by electrophilic metal species occurs at the most electron-
rich and most nucleophilic C-H bond of an arene. Following C-H bond cleavage, reaction 
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with an alkene or alkyne provides a reduced product from hydroarylation of the 
unsaturated molecule.9 Common catalysts for these transformations include Pd(OAc)2 
and Pt(OAc)2 in combination with trifluoroacetic acid (TFA). Mechanistic proposals for 
the Pd-catalyzed process suggest reaction of Pd(OAc)2 with TFA forms a highly 
electrophilic, unsaturated, cationic Pd(TFA)+ species that undergoes reaction with an 
aromatic C-H bond (Scheme 3). Alkyne coordination and insertion into the aryl-Pd(II) 
trifluoroacetate complex followed by protonation of the carbon-palladium bond releases 
the hydroarylation product and regenerates the active catalyst. Electrophilic palladium 
catalysts have also been utilized for para-selective, oxidative, C-H/C-H biaryl formation 
with an N-fluorosulfonimide as the oxidant.10 Electrophilic Cu(III) catalysts, formed by 
reaction of Cu(II) precatalysts with aryliodonium salts, have been utilized for para-
selective arylation of aniline and phenol derivatives.11 
 
Scheme 3. Mechanism of electrophilic Pd-catalyzed hydroarylation of alkynes 
 Other electrophilic metal species have also been utilized in catalytic 
functionalization of aromatic C-H bonds. Electrophilic Rh(III) complexes have been 
utilized for site-selective carbonylation and carboxylation of aromatic C-H bonds 
(Scheme 4).12 The active catalyst for the carbonylation/carboxylation transformation is 
proposed to be a Rh(III)-TFA complex that catalyzes C-H cleavage at the most electron-
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rich position of the arene. Rh-catalyzed carboxylation of toluene furnishes high 
selectivity for p-toluic acid. Oxidative olefination of simple arenes with Ru complexes 
has also been reported, but modest site-selectivities were observed. Rate acceleration was 
observed with more electron-rich arenes, indicating the intermediacy of an electrophilic 
Ru center.13 
  
Scheme 4. Rhodium-catalyzed carboxylation of aromatic C-H bonds 
1.2.2 Control of Site-Selectivity of Aromatic C-H Bond Functionalization by 
Chelating Directing Groups  
In addition to site-selectivity determined by the electronic properties of the arene, 
the site-selectivity of aromatic C-H functionalization can be controlled by a directing 
group. In this approach, the substrate contains a functional group that is capable of 
serving as a temporary ancillary ligand and to bring the transition metal catalyst in 
proximity to a single C-H bond within the molecule. One of the first examples of the use 
of a directing group for aromatic C-H functionalization was reported by Murai. In this 
seminal report, Murai and co-workers observed ortho-alkylation of aromatic ketones with 
olefins catalyzed by RuH2(CO)(PPh3)3 (Scheme 5).14-15 High yields were generally 
observed, and a variety of olefins, including olefins bearing alkyl and aryl groups, in 
addition to vinyl and allyl silanes, could be utilized. Since this initial report, a variety of 
oxygen-directed, ortho-selective C-H functionalization methods for the construction of C-
C and C-X bonds have been reported.16 
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Scheme 5. Ruthenium-catalyzed, ketone-directed ortho-alkylation via aromatic C-H 
activation 
 Following the development of ketone-directed ortho-alkylation by Murai, other 
methods to utilize oxygen-based directing groups have been developed. In several 
methods, carboxylate directing groups in benzoic acids or phenylacetic acids in 
conjunction with Pd(II) catalysts and an oxidant direct formation of C-C or C-X bonds at 
the ortho-position (Scheme 6). These methods rely upon directed cyclometallation at the 
ortho position, followed by functionalization triggered by reaction with various coupling 
partners.17 In several of these transformations, Pd(0) is generated from reductive 
elimination during formation of the functionalized product. Therefore, to regenerate the 
active Pd(II) species, an external oxidant is required. This oxidant is often a silver salt of 
p-benzoquinone, but in some cases O2 gas or air can be used as a more economic and 
environmentally benign oxidant. 
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Scheme 6. Pd-catalyzed, carboxylate-directed ortho-selective functionalization of 
aromatic C-H bonds 
 Along with carboxylic acids, alcohols and amides have been used to direct Pd(II) 
catalyzed functionalization to ortho aromatic C-H bonds. These methods allow for ortho-
selective amination,18 fluorination,19 etherification,20 borylation,21 and alkenylation.22 
Along with carboxylic acids, amides and alcohols, esters have been utilized as an ortho 
directing group. A silica-supported iridium catalyst catalyzed the ortho borylation of aryl 
and heteroaryl esters, amides and ethers with B2pin2 as the boron source.23-24 
 While oxygen-containing functionality can be used directly as a steering group to 
control the site-selectivity of C-H functionalization, covalent modification of alcohols 
can also be used to introduce other directing groups. This approach has been successfully 
applied to the ortho-selective borylation25 and silylation26 of aromatic C-H bonds 
(Scheme 7). In both of these approaches, initial iridium-catalyzed, dehydrogenative 
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silylation of an alcohol with diethylsilane forms a hydrosilyl ether. In the case of ortho-
borylation, this hydrosilyl ether directs borylation with B2pin2 at the ortho C-H bond. In 
the case of ortho-silylation, after formation of the silyl ether, Ir/phenanthroline-catalyzed 
dehydrogenative arene silylation occurs, to form a benzosilole as the product. 
 
Scheme 7. Hydrosilyl-directed, iridium-catalyzed ortho borylation and silylation of 
aromatic C-H bonds 
In addition to oxygen-directed ortho-functionalization of aromatic C-H bonds, 
several methods for nitrogen-directed ortho-functionalization have been developed. Early 
examples of nitrogen-based directing groups demonstrated similar methods to the ketone-
directed alkylation pioneered by Murai. Rhodium27 and ruthenium28 complexes catalyze 
ortho-functionalization with pyridyl groups, imidates or imines as the internal, directing 
ligand (Scheme 8). In the cases of the ruthenium-catalyzed ortho-functionalization of 
imidates and imines, a minor amount of alkenylation product is observed, presumably 
from fast β-hydride elimination relative to C-H reductive elimination. Ru-catalyzed 
ortho-acylation can be performed by coupling of ortho C-H bonds with CO gas and an 
olefin.29-30  
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Scheme 8. Ruthenium-catalyzed, imine-directed ortho-alkylation of aromatic C-H bonds\ 
Nitrogen-directed arylation of ortho aromatic C-H bonds has also been 
accomplished with rhodium and ruthenium catalysts. Arylation of 2-phenylpyridine 
derivatives with Rh(PPh3)3Cl as the catalyst and Ar4Sn as the source of the aryl group has 
been demonstrated. A potentially more useful ruthenium-catalyzed ortho-arylation of 2-
phenylpyridine derivatives31 and aryl imines32 was reported by Oi and coworkers with 
aryl halides. The proposed mechanism for these transformations entails initial oxidative 
addition of the aryl halide by a Ru(II)-phosphine complex, followed by electrophilic 
attack of the resulting Ru(IV) aryl halide complex at the ortho position after coordination 
to the nitrogen directing group. Elimination of HX forms a nitrogen-coordinated diaryl 
complex, which undergoes reductive elimination to form the biaryl product and 
regenerate the Ru(II) species. 
Enantioselective, rhodium-catalyzed C-H activation/alkylation methods have also 
been developed. Bergman, Ellman and co-workers have developed chiral rhodium 
catalysts for imine-directed C-H functionalization followed by olefin insertion to form 
stereocenters in an enantioselective fashion (Scheme 9). Use of chiral, non-racemic 
phosphoramidite ligand in combination with a Rh(I) precatalysts enables enantioselective 
synthesis of substituted indanes and dihydrobenzofurans with high levels of 
enantioselectivity and diastereoselectivity.33-34 
12 
 
Scheme 9. Enantioselective, rhodium-catalyzed alkylation via nitrogen-directed aromatic 
C-H bond activation 
In addition to ruthenium and rhodium catalysts, palladium complexes have been 
utilized for nitrogen-directed, ortho-selective functionalization of aromatic C-H bonds.35 
The use of palladium catalysts for nitrogen-directed C-H functionalization has allowed 
for the introduction of more diverse functionality, including the formation of C-C, C-O, 
C-N, C-S and C-X (X=halogen) bonds. Palladium catalysts have been particularly 
effective for this type of transformation because they undergo reaction with a variety of 
reagents for functionalization, and palladium complexes readily undergo cyclometallation 
reactions with ortho C-H bonds with a variety of directing groups. A general mechanism 
for this transformation is shown in Scheme 10. In general, a Pd-carboxylate salt 
undergoes initial cyclometallation with an ortho, aromatic C-H bond, facilitated by a 
nitrogen directing group, with concomitant loss of acid. Following metallacycle 
formation, the Pd(II) center undergoes oxidation form a Pd(IV) (or Pd(III))36 intermediate 
with transfer of the transferable organic group. Following oxidation, this high-valent 
palladium intermediate undergoes reductive elimination to produce the functionalized 
product and regenerate Pd(II). 
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Scheme 10. General mechanism for Pd-catalyzed ortho-selective functionalization with 
nitrogen directing groups 
 Following initial development of Pd-catalyzed, ortho-selective oxygenation of 2-
phenylpyridine derivatives,37 a variety of methods for Pd-catalyzed, nitrogen-directed 
arene C-H functionalization have been developed (Scheme 11).35 Methods for 
oxygenation, sulfonylation, halogenation, trifluoromethylation, arylation and amination 
have been developed. In addition, a variety of directing groups, including pyridyl groups, 
pyrazines, pyrimidines, pyrazoles, imines, oxazolines, oximes and amides can be utilized. 
Along with aromatic C-H functionalization, many of these methods have been extended 
to allow for similar, directed functionalization of aliphatic C-H bonds.  
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Scheme 11. Diversity of bond constructions via nitrogen-directed functionalization of 
ortho C-H bonds 
 Directing groups can also be utilized to enable meta-selective arene 
functionalization. An example of this class of arene functionalization utilizes highly 
electrophilic copper catalysts to perform meta-selective arylation of aryl amides (Scheme 
12).38 In this methodology, pivaloyl anilines undergo arylation with aryliodonium salts in 
the presence of a catalytic amount of Cu(OTf)2. the meta selectivity is proposed to arise 
via a Heck-like intermediate that directs the Cu center to the ortho position by 
coordination to the anilide and delivers the aryl group to the meta position.39 In addition 
to meta-arylation of anilides, this methodology has been extended to meta-selective 
arylation of phenylacetic acid derivatives.40 Ruthenium-catalyzed meta-selective 
sulfonylation of 2-phenylpyridine derivatives has also been reported.41 
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Scheme 12. Copper-catalyzed meta-arylation of aryl amides with aryliodonium salts 
1.2.3 Control of Site-Selectivity of Aromatic C-H Bond Functionalization by the 
Steric Properties of the Arene  
Another general approach to the control of site-selectivity of aromatic C-H 
functionalization is through steric effects. These methods enable aromatic C-H bond 
activation with complementary regioselectivity to those methods which require a 
directing group. Several approaches for the selective functionalization of the most 
sterically-accessible C-H bond of an arene have been developed. Directed C-H 
functionalization is inherently limited by the presence of the directing group, which in the 
context of synthetic applications either must be a structural element of the desired target, 
or requires installation and removal following functionalization. While some directing 
groups are easily removed,42-43 other groups such as pyridyl groups, are not easily 
removed, thus limiting the synthetic applications of these directing groups in the context 
of organic synthesis. One of the first and most well-developed methods for arene 
functionalization with the site-selectivity controlled by steric effects is transition metal-
catalyzed borylation of aromatic C-H bonds.44 In the borylation of arenes, C-H 
functionalization generally occurs at the least hindered C-H bond of an arene. In addition 
to forming functionalized arenes with complementary site-selectivity to other methods, 
this method forms an aryl boronate by direct activation of a C-H bond, alleviating the 
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need for a pre-functionalized precursor, generally an aryl halide (Scheme 13). Two 
common methods for the preparation of aryl boronates from aryl halides are metallation 
of aryl halides with magnesium or lithium reagents followed by quenching with a borate 
electrophile, and a more mild Pd-catalyzed45 or Cu-catalyzed46 method for borylation of 
aryl halides with diboron or borane reagents. The direct borylation of C-H bonds provides 
a more direct borylation method which does not rely upon the synthesis of an aryl halide.  
 
Scheme 13. Approaches to the synthesis of aryl boronates from aryl halides and aromatic 
C-H bonds 
 Borylation of aromatic C-H bonds is catalyzed by iridium47 and rhodium48 
complexes, with iridium catalysts being more widely utilized. Two classes of catalysts for 
the iridium-catalyzed borylation of aromatic C-H bonds with bis(pinacolato)diboron 
(B2pin2) have been developed (Scheme 14). One class of catalysts utilizes an Ir(I) 
precatalyst in combination with monodentate or bidentate phosphine ligands.49 The 
second, more active catalyst class utilizes and Ir(I) precatalyst along with 4,4’-di-tert-
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butylbipyridine (dtbpy) as the ancillary ligand.50 Both catalysts can achieve high turnover 
numbers and maintain the sterically-controlled site-selectivity, providing borylation at the 
least hindered C-H bond of simple arenes. In addition to catalyst and ligand structure, the 
structure of the diboron compound imparts a significant effect on the borylation. The 
borylation occurs in higher yield and with higher turnover number when a more sterically 
hindered and more electron rich group is placed on the boron atoms of the diboron 
compound.51 Therefore, pinacolate boron esters provides higher yields in the iridium-
catalyzed C-H borylation reaction than does catecholate boron esters. In addition to the 
use of alkoxide substituents on the boron atom, the iridium-catalyzed C-H borylation can 
be conducted with HBDan (Dan = 1,8-diaminonaphthalene).52 Arenes containing the 
BDan group are useful in iterative Suzuki-Miyaura cross-coupling.53 
 
Scheme 14. Two classes of catalysts for iridium-catalyzed borylation of arenes 
While the meta-selectivity of the iridium catalyzed C-H borylation provides a 
method to access arenes with substitution patterns that would difficult to synthesize by 
other methods, the resulting boronate esters are of greater utility if they can be 
functionalized into a variety of other compounds to allow for the synthesis of several 
classes of substituted arenes.54 Apart from Suzuki-Miyaura coupling with aryl 
electrophiles, several methods for the introduction of diverse functionality by 
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functionalization of an aryl pinacol boronate ester formed by C-H borylation have been 
developed, generally in a one-pot fashion, which allows for increased synthetic efficiency 
(Scheme 15). 3,5-disubstituted phenols can be synthesized by oxidation of a pinacol 
boronate ester with Oxone.55 In an extension of this methodology, 3-aminophenols can by 
formed by borylation of a 3-substituted aryl halide, followed by Pd-catalyzed amination 
and oxidation of the aryl boronate.56 Chan-Lam coupling of the crude aryl boronate ester 
to form aryl amines57 and aryl nitriles58 occurs with readily available Cu catalysts. Aryl 
ethers can also by formed by hydrolysis of the aryl boronate ester to the boronic acid, 
followed by Cu-catalyzed coupling with an alcohol.57 Cu-catalyzed halogenation with 
CuX2 (X = Cl, Br) provides access to meta-substituted aryl halides, which are difficult to 
synthesize by conventional electrophilic aromatic substitution reactions.59 Meta-
substituted aryl fluorides were also synthesized by initial boronic acid formation by 
hydrolysis, followed by silver-catalyzed fluorination with an electrophilic fluorination 
reagent.60 Meta-substituted perfluoroalkyl arenes were formed by perfluoroalkylation of 
the pinacol boronate ester formed from C-H borylation with Cu-perfluoroalkyl complexes 
under oxidative conditions.61-62 Boronate esters formed in situ by Ir-catalyzed C-H 
borylation can be used for Rh-catalyzed conjugate addition to α,β–unsaturated ketones to 
form β-arylketones.63 Finally, other organoboron compounds can be synthesized from the 
crude pinacol boronates, including aryl boronic acids, by acidic hydrolysis in the 
presence of NaIO4, and the potassium trifluoroborate salt by treatment of the pinacol 
boronate with aqueous KHF2.64 The synthetic diversity that can be accomplished with the 
aromatic C-H borylation platform makes this transformation a useful method in organic 
synthesis. 
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Scheme 15. Functionalization of aryl boronate esters formed by meta-selective, iridium-
catalyzed C-H borylation 
 In addition to being used for the synthesis of simple, substituted arenes, iridium-
catalyzed C-H borylation has been used in the total synthesis of complex small molecules 
(Scheme 16).54 Meta-selective borylation followed by halogenation of the resulting 
pinacol boronate was utilized by Hartwig and co-workers in the synthesis of 
Taiwaniaquinol B and Taiwaniaquinone H.65 Meta-selective borylation and conversion of 
the aryl pinacol boronate ester to a primary amide was utilized by Shibasaki and co-
workers in the synthesis of SM-130686, a potent human growth secretagogue (Scheme 
15).66 These applications illustrate the potential for the use of iridium-catalyzed C-H 
borylation for the construction of complex targets. 
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Scheme 16. Use of C-H borylation in the total synthesis of natural products and 
pharmaceutical candidates 
 In addition to iridium-catalyzed C-H borylation, there are other methods for 
functionalization of aromatic C-H bonds with the site-selectivity governed by the steric 
properties of the arene. One example was reported by Yu and co-workers.67 This 
methodology describes the meta-selective olefination of electron-deficient arenes under 
aerobic, oxidative conditions (Scheme 17). The key to the development of the catalyst 
was the use of a bulky pyridine ligand, which enables selectivity for cleavage of the meta 
C-H bond. However, this method is limited to electron-deficient arenes and requires high 
catalyst loading. Other methods the meta-selective olefination68 and arylation69 of 
pyridines. These methods generally require large excess of the pyridine substrate, but 
nonetheless are potentially useful in the context of medicinal chemistry applications. 
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Scheme 17. Meta-selective, palladium-catalyzed olefination of electron-deficient arenes 
1.3 Transition Metal-Catalyzed Functionalization of Heteroaromatic C-H Bonds  
In addition to transition metal-catalyzed C-H functionalization of arenes, several 
methods have been developed for C-H activation of heteroaromatic C-H bonds. These 
methods can be divided into two categories based upon the heteroaromatic substrates: 
1) Functionalization of C-H bonds in pyridines and pyridine derivatives 
2) Functionalization of C-H bonds in azole rings 
The site-selectivity of the C-H functionalization is generally controlled by the electronic 
properties of the C-H bonds in the heteroarenes, or by association or temporary binding 
of the heteroatom of the substrate with the metal center. 
1.3.1 Transition Metal-Catalyzed Functionalization of C-H bonds in Pyridines and 
Pyridine Derivatives 
Rhodium catalysts have been utilized for the direct alkylation and arylation of 
pyridines at the 2-position.70 Bergman and Ellman have discovered rhodium catalysts for 
the selective alkylation of 2-substituted pyridines with olefins.71 This transformation is 
catalyzed by the combination of a Rh(I) precatalyst and PCy3-HCl as the ancillary ligand 
and a very high temperature is required to obtain a high yield. Use of the phosphonium 
salt of the ancillary ligand is crucial, presumably because the substoichiometric acid 
additive protonates the nitrogen atom of the pyridine, and this pyridinium salt undergoes 
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alkylation at the 2-position. This methodology has also been extended to Rh-catalyzed 
direct arylation at the 2-position of pyridines with aryl bromides.72 
 Nickel catalysts have also been utilized for the introduction of various functional 
groups at different sites of pyridines (Scheme 18). Nakao, Hiyama and co-workers have 
reported nickel catalysts for the alkenylation of pyridines at the 2-position in conjunction 
with a Lewis acid. In this methodology, reaction of a pyridine with an alkyne in the 
presence of a Ni-phosphine catalyst and AlMe3 as the Lewis acid provides 2-
alkenylpyridines in good yield and with high site-selectivity.73 The site-selectivity of this 
transformation can be altered to give alkenylation at the 4-position of pyridine simply by 
substituting a bidentate NHC-amine ligand for the phosphine.74 C-4- selective alkylation 
of pyridines with high site-selectivity has also been demonstrated by reaction of pyridines 
with alkenes in the presence of a Ni-NHC catalyst and an aluminum Lewis acid.75 
 
Scheme 18. Nickel-catalyzed alkenylation of pyridines at the C-2 and C4 positions 
 Pyridine N-oxide has also been used as a heteroaromatic substrate for direct C-H 
functionalization at the 2-position (Scheme 19). Fagnou and co-workers have 
demonstrated that pyridine N-oxides can undergo direct arylation with aryl bromides 
catalyzed by the complex formed from the combination of Pd(OAc)2 and PtBu3 in the 
presence of K2CO3 as the base.76 Imidazole N-oxides, oxazole N-oxides, and thiazole N-
oxides can also be utilized as substrates for arylation with aryl bromides, and this 
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methodology has been utilized in the total synthesis of complex small molecules with 
biological activity.77 This methodology has been extended to the oxidative direct 
arylation of pyridine N-oxides with olefins and arenes in the presence of Pd(OAc)2 and 
Ag2CO3 as both the base and the oxidant.78 
 
Scheme 19. Pd-catalyzed, direct arylation of pyridine N-oxides with aryl bromides 
1.3.2 Transition Metal-Catalyzed Functionalization of C-H bonds in Azole 
Heterocycles 
Due to their importance in natural product synthesis and medicinal chemistry, 
many synthetic methods have been developed for C-H activation of azole heterocycles. In 
general, azole heterocycles exhibit high reactivity towards transition metal-catalyzed C-H 
functionalization relative to simple arenes. In addition, the electronic properties of the 
various C-H bonds in an azole heterocycle allow for catalyst discrimination between the 
various C-H bonds and enable site-selective synthetic manipulation of these heteroarenes 
(Scheme 20). In more recent developments, catalyst design or other strategies have 
allowed for the development of transition metal complexes that can modify the site-
selectivity from this inherent reactivity of azole C-H bonds. 
24 
 
Scheme 20. Commonly reactive C-H bonds for transition metal-catalyzed C-H 
functionalization of azole rings 
 Many of the methods for C-H functionalization of azole C-H bonds can be placed 
into three different categories based upon mechanistic considerations (Scheme 21). The 
first type of transition metal-catalyzed azole functionalization is electrophilic aromatic 
substitution with an electron-deficient metal center. Nucleophilic attack of the azole on 
the metal center followed by deprotonation with an external base forms a heteroaryl 
metal complex. This complex then undergoes functionalization to form the product and 
regenerate the catalyst. In the second mechanism, the heteroarenes undergoes olefin 
insertion with a metal center, generally into a metal-carbon bond form a new bond and a 
dearomatized intermediate. β-hydride elimination then occurs to rearomatize and form 
the product and release a metal-hydride, which then regenerates the active catalyst. The 
final general mechanism for azole C-H functionalization involves deprotonation of the 
most acidic C-H bond of the azole ring followed by transmetallation with a transition 
metal species. This heteroaryl metal intermediate then undergoes functionalization to 
form the final product. 
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Scheme 21. General mechanisms for transition metal-catalyzed C-H functionalization of 
azole heterocycles 
 Direct C-H arylation is one of the most utilized methods for C-H functionalization 
of azole heterocycles.16 Several palladium catalysts have been developed for 
intramolecular and intermolecular direct arylation of imidazoles, oxazoles and thiazoles 
(Scheme 22). Miura and co-workers demonstrated the arylation of 2-substituted N-
alkylimidazoles, 2-substituted oxazoles, and 2-substituted thiazoles occurs at the 5-
position with aryl iodides with palladium catalysts bearing simple arylphosphine 
ligands.79 The scope of this reaction can be extended to aryl bromides with the use of 
P(tBu)3 or JohnPhos as the ancillary ligand. Direct arylation of these heterocycles with 
aryl bromides and pivalic acid as an additive has also been reported.80 Copper additives 
have also been demonstrated to affect the reactivity and selectivity of these direct 
arylation reactions, and to act as a catalysts themselves in the absence of palladium 
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complexes.81-83 In addition to direct arylation, Pd-catalyzed and Ni-catalyzed direct 
alkylation of oxazoles, benzoxazoles and benzothiazoles with primary alkyl halides has 
been reported.84 
 
Scheme 22. Pd-catalyzed direct arylation of imidazoles, oxazoles and thiazoles with aryl 
bromides and aryl iodides  
 Rhodium catalysts have also been developed for the direct arylation and 
alkylation of (benz)imidazoles, (benz)oxazoles, and (benzo)thiazoles.70 Arylation at the 
2-position of azole heterocycles bearing two heteroatoms occurs with aryl iodides with 
Rh(I) catalysts bearing alkylphosphine ligands (Scheme 23). Although high temperatures 
are required, the scope is broad and the yield and site-selectivity of this transformation 
are generally high. This methodology was later extended to arylation with aryl bromides 
with a phosphepine ligand.85-86  
 
Scheme 23. Rhodium-catalyzed direct C-H arylation of azole heteroarenes with aryl 
iodides 
A similar method for rhodium-catalyzed alkylation of heteroaromatic C-H bonds 
with olefins has also been developed. An intramolecular alkylation of imidazoles and 
benzimidazoles was initially developed (Scheme 24).87 Alkylation occurs at the 2-
position with a Rh(I)-PCy3 catalyst in good yield. Later developments extended this 
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methodology to intermolecular alkylation with terminal alkenes or cyclic internal 
alkenes.88 Mechanistically, these arylation and alkylation reactions have been 
demonstrated to proceed via formation of an N-heterocyclic carbene complex following 
C-H activation by the Rh-phosphine catalyst, which then undergoes reaction with either 
an aryl halide or alkene to form the new C-C bond in the final product.89 
 
Scheme 24. Intramolecular and intermolecular, rhodium-catalyzed alkylation of azole 
heterocycles via hydroheteroarylation of alkenes 
 Although most methods for the functionalization of heteroarenes involve C-C 
bond formation, methods for C-N bond formation via heteroaromatic C-H 
functionalization have been developed. Cu-catalyzed amination of oxazoles and 
benzoxazoles with chloramines or hydroxylamine derivatives was developed by Miura 
and co-workers (Scheme ).90-91 This transformation likely occurs via deprotonation and 
transmetallation of the heteroarenes with the copper catalysts, followed by oxidative 
addition of the chloramines. Reductive elimination then forms the new C-N bond and 
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regenerates the low-valent copper catalyst. An oxidative approach to azole amination has 
also been developed.92 
Several methods for C-H functionalization of heterocycles bearing one 
heteroatom have been developed. The vast majority of methods for direct C-H 
functionalization of pyrroles, indoles, furans, benzofurans, thiophenes and 
benzothiophenes for new C-C bonds at the 2-position or 3-position of these heterocycles 
(Scheme 25). Early examples focused on intramolecular direct arylation with tethered 
aryl halides or aryl pseudohalides catalyzed by palladium complexes in the presence of 
base. While formation of 5-membered and 6-membered rings by this cyclization strategy 
is most common, intramolecular direct arylation to form 7-membered and 8-membered 
rings has also been reported. A particularly active catalyst from the combination of 
Pd(OAc)2 with DavePhos (2-Dicyclohexylphosphino-2′-(N,N-dimethylamino)biphenyl) 
as the ancillary ligand has been reported by Fagnou and co-workers.93 This catalytic 
protocol has been utilized by Trauner94 and Fagnou95 in natural product total syntheses. 
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Scheme 25. Intramolecular direct arylation of heterocyclic C-H bonds with aryl halides 
and pseudohalides and application in total synthesis 
 Following demonstration of methods for intramolecular direct arylation, 
approaches to intermolecular direct arylation have developed. Arylation can be conducted 
with aryl halides and aryl pseudohalides with a variety of palladium catalysts. Arylation 
generally occurs at the 2-position, but in some cases the site-selectivity can be altered and 
arylation occurs at the 3-position.96-97 In addition to methods utilizing palladium catalysts, 
Sames and co-workers have developed rhodium catalysts bearing electron-deficient aryl 
phosphine ligands for C-2 selective arylation of pyrroles and indoles with aryl iodides 
(Scheme 26).98 
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Scheme 26. Intermolecular, direct arylation of heteroarenes with aryl halides 
 Direct arylation of thiophenes is of particular interest because poly(3-
alkyl)thiophenes are utilized as π-conjugated polymers for the construction and 
development of flexible electronic devices.99 This class of polymers has been 
traditionally prepared by palladium-catalyzed cross-coupling of bifunctional thiophenes 
bearing an aryl bromide or iodide and an organometallic functionality, such as Mg, SnR3, 
ZnX or B(OR)2. While these approaches enable polymer synthesis, a potentially more 
direct route to these polymers would be to utilize direct arylation of thiophenes to 
perform the polymerization. Ozawa and co-workers have developed an effective method 
for the polymerization of 3-alkyl-2-bromothiophenes catalyzed by the combination of 
Hermann’s catalyst and tris(o-N,N-dimethylaminophenyl)phosphine) as the ancillary 
ligand (Scheme 27).100 This method enabled the synthesis of poly(3-hexylthiophene) with 
a high molecular weight and excellent regioregularity. 
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Scheme 27. Application of thiophene direct arylation for synthesis of poly(3-
hexylthiophene) 
In addition to direct arylation with aryl halides, transition metal catalysts have 
been used for electrophilic C-H functionalization of heteroarenes with aryliodonium salts 
(Scheme 28). Electrophilic palladium catalysts, formed from oxidation with an 
aryliodonium salt, have been used to promote C-2 selective arylation of indoles.101 In this 
methodology, indoles and pyrroles with a variety of substituents are arylated with 
diaryliodonium salts in the presence of (IMes)Pd(OAc)2 (IMes = 1,3-bis(2,4,6-
trimethylphenyl)imidazol-2-ylidene) to yield 2-arylindole products in good yields. 
Although these examples occur with electron-deficient catalysts, arylation occurs at the 
most acidic C-H bond. Electrophilic copper complexes allow for another approach to 
indole arylation. With Cu(OTf)2 as the precatalyst, arylation of indoles occurs at the 3-
position with an aryliodonium salt as both the source of the aryl group and the oxidant.102 
In this reaction, a Cu(III) intermediate formed from oxidation of the copper precatalyst 
with the aryliodonium salt likely is the species that performs the C-H cleavage, which 
occurs at C-3, the most nucleophilic site. The use of an electrophilic copper catalyst 
provides a change in site-selectivity for indole arylation with aryl iodonium salts. 
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Scheme 28. Pd- and Cu-catalyzed arylation of indoles with aryliodonium salts 
Iridium-catalyzed C-H borylation also occurs with heteroaromatic C-H bonds 
(Scheme 29). In contrast to the borylation of arene C-H bonds, the iridium-catalyzed 
borylation of the heteroaromatic C-H bonds of 5-membered ring heteroarenes and 
benzofused heteroarenes occurs at the C-H bond adjacent to the heteroatom (2-
position).103-105 the site-selectivity of iridium-catalyzed C-H borylation can be altered in 
pyrrole or indole heterocycles by incorporation of a bulky group, such as a tri-
isopropylsilyl group or tert-butoxycarbonyl group, as the substituent on the nitrogen atom. 
In these cases, borylation occurs at the 3-position of pyrroles or indoles with high site-
selectivity.106 The borylation of 5-membered ring is facile, and the borylation on many of 
these substrates can be conducted at room temperature in high yield. In addition, the 
borylation of quinoline occurs predominantly at the 3-position of quinoline, and no 
borylation occurs on the benzene ring of quinoline. As with the iridium-catalyzed 
borylation of arenes, iridium-catalyzed borylation of heteroarenes has been utilized in 
natural product total synthesis. Iridium-catalyzed C-H borylation of a tryptamine 
derivative and subsequent Pd-catalyzed Suzuki-Miyaura cross-coupling with a heteroaryl 
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iodide was used by Movassaghi and coworker in the synthesis of several members of the 
Trigonoliimine class of natural products (Scheme 29).107  Borylation of a pyrrole 
followed by Suzuki-Miyaura cross-coupling of the resulting heteroaryl boronate ester was 
a key step in the total synthesis of Rhazinicine by Gaunt and co-workers.108 
 
Scheme 29. Site-selectivity of iridium-catalyzed borylation of heteroarenes and 
utilization in total synthesis 
1.4 Summary and Objectives 
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While not comprehensive, this review summarizes many of the major developments 
in methods for the transition metal-catalyzed functionalization of aromatic and 
heteroaromatic C-H bonds. Clearly, transition metal catalysis has allowed for tremendous 
progress in the control of site-selectivity in arene functionalization, as well in the variety 
of functionality that can be appended to an aromatic framework. These methods have had 
a significant impact on the methods used to assemble complex molecules with a variety 
of functions. Due to the increasing demand for more direct synthetic methods which 
product less waste and operate under more mild conditions, the development of these 
methods will surely continue at a rapid pace in the future. To contribute to this further 
development of effective C-H functionalization reactions which address unmet 
challenges in synthetic methodology, the work described in subsequent chapters in this 
thesis will describe the following contributions: 
1) The development of a general method for the meta-selective alkylation of arenes 
via iridium-catalyzed C-H borylation and subsequent Pd- or Ni- catalyzed cross-
coupling of the resulting pinacol boronate ester with various alkyl electrophiles. 
(Chapter 3) 
2) The use of the pinacol boronate esters formed via iridium-catalyzed of 
heteroarenes and fluoroarenes as surrogates for unstable boronic acids in Suzuki-
Miyaura cross-coupling with aryl halides under mild reaction conditions. (Chapter 
4) 
3) The development of a synthetic method for the iridium-catalyzed, silyl-directed 
borylation of nitrogen-containing heterocycles which allows for the access to 
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substituted heterocycles that would be difficult to access by other methods. 
(Chapter 5) 
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Chapter 2. Overview of Approaches to Reaction and Catalyst Discovery Based Upon 
High-Throughput Screening 
2.1 Introduction 
 The discovery of new chemical reactions provides essential tools that can enable 
organic synthesis and significantly accelerate advances in many areas of science.1 While 
reaction discovery in many fields continues, catalytic reactions involving transition 
metals have grown into some of the most commonly used methods for the construction of 
many classes of molecules. Transition metal complexes catalyze many important 
reactions used in medicine,2 materials science3-4 and energy production,5-6 making 
development of new metal-catalyzed processes highly attractive in both academic and 
industrial settings. It is estimated that transition metal catalysis contributes to 
approximately one-quarter of the economy of the United States, which highlights the 
importance of these technologies in a variety of applications with tremendous value.7 
2.2 General drivers for the discovery of new chemical reactions 
2.2.1 Reaction discovery driven by synthesis of a target molecule or target structure  
Several approaches have proven successful in discovering and developing 
transition metal catalysts for applications in synthetic chemistry. One approach has 
focused on developing an organometallic catalyst for a specific bond construction or for a 
specific structural feature found in a target molecule or class of target molecules. An 
example of this approach can be seen in the work of Wender and co-workers in 
developing novel, transition metal-catalyzed cycloaddition reactions of alkenes, allenes, 
alkynes, and other unsaturated moieties to form unusual carbocycles, including 7-
membered and 8-membered rings (Scheme 30).8,9 For example, Wender and Snapper 
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utilized a nickel-catalyzed [4+4] cycloaddition of two 1,3-diene units to construct the 8-
membered ring at the core of paclitaxel, the active ingredient in Taxol, a common 
chemotherapeutic agent.10 Wender and co-workers have also utilized a rhodium-catalyzed 
[5+2] cycloaddition of an allene and a vinylcyclopropane to construct the bicyclic 
structure of dictamnol, a sesquiterpene natural product.11  
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Scheme 30. Transition-metal catalyzed cycloaddition reactions for the synthesis of core 
structures of natural products 
2.2.2 Reaction discovery driven by fundamental reactivity of a catalyst 
 In addition to catalyst discovery motivated by the synthesis of a target structure, 
the discovery and development of transition metal-catalyzed reactions can be inspired by 
the fundamental reactivity of organometallic complexes. While there are many examples 
of mechanistic understanding leading to useful catalytic chemistry, one of the most 
prominent examples is the development of the Mizoroki-Heck reaction from fundamental 
studies of the reactivity of arylpalladium complexes with olefins. In landmark studies in 
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this area, Heck demonstrated that transmetallation of an aryl mercury compound with 
Pd(OAc)2 forms an arylpalladium complex. This arylpalladium complex then undergoes 
reaction with an olefin to form a vinylarene, presumably through olefin coordination, 
olefin insertion, and β-hydride elimination (Scheme 31a).12 While this study provides 
crucial understanding of the fundamental reactivity of arylpalladium complexes with 
olefins, it does not represent a useful synthetic process, primarily because it uses a toxic 
mercury reagent and a stoichiometric quantity of the palladium salt. However, with this 
fundamental knowledge, Mizoroki and Heck developed a catalytic reaction that allows 
for coupling of aryl halides with olefins with catalytic quantities of palladium (Scheme 
31b).13-14 From this initial discovery, highly active palladium catalysts have been 
discovered,15-17 and the Mizoroki-Heck reaction has evolved into one of the most 
commonly used cross-coupling reactions in the synthesis of complex small molecules.18 
 
Scheme 31. Stoichiometric reactivity of arylpalladium complexes with olefins, leading to 
development of the Mizoroki-Heck reaction 
2.2.3 Reaction discovery initiated by a serendipitous observation 
 Along with reaction discovery motivated by the synthesis of a key organic 
structure or inspired by the fundamental, stoichiometric reactivity of an organometallic 
complex, several transition metal-catalyzed reactions have been discovered 
serendipitously while seeking other outcomes. One of the most commercially important 
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examples of this type of catalyst discovery is the initial identification of organometallic 
catalysts for ethylene polymerization. Ziegler and co-workers had demonstrated that the 
reaction of alkyl aluminum compounds with ethylene afforded trialkylaluminum 
compounds with increased molecular weight (Scheme 32). However, inadvertent 
contamination of the reaction vessel with Ni salts hindered ethylene oligomerization and 
resulted in ethylene dimerization to form 1-butene. This serendipitous discovery led 
Ziegler and co-workers to the crucial insight that a transition metal complex could affect 
the reaction of aluminum alkyl compounds with olefins. Following this insight, Ziegler 
and co-workers performed a systematic investigation of other metal salts to affect the 
oligomerization of ethylene. These investigations resulted in the identification of TiCl3 
and Et2AlCl as a highly active catalyst for olefin polymerization. Ti/Al catalysts are now 
known as Ziegler-Natta polymerization catalysts and are used on a large, industrial scale 
to produce more than 40 million tons of polyolefins each year.19 
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Scheme 32. Serendipitous discovery of the effect of transition metal complexes on the 
polymerization of ethylene 
 Olefin metatheis is another example of serendipitous discovery of a new, metal-
catalyzed reaction. While attempting to discover transition metal catalysts for the 
polymerization of propylene, Eleuterio, working at DuPont, analyzed the off gas from 
this process and determined that in addition to propylene, ethylene and butene were 
formed (Scheme 33).20 Because ethylene and butene cannot be formed from 
oligomerization of propylene, it was determined that ethylene and butene must have 
formed from redistribution of the olefin fragments. This discovery led to the 
identification of transition metal-catalyzed olefin metathesis as a viable synthetic process. 
Since that initial, serendipitous discovery, the mechanism of olefin metathesis has been 
delineated, highly active catalysts have been developed, and olefin metathesis has found 
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widespread use of in the synthesis of natural products and even in commercial 
applications to synthesize functional polymeric materials.21-27 
 
Scheme 33. Serendipitous discovery of transition metal catalysts for olefin metathesis 
2.3 Reaction discovery via high-throughput screening 
While these general approaches to the discovery of fundamentally new chemical 
transformations have resulted in important contributions to the development of synthetic 
methodology, another potential approach to the discovery of new catalysts and new 
synthetic transformations is through the high-throughput evaluation of catalyst and 
substrate combinations. High-throughput screening has been used in the discovery of lead 
compounds in drug discovery,28 medicinal chemistry,29 and to discover new classes of 
materials for materials science applications.30-33 Inspired by these successes, many 
chemists have begun to utilize high-throughput screening for catalyst identification and 
optimization in a variety of different catalysis applications.34-35 These approaches for 
catalyst discovery can generally be placed into one of three different categories based 
upon the areas or dimensions of potential chemical space that are surveyed: 
1) Examination of many catalysts for the discovery and optimization of a catalyst for 
a single chemical transformation 
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2) Examination of a single catalyst with many different substrates for the potential 
discovery of a new bond construction or a new catalyst for an existing bond 
construction 
3) Examination of many catalysts and many organic substrates for the potential 
discovery of new catalysts and new strategies for bond construction 
This chapter will review approaches to the discovery, development or optimization of 
catalysts with high-throughput screening techniques. 
2.3.1 Examination of many catalysts for the discovery and optimization of a catalyst 
for a single chemical transformation 
One approach to high-throughput screening in catalysis focuses on a single reaction, 
between two substrates, and surveys a variety of potential catalysts. Within transition 
metal catalysts, the steric and electronic properties of the metal complex generally control 
the reactivity of the catalyst. Because it is very difficult to generate a general catalyst 
structure for a new catalytic reaction or to design an optimal catalyst for a specific 
transformation de novo, combinatorial examination of catalysts has emerged as an 
attractive strategy for catalyst development for both academic and industrial applications.  
 Libraries of catalysts have been used for discovery and optimization of a single 
synthetic transformation. Hoveyda and co-workers and Jacobsen and co-workers have 
utilized solid-phase synthesis to construct libraries of chiral small molecules for various 
applications in asymmetric catalysis (Scheme 34). Hoveyda and co-workers synthesized a 
small library of peptide-based catalysts and utilized these ligands in combination with 
Ti(OiPr)4 to develop the first method for the catalytic, enantioselective addition of 
TMSCN to meso-epoxides.36 In a similar approach, Jacobsen and Sigman examined a 
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small library of (thio)urea catalysts for the asymmetric addition of cyanide to imines.37 In 
this approach, a series of transition metal salts and urea-based ligands were examined, 
and the best results were obtained in the absence of a metal salt. Further catalyst 
optimization revealed a thiourea catalyst that enabled the addition of HCN to imines with 
good yield and generally high enantioselectivity. Both of these methods begin with 
iterative construction of libraries based upon the identification of “lead” catalysts, 
followed by rational variation and optimization of the key molecular elements of the 
catalyst structure. Most notably, both of these approaches led to the discovery of classes 
of catalysts that have been developed further into a variety of useful methodologies in 
asymmetric catalysis.38-43 The use of ligand libraries has also been applied to the 
discovery of catalysts for other applications, including C-H insertion reactions44 and 
Ullmann coupling.45 
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Scheme 34. Use of libraries of chiral catalysts for the discovery of useful methods for the 
catalytic, asymmetric addition of cyanide to meso-epoxides and the catalytic, asymmetric 
Strecker reaction 
High-throughput screening of organometallic complexes has also been used to 
discover new catalysts for olefin polymerization.46-48 Several different approaches have 
been adopted to discover new single-site olefin polymerization catalysts as well as new 
organometallic complexes for olefin metathesis polymerization. In addition to solid phase 
synthesis techniques, Murphy and co-workers utilized a fully integrated method to 
examine early metal olefin polymerization catalysts for the co-polymerization of ethylene 
and 1-octene (Scheme 35). These catalysts product linear low-density polyethylene 
(LLDPE), an important commercial polymer. In this approach, an initial screen of 
bidentate and tridentate ligands with early metal alkyl complexes in combination with 
several different potential activators was conducted for the polymerization of 1-octene. 
Although a copolymer of ethylene and 1-octene is the final target, because ethylene 
generally undergoes olefin insertion more rapidly than does 1-octene, it was hypothesized 
that a catalyst which provides rapid and high-yielding polymerization of 1-octene would 
effectively co-polymerize ethylene and 1-octene. In the initial catalyst screen, 2 catalyst 
precursors, 24 ligands and 8 distinct activation conditions were examined for 
polymerization of 1-octene. Rapid GPC was the analysis tool, and a ligand derived from 
an aminoalcohol was selected to provide the general ligand structure for further 
optimization. A secondary library of ligands was then synthesized and screened with a Hf 
catalyst precursor, and several ligands were discovered that enable ethylene and 1-octene 
co-polymerization with high molecular weight and high chemical yield.47 Because 
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automated robotic equipment was used for assembly of the individual reaction and rapid 
GPC was used as the analysis tool, all of these catalysts can be screened extremely 
rapidly, accelerating the timeline for catalyst discovery. Catalysts of this type are now 
used at Dow Chemical to produce polyolefins and block co-polymers on an industrial 
scale for a variety of commercial applications. 
 
Scheme 35. High-throughput screening of early metal catalysts for the co-polymerization 
of ethylene and 1-octene 
 Simultaneous screening of multiple ancillary ligands with a single transition metal 
complex in solution is another strategy for high-throughput screening of transition metal 
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catalysts. In these approaches, mixtures of ligands are combined with a single transition 
metal catalyst precursor, and these mixtures are evaluated for a single catalytic 
transformation (Scheme 36). While scientists generally seek a single, well-defined 
homogeneous catalysts, this approach demonstrates that mixtures of catalysts can be used 
effectively for the purposes of catalyst discovery and development, generally for 
applications in asymmetric homogenous catalysis.49  
 
Scheme 36. Use of two distinct monodentate ligands for formation of homoleptic and 
heteroleptic complexes for catalyst screening 
One of the first demonstrations of this strategy was by Reetz and co-workers in 
the investigation of new catalysts for asymmetric hydrogenation of enamides. In this 
investigation, a rhodium precatalyst was mixed with two different monodentate phosphite 
or phosphinite ligands, and the efficacy of the catalysts formed in situ were examined for 
the asymmetric hydrogenation of an enamide substrate (Scheme 37).50 A relatively small 
library of just 14 ligands was examined, which allows for up to 91 potential heteroleptic 
catalysts. With this technique, it was discovered that combinations of 2 different ligands 
could form active catalysts for asymmetric hydrogenation, and that these catalysts could 
provide higher enantioselectivity than even the best catalysts formed from 2 of the same 
ligand. This approach to the discovery of chiral catalysts has been extended to conjugate 
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addition of organoboron compounds to enones.51 Other forms of reaction and catalyst 
selectivity have been examined with achiral, monodentate ligands, including site-
selectivity of hydroformylation52 and diastereoselectivity of imine reduction.53  
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Scheme 37. Screening of mixtures of monodentate ligands to discover catalysts for 
rhodium-catalyzed asymmetric hydrogenation 
 Supramolecular self-assembly can also be used to rapidly examine mixtures of 
catalysts for a given catalytic reaction.54 Breit and Seiche pioneered this approach by 
applying hydrogen bonding non-covalent interactions based upon Watson-Crick base 
pairing of two molecules, each containing a recognition element and a functional group, 
to serve as an ancillary ligand within a transition metal complex (Scheme 38).55 This 
approach allows for positioning of two monodentate ligands around a metal center to 
form a self-assembled bidentate ligand, which alleviates the often-tedious process of 
synthesizing a library of bidentate ligands. The combination of a variety of monodentate 
ligands with various steric and electronic effects would essentially allow for rapid 
examination of a wide variety of pseudobidentate ligands. With this approach to catalyst 
discovery, rhodium catalysts were identified for site-selective hydroformylation to form 
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linear aldehydes55 and alkene hydrocyanation.56 While these approaches led to the 
discovery of new catalysts, they require large numbers of individual reactions involving 
two ligands, a metal catalyst precursor and the reactive substrates. A significant advance 
in the application of ligand self-assembly for transition metal catalysis was developed by 
Wieland and Breit in the screening of rhodium catalysts for asymmetric hydrogenation.57 
In this study, they demonstrated that mixtures of a single catalyst precursor and a library 
of ligands with molecular recognition functionalities to allow for the self-assembly of 
combinations of ligands in the reaction mixture could be utilized to accelerate catalyst 
discovery. An iterative deconvolution strategy was devised to identify the active catalyst 
that provided high yield and enantioselectivity for rhodium-catalyzed asymmetric 
hydrogenation of enamides. For deconvolution, the catalyst library was divided into four 
groups. The rhodium precatalyst and the substrate was added to each group of ligand 
mixtures, the hydrogenation was conducted, and the enantioselectivity and yield was 
determined. The ligands in the group which catalyzed the hydrogenation with the highest 
yield and enantioselectivity were then selected and the other ligands were eliminated. 
Two further iterations of this process led to the most active catalyst for this 
hydrogenation reaction. 
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Scheme 38. General approach for the use of supramolecular self-assembly for the high-
throughput screening of ligand libraries 
 In similar work, Reek, van Leeuwen and co-workers have used a metal binding 
template as the organizational element in supramolecular self-assembly of ligand systems 
for catalyst screening.58  While these approaches to examine mixtures of ligands is an 
important contribution in the development of strategies for the high-throughput screening 
of catalysts, this approach has been applied primarily to asymmetric olefin hydrogenation, 
which is a relatively well-developed area in homogenous catalysis.59-61 Future 
investigations to discover new catalysts that address synthetic challenges for which there 
are few current solutions will further highlight the value of this approach to catalyst 
screening. 
Previously described approaches involving ligand libraries and self-assembled 
bidentate ligands for catalyst screening generally employ conventional product analysis 
techniques, such as gas chromatography (GC) and high-performance liquid 
chromatography (HPLC) for the analysis of small molecules and gel permeation 
chromatography (GPC) for polymer analysis. Fluorescence-based assays for the 
determination of catalyst activity are another approach to the high-throughput screening 
of transition metal complexes. This strategy has been used for the discovery of new 
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cross-coupling catalysts, including for Heck coupling,15 arylation of enolates,62 and 
Buchwald-Hartwig amination.63 The use of a fluorescence assay for the discovery of a 
new catalyst for Heck coupling is an illustrative example. In this investigation of 
palladium catalysts for Heck coupling of aryl halides with vinylarenes, two substrates 
were specifically designed to utilized fluorescence resonance energy transfer (FRET) as 
an assay for catalyst activity (Scheme 39). The vinylarene substrate provides a strong 
fluorescence signal, but when it becomes covalently bonded to the aryl bromide substrate 
through the Heck coupling, the fluorescence is quenched, and the fluorescence signal 
becomes weak. The use of fluorescence as the reaction assay provides a rapid method for 
determination of the reaction yield because FRET can be measured with a standard plate 
reader and is quantitative. 96 different ligands were screened, and as a result, two highly 
active catalysts were identified.15 These catalysts were formed from the combination of a 
Pd-precatalyst and either 1-adamantyl-di-tert-butyl phosphine or Q-Phos as the ancillary 
phosphine ligand. Both of these catalysts enabled room-temperature Heck reactions of 
aryl bromides. Because Heck reactions commonly require temperatures in excess of 
100 °C, making a catalyst which enables Heck coupling at ambient temperature a 
significant advance in this area of cross-coupling.64 Along with the discovery of Pd-
catalysts for cross-coupling applications, Miller and co-workers have applied 
fluorescence-based assays for the discovery of small peptide catalysts65 for the kinetic 
resolution of secondary alcohols66 and for the site-selective derivatization of natural 
products.67 
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Scheme 39. Fluorescence assay for the discovery of palladium catalysts for room-
temperature Heck reactions 
 Several innovative methods have been developed for the application of mass 
spectrometry as an analysis tool for high-throughput catalyst screening. Mass 
spectrometry is a particularly appealing and useful method for analysis of transition metal 
catalysts because it is very sensitive, does not require product purification, readily 
available in many laboratories, and is amenable to high-throughput analysis. Chen and 
co-workers developed a system that uses electrospray ionization (ESI) mass spectrometry 
to examine the activity of mixtures of catalysts in a single vessel for a single catalytic 
reaction.48,68 This method relies upon the fact that ESI mass spectrometry detects charged 
species. Charged substrates, generally including a phosphonium or ammonium group, 
must be used to generate charged intermediates, which can then be detected by ESI mass 
spectrometry. This approach has been applied to the screening of catalysts for Ir-
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catalyzed olefin hydrogenation,69 Ru-catalyzed olefin metathesis,70 C-H activation by Ir 
complexes,71 and olefin polymerization.72-73 A distinguishing feature of this method of 
catalyst screening is that it allows for analysis of the catalytic intermediates, not the 
analysis of the final products. Therefore, this approach measures the true activity of a 
catalyst, and this analysis is not influenced by other factors, such as product 
decomposition, changes in the active catalyst species, or catalysis which occurs by minor 
impurities often formed in the synthesis of organometallic complexes. 
Based upon the work of Chen and co-workers, Pfaltz and co-workers have applied 
ESI mass spectrometry to rapidly examine catalysts for their performance in a variety of 
applications in asymmetric catalysis.74 This technique relies upon the use of 
“quasienantiomeric” substrates and the examination and quantification of charged 
catalytic intermediates that are formed upon reaction of these substrates with an 
organometallic catalyst. This strategy was initially applied to palladium-catalyzed kinetic 
resolution of allylic esters (Scheme 40).75 This particular reaction was selected because 
the mechanism is well understood, and most importantly, proceeds via the formation of 
cationic intermediates. The first step in this reaction is oxidative addition of the allylic 
ester to a Pd(0) complex to form an allyl-palladium complex. This intermediate then 
undergoes nucleophilic attack by an external nucleophile to form the allylic substitution 
product. Because nucleophilic attack is the turnover-limiting step of the catalytic cycle, 
the allyl-palladium intermediate is the catalyst resting state, indicating that it should be 
present in solution in high enough concentration to be observed with ESI-MS. Pfaltz and 
co-workers hypothesized that if two quasienantiomeric substrates were subjected to the 
activity of a chiral catalyst, the relative population of the two quasidiastereomeric allyl-
62 
palladium intermediates should indicate the selectivity of the catalyst. When this 
experiment was conducted with a 1:1 mixture of quasienantiomeric allylic esters, one 
bearing a 4-methylphenyl group and one bearing a 4-ethylphenyl group, 
quasidiastereomeric mixtures of allylpalladium complexes were observed. In addition to 
examining ligands individually, mixtures of up to 5 ligands were examined 
simultaneously in the same reaction mixture to determine the selectivity of the catalysts 
formed from each of these ligands. After this rapid screening protocol was applied to a 
small library of P,N- ligand and chiral bisphosphine ligands, a new P,N-ligand in 
combination with [Pd(C3H5)(MeCN)2]OTf, provided a 9:91 ratio of the two 
quasienantiomers, as observed by ESI-MS. After further optimization, a selectivity factor 
of 100 could be obtained for kinetic resolution of allylic esters, which represented the 
highest value obtained at the time of the work. This result exemplifies the utility of this 
approach to rapid screening of chiral catalysts. This general approach to chiral catalyst 
screening has been applied to other reactions, including desymmetrization of meso 
substrates via palladium-catalyzed allylic substitution74 and enantioselective Diels-Alder 
reactions.76 While this approach has been demonstrated to be useful for several 
applications, the primary limitation of this strategy for catalyst screening is that the 
reaction being examined must involve cationic intermediates, which inherently limits the 
scope and generality of this method. In addition to mass spectrometry, colorimetric 
assays,77-78 isotopic labeling,79-80 and infrared thermography81 are useful tools for high-
throughput analysis of catalyst libraries for various transformations. 
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Scheme 40. Determination of selectivity factor of chiral palladium catalysts for kinetic 
resolution of allylic esters by screening of quasienantiomers by ESI-MS 
2.3.2. Examination of a single catalyst with many different substrates for the 
potential discovery of a new bond construction or a new catalyst for an existing 
bond construction 
As demonstrated by the previous approaches to the use of high-throughput 
screening, most strategies focus on the discovery and optimization of a catalyst or reagent 
for a single chemical transformation. While this approach is very useful for reaction 
development and improvement, the ability to use a high-throughput approach for the 
discovery of a catalyst for a previously unknown chemical reaction would open up many 
new avenues of chemical reactivity. A pioneering study by Liu and co-workers applied 
DNA-templated synthesis and in vitro selection to evaluate many different substrates 
bearing a single functional group to discover new bond forming processes (Scheme 41).82 
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In this study, a small library of substrates containing a unique functional group tethered 
to a DNA fragment, split into two pools, was prepared. It was then hypothesized that 
upon mixing of these substrates in an aqueous solution, Watson-Crick pairing would 
occur to bring together each possible combination of the substrates in pool 1 with the 
substrates in pool 2. Following self-assembly in solution, exposure to a reagent or 
catalyst could result in an effectively intramolecular reaction between the functional 
groups on each of the two substrates. Following a standardized procedure involving 
Streptavidin affinity selection and DNA amplification with PCR, the two substrates that 
engaged in a bond forming process could be identified, and the potential new reaction 
could be identified through mass spectrometric analysis. In the first implementation of 
this system, after performing positive control experiments to identify EDC-mediated 
amide coupling and Cu(I) catalyzed Huisgen alkyne-azide cycloaddition, Liu and co-
workers identified a Pd(II)-catalyzed coupling of an alkene and an alkyne to form a trans-
enone. This approach to reaction discovery was later adopted for use in organic solvents, 
and a gold-catalyzed (or acid-catalyzed) alkene hydroarylation with indoles was 
discovered.83 
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Scheme 41. Use of DNA-templated synthesis for discovery of new bond forming 
reactions 
 While this approach to reaction discovery based upon DNA-templated synthesis 
represents a tremendous development in the high-throughput screening of catalysts to 
discover new reactions, there are several limitations to this system. First, each DNA-
linked substrate must be independently prepared, which is a laborious and time-
consuming process. Second, it is not clear whether this system can tolerate transition 
metal catalysts that can be deactivated or “poisoned” by the DNA fragments present on 
each of the substrates. While most of the catalysts examined thus far are generally robust, 
such as Pd(II) or Au(III) salts, many useful transformations are catalyzed by water-
sensitive or air-sensitive catalysts. Sensitive organometallic complexes have not been 
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investigated with this approach to reaction discovery and it is unclear what interaction, if 
any, would occur between these complexes, the DNA fragments which are a crucial 
element of the substrate, and the aqueous solvent, which is needed in this system. Last, 
this approach allows for examination of a single catalyst in each experiment. 
2.3.3. Examination of many catalysts and many organic substrates for the potential 
discovery of new catalysts and new bond construction strategies 
The examination of many catalysts for many different potential bond-forming 
reactions presents another opportunity to apply high-throughput screening to discover 
new chemical transformations. An innovative approach to this goal was demonstrated by 
Porco and co-workers. In their investigations, a molecular scaffold was selected that was 
known to undergo a certain class of reaction and known to react with a certain type of 
coupling partner, such as a nucleophiles or electrophile. Transition metal complexes were 
then examined for their ability to promote this process. The initial application of this 
approach was to the discovery of new catalysts to promote reactions with an ortho-
alkynylbenzaldehyde (Scheme 42).84 This substructure was previously known to undergo 
a variety of transition metal-catalyzed processes, such as cycloaddition reactions or 
cycloisomerization reactions. Therefore, Porco and co-workers reasoned that this 
structure should be amenable to a variety of metal-catalyzed processes with electrophiles, 
nucleophiles and cycloaddition partners. To implement this reaction discovery approach, 
they mixed an ortho-alkynylbenzaldhyde with a variety of nucleophiles, such as 
malonates, nucleophilic (hetero)arenes and alcohols, electrophiles, such as epoxides and 
enals, and cycloaddition partners, such as dienes and phthalimides. These binary 
combinations of substrates were then exposed systematically to a single transition metal 
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catalyst. The array of reactions was then heated, and assayed by LC/MS/ELSD. If a new 
species in a significant quantity was observed in the LC trace, then the reaction was 
repeated on a larger scale and the product was identified through standard spectroscopic 
and computational techniques. 
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Scheme 42. Multidimensional reaction discovery with ortho-alkynylbenzaldehydes 
Porco and co-workers were able to discover several new transformations of ortho-
alkynylbenzaldehydes. These new transformations include silver-catalyzed dimerization 
of the ortho-alkynylbenzaldehyde, gold-catalyzed or rhodium-catalyzed 
cycloisomerization/addition of 1,3-dicarbonyl compounds, and silver-catalyzed or 
platinum-catalyzed cycloisomerization/Friedel-Crafts addition (Scheme 43). All of these 
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transformations could be scaled to a mmol-scale reaction with high reaction yield. While 
all of these reactions are based on a single framework, many of them could not have been 
predicted de novo, highlighting the utility of this approach to reaction discovery. This 
technique has been extended to a variety of other applications, including identification of 
tandem processes based upon nucleophilic additions to imines,85 derivatization of a 
natural product scaffold,86 and extension to reaction screening and discovery in a flow 
reactor.87-88 While this strategy for reaction and catalyst discovery has yielded interesting 
results, because these reactions are based on a single central structure, the broad utility of 
the transformations discovered with this approach is inherently limited. Future 
applications where this limitation can be overcome will broaden the utility of multi-
dimensional reaction discovery. 
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Scheme 43. New transition metal-catalyzed transformations of ortho-
alkynylbenzaldehydes discovered via catalyst screening 
2.4 Summary and Objectives 
This review encompasses many of the major developments in the application of 
high-throughput screening to the discovery and development of transition metal catalysts. 
Although combinatorial approaches to catalyst discovery have only begun to be broadly 
embraced recently, advances in the technology for the use of high-throughput catalyst 
screening has already had a significant impact on how catalysts are developed in both 
academic and industrial settings. These developments are likely to continue in the future, 
especially as the specialized technology used for screening and reaction analysis becomes 
available to more laboratories. Chapter 6 will describe the invention and development of 
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a new, simple reaction discovery based on multidimensional screening of transition metal 
catalysts, and the application of this system to the discovery of several new transition 
metal-catalyzed transformations of simple organic substrates. 
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Chapter 3. Alkylation of Arenes with Steric Control via Iridium-Catalyzed C-H 
Borylation 
3.1 Introduction 
Selective functionalization of C-H bonds has significant potential to improve the 
efficiency of organic synthesis.1  Because substituted arenes are key structures in bulk 
chemicals, polymeric materials and complex natural products and pharmaceuticals, 
methods for arene functionalization are particularly useful. Classical functionalizations of 
arenes that form carbon-carbon bonds are based on electrophilic aromatic substitution 
with carbon electrophiles (Friedel-Crafts Reactions). Because electronic effects generally 
control the site-selectivity of Friedel-Crafts reactions, arenes containing electron-
donating groups undergo these processes, and the carbon-carbon bond is formed at the 
positions ortho and para to the donating groups (Equation 1). Arenes containing electron-
withdrawing groups undergo reactions at positions meta to the substituents, but arenes 
with such substituents are significantly less reactive than those with electron-donating 
groups, and harsh reaction conditions are often needed for reactions of these electron-
poor arenes. 
 
The site-selectivity for formation of C-C bonds at aromatic systems can be 
controlled by transition metal-catalyzed chemistry.  Cross-coupling reactions occur at a 
specific site, but these reactions require the arene to contain a halide or pseudohalide at 
the reactive site, and this group is installed by electrophilic aromatic substitution that is 
governed by the same effects as Friedel-Crafts reactions. Transition metal-catalyzed 
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functionalizations of aromatic C-H bonds have been studied extensively, but most of 
these reactions that form C-C bonds occur with a group on the arene that leads to reaction 
at the position ortho to this substituent.2 
3.2 Background 
The site-selectivity of iridium-catalyzed C-H borylation is predominantly 
controlled by steric factors that lead to borylation at the least hindered C-H bond 
(Equation 1).3 Therefore, 1,3-disubstituted and 1,2,3-trisubstituted arenes yield 3,5-
disubstituted and 3,4,5-trisubstituted arylboronate esters, respectively.  In addition to the 
meta-selectivity of this C-H activation reaction, aryl pinacol boronate esters offer several 
advantages over other boron compounds, including stability to chromatography which 
allows for isolation, and stability to other synthetic processes.  One of the significant 
challenges in the utilization iridium-catalyzed arene borylation to develop useful 
synthetic methods is the discovery and development of methods for functionalization of 
the pinacol boronate ester, which is significantly less reactive than other aryl boron 
species, such as aryl boronic acids or neopentyl boronate esters. Meta-selective arene 
borylation has been used to develop methods for the synthesis of aryl chlorides and 
bromides,4 phenols,5 boronic acids, potassium trifluoroborates,6 nitriles,7 aryl amines and 
ethers,8 and perfluoroalkyl groups.9 
Thus, a method to form C-C bonds in which the arene is linked to an sp3-
hybridized groups by a reaction with site selectivity that is governed by steric, rather than 
electronic or directing effects, would create new methods to form arenes with new 
substitution patterns.  Methods for meta-arylation10 and meta-olefination11 have been 
developed recently, but these methods suffer from the need for a different type of 
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directing group, high catalyst loading, limited substrate scope, poor regioselectivity, or a 
need for a large excess of the arene substrate.  We have developed a one-pot method for 
meta-selective alkylation of arenes by Ir-catalyzed C-H borylation, followed by Pd-
catalyzed or Ni-catalyzed coupling of the resulting arylboronate ester with alkyl 
electrophiles. This transformation represents a general method for meta-selective Friedel-
Crafts type arene alkylation with the site-selectivity controlled by steric effects as 
opposed to electronic effects. 
3.3 Results and Discussion 
We began our investigation by developing a method for the meta-selective 
allylation of arenes. The development of a method for meta-selective allylation of arenes 
required the development of a method to couple aryl pinacolboronates with allylic 
electrophiles.  Several methods for the Pd-catalyzed coupling of organoboranes with 
allylic acetates, alcohols and halides have been developed.12  These methods generally 
utilize a Pd(0) or Pd(II) catalyst precursor, phosphine ligand, and a basic additive, such as 
carbonate or fluoride.  After surveying reaction conditions for the allylation of electron-
rich and electron-deficient aryl boronate esters with cinnamyl acetate, Pd(dba)2 with KF 
as an additive in MeOH solvent at room temperature was found to provide the meta-
allylation products in good yield.13 
Similar to the method for meta-allylation, a method for meta-benzylation of 
arenes was sought.  Several methods for Pd-catalyzed coupling of organometallic 
reagents with benzylic electrophiles, including halides and phosphates, have been 
developed.14  Direct benzylation of aromatic and heteroaromatic C-H bonds has also been 
developed, but these methods require either acidic C-H bonds or a directing group.15  We 
79 
found that a catalyst formed in situ from the combination of Pd(dba)2 and PPh3 with 
Na2CO3 in a mixture of THF and H2O at 100 °C provided good yields of the product 
from the coupling of electron-rich and electron-deficient aryl boronate esters with 4-
methylbenzyl bromide. 
With these methods for coupling of aryl boronate esters with cinnamyl acetate and 
4-methylbenzyl bromide, we developed one-pot methods for meta-allylation and meta-
benzylation of arenes. Reactions of 1,3-disubstituted arenes with bis(pinacolato)diboron 
in the presence of a catalyst formed in situ from the combination of [Ir(cod)OMe]2 and 
4,4’-di-tert-butylbipyridine (dtbpy) in THF at 80 °C, followed by addition of the 
appropriate Pd catalyst, the allylic or benzylic electrophile, additive and solvent gave 
good yield of the meta-allylation or meta-benzylation product. 
After identification of these conditions, the scope of meta-allylation with 1,2-, or 
1,3-  substituted arenes for coupling with cinnamyl acetate was explored (Table 1).  This 
methodology gives good yields of the meta-allylation products from electron-rich and 
electron-deficient arenes and tolerates a variety of functional groups, including aryl 
fluorides, chlorides and bromides, esters, amides, ketones, ethers, and trifluoromethyl 
groups.  Tetrasubstituted arenes were also be synthesized from 1,2,4-trisubstituted arenes 
by borylation ortho to a fluorine substituent on the arene.  Meta-benzylation also 
furnishes good yield for electron-rich and electron-deficient arenes and tolerates a variety 
of functional groups. The meta-benzylation methodology also tolerates heteroarenes, 
including benzothiophene and pyridine derivatives (Table 2). Alkylation of 
benzothiophene occurs at C-2, whereas the uncatalyzed addition of alkyl halides occurs at 
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C-3, so the borylation-alkylation approach also gives orthogonal site-selectivity for the 
alkylation of heteroarenes. 
Table 1.  Scope of allylation of 1,3-disubstituted arenes with cinnamyl acetate 
+ Ph OAc
Ph
R
R
1) [Ir(cod)OMe]2 (0.25 mol %),
dtbpy (0.5 mol %),
B2pin2 (0.7 equiv),
THF, 80 oC
2) Pd(dba)2 (1 mol %),
KF (2.6 equiv), MeOH, rt
Ph
X
Me
X = Cl; 66%
X = CO2Me; 69%
X = Me; 78%a
X = C(O)NEt2; 77%b
Ph
OMe
MeO
77%a
Ph
X
F3C
X = CF3; 76%
X = OMe; 85%
X = Br; 57%
Ph
Cl
Me
72%
F
Ph
Br
MeO
76%
Ph
MeO
MeO
66%a
Ph
X
Cl
X = Br; 57%
X = OMe; 73%
Ph
Me
Me
74%a
Ph
Br
O
48%a
R H
R
 
aBorylation conducted with 0.5 mol% [Ir(cod)OMe]2 and 1.0 mol% dtbpy, bBorylation 
conducted with 1.0 mol% [Ir(cod)OMe]2 and 2.0 mol% dtbpy 
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Table 2.  Scope of benzylation of 1,3-disubstituted arenes with 4-methylbenzyl bromide 
+ Br
R
R
2) Pd(dba)2 (1%), PPh3 (4%)
benzyl halide,
Na2CO3 (4 equiv),
THF/H2O (10:1), 100 oC
Me Me
Cl
X
Me
X = OMe; 80%
X = CN; 81%
F3C
X
Me
Me
X
Me
X = CO2Me; 69%
X = CN; 83%
X = C(O)NEt2; 71%b
X = Cl; 57%
Cl
Me
Me
83%
F
MeO
OMe
MeMeO
71%a
Br
Me
O
50%a
1) [Ir(cod)OMe]2 (0.25 mol %),
dtbpy (0.5 mol %),
B2pin2 (0.7 equiv),
THF, 80 oC
X = CF3; 78%
X = OMe; 69%
Me
F
F
F
F
89%
N
Cl
Cl
Me
71%c
S
Me83%
HR
R
 
aBorylation conducted with 0.5 mol% [Ir(cod)OMe]2 and 1.0 mol% dtbpy, bBorylation 
conducted with 1.0 mol% [Ir(cod)OMe]2 and 2.0 mol% dtbpy; cBorylation conducted 
with 2.0 mol% [Ir(cod)OMe]2 and 4.0 mol% dtbpy 
 
These borylation-allylation and borylation-benzylation methodologies can also be 
applied to the regioselective allylation and benzylation of heteroarenes. The allylation of 
nitrogen, oxygen and sulfur heterocycles occurred in good overall yields (Table 3). 
Cinnamyl chloride was found to be a more effective allylic electrophile than cinnamyl 
acetate for the allylation of heteroarenes. The benzylation with 4-methylbenzyl bromide 
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also occurred with nitrogen, oxygen and sulfur heterocycles in good yield (Table 4).  
These allylation and benzylation methodologies give site-selectivity that is orthogonal to 
that of uncatalyzed electrophilic addition to the heterocycle in most cases.  For example, 
the borylation of benzofuran and ethyl indole-2-carboxylate leads to functionalization at 
the 2-position and 7-position, whereas electrophilic addition would lead to 
functionalization at the 3-position of these heteroarenes. 
Table 3.  Scope of allylation of heterocycles with cinnamyl chloride 
 
Table  4.  Scope of benzylation of heteroarenes with 4-methylbenzyl bromide 
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N
Cl
Cl
Me
54 71%a
X
Me
47 X = NH; 58%
48 X = O; 69%
49 X = S; 83%
N
H
Me
MeO2C
50 76%
X
Me51 X = NH; 49%
52 X = O; 68%
O
S
Me
Me
53 65%
+ Br
MeX
X
Me
X = NH, O, S
2) Pd(dba)2 (1%), PPh3 (4%)
benzyl halide,
Na2CO3 (4 equiv),
THF/H2O (10:1), 100 oC
1) [Ir(cod)OMe]2 (0.25 mol %),
dtbpy (0.5 mol %),
B2pin2 (0.5 equiv),
THF, 80 oC
 
aBorylation conducted with 2.0 mol% [Ir(cod)OMe]2 and 4.0 mol% dtbpy 
Table 5.  Scope of allylation with various allylic electrophiles 
 
aAllylation conducted with 2 mol% Pd(dba)2 
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Several natural products contain a meta-allyl arene substructure. One such natural 
product, elemicin, has been synthesized in a one-pot borylation-allylation sequence 
(Equation 2).  Elemicin has shown activity as a potential antibacterial agent.17  These 
natural products have been synthesized previously by starting with prefunctionalized 
substrates, such as aryl halides or aryl boron compounds,18 making this approach a more 
attractive synthesis because it was accomplished in a one-pot procedure from easily-
obtained starting materials.  
MeO
+ Cl
OMe
MeO
1) [Ir(cod)OMe]2 (0.5 mol %),
dtbpy (1.0 mol %),
B2pin2 (0.7 equiv),
THF, 80 oC
2) Pd(dba)2 (2 mol %),
KF (2 equiv), MeOH, rtOMe
MeO
MeO
one pot
51 Elemicin 67%
(2)
H
 
In addition to the coupling with 4-methylbenzyl bromide, the meta-selective 
borylation and benzylation was performed with a variety of benzyl halides (Table 6).  
Benzyl bromides and benzyl chlorides coupled with similar efficiency.  Benzyl halides 
containing electron-donating groups, electron-withdrawing groups and ortho-substituents 
all reacted in good yield. 
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Table 6.  Scope of meta-benzylation with various benzyl bromides and chlorides 
 
After a general method for meta-selective benzylation of arenes had been 
developed, we sought to extend this methodology to the equivalent of a meta-acylation of 
arenes. This transformation could be effected by the meta-benzylation of an arene, 
followed by oxidation of the resulting diarylmethane to a diarylketone.  After a survey of 
various oxidation conditions, we found that treatment of the diarylmethane with AuCl3 
and tert-butylhydroperoxide in pyridine at 80 °C provided good yield of a variety of 
diarylketone products (Table 7).19  This oxidation methodology furnished substituted 
benzophenones in good yield from both electron-rich and electron-deficient arenes. 
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Table 7. Scope of oxidation of diarylmethanes to diarylketones 
Me
CO2Me
O
R1=Me, R2 = H, R3 = CO2Me; 73%
OMe
Me
CN
O
R1
R3
O
R1=OMe, R2 = H, R3 = Cl; 76%
R1=OMe; R2=OMe; R3=H; 78%
R1=OMe, R2 = OMe, R3 = OMe; 67%
OMe
55%
R1
R3
AuCl3 (10 mol%),
TBHP (3 equiv),
pyridine, 80 oC
R1
R3
O
R R
R2
R2 R2
 
This meta-benzylation and oxidation methodology was applied to the synthesis of 
a key intermediate in the production of a non-nucleotide reverse transcriptase inhibitor 
(NNRTI). A recent class of NNRTIs with a benzophenone core structure has recently 
been discovered and is in clinical development (Scheme 44).20 Meta-benzylation of 3-
chlorobenzonitrile with the appropriate benzyl halide provided the tetrasubstituted 
diarylmethane in 71% yield.  The benzyl halide is readily synthesized from the 
corresponding methyl ester in two steps.  In this case, oxidation of the diarylmethane to 
the diarylketone with a catalytic quantity of CrO3 with periodic acid21 as the terminal 
oxidant provided the substituted benzophenone. This ketone is a known intermediate in 
the synthesis of the final drug candidate in two steps. 
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Scheme 44.  Synthesis of NNRTI drug candidate via meta-benzylation and oxidation 
While meta-selective introduction of allyl and benzyl groups yields useful 
products, a method for the introduction of other alkyl groups to an arene with steric 
control would significantly increase the scope of this transformation. This methodology 
requires a method for the coupling of aryl pinacol boronates with unactivated alkyl 
halides. For this coupling, palladium catalysts are generally less effective due to slow 
oxidative addition and β-hydride elimination from the Pd-alkyl complex formed after 
oxidative addition. To address these challenges, nickel22 and copper23 catalysts have been 
developed for Suzuki coupling with alkyl halides or pseudohalides.24 The method for 
copper-catalyzed alkylation reported only a single example. Methods for nickel-catalyzed 
alkylation have generally utilized boronic acids or aryl 9-BBN-derivatives. Because 
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transmetallation have been proposed to be the rate-limiting step in nickel-catalyzed cross-
coupling with alkyl halides, it was unclear whether the generally less-reactive pinacol 
boronate esters would participate in this transformation.25 With these methods as a 
starting point, we sought to develop a general method for the coupling of aryl pinacol 
boronates with alkyl halides. 
We initiated this study by examining various copper and nickel catalysts for the 
coupling of phenyl pinacol boronate with alkyl electrophiles. We examined various 
copper and nickel catalysts with 1-iodooctane or 1-octyl p-toluenesulfonate (Table 8). For 
reactions utilizing copper catalysts, we employed LiOtBu as a base in DMF solvent. For 
reactions with nickel catalysts, KOtBu was used with 2-butanol in dioxane solvent. We 
found that the best yield of 1-phenyloctane was obtained in the coupling of phenyl 
pinacol boronate ester with 1-iodooctane when NiBr2-dme was used as the precatalyst 
with trans-N,N′-dimethylcyclohexane-1,2-diamine as the ancillary ligand.22e 1-
bromooctane could also be utilized as the electrophile, albeit in lower yield. However, the 
yield could be increased by addition of NaI. 
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Table 8. Optimization of catalyst and reaction conditions for alkylation of aryl pinacol 
boronate esters 
 
Entry Catalyst Ligand X Yield 
1 CuI None OTs 44% 
2 CuI PPh3 OTs 57% 
3a CuI 1,10-phen OTs 32% 
4 Ni(cod)2 L1 I 44% 
5b NiCl2-dme L2 I 26% 
6 NiCl2-dme L3 I 44% 
7 NiCl2-dme L4 I 58% 
8 NiCl2-dme L5 I 27% 
9 NiBr2-dme L4 I 68% 
10 NiBr2-dme L4 Br 55% 
11c NiBr2-dme L4 Br 69% 
Yield determined by GC with an internal standard; a 10 mol% ligand used; bKHMDS (1.2 
equiv) used as the base; cNaI (1 equiv) added 
90 
 
The scope of meta-selective alkylation with unactivated alkyl halides is shown in 
Table 9. Arenes with a variety of substituents were well tolerated, including ethers, aryl 
halides, nitriles, amides and trifluoromethyl groups. Arene borylation could be conducted 
ortho to fluorine and at the 2-position of benzofused heteroarenes, and these ortho-
fluoropinacol boronates and heteroaryl pinacol boronates could be coupled with alkyl 
iodides in good yield, despite their increased propensity for protodeborylation in the 
context of other Suzuki coupling processes.26 Primary alkyl iodides were utilized for the 
meta-selective alkylation, and primary alkyl bromides were utilized with addition of NaI, 
presumably to initiate halogen exchange, followed by coupling of the in situ generated 
alkyl iodide with the aryl pinacol boronate ester. Alkyl iodides with alkyl branching at the 
β-position were also tolerated. 
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Table 9. Scope of alkylation with unactivated alkyl electrophiles 
Me
X
Ph
X = Me; 67%a
X = C(O)NEt2; 69%c
X
OMe
Ph
X = Cl; 83% (80%a)
X = Br; 71%
X = CF3; 68%
H
+
R
1) Ir-cat. borylation
2)NiBr2-dme (10%),
L1 (20%),R
R
R
I
R
R
KOtBu, 2-butanol,
dioxane, 60 oC
Cl
OMe
X
X=CN; n=4; 59%a
X=OTBS; n=2; 70%
n
MeO
OMe
Ph
50%
MeO
X
CN
Y
X=Cl; Y=Ph; 71%
X=Me; Y=Cl; 59 Me
Ph
76%
F
Br
OMe
Ph
F
F
Me
OMe
MeO
MeO
Me
Me
OMe
Br
Me
51%b
50%
69%
O
Ph85%
OMe
MeO
MeO
74%b,d
OMe
X
X = Cl; n =1, 80%d
X = CF3; n = 2; 55%d
Br
CO2tBu
Me
63%
n
OMe
MeO
MeO
X
Me
X=Me; 51%b,d
X=nPr; 64%b,d
OMe
Cl
X=O; n=1; 80%d
X=NBoc; n=2; 54%d
X
n
 
aAlkylation conducted with alkyl bromide and NaI; bBorylation conducted with 0.5 mol% 
[Ir(cod)OMe]2 and 1.0 mol% dtbpy; cBorylation conducted with 1.0 mol% [Ir(cod)OMe]2 
and 2.0 mol% dtbpy; dAlkylation reaction conducted with L1 in place of L4 
 
When we attempted to apply these reaction conditions to meta-selective alkylation 
of arenes with secondary alkyl halides, low conversion and low yield of the alkylation 
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product was observed. We reexamined the catalyst used for this coupling reaction with 
secondary alkyl iodides, and found that increased yields were obtained when L1 was 
utilized as the ancillary ligand in combination with NiBr2-dme in place of L4. With L4 as 
the ancillary ligand, secondary alkyl iodides could be employed as the alkyl electrophile 
in good yield (Table 9). 
3.4 Conclusion and Outlook 
In conclusion, a general method for the regioselective alkylation of arenes via Ir-
catalyzed borylation and Pd- or Ni-catalyzed coupling has been developed.  This method 
has a high tolerance for functional groups and occurs with various allylic, benzylic and 
unactivated aliphatic electrophiles. These arene functionalizations give products with 
regioselectivity that is complementary to directed C-H functionalization methods or C-H 
functionalization methods in which the regioselectivity is governed by electronic effects. 
The meta-allylation methodology has been used to perform a one-pot synthesis of a 
natural product, and the meta-benzylation has been used to perform meta-selective arene 
acylation via oxidation of the diarylmethane products, including the use of this sequence 
as a formal synthesis of an HIV drug candidate. 
Future investigations will focus on the development of other useful and general 
regioselective functionalizations of arenes via iridium-catalyzed C-H borylation. As 
demonstrated in the two-pot method developed for meta-selective acylation of arenes, a 
direct method for this transformation has not been developed. Several classes of meta-
acylation reactions are desireable, including methods for the synthesis of diarylketones, 
aryl-alkyl ketones, aryl amides and aryl esters. To begin to address this goal, we have 
developed conditions for the meta-selective amidation of arenes by a sequence of Ir-
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catalyzed C-H borylation followed by palladium-catalyzed cross-coupling of the resulting 
pinacol boronate ester with a carbamoyl chloride (Table 10). 
HR
R
NEt2
R
R
O
+ Cl NEt2
O 1) Ir-catalyzed C-H
Borylation
2) (PPh3)2PdCl2 (3%),
CsF (2 equiv), THF, 80oC2 equiv
NEt2
Me
Cl
O
NEt2
F3C
CF3
O
85% (isolated) 89% (isolated)  
Table 10. Meta-selective amidation of arenes via iridium-catalyze C-H borylation 
followed by palladium-catalyzed  coupling with a carbamoyl chloride 
Future investigations will lead to other methods for meta-functionalization of 
arenes via C-H borylation. These methods will contribute solutions to unsolved problems 
in the synthetic methodology and will likely find utility in complex molecule synthesis. 
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3.5 Experimental Information 
General Procedures. All reactions were conducted under an argon or nitrogen 
atmosphere in flame-dried glassware or in an Innovative Technologies drybox. Dry and 
degassed solvents were used unless otherwise noted. Column chromatography was 
performed with a Teledyne Isco Combiflash® Rf system with RediSep Rf columns.  
Analytical thin-layer chromatography was performed on glass plates coated with silica 
gel (Silicycle, 60 A pore size, 40-64 um particle size) impregnated with a fluorescent 
indicator (254 nm). TLC plates were visualized by ultraviolet light and staining solution 
of p-anisaldehyde or KMnO4. 
Materials.  [Ir(cod)OMe]2 was obtained from Johnson Matthey and used as received. 
4,4’-di-tert-butylbipyridine, NiCl2-dme, NiBr2-dme, trans-cyclohexane-1,2-diamine, 
trans-N,N′-Dimethylcyclohexane-1,2-diamine, S-prolinol, TMEDA, 1,10-phenanthroline, 
2-butanol, dry 1,4-dioxane, LiOtBu and KOtBu were obtained from Aldrich Chemicals 
and used as received. B2pin2 was obtained from Allychem and used as received.  Arenes, 
heteroarenes, cinnamyl acetate, cinnamyl chloride, benzyl halides, allyl chloride, alkyl 
halides, triphenylphosphine, sodium carbonate, TBHP, H5IO6, CrO3 and pyridine were 
obtained from Aldrich, Alfa Aesar, Acros or TCI America and used as received.  Allylic 
electrophiles that were not commercially available were synthesized from the 
corresponding cinnamic acid derivative by reduction with DIBAL and acylation of the 
resulting alcohol with acetic anhydride.  KF was obtained from Alfa Aesar and used as 
received. NaI was obtained from Fisher Scientific and used as received. AuCl3, CuI, 
Ni(cod)2, and bathophenanthroline were obtained from Strem Chemicals and used as 
received.  Pd(dba)2 was synthesized according to literature precedent.27 
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Instruments.  1H NMR spectra were recorded on a 500 MHz Varian instrument (126 
MHz for 13C).  Chemical shifts are reported in parts per million relative to residual 
protiated solvent (7.26 ppm for CDCl3).  GC-MS data were obtained on an Agilient 6890-
N GC system containing an Alltech EC-1 capillary column and an Agilient 5973 mass 
selective detector. 
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Experimental Procedures 
 
General Procedure for Allylation of Arenes.  Inside a glove box, [Ir(cod)OMe]2 (2.1 
mg, 0.0033 mmol, 0.0033 equiv), dtbpy (1.8 mg, 0.0065 mmol, 0.0065 equiv), B2pin2 
(231 mg, 0.910 mmol, 0.910 equiv), arene or heteroarene (1.30 mmol, 1.30 equiv), and 
THF (2 mL) were added to a dry vial with a magnetic stir bar.  The vial was sealed and 
heated at 80 C for 18 h.  The reaction mixture was cooled to room temperature and the 
volatile materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 
equiv), the allylic acetate or chloride (1.00 mmol, 1.00 equiv) and MeOH (3 mL) were 
added to the reaction mixture.   The reaction mixture was stirred at room temperature for 
10 min. KF (154 mg, 2.60 mmol, 2.60 equiv) was added and the reaction mixture was 
sealed and stirred at room temperature for 24 h.  The reaction mixture was cooled to 
room temperature, filtered through silica gel washing with EtOAc, and concentrated 
under vacuum.  The reaction mixture was purified by column chromatography to give the 
product. 
 
Allylation of 3-chlorotoluene with cinnamyl acetate (1).  Prepared according to the 
general procedure with 3-chlorotoluene (165 mg, 1.30 mmol, 1.30 equiv) and cinnamyl 
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acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (161 mg, 66%).  1H NMR 
(499 MHz, CDCl3) δ 7.43 (d, J = 7.7 Hz, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 7.3 Hz, 
1H), 7.10 (d, J = 6.1 Hz, 2H), 6.99 (s, 1H), 6.52 (d, J = 15.8 Hz, 1H), 6.37 (dt, J = 15.7, 
6.9 Hz, 1H), 3.54 (d, J = 6.9 Hz, 2H), 2.37 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
142.21, 140.15, 137.55, 134.27, 131.86, 128.82, 128.61, 127.98, 127.55, 127.29, 126.47, 
126.06, 39.22, 21.42.  HRMS (EI+) calcd for [C16H15Cl]+ m/z = 242.0862, found m/z = 
242.0859. 
 
Allylation of methyl m-toluate with cinnamyl acetate (2).  Prepared according to the 
general procedure with methyl m-toluate (196 mg, 1.30 mmol, 1.30 equiv) and cinnamyl 
acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (15% EtOAc:85% hexanes) to give the product (182 mg, 69%).  1H 
NMR (499 MHz, CDCl3) δ 7.77 (s, 1H), 7.40 (dd, J = 8.2, 1.0 Hz, 1H), 7.34 (t, J = 7.6 
Hz, 2H), 7.28 (s, 1H), 7.24 (m, 3H), 6.50 (d, J = 15.8 Hz, 1H), 6.38 (dt, J = 15.7, 6.9 Hz, 
1H), 3.94 (s, 2H), 3.59 (s, 3H), 2.42 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 167.56, 
140.64, 138.61, 137.52, 134.33, 131.63, 130.50, 128.87, 128.75, 128.37, 127.45, 127.17, 
126.39, 52.29, 39.32, 21.46.  HRMS (EI+) calcd for [C18H18O2]+ m/z = 266.1307,found 
m/z = 266.1313. 
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Allylation of m-xylene with cinnamyl acetate (3).  Prepared according to the general 
procedure with m-xylene (138 mg, 1.30 mmol, 1.30 equiv) and cinnamyl acetate (177 mg, 
1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(15% EtOAc:85% hexanes) to give the product (174 mg, 78%). 1H NMR (499 MHz, 
CDCl3) δ 7.42 (dd, J = 8.2, 1.4 Hz, 2H), 7.34 (dd, J = 8.4, 6.9 Hz, 2H), 7.25 (m, 1H), 
7.14 (m, 1H), 6.91 (s, 2H), 6.51 (dd, J = 15.8, 1.4 Hz, 1H), 6.39 (dt, J = 15.8, 6.9 Hz, 1H), 
3.53 (d, J = 6.9 Hz, 2H), 2.35 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 140.32, 138.27, 
131.08, 129.74, 129.00, 128.74, 128.08, 127.30, 126.72, 126.39, 39.53, 21.53.  HRMS 
(EI+) calcd for [C17H18]+ m/z = 222.1409, found m/z = 222.1408. 
 
Allylation of N,N-Diethyl-3-methylbenzamide with cinnamyl acetate (4).  Prepared 
according to the general procedure with N,N-Diethyl-3-methylbenzamide (249 mg, 1.30 
mmol, 1.30 equiv) and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (20% EtOAc:80% hexanes) to give the 
product (237 mg, 77%).  1H NMR (499 MHz, CDCl3) δ 7.36 (d, J = 7.3 Hz, 1H), 7.28 (m, 
2H), 7.21 (d, J = 2.9 Hz, 1H), 7.19 (s, 1H), 7.15 (d, J = 7.5 Hz, 1H), 7.08 (s, 1H), 7.04 (s, 
1H), 6.46 (d, J = 15.8 Hz, 1H), 6.34 (dt, J = 15.7, 6.8 Hz, 1H), 3.53 (d, J = 6.7 Hz, 2H), 
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3.25 (s, 4H), 2.37 (s, 3H), 1.18 (d, J = 74.0 Hz, 6H).  13C NMR (126 MHz, CDCl3) δ 
171.77, 140.57, 138.60, 137.69, 137.58, 131.56, 130.38, 128.99, 128.73, 127.39, 126.35, 
124.98, 123.73, 43.50, 39.36, 25.00, 21.54, 14.43, 13.14.  HRMS (EI+) calcd for 
[C21H25NO]+ m/z = 307.1936, found m/z = 307.1928. 
 
Allylation of 3-bromochlorobenzene with cinnamyl acetate (5).  Prepared according to 
the general procedure with 3-bromochlorobenzene (249 mg, 1.30 mmol, 1.30 equiv) and 
cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (175 mg, 57%).  
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 7.0 Hz, 3H), 7.34 (t, J = 7.6 Hz, 2H), 7.30 (s, 
1H), 7.27 (dd, J = 8.4, 6.1 Hz, 1H), 7.19 (s, 1H), 6.49 (d, J = 15.8 Hz, 1H), 6.28 (dt, J = 
15.7, 7.0 Hz, 1H), 3.51 (d, J = 6.9 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 144.09, 
137.16, 135.29, 132.65, 130.29, 129.49, 128.86, 127.89, 127.79, 127.35, 126.49, 122.98, 
38.90.  HRMS (EI+) calcd for [C15H12ClBr]+ m/z = 305.9811, found m/z = 305.9827. 
 
Allylation of 3-chloroanisole with cinnamyl acetate (6).  Prepared according to the 
general procedure with 3-chloroanisole (186 mg, 1.30 mmol, 1.30 equiv) and cinnamyl 
acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
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chromatography (5% EtOAc:95% hexanes) to give the product (187 mg, 73%).  1H NMR 
(499 MHz, CDCl3) δ 7.39 (d, J = 7.5 Hz, 2H), 7.33 (t, J = 7.6 Hz, 2H), 7.25 (t, J = 7.3 Hz, 
1H), 6.87 (s, 1H), 6.79 (s, 1H), 6.70 (s, 1H), 6.49 (d, J = 15.7 Hz, 1H), 6.32 (dt, J = 15.7, 
6.9 Hz, 1H), 3.81 (s, 3H), 3.51 (d, J = 6.8 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 
160.63, 143.32, 137.44, 135.03, 132.01, 128.79, 128.25, 127.55, 126.43, 121.40, 113.35, 
112.19, 55.70, 39.34.  HRMS (EI+) calcd for [C16H15ClO]+ m/z = 258.0811, found m/z = 
258.0804. 
F3C CF3
+ Ph OAc
Ph
CF3
F3C
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2,
cinnamyl acetate,
KF, MeOH, rt  
Allylation of 1,3-bis(trifluoromethyl)benzene with cinnamyl acetate (7).  Prepared 
according to the general procedure with 1,3-bis(trifluoromethyl)benzene (279 mg, 1.30 
mmol, 1.30 equiv) and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% EtOAc:95% hexanes) to give the 
product (251 mg, 76%).  1H NMR (500 MHz, CDCl3) δ 7.82 (s, 1H), 7.75 (s, 2H), 7.44 (d, 
J = 7.3 Hz, 2H), 7.38 (t, J = 7.6 Hz, 2H), 7.30 (t, J = 7.3 Hz, 1H), 6.58 (d, J = 15.8 Hz, 
1H), 6.36 (dt, J = 15.7, 7.0 Hz, 1H), 3.71 (d, J = 6.9 Hz, 2H). 13C NMR (126 MHz, 
CDCl3) δ 142.98, 137.00, 133.14, 131.99 (q, J = 33.1 Hz), 129.06 (d, J = 3.8 Hz), 128.90, 
127.94, 126.83, 126.55, 123.68 (q, J = 273 Hz), 120.62 (hept, J = 4.0 Hz), 39.15. 19F 
NMR (376 MHz, CDCl3) δ -63.47. HRMS (EI+) calcd for [C17H12F6]+ m/z = 330.0843, 
found m/z = 330.0828. 
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Allylation of 3-methoxybenzotrifluoride with cinnamyl acetate (8).  Prepared 
according to the general procedure with 3-methoxybenzotrifluoride (229 mg, 1.30 mmol, 
1.30 equiv) and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(247 mg, 85%).  1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 7.3 Hz, 2H), 7.34 (t, J = 7.6 
Hz, 2H), 7.26 (dd, J = 10.3, 4.3 Hz, 1H), 7.14 (s, 1H), 7.03 (s, 1H), 6.99 (s, 1H), 6.52 (d, 
J = 15.8 Hz, 1H), 6.35 (dt, J = 15.7, 6.9 Hz, 1H), 3.86 (s, 3H), 3.59 (d, J = 6.9 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 160.18, 143.05, 137.37, 132.19, 132.10 (q, J = 32.3 Hz) 
128.82, 128.08, 127.63, 126.46, 124.30 (q, J = 273 Hz), 118.20 (d, J = 1.4 Hz), 117.95 (q, 
J = 3.8 Hz), 108.64 (q, J = 3.8 Hz), 55.70, 39.43. 19F NMR (376 MHz, CDCl3) δ -62.99. 
HRMS (EI+) calcd for [C17H15F3O]+ m/z = 292.1075, found m/z = 292.1057. 
F3C Br
+ Ph OAc
Ph
CF3
Br
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2,
cinnamyl acetate,
KF, MeOH, rt  
Allylation of 3-bromobenzotrifluoride with cinnamyl acetate (9).  Prepared according 
to the general procedure with 3-bromobenzotrifluoride (293 mg, 1.30 mmol, 1.30 equiv) 
and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (282 mg, 
84%).  1H NMR (499 MHz, CDCl3) δ 7.69 (s, 1H), 7.62 (s, 1H), 7.48 (s, 1H), 7.44 (d, J = 
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1.4 Hz, 1H), 7.42 (s, 1H), 7.37 (t, J = 7.6 Hz, 2H), 7.31 (m, 1H), 6.54 (d, J = 15.7 Hz, 
1H), 6.33 (dt, J = 15.7, 7.0 Hz, 1H), 3.61 (d, J = 6.9 Hz, 2H). 13C NMR (126 MHz, 
CDCl3) δ 143.69, 137.07, 135.31, 132.89, 132.70 (q, J = 32.9 Hz), 128.87, 127.85, 
127.10, 126.64 (q, J = 3.9 Hz), 126.51, 124.43 (q, J = 3.7 Hz), 123.45 (q, J = 273 Hz), 
123.02, 39.01. 19F NMR (376 MHz, CDCl3) δ -63.16 . HRMS (EI+) calcd for 
[C16H12BrF3]+ m/z = 340.0074, found m/z = 340.0066. 
MeO Br
+ Ph OAc
Ph
Br
MeO
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2,
cinnamyl acetate,
KF, MeOH, rt  
Allylation of 3-bromoanisole with cinnamyl acetate (10).  Prepared according to the 
general procedure with 3-bromoanisole (244 mg, 1.30 mmol, 1.30 equiv) and cinnamyl 
acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (230 mg, 76%).  1H NMR 
(500 MHz, CDCl3) δ 7.43 (m, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 7.2 Hz, 1H), 7.06 
(s, 1H), 6.99 (d, J = 1.8 Hz, 1H), 6.78 (s, 1H), 6.52 (d, J = 15.8 Hz, 1H), 6.35 (dt, J = 
15.7, 6.9 Hz, 1H), 3.81 (s, 3H), 3.53 (d, J = 6.9 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 
160.72, 143.70, 137.47, 132.07, 128.86, 128.28, 127.63, 126.51, 124.37, 123.11, 115.09, 
113.96, 55.73, 39.34.  HRMS (EI+) calcd for [C16H15BrO]+ m/z = 302.0306, found m/z = 
302.0299. 
MeO
+ Ph OAc
Ph
MeO
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2,
cinnamyl acetate,
KF, MeOH, rt
MeO
MeO
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Allylation of veratrole with cinnamyl acetate (11).  Prepared according to the general 
procedure with veratrole (180 mg, 1.30 mmol, 1.30 equiv) and cinnamyl acetate (177 mg, 
1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography (5% 
EtOAc:95% hexanes) to give the product (168 mg, 66%).  1H NMR (500 MHz, CDCl3) δ 
7.39 (d, J = 7.3 Hz, 1H), 7.32 (t, J = 7.6 Hz, 2H), 7.23 (t, J = 7.3 Hz, 2H), 6.82 (m, 3H), 
6.47 (d, J = 15.8 Hz, 1H), 6.38 (dt, J = 15.7, 6.7 Hz, 1H), 3.89 (s, 3H), 3.89 (s, 3H), 3.52 
(d, J = 6.6 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 149.18, 147.71, 137.72, 132.95, 
131.09, 129.73, 128.77, 127.36, 126.38, 120.76, 112.16, 111.51, 56.19, 56.09, 39.22.  
HRMS (EI+) calcd for [C17H18O2]+ m/z = 254.1307, found m/z = 254.1309. 
MeO OMe
+ Ph OAc
Ph
OMe
MeO
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2,
cinnamyl acetate,
KF, MeOH, rt  
Allylation of 1,3-dimethoxybenzene with cinnamyl acetate (12).  Prepared according 
to the general procedure with 1,3-dimethoxybenzene (180 mg, 1.30 mmol, 1.30 equiv) 
and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (196 mg, 
77%).  1H NMR (400 MHz, CDCl3) δ 7.37 (d, J = 1.0, 2H), 7.35 (s, 2H), 7.29 (t, J = 7.6, 
2H), 7.20 (m, 1H), 6.46 (d, J = 15.8, 1H), 6.40 (d, J = 2.2, 1H), 6.33 (tt, J = 6.8, 13.6, 1H), 
3.77 (s, 6H), 3.48 (d, J = 6.7, 2H).  13C NMR (126 MHz, CDCl3) δ 161.13, 142.84, 
137.67, 131.46, 129.06, 128.73, 127.36, 126.39, 106.92, 98.42, 55.54, 39.85.  HRMS 
(EI+) calcd for [C17H18O2]+ m/z = 254.1307, found m/z = 254.1304. 
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Allylation of o-xylene with cinnamyl acetate (13).  Prepared according to the general 
procedure with o-xylene (138 mg, 1.30 mmol, 1.30 equiv) and cinnamyl acetate (177 mg, 
1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography (5% 
EtOAc:95% hexanes) to give the product (165 mg, 74%).  1H NMR (500 MHz, CDCl3) δ 
7.49 (d, J = 7.3 Hz, 1H), 7.41 (t, J = 7.6 Hz, 2H), 7.32 (dd, J = 10.3, 4.2 Hz, 2H), 7.21 (d, 
J = 7.6 Hz, 1H), 7.15 (s, 1H), 7.12 (d, J = 7.6 Hz, 1H), 6.58 (d, J = 15.8 Hz, 1H), 6.48 (dt, 
J = 15.7, 6.8 Hz, 1H), 3.61 (d, J = 6.8 Hz, 2H), 2.38 (s, 3H), 2.37 (s, 3H).  13C NMR (126 
MHz, CDCl3) δ 137.92, 137.90, 136.97, 134.65, 131.08, 130.34, 130.11, 129.98, 128.84, 
127.38, 126.48, 126.39, 39.33, 20.13, 19.72.  HRMS (EI+) calcd for [C17H18]+ m/z = 
222.1408, found m/z = 222.1401. 
 
Allylation of 3’-bromopropiophenone with cinnamyl acetate (14).  Prepared according 
to the general procedure with 3’-bromoprophiophenone (277 mg, 1.30 mmol, 1.30 equiv) 
and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (261 mg, 
79%).  1H NMR (499 MHz, CDCl3) δ 7.95 (s, 1H), 7.77 (s, 1H), 7.59 (s, 1H), 7.39 (m, 
2H), 7.33 (t, J = 7.6 Hz, 2H), 7.25 (t, J = 7.3 Hz, 1H), 6.50 (d, J = 15.7 Hz, 1H), 6.31 (dt, 
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J = 15.7, 6.9 Hz, 1H), 3.59 (d, J = 6.8 Hz, 2H), 2.98 (q, J = 7.2 Hz, 2H), 1.23 (t, J = 7.2 
Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 199.68, 143.21, 139.05, 137.20, 136.09, 132.53, 
129.28, 128.83, 127.73, 127.66, 127.07, 126.47, 123.19, 39.09, 32.23, 8.36.  HRMS (EI+) 
calcd for [C18H17BrO]+ m/z = 328.0462, found m/z = 328.0446. 
 
Allylation of 3-chloro-4-fluorotoluene with cinnamyl acetate (15).  Prepared according 
to the general procedure with 3-chloro-4-fluorotoluene (160 mg, 1.30 mmol, 1.30 equiv) 
and cinnamyl acetate (177 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (187 mg, 
72%).  1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.4 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 
7.23 (t, J = 7.3 Hz, 1H), 7.08 (m, 1H), 6.94 (m, 1H), 6.48 (d, J = 15.8 Hz, 1H), 6.31 (dt, J 
= 15.7, 6.9 Hz, 1H), 3.55 (d, J = 6.9 Hz, 2H), 2.29 (s, 3H). 13C NMR (126 MHz, CDCl3) 
δ 154.65 (d, J = 244.9 Hz), 137.37, 134.47 (d, J = 4.4 Hz), 132.04, 129.63 (d, J = 3.8 Hz), 
129.06, 128.77, 128.47 (d, J = 16.0 Hz), 127.57, 127.14, 126.41, 120.60 (d, J = 18.4 Hz), 
32.70 (d, J = 2.8 Hz), 20.80. 19F NMR (376 MHz, CDCl3) δ -121.91. HRMS (EI+) calcd 
for [C16H14ClF]+ m/z = 260.0768, found m/z = 260.0783. 
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Allylation of 3-chloroanisole with 4-methoxycinnamyl acetate (46).  Prepared 
according to the general procedure with 3-chloroanisole (186 mg, 1.30 mmol, 1.30 equiv) 
and 4-methoxycinnamyl acetate (207 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(206 mg, 71%).  1H NMR (499 MHz, CDCl3) δ 7.33 (d, J = 8.7 Hz, 2H), 6.89 (s, 1H), 
6.87 (s, 2H), 6.79 (s, 1H), 6.71 (s, 1H), 6.44 (d, J = 15.7 Hz, 1H), 6.18 (dt, J = 15.7, 7.0 
Hz, 1H), 3.83 (s, 3H), 3.81 (s, 3H), 3.49 (d, J = 6.9 Hz, 2H).  13C NMR (126 MHz, 
CDCl3) δ 160.63, 159.26, 143.67, 134.99, 131.41, 130.29, 127.57, 126.06, 121.39, 114.22, 
113.33, 112.14, 55.69, 55.53, 39.34.  HRMS (EI+) calcd for [C17H17ClO2]+ m/z = 
288.0917, found m/z = 288.0910. 
 
Allylation of 3-chloroanisole with 2-methoxycinnamyl acetate (47).  Prepared 
according to the general procedure with 3-chloroanisole (186 mg, 1.30 mmol, 1.30 equiv) 
and 2-methoxycinnamyl acetate (207 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(226 mg, 78%).  1H NMR (499 MHz, CDCl3) δ 7.50 (dd, J = 7.6, 1.5 Hz, 1H), 7.29 (m, 
1H), 6.99 (t, J = 7.5 Hz, 1H), 6.94 (s, 2H), 6.91 (d, J = 8.6 Hz, 1H), 6.84 (m, 1H), 6.78 (d, 
J = 1.2 Hz, 1H), 6.38 (dt, J = 15.8, 7.1 Hz, 1H), 3.90 (s, 3H), 3.83 (s, 3H), 3.57 (d, J = 7.0 
Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 160.68, 156.82, 143.82, 135.01, 128.86, 128.66, 
126.99, 126.88, 126.53, 121.44, 120.96, 113.34, 112.20, 111.14, 55.70 (2 carbons), 39.92.  
HRMS (EI+) calcd for [C17H17ClO2]+ m/z = 288.0917, found m/z = 288.0911. 
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Allylation of methyl m-toluate with 4-chlorocinnamyl acetate (48).  Prepared 
according to the general procedure with methyl m-toluate (195 mg, 1.30 mmol, 1.30 
equiv) and 4-chlorocinnamyl acetate (211 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(211 mg, 70%). 1H NMR (499 MHz, CDCl3) δ 7.74 (m, 2H), 7.27 (m, 5H), 6.41 (m, 1H), 
6.32 (dt, J = 15.8, 6.7 Hz, 1H), 3.92 (s, 3H), 3.56 (d, J = 6.7 Hz, 2H), 2.40 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 167.50, 140.36, 138.67, 136.05, 134.29, 133.03, 130.63, 
130.44, 129.67, 128.87, 128.46, 127.61, 127.18, 52.27, 39.26, 21.44.  HRMS (EI+) calcd 
for [C18H17ClO2]+ m/z = 300.0917, found m/z = 344.0925. 
 
Allylation of methyl m-toluate with 3-bromocinnamyl acetate (49).  Prepared 
according to the general procedure with methyl m-toluate (195 mg, 1.30 mmol, 1.30 
equiv) and 3-bromocinnamyl acetate (256 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(269 mg, 78%).  1H NMR (499 MHz, CDCl3) δ 7.75 (d, J = 9.6 Hz, 2H), 7.52 (t, J = 1.6 
Hz, 1H), 7.34 (m, 1H), 7.25 (m, 2H), 7.16 (t, J = 7.8 Hz, 1H), 6.36 (m, 2H), 3.92 (s, 3H), 
3.56 (d, J = 5.2 Hz, 2H), 2.40 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 167.46, 140.21, 
139.72, 138.70, 134.31, 130.64, 130.62, 130.30, 130.25, 129.28, 128.52, 127.21, 126.43, 
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125.09, 122.98, 52.29, 39.25, 21.47. HRMS (EI+) calcd for [C18H17BrO2]+ m/z = 
344.0412, found m/z = 344.0407. 
 
 
Allylation of 3-chloroanisole with γ-methylcinnamyl acetate (50).  Prepared according 
to the general procedure with 3-chloroanisole (186 mg, 1.30 mmol, 1.30 equiv) and γ-
methylcinnamyl acetate (191 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (157 mg, 
58%).  1H NMR (499 MHz, CDCl3) δ 7.41 (m, 2H), 7.34 (t, J = 7.6 Hz, 2H), 7.26 (dd, J = 
11.5, 4.3 Hz, 1H), 6.91 (s, 1H), 6.81 (m, 1H), 6.76 (d, J = 1.3 Hz, 1H), 6.47 (d, J = 15.9 
Hz, 1H), 6.36 (dd, J = 15.9, 6.8 Hz, 1H), 3.82 (s, 3H), 3.63 (dd, J = 18.2, 11.4 Hz, 1H), 
1.49 (d, J = 7.0 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 160.66, 148.90, 137.56, 135.05, 
134.36, 129.41, 128.79, 127.51, 126.47, 120.16, 112.33, 112.01, 55.70, 42.76, 21.27.  
HRMS (EI+) calcd for [C17H17ClO]+ m/z = 292.0968, found m/z = 292.0956. 
General Procedure for Allylation of Heteroarenes.  Inside a glove box, [Ir(cod)OMe]2 
(2.1 mg, 0.0033 mmol, 0.0033 equiv), dtbpy (1.8 mg, 0.0065 mmol, 0.0065 equiv), 
B2pin2 (166 mg, 0.650 mmol, 0.650 equiv), arene or heteroarene (1.30 mmol, 1.30 equiv), 
and THF (2 mL) were added to a dry vial with a magnetic stir bar.  The vial was sealed 
and heated at 80 C for 18 h.  The reaction mixture was cooled to room temperature and 
the volatile materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 
equiv), cinnamyl chloride (153 mg, 1.00 mmol, 1.00 equiv) and MeOH (3 mL) were 
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added to the reaction mixture.   The reaction mixture was stirred at room temperature for 
10 min. KF (154 mg, 2.60 mmol, 2.60 equiv) was added and the reaction mixture was 
sealed and stirred at room temperature for 24 h.  The reaction mixture was cooled to 
room temperature, filtered through silica gel washing with EtOAc, and concentrated 
under vacuum.  The reaction mixture was purified by column chromatography to give the 
product. 
OMe
Me + Ph Cl
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2,
cinnamyl chloride,
KF, MeOH, rt
OMe Me
Ph  
Allylation of 2,5-dimethylfuran with cinnamyl chloride (29).  Prepared according to 
the general procedure with 2,5-dimethylfuran (125 mg, 1.30 mmol, 1.30 equiv) and 
cinnamyl chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (119 mg, 56%).  
1H NMR (499 MHz, CDCl3) δ 7.38 (d, J = 7.6 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.23 (t, J 
= 7.3 Hz, 1H), 6.44 (d, J = 15.8 Hz, 1H), 6.30 (dt, J = 15.7, 6.5 Hz, 1H), 5.85 (s, 1H), 
3.24 (d, J = 6.4 Hz, 2H), 2.27 (s, 3H), 2.25 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
149.53, 145.83, 137.84, 130.37, 129.28, 128.72, 127.22, 126.31, 117.48, 108.00, 28.86, 
13.72, 11.70.  HRMS (EI+) calcd for [C15H16O]+ m/z = 212.1201, found m/z = 212.1210. 
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Allylation of 2,5-dimethylthiophene with cinnamyl chloride (30).  Prepared according 
to the general procedure with 2,5-dimethylthiophene (146 mg, 1.30 mmol, 1.30 equiv) 
and cinnamyl chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (181 mg, 
79%).  1H NMR (499 MHz, CDCl3) δ 7.43 (d, J = 7.3 Hz, 2H), 7.37 (t, J = 7.6 Hz, 2H), 
7.32 – 7.24 (m, 1H), 6.59 (s, 1H), 6.48 (d, J = 15.8 Hz, 1H), 6.37 (dt, J = 15.7, 6.5 Hz, 
1H), 3.45 (d, J = 6.4 Hz, 2H), 2.48 (s, 3H), 2.42 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
137.86, 135.53, 135.13, 131.25, 130.63, 129.02, 128.79, 127.55, 127.33, 126.40, 32.21, 
15.45, 13.17.  HRMS (EI+) calcd for [C15H16S]+ m/z = 228.0973, found m/z = 228.0983. 
 
Allylation of 2-acetylpyrrole with cinnamyl chloride (31).  Prepared according to the 
general procedure with 2-acetylpyrrole (142 mg, 1.30 mmol, 1.30 equiv) and cinnamyl 
chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (10% EtOAc:90% hexanes) to give the product (119 mg, 53%).  1H 
NMR (500 MHz, CDCl3) δ 10.14 (s, 1H), 7.35 (d, J = 7.2 Hz, 2H), 7.31 (t, J = 7.6 Hz, 
2H), 7.24 (q, J = 7.4 Hz, 1H), 7.06 (s, 1H), 6.94 (d, J = 3.6 Hz, 1H), 6.91 – 6.87 (m, 1H), 
6.51 (d, J = 15.7 Hz, 1H), 6.35 – 6.25 (m, 2H), 3.60 (d, J = 6.8 Hz, 2H), 2.45 (s, 3H).  13C 
NMR (126 MHz, CDCl3) δ 187.58, 137.25, 132.68, 128.74, 127.65, 126.47, 125.90, 
118.33, 117.15, 110.74, 109.29, 31.64, 25.25.  HRMS (EI+) calcd for [C15H15NO2]+ m/z 
= 225.1154, found m/z = 225.1149. 
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Allylation of methyl pyrrole-2-carboxylate with cinnamyl chloride (32).  Prepared 
according to the general procedure with methyl pyrroles-2-carboxylate (163 mg, 1.30 
mmol, 1.30 equiv) and cinnamyl chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (166 mg, 69%).  1H NMR (499 MHz, CDCl3) δ 9.15 (s, 1H), 7.38 (d, J = 7.6 Hz, 
2H), 7.33 (t, J = 7.5 Hz, 2H), 7.26 (dd, J = 11.9, 4.4 Hz, 1H), 6.96 (d, J = 17.8 Hz, 1H), 
6.91 – 6.85 (m, 1H), 6.52 (d, J = 15.7 Hz, 1H), 6.36 – 6.26 (m, 1H), 6.07 (s, 1H), 3.85 (s, 
3H), 3.58 (d, J = 6.7 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 161.83, 137.09, 132.73, 
128.82, 127.77, 126.48, 125.94, 121.88, 116.40, 110.70, 109.03, 51.56, 31.73.  HRMS 
(EI+) calcd for [C15H15NO2]+ m/z = 241.1103, found m/z = 241.1107. 
 
Allylation of benzofuran with cinnamyl chloride (33).  Prepared according to the 
general procedure with benzofuran (154 mg, 1.30 mmol, 1.30 equiv) and cinnamyl 
chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (122 mg, 52%).  1H NMR 
(499 MHz, CDCl3) δ 7.58 – 7.53 (s, 1H), 7.52 – 7.47 (d, J = 7.8 Hz, 2H), 7.46 – 7.41 (s, 
2H), 7.40 – 7.33 (s, 2H), 7.31 – 7.21 (m, 2H), 6.67 – 6.59 (d, J = 15.8 Hz, 1H), 6.54 – 
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6.50 (s, 1H), 6.48 – 6.38 (dd, J = 14.7, 7.8 Hz, 1H), 3.81 – 3.68 (d, J = 6.7 Hz, 2H).  13C 
NMR (126 MHz, CDCl3) δ 157.37, 155.16, 137.35, 133.00, 129.14, 128.83, 127.72, 
126.53, 124.86, 123.66, 122.81, 120.66, 111.14, 103.02, 32.44.  HRMS (EI+) calcd for 
[C17H14O]+ m/z = 234.1045, found m/z = 234.1052. 
 
Allylation of ethyl indole-2-carboxylate with cinnamyl chloride (34).  Prepared 
according to the general procedure with ethyl indole-2-carboxylate (246 mg, 1.30 mmol, 
1.30 equiv) and cinnamyl chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(174 mg, 57%).  1H NMR (500 MHz, CDCl3) δ 9.13 (s, 1H), 7.63 (d, J = 8.0 Hz, 1H), 
7.36 (d, J = 7.2 Hz, 2H), 7.32 (s, 1H), 7.31 (s, 1H), 7.29 – 7.27 (m, 1H), 7.26 – 7.20 (m, 
2H), 7.18 – 7.11 (m, 1H), 6.59 (d, J = 15.8 Hz, 1H), 6.45 (dt, J = 15.8, 6.6 Hz, 1H), 4.41 
(q, J = 7.1 Hz, 2H), 3.82 (d, J = 6.6 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H).  13C NMR (126 
MHz, CDCl3) δ 162.42, 137.29, 136.59, 132.07, 128.81, 127.93, 127.75, 127.71, 127.62, 
126.45, 125.35, 123.68, 121.37, 121.23, 109.39, 77.60, 77.35, 77.09, 61.33, 35.40, 14.63.  
HRMS (EI+) calcd for [C20H19NO2]+ m/z = 305.1416, found m/z = 305.1416. 
General Procedure for Allylation of arenes with allyl chloride.  Inside a glove box, 
[Ir(cod)OMe]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 
0.0050 equiv), B2pin2 (178 mg, 0.700 mmol, 0.700 equiv), arene (1.30 mmol, 1.30 equiv), 
and THF (2 mL) were added to a dry vial with a magnetic stir bar.  The vial was sealed 
and heated at 80 C for 18 h.  The reaction mixture was cooled to room temperature and 
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the volatile materials were removed under vacuum.  Pd(dba)2 (11.6 mg, 0.02 mmol, 0.02 
equiv), allyl chloride (153 mg, 2.00 mmol, 2.00 equiv) and MeOH (3 mL) were added to 
the reaction mixture.   The reaction mixture was stirred at room temperature for 10 min. 
KF (118 mg, 2.00 mmol, 2.00 equiv) was added and the reaction mixture was sealed and 
stirred at room temperature for 24 h.  The reaction mixture was cooled to room 
temperature, filtered through silica gel washing with EtOAc, and concentrated under 
vacuum.  The reaction mixture was purified by column chromatography to give the 
product. 
 
Allylation of veratrole with allyl chloride (43).  Prepared according to the general 
procedure with 3-chlorotoluene (138 mg, 1.00 mmol, 1.00 equiv) and allyl chloride (153 
mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(10% EtOAc:90% hexanes) to give the product (131 mg, 74%).  1H NMR (500 MHz, 
CDCl3) δ 6.81 (d, J = 7.9 Hz, 1H), 6.73 (d, J = 12.1 Hz, 2H), 5.96 (tt, J = 9.9, 6.7 Hz, 1H), 
5.10 (s, 1H), 5.06 (m, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 3.34 (d, J = 6.4 Hz, 2H).  13C NMR 
(126 MHz, CDCl3) δ 149.14, 147.63, 137.91, 132.88, 120.63, 115.81, 112.13, 111.52, 
56.18, 56.04, 40.03.  HRMS (EI+) calcd for [C11H14O2]+ m/z = 178.0994, found m/z = 
178.0992. 
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Allylation of 3-chloroanisole with allyl chloride (44).  Prepared according to the 
general procedure with 3-chlorotoluene (142 mg, 1.00 mmol, 1.00 equiv) and allyl 
chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (113 mg, 62%).  1H NMR 
(499 MHz, CDCl3) δ 6.80 (d, J = 1.1 Hz, 1H), 6.76 (s, 1H), 6.64 (d, J = 1.4 Hz, 1H), 5.93 
(ddt, J = 16.4, 9.5, 6.7 Hz, 1H), 5.14 (m, 1H), 5.10 (m, 1H), 3.79 (s, 3H), 3.34 (d, J = 6.7 
Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 160.56, 143.17, 136.60, 134.91, 121.34, 116.80, 
113.22, 112.11, 55.64, 40.17.  HRMS (EI+) calcd for [C10H11ClO]+ m/z = 182.0499, 
found m/z = 182.0508. 
 
Allylation of methyl m-toluate with allyl chloride (45).  Prepared according to the 
general procedure with methyl m-toluate (150 mg, 1.00 mmol, 1.00 equiv) and allyl 
chloride (153 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (10% EtOAc:90% hexanes) to give the product (mg, %).  1H NMR (499 
MHz, CDCl3) δ 7.72 (s, 1H), 7.69 (s, 1H), 7.20 (s, 1H), 5.96 (ddt, J = 18.9, 9.5, 6.7 Hz, 
1H), 5.09 (m, 2H), 3.90 (s, 3H), 3.39 (d, J = 6.7 Hz, 2H), 2.37 (s, 3H).  13C NMR (126 
MHz, CDCl3) δ 167.49, 140.49, 138.44, 137.13, 134.24, 130.47, 128.24, 127.11, 116.44, 
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52.17, 40.11, 21.38.  HRMS (EI+) calcd for [C12H14O2]+ m/z = 190.0994, found m/z = 
190.1004. 
 
Synthesis of Elemicin (51).  Prepared according to the general procedure with 1,2,3-
trimethoxybenzene (169 mg, 1.00 mmol, 1.00 equiv) and allyl chloride (153 mg, 1.00 
mmol, 1.00 equiv).  The mixture was purified by flash column chromatography (10% 
EtOAc:90% hexanes) to give the product (140mg, 67%).  1H NMR (500 MHz, CDCl3) δ 
6.40 (s, 2H), 5.95 (ddd, J = 13.9, 10.1, 4.9 Hz, 1H), 5.10 (t, J = 13.7 Hz, 2H), 3.84 (s, 6H), 
3.82 (s, 3H), 3.33 (d, J = 6.6 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 153.38, 137.42, 
136.02, 123.87, 116.24, 105.57, 61.07, 56.25, 40.77.  HRMS (EI+) calcd for [C12H16O3]+ 
m/z = 208.1099, found m/z = 208.1092. 
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General Procedure for Benzylation of Arenes.  Inside a glove box, [Ir(cod)OMe]2 (1.8 
mg, 0.0028 mmol, 0.0028 equiv), dtbpy (1.5 mg, 0.0055 mmol, 0.0055 equiv), B2pin2 
(196 mg, 0.770 mmol, 0.770 equiv), arene (1.10 mmol, 1.10 equiv), and THF (2 mL) 
were added to a dry vial with a magnetic stir bar.  The vial was sealed and heated at 80 
C for 18 h.  The reaction mixture was cooled to room temperature and the volatile 
materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 equiv), PPh3 
(10.5 mg, 0.04 mmol, 0.04 equiv), benzyl halide (1.00 mmol, 1.00 equiv), Na2CO3 (424 
mg, 4.00 mmol, 4.00 equiv), THF (4 mL) and H2O (0.4 mL) were added to the reaction 
mixture.  The reaction mixture was sealed and heated at 100 C for 18 h.  The reaction 
mixture was cooled to room temperature, filtered through silica gel washing with EtOAc, 
and concentrated under vacuum.  The reaction mixture was purified by column 
chromatography to give the product. 
 
Benzylation of methyl m-toluate with 4-Methylbenzyl bromide (16).  Prepared 
according to the general procedure with methyl m-toluate (166 mg, 1.10 mmol, 1.10 
equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
117 
(134 mg, 53%). 1H NMR (500 MHz, CDCl3) δ 7.71 (s, 2H), 7.20 (d, J = 1.9 Hz, 1H), 
7.10 (d, J = 5.8 Hz, 4H), 3.95 (s, 2H), 3.90 (s, 3H), 2.36 (s, 3H), 2.33 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 167.58, 141.88, 138.55, 137.85, 135.96, 134.54, 130.45, 129.48, 
128.96, 128.24, 127.42, 126.29, 122.91, 52.25, 41.51, 21.47, 21.26. HRMS (EI+) calcd 
for [C17H18O2]+ m/z = 254.1306, found m/z = 254.1301. 
 
Benzylation of 3-methylbenzonitrile with 4-Methylbenzyl bromide (17).  Prepared 
according to the general procedure with 3-methylbenzonitrile (129 mg, 1.10 mmol, 1.10 
equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(182 mg, 83%).  1H NMR (500 MHz, CDCl3) δ 7.30 (s, 1H), 7.27 (s, 1H), 7.24 (s, 1H), 
7.14 (d, J = 7.9 Hz, 2H), 7.06 (d, J = 7.9 Hz, 2H), 3.92 (s, 2H), 2.35 (s, 6H).  13C NMR 
(126 MHz, CDCl3) δ 142.99, 139.54, 136.81, 136.41, 134.50, 130.52, 129.76, 129.66, 
129.00, 119.38, 112.48, 41.20, 21.35, 21.28.  HRMS (EI+) calcd for [C16H15N]+ m/z = 
221.1204, found m/z = 221.1199. 
 
Benzylation of N,N-Diethyl-m-toluamide with 4-Methylbenzyl bromide (18).  
Prepared according to the general procedure with N,N-Diethyl-m-toluamide (211 mg, 
1.10 mmol, 1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  
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The mixture was purified by flash column chromatography (20% EtOAc:80% hexanes) 
to give the product (210 mg, 71%). 1H NMR (499 MHz, CDCl3) δ 7.07 (m, 4H), 7.01 (d, 
J = 2.1 Hz, 2H), 6.96 (d, J = 1.8 Hz, 1H), 3.90 (s, 2H), 3.41 (m, 4H), 2.31 (s, 3H), 2.31 (s, 
3H), 1.13 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 171.77, 141.75, 138.57, 137.89, 
137.56, 135.88, 130.59, 129.40, 129.04, 124.90, 123.95, 43.46, 41.54, 39.34, 21.56, 21.25, 
14.36, 13.11.  HRMS (EI+) calcd for [C20H25NO]+ m/z = 295.1936, found m/z = 
295.1930. 
 
Benzylation of 3-chlorotoluene with 4-Methylbenzyl bromide (19).  Prepared 
according to the general procedure with 3-chlorotoluene (140 mg, 1.10 mmol, 1.10 equiv) 
and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(131 mg, 57%).  1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 8.0 
Hz, 2H), 7.03 (s, 1H), 7.01 (s, 1H), 6.91 (s, 1H), 3.90 (s, 2H), 2.36 (s, 3H), 2.31 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 143.41, 140.05, 137.58, 136.07, 134.15, 129.52, 129.03, 
128.17, 127.09, 126.24, 41.40, 21.42, 21.30.  HRMS (EI+) calcd for [C15H15Cl]+ m/z = 
230.0862, found m/z = 230.0873. 
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Benzylation of 1,3-bis(trifluoromethyl)benzene with 4-Methylbenzyl bromide (21).  
Prepared according to the general procedure with 1,3-bis(trifluoromethyl)benzene (236 
mg, 1.10 mmol, 1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (5% EtOAc:95% 
hexanes) to give the product (248 mg, 78%).  1H NMR (500 MHz, CDCl3) δ 7.78 (s, 1H), 
7.69 (s, 2H), 7.20 (d, J = 7.9 Hz, 2H), 7.12 (d, J = 7.9 Hz, 2H), 4.10 (s, 2H), 2.39 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 144.17, 136.79, 136.00, 131.93 (q, J = 33.1 Hz), 129.85, 
129.17 (d, J = 3.8 Hz), 129.00, 123.65 (q, J = 273 Hz), 120.44 (hept, J = 4.1 Hz), 41.35, 
21.21. 19F NMR (376 MHz, CDCl3) δ -63.33. HRMS (EI+) calcd for [C16H12F6]+ m/z = 
318.0843, found m/z = 318.0853. 
 
Benzylation of 3-methoxybenzotrifluoride with 4-Methylbenzyl bromide (22).  
Prepared according to the general procedure with 3-methoxybenzotrifluoride (193 mg, 
1.10 mmol, 1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  
The mixture was purified by flash column chromatography (5% EtOAc:95% hexanes) to 
give the product (197 mg, 69%).  1H NMR (499 MHz, CDCl3) δ 7.14 (d, J = 7.9 Hz, 2H), 
7.08 (m, 3H), 6.98 (s, 1H), 6.90 (s, 1H), 3.97 (s, 2H), 3.82 (s, 3H), 2.35 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 160.10, 144.18, 137.04, 136.24, 132.01 (q, J = 32 Hz), 129.56, 
128.97, 124.25 (q, J = 273 Hz), 118.51, 118.18 (q, J = 3.9 Hz), 108.38 (q, J = 3.9 Hz), 
55.66, 41.61, 21.23. 19F NMR (376 MHz, CDCl3) δ -63.02. HRMS (EI+) calcd for 
[C16H15F3O]+ m/z = 280.1075, found m/z = 280.1062. 
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Benzylation of 3-chloroanisole with 4-Methylbenzyl bromide (23).  Prepared 
according to the general procedure with 3-chloroanisole (157 mg, 1.10 mmol, 1.10 equiv) 
and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(197 mg, 80%). 1H NMR (499 MHz, CDCl3) δ 7.11 (m, 4H), 6.79 (s, 1H), 6.75 (s, 1H), 
6.64 (s, 1H), 3.88 (s, 2H), 3.77 (s, 3H), 2.34 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
160.57, 144.53, 137.23, 136.14, 134.97, 129.51, 129.01, 121.64, 113.69, 111.95, 55.64, 
41.55, 21.26.  HRMS (EI+) calcd for [C15H15ClO]+ m/z = 246.0812, found m/z = 
246.0817. 
 
Benzylation of 1,2,3,4-tetrafluorobenzene with 4-Methylbenzyl bromide (24).  
Prepared according to the general procedure with 1,2,3,4-tetrafluorobenzene (166 mg, 
1.10 mmol, 1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  
The mixture was purified by flash column chromatography (5% EtOAc:95% hexanes) to 
give the product (226 mg, 89%).  1H NMR (499 MHz, CDCl3) δ 7.22 (d, J = 7.5 Hz, 2H), 
7.16 (d, J = 7.4 Hz, 2H), 6.79 (d, J = 8.0 Hz, 1H), 4.00 (s, 2H), 2.42 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 147.51 (m), 145.67 (m), 141.35 (m), 139.08 (m), 136.83, 135.12, 
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129.78, 128.92, 125.26 (ddd, J = 14.8, 6.5, 4.1 Hz), 111.70 (dt, J = 19.5, 3.8 Hz), 33.95, 
21.14. 19F NMR (376 MHz, CDCl3) δ -140.43 (dt, J = 22.1, 11.6 Hz), -143.89 (m), -
156.65 (t, J = 20.0 Hz), -159.46 (td, J = 20.4, 8.1 Hz). HRMS (EI+) calcd for [C14H10F4]+ 
m/z = 254.0719, found m/z = 254.0727. 
 
Benzylation of 1,2,3-trimethoxybenzene with 4-Methylbenzyl bromide (25).  
Prepared according to the general procedure with 1,2,3-trimethoxybenzene (186 mg, 1.10 
mmol, 1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The 
mixture was purified by flash column chromatography (10% EtOAc:90% hexanes) to 
give the product (193 mg, 71%).  1H NMR (500 MHz, CDCl3) δ 7.12 (d, J = 8.3 Hz, 2H), 
7.10 (d, J = 8.4 Hz, 2H), 6.41 (s, 2H), 3.89 (s, 2H), 3.83 (s, 3H), 3.82 (s, 6H), 2.34 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 153.39, 138.07, 137.27, 136.44, 135.89, 129.40, 128.88, 
106.06, 61.09, 56.27, 42.06, 21.27.  HRMS (EI+) calcd for [C17H20O3]+ m/z = 272.1412, 
found m/z = 272.1405. 
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Benzylation of 3’-bromopropiophenone with 4-Methylbenzyl bromide (26).  Prepared 
according to the general procedure with 3’-bromopropiophenone (235 mg, 1.10 mmol, 
1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% EtOAc:95% hexanes) to give the 
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product (159 mg, 50%).  1H NMR (499 MHz, CDCl3) δ 7.92 (s, 1H), 7.73 (s, 1H), 7.51 (s, 
1H), 7.14 (d, J = 7.8 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 3.97 (s, 2H), 2.95 (q, J = 7.2 Hz, 
2H), 2.34 (s, 3H), 1.22 (t, J = 7.2 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 199.68, 
144.44, 138.96, 136.72, 136.43, 136.24, 129.68, 129.12, 128.98, 127.23, 123.15, 41.31, 
32.20, 21.26, 8.33.  HRMS (EI+) calcd for [C17H17BrO]+ m/z = 316.0463, found m/z = 
316.0456. 
 
Benzylation of 3-chlorobenzonitrile with 4-Methylbenzyl bromide (27).  Prepared 
according to the general procedure with 3-chlorobenzonitrile (152 mg, 1.10 mmol, 1.10 
equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(195 mg, 81%).  1H NMR (499 MHz, CDCl3) δ 7.47 (s, 1H), 7.42 (s, 1H), 7.36 (s, 1H), 
7.17 (d, J = 7.8 Hz, 2H), 7.07 (d, J = 7.9 Hz, 2H), 3.96 (s, 2H), 2.37 (s, 3H).  13C NMR 
(126 MHz, CDCl3) δ 145.24, 136.87, 135.70, 135.40, 133.78, 130.82, 129.87, 129.77, 
129.05, 117.81, 114.09, 41.00, 21.28.  HRMS (EI+) calcd for [C15H12ClN]+ m/z = 
241.0658, found m/z = 241.0656. 
 
Benzylation of 3-chloro-4-fluorotoluene with 4-Methylbenzyl bromide (28).  Prepared 
according to the general procedure with 3-chloro-4-fluorotoluene (160 mg, 1.10 mmol, 
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1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% EtOAc:95% hexanes) to give the 
product (205 mg, 83%).  1H NMR (500 MHz, CDCl3) δ 7.15 (s, 4H), 7.08 (d, J = 6.5 Hz, 
1H), 6.87 (d, J = 6.3 Hz, 1H), 3.96 (s, 2H), 2.37 (s, 3H), 2.27 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 154.67 (d, J = 244.8 Hz), 136.53, 136.22, 134.44 (d, J = 4.5 Hz), 129.97 
(d, J = 3.7 Hz), 129.78 (d, J = 15.8 Hz), 129.55, 129.01, 128.92, 120.64 (d, J = 18.4 Hz), 
34.87 (d, J = 2.5 Hz), 21.30, 20.82. 19F NMR (376 MHz, CDCl3) δ -125.66. HRMS (EI+) 
calcd for [C15H14ClF]+ m/z = 248.0768, found m/z = 248.0775. 
 
Benzylation of 2,6-dichloropyridine with 4-Methylbenzyl bromide (42).  Inside a 
glove box, [Ir(cod)OMe]2 (21.6 mg, 0.033 mmol, 0.033 equiv), dtbpy (18 mg, 0.066 
mmol, 0.066 equiv), B2pin2 (196 mg, 0.770 mmol, 0.770 equiv), 2,6-dichloropyridine 
(163 mg, 1.10 mmol, 1.10 equiv) and THF (2 mL) were added to a dry vial with a 
magnetic stir bar.  The vial was sealed and heated at 80 C for 18 h.  The reaction mixture 
was cooled to room temperature and the volatile materials were removed under vacuum.  
Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 equiv), PPh3 (10.5 mg, 0.04 mmol, 0.04 equiv), 4-
Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv), Na2CO3 (424 mg, 4.00 mmol, 
4.00 equiv), THF (4 mL) and H2O (0.4 mL) were added to the reaction mixture.  The 
reaction mixture was sealed and heated at 100 C for 18 h.  The reaction mixture was 
cooled to room temperature, filtered through silica gel washing with EtOAc, and 
concentrated under vacuum. The mixture was purified by flash column chromatography 
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(10% EtOAc:90% hexanes) to give the product (177 mg, 71%).  1H NMR (500 MHz, 
CDCl3) δ 7.16 (d, J = 7.7 Hz, 2H), 7.06 (d, J = 2.8 Hz, 2H), 7.04 (s, 2H), 3.90 (s, 2H), 
2.35 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 156.66, 150.77, 137.17, 134.36, 129.95, 
129.14, 123.33, 40.55, 21.31.  HRMS (EI+) calcd for [C13H11Cl2N]+ m/z = 251.0268, 
found m/z = 251.0263.  Anal Calc. for C13H11NCl2:  C, 61.93; H, 4.40; N, 5.56.  Found: 
C, 62.05; H, 4.29; N, 5.39. 
 
General Procedure for Benzylation of Heteroarenes.  Inside a glove box, 
[Ir(cod)OMe]2 (1.8 mg, 0.0028 mmol, 0.0028 equiv), dtbpy (1.5 mg, 0.0055 mmol, 
0.0055 equiv), B2pin2 (140 mg, 0.550 mmol, 0.550 equiv), heteroarene (1.10 mmol, 1.10 
equiv), and THF (2 mL) were added to a dry vial with a magnetic stir bar.  The vial was 
sealed and heated at 80 C for 18 h.  The reaction mixture was cooled to room 
temperature and the volatile materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 
0.01 mmol, 0.01 equiv), PPh3 (10.5 mg, 0.04 mmol, 0.04 equiv), benzyl halide (1.00 
mmol, 1.00 equiv), Na2CO3 (424 mg, 4.00 mmol, 4.00 equiv), THF (4 mL) and H2O (0.4 
mL) were added to the reaction mixture.  The reaction mixture was sealed and heated at 
100 C for 18 h.  The reaction mixture was cooled to room temperature, filtered through 
silica gel washing with EtOAc, and concentrated under vacuum.  The reaction mixture 
was purified by column chromatography to give the product. 
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Benzylation of Indole with 4-Methylbenzyl bromide (35).  Prepared according to the 
general procedure with indole (129 mg, 1.10 mmol, 1.10 equiv) and 4-Methylbenzyl 
bromide (186 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (10% EtOAc:90% hexanes) to give the product (128 mg, 58%).  1H 
NMR (499 MHz, CDCl3) δ 7.73 (s, 1H), 7.68 – 7.59 (m, 1H), 7.37 – 7.07 (m, 7H), 6.45 – 
6.35 (m, 1H), 4.14 (s, 2H), 2.44 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 138.44, 136.61, 
136.56, 135.76, 129.71, 129.06, 128.53, 121.54, 120.28, 120.00, 110.80, 101.24, 34.56, 
21.37.  HRMS (EI+) calcd for [C16H15N]+ m/z = 221.1204, found m/z = 221.1199.  Anal 
Calc. for C16H15N:  C, 86.84; H, 6.83; N, 6.33.  Found: C, 86.51; H, 6.69; N, 5.99. 
 
Benzylation of benzofuran with 4-Methylbenzyl bromide (36). Prepared according to 
the general procedure with benzofuran (130 mg, 1.10 mmol, 1.10 equiv) and 4-
Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv). The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (154 mg, 
69%).  1H NMR (500 MHz, CDCl3) δ 7.63 – 7.59 (m, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.37 
– 7.30 (m, 5H), 7.28 (s, 1H), 7.27 (s, 1H), 6.49 (d, J = 0.6 Hz, 1H), 4.19 (s, 2H), 2.48 (s, 
3H).  13C NMR (126 MHz, CDCl3) δ 158.50, 155.36, 136.66, 134.53, 129.68, 129.24, 
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129.19, 123.73, 122.87, 120.76, 111.29, 103.60, 34.95, 21.45.  HRMS (EI+) calcd for 
[C16H14O]+ m/z = 222.1044, found m/z = 222.1040. 
 
Benzylation of benzothiophene with 4-Methylbenzyl bromide (37). Prepared 
according to the general procedure with benzothiophene (148 mg, 1.10 mmol, 1.10 equiv) 
and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv). The mixture was purified 
by flash column chromatography (5% EtOAc:95% hexanes) to give the product (198 mg, 
83%).  1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 7.9 Hz, 1H), 
7.41 (t, J = 7.5 Hz, 1H), 7.35 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 7.9 Hz, 2H), 7.26 (d, J = 7.8 
Hz, 2H), 7.10 (s, 1H), 4.29 (s, 2H), 2.46 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 145.93, 
140.45, 140.20, 136.88, 136.62, 129.67, 129.03, 124.46, 123.95, 123.28, 122.52, 121.84, 
36.94, 21.47.  HRMS (EI+) calcd for [C16H14S]+ m/z = 238.0816, found m/z = 238.0818.  
Anal Calc. for C16H14S:  C, 80.63; H, 5.92.  Found: C, 80.33; H, 5.95. 
 
Benzylation of Methyl Pyrrole-2-carboxylate with 4-Methylbenzyl bromide (38). 
Prepared according to the general procedure with methyl pyrrole-2-carboxylate (138 mg, 
1.10 mmol, 1.10 equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv). 
The mixture was purified by flash column chromatography (10% EtOAc:90% hexanes) 
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to give the product (173 mg, 76%).  1H NMR (499 MHz, CDCl3) δ 8.89 (s, 1H), 7.14 (d, 
J = 8.0 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H), 6.92 – 6.78 (m, 1H), 6.10 – 5.97 (m, 1H), 3.96 
(s, 2H), 3.81 (s, 3H), 2.35 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 161.77, 137.28, 
136.62, 135.23, 129.70, 128.79, 121.84, 116.25, 109.32, 51.49, 33.99, 21.24.  HRMS 
(EI+) calcd for [C14H15NO2]+ m/z = 229.1103, found m/z = 229.1110.  Anal Calc. for 
C14H15NO2:  C, 73.34; H, 6.59; N, 6.11.  Found: C, 73.14; H, 6.75; N, 6.07. 
+ Br
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2, PPh3
benzyl halide,
Na2CO3, THF/H2O, 100 oC
N
H Me
N
H
Me
O O
 
Benzylation of 2-Acetylpyrrole with 4-Methylbenzyl bromide (39). Prepared 
according to the general procedure with 2-acetylpyrrole (120 mg, 1.10 mmol, 1.10 equiv) 
and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv). The mixture was purified 
by flash column chromatography (10% EtOAc:90% hexanes) to give the product (104 mg, 
49%).  1H NMR (499 MHz, CDCl3) δ 9.31 (s, 1H), 7.13 (d, J = 8.1 Hz, 2H), 7.10 (d, J = 
8.2 Hz, 2H), 6.84 (dd, J = 3.6, 2.6 Hz, 1H), 6.11 – 5.97 (m, 1H), 3.96 (s, 2H), 2.38 (s, 
3H), 2.34 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 187.42, 139.50, 136.66, 134.99, 
131.76, 129.71, 128.83, 117.97, 109.56, 34.01, 25.26, 21.25.  HRMS (EI+) calcd for 
[C14H15NO]+ m/z = 213.1154, found m/z =213.1164.  Anal Calc. for C14H15NO:  C, 78.84; 
H, 7.09; N, 6.57.  Found: C, 78.44; H, 7.07; N, 6.58. 
+ Br
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2, PPh3
benzyl halide,
Na2CO3, THF/H2O, 100 oC
O
Me O
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Benzylation of 2-acetylfuran with 4-Methylbenzyl bromide (40). Prepared according 
to the general procedure with 2-acetylfuran (121 mg, 1.10 mmol, 1.10 equiv) and 4-
Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv). The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (146 mg, %).  
1H NMR (500 MHz, CDCl3) δ 7.13 (s, 4H), 7.09 (d, J = 3.5 Hz, 1H), 6.09 (d, J = 3.5 Hz, 
1H), 4.00 (s, 2H), 2.42 (s, 3H), 2.33 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 186.54, 
160.74, 152.06, 136.78, 133.64, 129.62, 128.96, 119.29, 109.43, 34.67, 26.01, 21.28.  
HRMS (EI+) calcd for [C14H14O2]+ m/z = , found m/z = . 
 
Benzylation of 2-methylthiophene with 4-Methylbenzyl bromide (41). Prepared 
according to the general procedure with 2-methylthiophene (108 mg, 1.10 mmol, 1.10 
equiv) and 4-Methylbenzyl bromide (186 mg, 1.00 mmol, 1.00 equiv). The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(131 mg, 65%).  1H NMR (500 MHz, CDCl3) δ 7.26 (d, J = 8.1 Hz, 2H), 7.23 (d, J = 8.2 
Hz, 2H), 6.69 (d, J = 3.3 Hz, 1H), 6.66 (dd, J = 3.3, 1.0 Hz, 1H), 4.14 (s, 2H), 2.52 (s, 
3H), 2.44 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 142.55, 138.61, 137.93, 136.21, 
129.54, 128.78, 125.03, 125.00, 36.23, 21.42, 15.67.  HRMS (EI+) calcd for [C13H14S]+ 
m/z = 202.0816, found m/z = 202.0811. 
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Benzylation of 3-chlorotoluene with benzyl chloride (52).  Prepared according to the 
general procedure with 3-chlorotoluene (140 mg, 1.10 mmol, 1.10 equiv) and benzyl 
chloride (127 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (160 mg, 74%).  1H NMR 
(499 MHz, CDCl3) δ 7.38 (t, J = 7.5 Hz, 2H), 7.30 (t, J = 7.3 Hz, 1H), 7.26 (d, J = 7.4 Hz, 
2H), 7.09 (s, 1H), 7.07 (s, 1H), 6.96 (s, 1H), 3.98 (s, 2H), 2.35 (s, 3H).  13C NMR (126 
MHz, CDCl3) δ 143.15, 140.66, 140.13, 134.26, 129.21, 128.88, 128.28, 127.23, 126.61, 
126.36, 41.86, 21.45.  HRMS (EI+) calcd for [C14H13Cl]+ m/z = 216.0706, found m/z = 
216.0704. 
 
Benzylation of 3-chlorotoluene with 2-fluorobenzyl chloride (53).  Prepared according 
to the general procedure with 3-chlorotoluene (140 mg, 1.10 mmol, 1.10 equiv) and 2-
fluorobenzyl chloride (145 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (185 mg, 
79%).  1H NMR (499 MHz, CDCl3) δ 7.26 (dd, J = 13.9, 6.8 Hz, 1H), 7.20 (t, J = 7.3 Hz, 
1H), 7.16 – 7.11 (m, 1H), 7.10 (d, J = 1.1 Hz, 1H), 7.08 (d, J = 6.9 Hz, 2H), 6.97 (s, 1H), 
3.98 (s, 2H), 2.34 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 161.14 (d, J = 246 Hz), 160.61 , 
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142.98 , 135.04 , 131.26 (d, J = 4.5 Hz), 128.57 (d, J = 8.1 Hz), 127.30 (d, J = 15.9 Hz), 
124.46 (d, J = 3.5 Hz), 121.50 , 115.69 (d, J = 21.9 Hz), 113.63 , 112.18 , 55.64 , 34.87 
(d, J = 3.1 Hz). HRMS (EI+) calcd for [C14H12ClF]+ m/z = 234.0612, found m/z = 
234.0617. 
 
Benzylation of 1,3-bis(trifluoromethyl)benzene with 4-tert-butylbenzyl bromide (54). 
Prepared according to the general procedure with 1,3-bis(trifluoromethyl)benzene (236 
mg, 1.10 mmol, 1.10 equiv) and 4-tert-butylbenzyl bromide (228 mg, 1.00 mmol, 1.00 
equiv). The mixture was purified by flash column chromatography (5% EtOAc:95% 
hexanes) to give the product (293 mg, 81%).  1H NMR (499 MHz, CDCl3) δ 7.78 (s, 1H), 
7.70 (s, 2H), 7.40 (d, J = 8.2 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 4.11 (s, 2H), 1.36 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 150.07, 143.96, 136.00, 131.93 (q, J = 33.1 Hz), 129.26 
(d, J = 4.1 Hz), 128.69, 126.07, 123.64 (q, J = 273 Hz), 120.47 (p, J = 4.9, 4.4 Hz), 41.29, 
34.70, 31.55. 19F NMR (376 MHz, CDCl3) δ -63.28. HRMS (EI+) calcd for [C19H18F6]+ 
m/z = 360.1313, found m/z = 360.1321. 
 
Benzylation of 3-chloroanisole with 3,5-(bistrifluoromethyl)benzyl bromide (55).  
Prepared according to the general procedure with 3-chloroanisole (157 mg, 1.10 mmol, 
1.10 equiv) and 3,5-(bistrifluoromethyl)benzyl bromide (307 mg, 1.00 mmol, 1.00 equiv).  
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The mixture was purified by flash column chromatography (5% EtOAc:95% hexanes) to 
give the product (328 mg, 89%).  1H NMR (500 MHz, CDCl3) δ 7.75 (s, 1H), 7.62 (s, 
2H), 6.80 (t, J = 2.0 Hz, 1H), 6.76 (s, 1H), 6.58 (s, 1H), 4.02 (s, 2H), 3.78 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 160.86, 142.74, 141.73, 135.57, 132.10 (q, J = 33.2 Hz), 
129.19 (d, J = 3.9 Hz), 123.51 (q, J = 273 Hz), 121.55, 120.85 (m), 113.92, 112.64, 55.71, 
41.39. 19F NMR (376 MHz, CDCl3) δ -63.34. HRMS (EI+) calcd for [C16H11ClF6O]+ m/z 
= 368.0404, found m/z = 368.0415. 
 
Benzylation of m-xylene with 4-chlorobenzyl chloride (56).  Prepared according to the 
general procedure with m-xylene (117 mg, 1.10 mmol, 1.10 equiv) and 4-chlorobenzyl 
chloride (162 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (129 mg, 56%).  1H NMR 
(500 MHz, CDCl3) δ 7.30 (d, J = 8.4 Hz, 2H), 7.16 (d, J = 8.3 Hz, 2H), 6.91 (s, 1H), 6.84 
(s, 2H), 3.91 (s, 2H), 2.33 (s, 6H).  13C NMR (126 MHz, CDCl3) δ 140.71, 140.10, 
138.34, 132.03, 130.51, 128.79, 128.21, 126.97, 41.40, 21.56.  HRMS (EI+) calcd for 
[C15H15Cl]+ m/z = 230.0862, found m/z = 230.0865. 
MeO Cl
+ Cl
MeO
Cl
1) [Ir(cod)OMe]2,
dtbpy, B2pin2, THF
2) Pd(dba)2, PPh3
benzyl halide,
Na2CO3, THF/H2O, 100 oC
Me Me
 
Benzylation of 3-chloroanisole with 2-methylbenzyl chloride (57).  Prepared according 
to the general procedure with 3-chloroanisole (157 mg, 1.10 mmol, 1.10 equiv) and 2-
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methylbenzyl chloride (141 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (228  mg, 
92%).  1H NMR (500 MHz, CDCl3) δ 7.22 (dd, J = 6.1, 3.5 Hz, 3H), 7.15 (d, J = 5.2 Hz, 
1H), 6.78 (m, 2H), 6.62 (s, 1H), 3.97 (s, 2H), 3.78 (s, 3H), 2.29 (s, 3H).  13C NMR (126 
MHz, CDCl3) δ 160.59, 143.72, 138.11, 136.87, 135.03, 130.70, 130.24, 127.07, 126.42, 
121.51, 113.66, 111.83, 55.64, 39.52, 19.95.  HRMS (EI+) calcd for [C15H15ClO]+ m/z = 
246.0812, found m/z = 246.0818. 
 
Benzylation of 3-chloroanisole with benzyl chloride (58).  Prepared according to the 
general procedure with 3-chloroanisole (157 mg, 1.10 mmol, 1.10 equiv) and benzyl 
chloride (127 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (195 mg, 84%).  1H NMR 
(500 MHz, CDCl3) δ 7.32 (t, J = 7.4 Hz, 2H), 7.25 (d, J = 7.6 Hz, 1H), 7.20 (d, J = 8.0 
Hz, 2H), 6.81 (s, 1H), 6.77 (s, 1H), 6.65 (s, 1H), 3.93 (s, 2H), 3.77 (s, 3H).  13C NMR 
(126 MHz, CDCl3) δ 160.56, 144.21, 140.29, 135.00, 129.15, 128.85, 126.64, 121.69, 
113.76, 111.98, 55.66, 41.95.  HRMS (EI+) calcd for [C14H13ClO]+ m/z = 232.0655, 
found m/z = 232.0665. 
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Benzylation of 3-chloroanisole with 2-methoxybenzyl chloride (59).  Prepared 
according to the general procedure with 3-chloroanisole (157 mg, 1.10 mmol, 1.10 equiv) 
and 2-methoxybenzyl chloride (157 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(197 mg, 75%).  1H NMR (500 MHz, CDCl3) δ 7.24 (m, 1H), 7.10 (d, J = 7.4 Hz, 1H), 
6.91 (dd, J = 16.3, 7.9 Hz, 2H), 6.83 (s, 1H), 6.74 (s, 1H), 6.69 (s, 1H), 3.93 (s, 2H), 3.84 
(s, 3H), 3.77 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 160.40, 157.49, 144.28, 134.70, 
130.60, 128.79, 128.03, 121.68, 120.80, 113.71, 111.72, 110.72, 55.61, 55.57, 35.99.  
HRMS (EI+) calcd for [C15H15ClO2]+ m/z = 262.0760, found m/z = 262.0752. 
MeO Cl
+ Cl
MeO
Cl
1) [Ir(cod)OMe]2,
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2) Pd(dba)2, PPh3
benzyl halide,
Na2CO3, THF/H2O, 100 oC
F F
 
Benzylation of 3-chloroanisole with 2-fluorobenzyl chloride (60).  Prepared according 
to the general procedure with 3-chloroanisole (157 mg, 1.10 mmol, 1.10 equiv) and 2-
fluorobenzyl chloride (145 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (223 mg, 
89%).  1H NMR (499 MHz, CDCl3) δ 7.24 (m, 1H), 7.18 (t, J = 7.5 Hz, 1H), 7.08 (m, 
2H), 6.84 (s, 1H), 6.78 (t, J = 1.9 Hz, 1H), 6.69 (s, 1H), 3.96 (s, 2H), 3.78 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 161.14, (J = 246 Hz), 160.61 , 142.98 , 135.04 , 131.26 (d, J 
= 4.5 Hz), 128.57 (d, J = 8.1 Hz), 127.30 (d, J = 15.9 Hz), 124.46 (d, J = 3.5 Hz), 121.50 , 
115.69 (d, J = 21.9 Hz), 113.63 , 112.18 , 55.64 , 34.87 (d, J = 3.1 Hz). 19F NMR (376 
MHz, CDCl3) δ -118.11. HRMS (EI+) calcd for [C14H12ClFO]+ m/z = 250.0561, found 
m/z = 250.0576. 
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Benzylation of 3-chlorobenzonitrile with 2-methoxybenzyl chloride (61).  Prepared 
according to the general procedure with 3-chloroanisole (152 mg, 1.10 mmol, 1.10 equiv) 
and 2-methoxybenzyl chloride (157 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(219 mg, 85%).  1H NMR (499 MHz, CDCl3) δ 7.46 (s, 1H), 7.43 (s, 1H), 7.41 (d, J = 1.4 
Hz, 1H), 7.30 (td, J = 7.9, 1.7 Hz, 1H), 7.15 (dd, J = 7.4, 1.6 Hz, 1H), 6.97 (td, J = 7.4, 
1.0 Hz, 1H), 6.93 (d, J = 8.3 Hz, 1H), 3.98 (s, 2H), 3.83 (s, 3H).  13C NMR (126 MHz, 
CDCl3) δ 157.46, 145.07, 135.06, 133.79, 130.88, 130.71, 129.48, 128.80, 127.34, 121.05, 
118.04, 113.77, 111.00, 55.57, 35.97.  HRMS (EI+) calcd for [C15H12ClNO]+ m/z = 
257.0607, found m/z = 257.0616. 
 
General Procedure for methylene oxidation of diarylmethanes to benzophenone 
derivatives.  AuCl3 (31 mg, 0.10 mmol, 0.10 equiv), diarylmethane (1.00 mmol, 1.00 
equiv), TBHP (5.5 M in nonane, 0.55 mL, 3.0 mmol, 3.0 equiv) and pyridine (1 mL) 
were added to vial with a magnetic stir bar.  The reaction mixture was stirred at 80 °C for 
24 h.  The reaction mixture was cooled to room temperature, filtered through silica gel 
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washing with EtOAc, and concentrated under vacuum. The mixture was purified by flash 
column chromatography to give the product. 
 
Oxidation of methyl 3-(4-methoxybenzyl)-5-methylbenzoate (62).  Prepared according 
to the general procedure with methyl 3-(4-methoxybenzyl)-5-methylbenzoate (270 mg, 
1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(10% EtOAc:90% hexanes) to give the product (208 mg, 73%).  1H NMR (500 MHz, 
CDCl3) δ 8.14 (s, 1H), 8.02 (s, 1H), 7.78 (d, J = 8.8 Hz, 2H), 7.74 (s, 1H), 6.94 (d, J = 8.8 
Hz, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 2.44 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 194.93, 
166.72, 163.65, 138.88, 138.85, 134.55, 133.56, 132.73, 130.27, 129.95, 128.20, 113.93, 
55.72, 52.50, 21.43.  HRMS (EI+) calcd for [C17H16O4]+ m/z = 284.1049, found m/z = 
284.1058. 
 
Oxidation of 4-benzyl-1,2-dimethoxybenzene (63).  Prepared according to the general 
procedure with 1,2-dimethoxy-4-(4-methoxybenzyl)benzene (259 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (10% EtOAc:90% 
hexanes) to give the product (212 mg, 78%).  1H NMR (499 MHz, CDCl3) δ 7.69 (d, J = 
7.1 Hz, 2H), 7.48 (t, J = 7.4 Hz, 1H), 7.43 (d, J = 1.8 Hz, 1H), 7.39 (t, J = 7.5 Hz, 2H), 
7.30 (dd, J = 8.3, 1.9 Hz, 1H), 6.81 (d, J = 8.4 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H).  13C 
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NMR (126 MHz, CDCl3) δ 195.60, 153.25, 149.21, 138.45, 132.03, 130.36, 129.84, 
128.33, 125.65, 112.37, 110.04, 56.23, 56.17.  HRMS (EI+) calcd for [C15H14O3]+ m/z = 
242.0943, found m/z = 242.0948. 
 
Oxidation of 1-benzyl-3-chloro-5-methoxybenzene (64).  Prepared according to the 
general procedure with 1-benzyl-3-chloro-5-methoxybenzene (233 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (10% EtOAc:90% 
hexanes) to give the product (188 mg, 76%).  1H NMR (499 MHz, CDCl3) δ 7.78 (m, 2H), 
7.58 (m, 1H), 7.47 (t, J = 7.8 Hz, 2H), 7.30 (m, 1H), 7.21 (dd, J = 2.3, 1.3 Hz, 1H), 7.09 
(t, J = 2.1 Hz, 1H), 3.82 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 195.16, 160.44, 140.14, 
137.15, 135.17, 133.02, 130.19, 128.64, 122.63, 118.62, 113.72, 55.98.  HRMS (EI+) 
calcd for [C14H11ClO2]+ m/z = 246.0448, found m/z = 246.0449. 
 
Oxidation of 5-benzyl-1,2,3-trimethoxybenzene (65).  Prepared according to the 
general procedure with 5-benzyl-1,2,3-trimethoxybenzene (259 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (10% EtOAc:90% 
hexanes) to give the product (182 mg, 67%).  1H NMR (499 MHz, CDCl3) δ 7.75 (m, 2H), 
7.53 (dd, J = 10.6, 4.3 Hz, 1H), 7.44 (t, J = 7.6 Hz, 2H), 7.03 (s, 2H), 3.89 (s, 3H), 3.82 (s, 
6H).  13C NMR (126 MHz, CDCl3) δ 195.83, 153.08, 142.34, 138.00, 132.76, 132.45, 
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130.03, 128.45, 108.02, 61.11, 56.49.  HRMS (EI+) calcd for [C16H16O4]+ m/z = 
272.1049, found m/z = 272.1056. 
 
Oxidation of 3-(2-methoxybenzyl)-5-methylbenzonitrile (66).  Prepared according to 
the general procedure with 3-(2-methoxybenzyl)-5-methylbenzonitrile (208 mg, 1.00 
mmol, 1.00 equiv).  The mixture was purified by flash column chromatography (10% 
EtOAc:90% hexanes) to give the product (123 mg, 55%).  1H NMR (500 MHz, CDCl3) δ 
7.85 (d, J = 0.6 Hz, 1H), 7.77 (s, 1H), 7.60 (s, 1H), 7.51 (m, 1H), 7.38 (dd, J = 7.5, 1.7 
Hz, 1H), 7.06 (td, J = 7.5, 0.7 Hz, 1H), 7.00 (d, J = 8.4 Hz, 1H), 3.69 (s, 3H), 2.42 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 194.77, 157.65, 139.89, 139.12, 136.25, 134.16, 133.15, 
131.03, 130.14, 127.69, 121.09, 118.54, 112.59, 111.83, 55.77, 21.33.  HRMS (EI+) 
calcd for [C16H13NO2]+ m/z = 251.0946, found m/z = 251.0949. 
 
Synthesis of 2-methoxy-5-chlorobenzyl chloride.  Inside a glove box, LiAlH4 (760 mg, 
20.0 mmol, 1.00 equiv) and dry Et2O (30 mL) were added to a dry flask containing a 
magnetic stir bar.  The flask was removed from the glove box and cooled to 0 °C.  
Methyl 5-chloro-2-methoxybenzoate (4.00 g, 20.0 mmol, 1.00 equiv) in 20 mL of dry 
Et2O was added dropwise to the flask.  The reaction mixture was allowed to warm to 
room temperature over 12 h.  In succession, 1 mL H2O, 0.5 mL 4 M NaOH (aq) and 3 
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mL H2O were added.  The reaction mixture was filtered through Celite and MgSO4, 
washing with Et2O.  The reaction mixture was concentrated and used in the next step 
without further purification.  PPh3 (10.5 g, 40.0 mmol, 2 equiv), CCl4 (6.16 g, 40.0 mmol, 
2.00 equiv) and CH2Cl2 (75 mL) were added to a dry flask and cooled to 0 °C.  The crude 
product from the reduction step in 25 mL CH2Cl2 was added dropwise to the reaction 
mixture.  The reaction mixture was allowed to warm to room temperature over 8 h.  After 
8 h, the solvent was removed under vacuum and the product was purified by column 
chromatography (10% EtOAc: 90% hexanes) to give 2-methoxy-5-chlorobenzyl chloride.  
Spectral properties matched previously reported values.28 
 
Coupling of 3-chlorobenzonitrile with 2-methoxy-5-chlorobenzyl chloride (67).  
Prepared according to the general procedure with 3-chlorobenzonitrile (152 mg, 1.10 
mmol, 1.10 equiv) and 2-methoxy-5-chlorobenzyl chloride (191 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (10% EtOAc:90% 
hexanes) to give the product (208 mg, 71%).  1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 
6.0 Hz, 1H), 7.36 (s, 1H), 7.20 (dd, J = 8.7, 2.6 Hz, 1H), 7.07 (d, J = 2.5 Hz, 1H), 6.81 (s, 
1H), 6.80 (s, 1H), 3.90 (s, 2H), 3.79 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 156.06, 
144.09, 135.19, 133.71, 130.79, 130.39, 129.74, 129.09, 128.37, 125.72, 117.89, 113.89, 
112.16, 55.93, 35.66.  HRMS (EI+) calcd for [C15H11Cl2NO]+ m/z = 291.0218, found m/z 
= 291.0221. 
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Oxidation of 3-chloro-5-(2-chloro-5-methoxybenzyl)benzonitrile to 3-chloro-5-(2-
chloro-5-methoxybenzoyl)benzonitrile (68).  CrO3 (3 mg, 0.03 mol, 0.1 equiv) and 
H5IO6 (171 mg, 0.750 mmol, 2.5 equiv) were added to a vial containing a magnetic stir 
bar.  3-chloro-5-(2-chloro-5-methoxybenzyl)benzonitrile (88 mg, 0.3 mmol, 1.0 equiv) in 
MeCN (1.5 mL) was added and the reaction mixture was stirred at room temperature for 
3 h.  After 3 h, the reaction mixture was filtered through silica gel washing with EtOAc, 
and concentrated under vacuum. The mixture was purified by flash column 
chromatography (15% EtOAc:85% hexanes) to give the product (67 mg, 73%).  1H NMR 
(499 MHz, CDCl3) δ 7.97 (m, 1H), 7.86 (t, J = 1.4 Hz, 1H), 7.80 (m, 1H), 7.50 (dd, J = 
8.9, 2.6 Hz, 1H), 7.39 (d, J = 2.6 Hz, 1H), 6.97 (s, 1H), 6.95 (s, 1H), 3.70 (s, 3H).  13C 
NMR (126 MHz, CDCl3) δ 191.70, 156.22, 140.25, 135.95, 135.52, 133.58, 133.29, 
131.40, 129.99, 128.17, 126.71, 116.92, 114.44, 113.37, 56.19.  HRMS (EI+) calcd for 
[C15H9Cl2NO2]+ m/z = 306.0089, found m/z = 306.0095. 
 
General Procedure for Alkylation of Arenes.  Inside a glove box, [Ir(cod)OMe]2 (2.5 
mg, 0.0038 mmol, 0.0038 equiv), dtbpy (2.0 mg, 0.0075 mmol, 0.0075 equiv), B2pin2 
(229 mg, 0.900 mmol, 0.900 equiv), arene (1.50 mmol, 1.50 equiv), and THF (3 mL) 
were added to a dry vial with a magnetic stir bar.  The vial was sealed and heated at 80 
140 
C for 18 h.  The reaction mixture was cooled to room temperature and the volatile 
materials were removed under vacuum.  NiBr2-dme (30.9 mg, 0.100 mmol, 0.100 equiv), 
trans-N,N′-Dimethylcyclohexane-1,2-diamine (28.5 mg, 0.200 mmol, 0.200 equiv), the 
alkyl halide (1.00 mmol, 1.00 equiv), KOtBu (135 mg, 1.20 mmol, 1.20 equiv), 2-butanol 
(149 mg, 2.00 mmol, 2.00 equiv) and 1,4-dioxane (2 mL) were added consecutively to 
the reaction mixture.   The reaction mixture was stirred at 60 °C for 15 hours. The 
reaction mixture was cooled to room temperature, filtered through silica gel washing with 
EtOAc, and concentrated under vacuum.  The reaction mixture was purified by column 
chromatography to give the product. 
 
Alkylation of m-xylene with 1-bromo-3-phenylpropane. Prepared according to the 
general procedure with m-xylene (159 mg, 1.50 mmol, 1.50 equiv), 1-bromo-3-
phenylpropane (199 mg, 1.00 mmol, 1.00 equiv) and NaI (150 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (5% Et2O:95% 
pentane) to give the product (150 mg, 67%). 1H NMR (499 MHz, CDCl3) δ 7.37 (m, 2H), 
7.28 (d, J = 7.3 Hz, 2H), 6.91 (d, J = 8.0 Hz, 4H), 2.75 (t, J = 7.7 Hz, 2H), 2.68 (t, J = 7.5 
Hz, 2H), 2.38 (s, 6H), 2.04 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 142.70, 142.53, 
138.01, 128.74, 128.58, 127.68, 126.59, 126.00, 35.90, 35.66, 33.32, 21.59. HRMS (EI+) 
calcd for [C17H20]+ m/z = 224.1565, found m/z = 224.1568. 
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Alkylation of 3-chloroanisole with 1-iodo-3-phenylpropane. Prepared according to the 
general procedure with 3-chloroanisole (213 mg, 1.50 mmol, 1.50 equiv) and 1-iodo-3-
phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% Et2O:95% pentane) to give the product (216 mg, 83%). 1H 
NMR (499 MHz, CDCl3) δ 7.34 (m, 2H), 7.24 (m, 3H), 6.84 (s, 1H), 6.79 (s, 1H), 6.67 (s, 
1H), 3.82 (s, 3H), 2.70 (t, J = 7.7 Hz, 2H), 2.64 (t, J = 7.7 Hz, 2H), 1.99 (p, J = 7.6, 7.0 
Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 160.55, 145.44, 142.21, 134.84, 128.70, 128.63, 
126.13, 121.27, 113.23, 111.78, 55.66, 35.59, 35.51, 32.82. HRMS (EI+) calcd for 
[C16H17ClO]+ m/z = 260.0968, found m/z = 260.0962. 
 
Alkylation of 3-bromoanisole with 1-iodo-3-phenylpropane. Prepared according to the 
general procedure with 3-bromoanisole (281 mg, 1.50 mmol, 1.50 equiv) and 1-iodo-3-
phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% Et2O:95% pentane) to give the product (216 mg, 71%). 1H 
NMR (499 MHz, CDCl3) δ 7.33 (m, 2H), 7.23 (m, 3H), 6.98 (s, 1H), 6.93 (s, 1H), 6.69 (s, 
1H), 3.80 (s, 3H), 2.68 (t, J = 7.7 Hz, 2H), 2.62 (t, J = 7.7 Hz, 2H), 1.98 (tdd, J = 9.4, 6.9, 
5.5 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 160.57, 145.75, 142.17, 128.68, 128.62, 
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126.11, 124.19, 122.86, 114.62, 113.75, 55.67, 35.57, 35.43, 32.82. HRMS (EI+) calcd 
for [C16H17BrO]+ m/z = 304.0463, found m/z = 304.0470. 
 
Alkylation of 3-(trifluoromethyl)anisole with 1-iodo-3-phenylpropane. Prepared 
according to the general procedure with 3-(trifluoromethyl)anisole (265 mg, 1.50 mmol, 
1.50 equiv) and 1-iodo-3-phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% Et2O:95% pentane) to give the 
product (201 mg, 68%). 1H NMR (500 MHz, CDCl3) δ 7.35 (m, 2H), 7.25 (m, 3H), 7.10 
(s, 1H), 7.02 (s, 1H), 6.94 (s, 1H), 3.86 (s, 3H), 2.71 (m, 4H), 2.02 (tt, J = 9.2, 7.0 Hz, 
2H). 13C NMR (126 MHz, CDCl3) δ 160.04, 145.10, 142.09, 131.91 (q, J = 31.8 Hz), 
128.70, 128.65, 126.17, 124.39 (q, J = 273 Hz), 118.03, 117.80 (q, J = 3.8 Hz), 108.17 (q, 
J = 3.9 Hz), 55.64, 35.60, 35.56, 32.87. HRMS (EI+) calcd for [C17H17F3O]+ m/z = 
294.1232, found m/z = 294.1240. 
 
Alkylation of N,N-Diethyl-3-methylbenzamide with 1-iodo-3-phenylpropane. 
Prepared according to the general procedure with N,N-Diethyl-3-methylbenzamide (287 
mg, 1.50 mmol, 1.50 equiv) and 1-iodo-3-phenylpropane (246 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (15% EtOAc:85% 
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hexanes) to give the product (214 mg, 69%). 1H NMR (499 MHz, CDCl3) δ 7.37 (s, 1H), 
7.29 (t, J = 7.6 Hz, 2H), 7.20 (d, J = 8.1 Hz, 3H), 7.02 (m, 2H), 3.56 (m, 2H), 3.26 (m, 
2H), 2.66 (dt, J = 10.6, 7.3 Hz, 4H), 2.35 (s, 3H), 1.97 (p, J = 7.8 Hz, 2H), 1.26 (s, 3H), 
1.11 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 171.93, 142.66, 142.35, 138.32, 137.55, 
130.23, 128.65, 128.56, 126.02, 124.59, 123.51, 43.53, 39.42, 35.70, 35.50, 33.08, 21.57, 
14.49, 13.19. HRMS (EI+) calcd for [C21H27NO]+ m/z = 309.2093, found m/z = 309.2100. 
 
Alkylation of 1,2,3-trimethoxybenzene with 1-iodo-3-phenylpropane. Prepared 
according to the general procedure with 1,2,3-trimethoxybenzene (252 mg, 1.50 mmol, 
1.50 equiv) and 1-iodo-3-phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% EtOAc:95% hexanes) to give the 
product (143 mg, 50%). 1H NMR (500 MHz, CDCl3) δ 7.30 (m, 2H), 7.21 (d, J = 6.8 Hz, 
3H), 6.41 (s, 2H), 3.85 (s, 6H), 3.84 (s, 3H), 2.68 (t, J = 7.7 Hz, 2H), 2.61 (t, J = 7.5 Hz, 
2H), 1.98 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 153.29, 142.41, 138.29, 128.68, 
128.56, 126.03, 122.67, 105.51, 61.09, 56.29, 36.09, 35.72, 33.19. HRMS (EI+) calcd for 
[C18H22O3]+ m/z = 286.1569, found m/z = 286.1565. 
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Alkylation of 3-chlorobenzonitrile with 1-iodo-3-phenylpropane. Prepared according 
to the general procedure with 3-chlorobenzonitrile (207 mg, 1.50 mmol, 1.50 equiv) and 
1-iodo-3-phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (182 mg, 
71%). 1H NMR (500 MHz, CDCl3) δ 7.46 (s, 1H), 7.40 (s, 1H), 7.35 (s, 1H), 7.31 (t, J = 
7.6 Hz, 2H), 7.22 (m, 1H), 7.18 (m, 2H), 2.66 (td, J = 7.8, 2.8 Hz, 4H), 1.96 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 145.89, 141.46, 135.25, 133.51, 130.51, 129.55, 128.73, 
128.61, 126.35, 117.89, 113.95, 35.40, 34.88, 32.52. HRMS (EI+) calcd for [C16H14ClN]+ 
m/z = 255.0815, found m/z = 255.0809. 
 
Alkylation of 2-bromo-4-fluorotoluene with 1-iodo-3-phenylpropane. Prepared 
according to the general procedure with 2-bromo-4-fluorotoluene (284 mg, 1.50 mmol, 
1.50 equiv) and 1-iodo-3-phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% Et2O:95% pentane) to give the 
product (234 mg, 76%). 1H NMR (499 MHz, CDCl3) δ 7.31 (dd, J = 8.7, 6.5 Hz, 2H), 
7.22 (m, 4H), 7.05 (d, J = 7.8 Hz, 1H), 2.68 (t, J = 7.7 Hz, 2H), 2.63 (t, J = 7.7 Hz, 2H), 
2.35 (s, 3H), 1.94 (tt, J = 9.6, 6.7 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 159.24 (d, J = 
246.7 Hz), 142.13 , 133.46 (d, J = 3.6 Hz), 132.29 (d, J = 5.5 Hz), 128.61 (d, J = 6.1 Hz), 
128.38 (d, J = 16.0 Hz), 126.09, 121.66 (d, J = 9.7 Hz), 119.42, 119.22, 35.69, 31.78, 
28.60, 22.20. 19F NMR (376 MHz, CDCl3) δ -121.48. HRMS (EI+) calcd for 
[C16H16BrF]+ m/z = 306.0419, found m/z = 306.0422. 
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Alkylation of 3,4-difluoroanisole with 1-iodo-3-phenylpropane. Prepared according to 
the general procedure with 3,4-difluoroanisole (216 mg, 1.50 mmol, 1.50 equiv) and 1-
iodo-3-phenylpropane (246 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% Et2O:95% pentane) to give the product (181 mg, 69%). 
1H NMR (500 MHz, CDCl3) δ 7.30 (t, J = 7.6 Hz, 2H), 7.20 (m, 3H), 6.56 (ddd, J = 11.8, 
6.2, 3.1 Hz, 1H), 6.46 (dd, J = 3.9, 1.7 Hz, 1H), 3.75 (s, 3H), 2.68 (t, J = 7.7 Hz, 4H), 
1.96 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 155.35 (d, J = 11.1 Hz), 150.816 (dd, J = 
14.6 Hz, 247.2 Hz), 143.75 (dd, J = 12.9 Hz, 238.9 Hz), 142.02 , 131.86 (d, J = 13.8 Hz), 
128.61 (d, J = 4.9 Hz), 126.11, 123.02, 110.28, 100.96 (d, J = 20.8 Hz), 56.01, 35.61, 
31.70, 29.05. 19F NMR (376 MHz, CDCl3) δ -137.05 (dd, J = 21.5, 11.7 Hz), -154.47 (d, 
J = 21.8 Hz). HRMS (EI+) calcd for [C16H16FO]+ m/z = 262.1169, found m/z = 262.1175. 
 
Alkylation of 3-chloroanisole with tert-Butyl(4-iodobutoxy)dimethylsilane. Prepared 
according to the general procedure with 3-chloroanisole (213 mg, 1.50 mmol, 1.50 equiv) 
and tert-Butyl(4-iodobutoxy)dimethylsilane (315 mg, 1.00 mmol, 1.00 equiv).  The 
mixture was purified by flash column chromatography (5% Et2O:95% pentane) to give 
the product (169 mg, 52%). 1H NMR (500 MHz, CDCl3) δ 6.78 (d, J = 1.6 Hz, 1H), 6.73 
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(d, J = 2.0 Hz, 1H), 6.62 (d, J = 1.9 Hz, 1H), 3.78 (s, 3H), 3.64 (m, 2H), 2.58 (t, J = 7.6 
Hz, 2H), 1.66 (m, 2H), 1.56 (m, 2H), 0.91 (s, 9H), 0.06 (s, 6H). 13C NMR (126 MHz, 
CDCl3) δ 160.45, 145.73, 134.72, 121.21, 113.10, 111.63, 63.10, 55.57, 35.75, 32.50, 
27.55, 26.22, 18.59, -5.04. HRMS (EI+) calcd for [C16H26ClO2Si]+ (M-CH3)+ m/z = 
313.1391, found m/z = 313.1383. 
 
Alkylation of 1,2,3-trimethoxybenzene with 1-iodo-2-methylpropane. Prepared 
according to the general procedure with 1,2,3-trimethoxybenzene (252 mg, 1.50 mmol, 
1.50 equiv) and 1-iodo-2-methylpropane (184 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (15% Et2O:85% pentane) to give the 
product (114 mg, 51%). 1H NMR (500 MHz, CDCl3) δ 6.36 (s, 2H), 3.85 (s, 6H), 3.83 (s, 
3H), 2.41 (d, J = 7.3 Hz, 2H), 1.85 (hept, J = 6.8 Hz, 1H), 0.91 (d, J = 6.6 Hz, 6H). 13C 
NMR (126 MHz, CDCl3) δ 153.08, 137.75, 122.91, 106.14, 61.08, 56.25, 46.11, 30.51, 
22.66. HRMS (EI+) calcd for [C13H20O3]+ m/z = 224.1413, found m/z = 224.1410. 
 
Alkylation of 3-bromoanisole with 1-iodo-2-methylpropane. Prepared according to the 
general procedure with 3-bromoanisole (281 mg, 1.50 mmol, 1.50 equiv) and 1-iodo-2-
methylpropane (184 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
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column chromatography (5% Et2O:95% pentane) to give the product (121 mg, 50%). 1H 
NMR (500 MHz, CDCl3) δ 6.90 (t, J = 1.6 Hz, 1H), 6.89 (t, J = 2.1 Hz, 1H), 6.62 (dd, J = 
2.4, 1.4 Hz, 1H), 3.78 (s, 3H), 2.41 (d, J = 7.2 Hz, 2H), 1.86 (hept, J = 7.0 Hz, 1H), 0.91 
(d, J = 6.6 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 160.35, 145.15, 124.77, 122.60, 
114.40, 114.35, 55.61, 45.39, 30.27, 22.55. HRMS (EI+) calcd for [C11H15BrO]+ m/z = 
242.0306, found m/z = 242.0298. 
 
Alkylation of 3-chloroanisole with 7-bromoheptanenitrile. Prepared according to the 
general procedure with 3-chloroanisole (213 mg, 1.50 mmol, 1.50 equiv), 7-
bromoheptanenitrile (190 mg, 1.00 mmol, 1.00 equiv), and NaI (150 mg, 1.00 mmol, 1.00 
equiv). The mixture was purified by flash column chromatography (10% Et2O:90% 
pentane) to give the product (149 mg, 59%). 1H NMR (499 MHz, CDCl3) δ 6.76 (t, J = 
1.7 Hz, 1H), 6.73 (t, J = 2.1 Hz, 1H), 6.60 (t, J = 1.9 Hz, 1H), 3.79 (s, 3H), 2.56 (t, J = 
7.7 Hz, 2H), 2.33 (t, J = 7.1 Hz, 2H), 1.64 (m, 4H), 1.48 (m, 2H), 1.37 (m, 2H). 13C NMR 
(126 MHz, CDCl3) δ 160.50, 145.47, 134.77, 121.13, 119.96, 113.13, 111.68, 55.65, 
35.81, 30.92, 28.71, 28.50, 25.50, 17.34. HRMS (EI+) calcd for [C14H18ClNO]+ m/z = 
251.1077, found m/z = 251.1074. 
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Alkylation of benzofuran with 1-iodo-3-phenylpropane. Prepared according to the 
general procedure with benzofuran (177 mg, 1.50 mmol, 1.50 equiv) and 1-iodo-2-
methylpropane (184 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% Et2O:95% pentane) to give the product (114 mg, 51%). 1H 
NMR (500 MHz, Chloroform-d) δ 7.53 (d, J = 7.0 Hz, 1H), 7.46 (d, J = 7.7 Hz, 1H), 7.34 
(t, J = 7.5 Hz, 2H), 7.25 (m, 5H), 6.44 (s, 1H), 2.84 (t, J = 7.4 Hz, 2H), 2.76 (t, J = 7.6 Hz, 
2H), 2.13 (p, J = 7.6 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 159.37, 154.92, 141.98, 
129.20, 128.77, 128.65, 126.19, 123.40, 122.68, 120.48, 111.00, 102.38, 35.48, 29.54, 
28.15. 
General Procedure for Alkylation of Arenes with Secondary Alkyl Halides.  Inside a 
glove box, [Ir(cod)OMe]2 (2.5 mg, 0.0038 mmol, 0.0038 equiv), dtbpy (2.0 mg, 0.0075 
mmol, 0.0075 equiv), B2pin2 (229 mg, 0.900 mmol, 0.900 equiv), arene (1.50 mmol, 1.50 
equiv), and THF (3 mL) were added to a dry vial with a magnetic stir bar.  The vial was 
sealed and heated at 80 C for 18 h.  The reaction mixture was cooled to room 
temperature and the volatile materials were removed under vacuum.  NiBr2-dme (30.9 mg, 
0.100 mmol, 0.100 equiv), bathophenanthroline (66.5 mg, 0.200 mmol, 0.200 equiv), the 
alkyl halide (1.00 mmol, 1.00 equiv), KOtBu (135 mg, 1.20 mmol, 1.20 equiv), 2-butanol 
(149 mg, 2.00 mmol, 2.00 equiv) and 1,4-dioxane (2 mL) were added consecutively to 
the reaction mixture.   The reaction mixture was stirred at 60 °C for 15 hours. The 
reaction mixture was cooled to room temperature, filtered through silica gel washing with 
EtOAc, and concentrated under vacuum.  The reaction mixture was purified by column 
chromatography to give the product. 
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Alkylation of 1,2,3-trimethoxybenzene with iodocyclohexane. Prepared according to 
the general procedure with 1,2,3-trimethoxybenzene (252 mg, 1.50 mmol, 1.50 equiv) 
and iodocyclohexane (210 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (15% Et2O:85% pentane) to give the product (184 mg, 
74%). 1H NMR (500 MHz, CDCl3) δ 6.43 (s, 2H), 3.86 (s, 6H), 3.82 (s, 3H), 2.44 (ddt, J 
= 11.2, 7.1, 3.6 Hz, 1H), 1.85 (m, 4H), 1.75 (m, 1H), 1.39 (m, 3H), 1.26 (qt, J = 11.6, 7.5, 
6.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 153.22, 144.24, 128.55, 103.86, 61.04, 56.24, 
45.28, 34.85, 27.13, 26.37. HRMS (EI+) calcd for [C15H22O3]+ m/z = 250.1569, found 
m/z = 250.1566. 
 
  
 
Alkylation of 3-chloroanisole with iodocyclopentane. Prepared according to the 
general procedure with 3-chloroanisole (213 mg, 1.50 mmol, 1.50 equiv) and 
iodocyclopentane (196 mg, 1.00 mmol, 1.00 equiv). The mixture was purified by flash 
column chromatography (5% Et2O:95% pentane) to give the product (169 mg, 80%). 1H 
NMR (500 MHz, CDCl3) δ 6.83 (m, 1H), 6.71 (d, J = 2.0 Hz, 1H), 6.67 (d, J = 1.9 Hz, 
1H), 3.78 (s, 3H), 2.93 (m, 1H), 2.05 (m, 2H), 1.80 (td, J = 6.6, 6.2, 3.4 Hz, 2H), 1.67 (m, 
2H), 1.56 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 160.38, 149.84, 134.69, 119.97, 
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112.08, 111.35, 55.63, 46.01, 34.58, 25.66. HRMS (EI+) calcd for [C12H15ClO]+ m/z = 
210.0812, found m/z = 210.0804. 
 
 
 
Alkylation of 3-(trifluoromethyl)anisole with iodocyclohexane. Prepared according to 
the general procedure with 3-(trifluoromethyl)anisole (264 mg, 1.50 mmol, 1.50 equiv) 
and iodocyclohexane (210 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% Et2O:95% pentane) to give the product (141 mg, 55%). 
1H NMR (499 MHz, CDCl3) δ 7.09 (s, 1H), 6.96 (s, 1H), 6.94 (s, 1H), 3.85 (s, 3H), 2.55 
(m, 1H), 1.88 (qd, J = 8.5, 7.1, 3.7 Hz, 4H), 1.78 (m, 1H), 1.42 (m, 4H), 1.29 (ddt, J = 
13.3, 7.8, 3.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 159.97, 150.86, 131.76 (q, J = 
31.8 Hz), 124.42 (q, J = 272.5 Hz), 116.63, 116.31 (q, J = 3.8 Hz), 107.89 (q, J = 3.8 Hz), 
55.61, 44.81, 34.46, 26.95, 26.24. 19F NMR (376 MHz, CDCl3) δ -62.99. HRMS (EI+) 
calcd for [C14H17F3O]+ m/z = 258.1232, found m/z = 258.1224. 
 
  
 
Alkylation of 3-chloroanisole with 3-iodotetrahydrofuran. Prepared according to the 
general procedure with 3-chloroanisole (213 mg, 1.50 mmol, 1.50 equiv) and 3-
iodotetrahydrofuran (198 mg, 1.00 mmol, 1.00 equiv). The mixture was purified by flash 
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column chromatography (5% Et2O:95% pentane) to give the product (171 mg, 81%). 1H 
NMR (500 MHz, CDCl3) δ 6.83 (s, 1H), 6.74 (s, 1H), 6.67 (s, 1H), 4.06 (m, 2H), 3.88 (m, 
1H), 3.78 (s, 1H), 3.70 (m, 1H), 3.33 (h, J = 7.7, 6.9 Hz, 1H), 2.34 (dtd, J = 12.5, 7.8, 4.5 
Hz, 1H), 1.96 (dq, J = 12.2, 7.9 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 160.61, 146.12, 
135.10, 119.97, 112.20, 104.69, 74.53, 68.62, 55.70, 45.00, 34.63. HRMS (EI+) calcd for 
[C11H13ClO3]+ m/z = 212.0604, found m/z = 212.0611. 
 
 
 
Alkylation of 1,2,3-trimethoxybenzene with 2-iodopropane. Prepared according to the 
general procedure with 1,2,3-trimethoxybenzene (252 mg, 1.50 mmol, 1.50 equiv) and 2-
iodopropane (170 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (15% Et2O:85% pentane) to give the product (107 mg, 51%). 1H 
NMR (500 MHz, CDCl3) δ 6.44 (s, 2H), 3.86 (s, 6H), 3.82 (s, 3H), 2.84 (hept, J = 6.9 Hz, 
1H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 153.25, 144.99, 136.12, 
103.44, 61.06, 56.25, 34.79, 24.34. HRMS (EI+) calcd for [C12H18O3]+ m/z = 210.1256, 
found m/z = 210.1264. 
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Alkylation of 1,2,3-trimethoxybenzene with 2-bromopentane. Prepared according to 
the general procedure with 1,2,3-trimethoxybenzene (252 mg, 1.50 mmol, 1.50 equiv), 2-
bromopentane (151 mg, 1.00 mmol, 1.00 equiv), and NaI (150 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (15% Et2O:85% 
pentane) to give the product (152 mg, 64%). 1H NMR (500 MHz, CDCl3) δ 6.39 (s, 2H), 
3.85 (s, 6H), 3.82 (s, 3H), 2.62 (h, J = 7.0 Hz, 1H), 1.51 (m, 2H), 1.27 (m, 1H), 1.21 (d, J 
= 6.9 Hz, 3H), 0.88 (td, J = 7.3, 1.0 Hz, 5H). 13C NMR (126 MHz, CDCl3) δ 153.20, 
144.11, 136.09, 103.92, 61.06, 56.25, 41.00, 40.38, 22.51, 21.08, 14.40. HRMS (EI+) 
calcd for [C14H22O3]+ m/z = 238.1569, found m/z = 238.1578. 
 
 
 
Alkylation of 3-chloroanisole with N-Boc-4-iodopiperidne. Prepared according to the 
general procedure with 3-chloroanisole (213 mg, 1.50 mmol, 1.50 equiv) and N-Boc-4-
iodopiperidine (312 mg, 1.00 mmol, 1.00 equiv). The mixture was purified by flash 
column chromatography (15% EtOAc:85% hexane) to give the product (176 mg, 54%). 
1H NMR (499 MHz, CDCl3) δ 6.79 (s, 1H), 6.74 (s, 1H), 6.63 (s, 1H), 4.23 (s, 2H), 3.78 
(s, 3H), 2.77 (s, 2H), 2.57 (dt, J = 13.4, 4.2 Hz, 1H), 1.79 (m, 2H), 1.57 (tt, J = 12.4, 6.3 
Hz, 2H), 1.48 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 160.60, 154.99, 148.92, 135.00, 
119.67, 112.05, 111.73, 79.75, 55.65, 42.87, 33.15, 28.70. HRMS (EI+) calcd for 
[C17H24ClNO3]+ m/z = 325.1445, found m/z = 325.1437. 
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Chapter 4. A C-H Borylation Approach to Suzuki-Miyaura Coupling of Typically 
Unstable 2-Heteroaryl and Polyfluorophenyl Boronates with Simple Catalysts 
4.1 Introduction 
Suzuki-Miyaura cross coupling is one of the most utilized methods for the 
construction of carbon-carbon bonds.1 Suzuki-Miyaura coupling has been utilized to 
construct molecules with a variety of functions, including pharmaceutical agents, natural 
products, and functional materials (Figure 1). The Suzuki-Miyaura coupling reaction has 
found widespread use because of several attractive features, including mild conditions, 
tolerance of a variety of functional groups, the ease of synthesis of organoboron 
compounds, and widespread access to a variety of coupling partners. Highly active 
catalysts have been developed for Suzuki-Miyaura cross-coupling and these catalysts 
have enabled for Suzuki coupling to be conducted with less reaction electrophiles, such 
as aryl chlorides and sulfonates, as well as with a wide variety of organoboron 
compounds.2 
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Figure 1. Large-scale applications of Suzuki-Miyaura coupling; the bond made by Pd-
catalyzed Suzuki-Miyaura coupling is highlighted in red 
4.2 Background 
Despite the broad utility of Suzuki-Miyaura cross-coupling, coupling with several 
classes of organoboron compounds, such as 2-heteroaryl and polyfluoroaryl boronates, 
are challenging because the boronic acids are unstable to protodeborylation.  Several 
approaches to enable cross coupling of these classes of organoboronates have been 
reported (Figure 2). By one approach, the boronic acid is converted to a boronic acid 
derivative, such as a trifluoroborate salt,3 a cyclic triolborate,4 a lithium borate salt5 or a 
MIDA boronate (MIDA = N-methyliminodiacetic acid).6 The protected organoboronate is 
then hydrolyzed in situ to the boronic acid, which participates in the cross-coupling 
reaction. These approaches require initial synthesis of the unstable boronic acid, often via 
lithiation of an arene or heteroarene at low temperatures. By a second approach, the 
coupling step is conducted with a highly active metallacyclic palladium catalyst bearing 
an expensive specialized biarylmonophosphine ligand to ensure that the coupling reaction 
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is faster than protodeborylation.7 While this approach furnishes good yields for the 
coupling products, it does not address the problem of isolating, handling, and storing the 
boronic acid. 
 
Figure 2. Boronic acid surrogates for Suzuki coupling of unstable boronates 
We considered that this synthetic problem could be addressed by exploiting the 
borylation of arenes and heteroarenes to form pinacol-substituted organoboronic esters 
(Scheme 45). Recent mechanistic studies of the Suzuki-Miyaura reaction8 imply that 
transmetallation of a neutral organoboron compound occurs with a pinacol boronate ester 
under mild conditions without the intermediacy of the boronic acid, even at -55 °C. In 
addition, we hypothesized that pinacol boronate esters formed by C-H borylation9 would 
be sufficiently stable to protodeborylation in pure form and in solution, due to the 
increased electron density and steric hindrance around the boron atom in these 
compounds.10  In addition, we envisioned that simple palladium catalysts could be 
identified for the cross coupling of these more stable pinacol boronate esters with aryl 
bromides. 
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Scheme 45.  Approaches to Suzuki-Miyaura cross-coupling of unstable organoboronates 
We report a general, one-pot method for arylation of heteroarenes and fluorinated 
arenes by Ir-catalyzed C-H borylation, followed by Pd-catalyzed cross-coupling with 
pinacol boronate esters as surrogates for unstable boronic acids. This method rests upon 
the simplicity of forming pinacol boronates by C-H borylation chemistry that creates 
gaseous H2 as the sole byproduct, the enhanced stability of pinacol boronates, relative to 
their corresponding boronic acids, and the rapid transmetallation of the resulting pinacol 
boronates with palladium complexes bearing simple phosphine ligands. 
4.3 Results and Discussion 
We chose to address the challenge of the Suzuki-Miyaura coupling of 2-heteroaryl 
boronates and polyfluoroaryl boronates because these aromatic groups are common 
substructures in medicinal chemistry but have been difficult to introduce by cross 
coupling. While these classes of (hetero)aryl pinacol boronates can be synthesized by 
lithation of an aryl bromide, followed by quenching with an alkoxyborate, or by the 
catalytic borylation of aryl halides, the borylation of the arene or heteroarene itself is a 
direct method to access these pinacol boronates.11 Although this reaction has been 
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reported previously, we found that the products from these reactions are stable both in the 
solid state and in solution. This stability enables the strategy for Suzuki coupling of 
unstable boronates with simple catalysts. While the isolated yields of the pinacol 
boronates are generally moderate to good, previous work has demonstrated that the GC 
yield of the pinacol boronate in the crude reaction mixture following the C-H borylation 
reaction is high,12 indicating that a method to utilize these boronates in situ could 
potentially be advantageous. 
Mono- and di-ortho-fluoroaryl pinacol boronates also form by iridium-catalyzed C-H 
borylation and are stable both in the solid state and in solution. Because the 
regioselectivity of the C-H borylation of arenes occurs at the least hindered C-H bond, we 
hypothesized that the reaction of a 3,5-difluoroarene with B2pin2 or HBpin in the 
presence of the same Ir catalyst would yield a 2,6-difluoroaryl pinacol boronate, as 
shown in Equation 3. This borylation occurs at the C-H bond ortho to both fluorine atoms 
due to the small size of fluorine. Indeed, the borylation of polyfluorinated arenes 
occurred ortho to the fluorine atom with 0.6 equivalents of B2pin2 or 1.1 equivalents of 
HBpin as the boron source (Table 11).  These reactions occur with 3,5-difluoroarenes 
containing electron-donating or electron-withdrawing substituents. They also occur with 
3,4-difluoroarenes to form a single arylboronate ester. Similar to 2-heteroaryl pinacol 
boronates, these fluoroarylpinacol boronate esters demonstrate sufficient stability to silica 
gel chromatography to allow for convenient laboratory purification, but some of the 
pinacol boronate ester is lost during isolation. However, GC yields of the borylation 
product from the crude reaction mixture are high, indicating that a method to utilize these 
boronates in situ could developed. 
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These heteroaryl and fluoroaryl pinacol boronates are stable indefinitely on the bench 
top. Unlike the corresponding boronic acids, both the 2-heteroaryl and polyfluoroaryl 
pinacol boronate esters are stable in air at room temperature for at least 60 days without 
decomposition. Because these compounds can be stored and used without the need for 
cryogenic or anaerobic conditions, which is often necessary for handling these classes of 
boronic acids, the corresponding pinacol boronate esters should be useful building blocks 
for the synthesis of complex molecules with a variety of functions. 
Table 11. Iridium-catalyzed borylation of heteroarenes and polyfluorobenzene 
derivatives 
 
aIsolated yield obtained when 1.1 equiv. of HBpin was used as the boron source; bGC 
yield 
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If the stability of these boronates is to be an asset, however, they must undergo cross 
coupling under mild conditions with accessible catalysts. After examining several 
catalyst and ligand combinations, we found that the classic catalyst generated from 1 
mol % Pd(dba)2 and 2 mol % P(o-tol)3 with Na2CO3 as base in a 10:1 mixture of 
THF:H2O led to the coupling of these organoboronates with a variety of aryl bromides at 
room temperature.13  
With a suitable catalyst and reaction conditions for the Suzuki-Miyaura coupling of 2-
heteroaryl boronates with aryl bromides in hand, we developed a one-pot process for Ir-
catalyzed heteroarene C-H borylation and Pd-catalyzed coupling. The scope of this 
sequence is shown in Table 12. A variety of heterocycles, including pyrroles, indoles, 
furans, benzofurans and thiophenes containing a variety of substituents underwent the 
borylation and coupling with a series of electron-rich and electron-poor aryl and 
heteroaryl bromides. In addition, ortho-substituted and ortho-di-substituted aryl bromides 
reacted with the intermediate heteroarylboronic ester in good yield.  Esters, aldehydes, 
aryl halides, trifluoromethyl groups, as well as ketones with enolizable hydrogens, were 
well tolerated. Silylated phenols, MOM-protected hydroxyalkylarenes, and an aryl 
pivalate, which can be used for orthogonal Ni-catalyzed cross-coupling,14 also underwent 
the one-pot sequence in good yield. Because aryl bromides are most commonly utilized 
in medicinal chemistry, this method for Suzuki coupling of heteroaryl pinacol boronates 
with aryl bromides using simple Pd catalysts should be widely utilized. 
In addition to the coupling of 2-heteroaryl boronates with aryl bromides, ortho-fluoro 
pinacol boronate esters were also coupled with aryl bromides. With appropriate 
substitution on the starting fluoroarene, the borylation occurs with site-selectivity ortho to 
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fluorine, and these resulting pinacol boronate esters were coupled with a variety of aryl 
bromides at room temperature in the presence of the Pd/P(o-tol)3 catalyst.  
Table 12. Scope of the combined Ir-catalyzed borylation and Pd-catalyzed cross coupling 
of heteroarenes with aryl bromides 
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aPd-catalyzed coupling at 50°C; bBorylation/coupling sequence conducted without use of 
a glovebox 
In addition to occurring with broad scope, the combination of heteroarene borylation 
and cross coupling occurred on a 5 mmol scale with lower catalyst loadings than the 
reactions on smaller scale (Equation 4). The borylation of indole on 5 mmol scale was 
performed with 50 ppm of iridium catalyst, and the subsequent coupling with 4-
bromotoluene occurred with 0.5 mol % of the palladium catalyst in similar yield to the 
reaction on a 1 mmol scale. In addition, decreasing the amount of the starting heteroarene 
to 1.05 equivalents did not diminish the yield of the biaryl product. This example 
illustrates the potential of this methodology to be used for large-scale applications. 
 
The coupling of 2-heteroaryl pinacol boronate esters with less reactive, but often 
more commercially available aryl chlorides, also occurs in good yield (Table 13). 
Because aryl chlorides are less reactive than aryl bromides, we conducted these reactions 
with a catalyst2d formed from the combination of 1 mol % Pd(dba)2 and 1 mol % of the 
hindered alkylphosphine Q-phos (1,2,3,4,5-pentaphenyl-1'-(di-tert-
butylphosphino)ferrocene), both of which are commercially available, with K3PO4 in a 
10:1 mixture of 1,4-dioxane:H2O at 40 °C. Similar to the borylation and coupling 
sequence with aryl bromides, this methodology tolerates a variety of functional groups, 
including cyano groups, nitro groups, alkoxycarbonyl, formyl, and trifluoromethyl groups. 
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Both electron-rich and electron-deficient aryl chlorides coupled with the intermediate 
pinacol boronate to give a good yield of product from the two-step, one-pot process. 
Table 13. Scope of Ir-catalyzed borylation/Pd-catalyzed cross-coupling of heteroarenes 
with aryl chlorides 
 
To create a process for the C-H borylation and coupling of fluoroarenes with aryl 
bromides, a more active catalyst for the coupling of the pinacol boronic esters than that 
containing P(o-tol)3 was needed because of the susceptibility of the polyfluoroarenes to 
protodeborylation. The coupling of 2,3-difluoroaryl and 2,6-di-fluoroaryl pinacol 
boronate esters with aryl bromides occurred in the presence of 1 mol % of the Pd-Q-phos 
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catalyst with K3PO4 as base in a 10:1 mixture of 1,4-dioxane:H2O at 50 °C. As shown in 
Table 14, the two-step, one-pot procedure for borylation of a difluoroarene and Suzuki 
coupling occurred with a variety of aryl bromides, including electron-rich and electron-
poor aryl bromides and ortho-substituted aryl bromides. Similar to the cross coupling 
with 2-heteroaryl pinacol boronates, this method tolerates a variety of functional groups 
having various electronic properties. In general, the coupling proceeded in higher yield 
with pinacolboronates containing an electron-donating substituent at the para position 
than with pinacolboronates containing an electron-withdrawing substituent at the para 
position. 
Having demonstrated the synthetic utility of the one-pot borylation and Suzuki-
Miyaura coupling of heteroarenes and difluoroarenes, we sought to determine the factors 
that enable the Suzuki-Miyaura coupling of the pinacol boronate esters to proceed in high 
yields. To determine the rate of decomposition of the pinacol boronate esters, relative to 
the rates of the coupling reaction, we treated a THF solution of three different 2-
heteroaryl pinacol boronate esters with 2M aqueous Na2CO3 to mimic the aqueous basic 
conditions in the catalytic reaction and monitored the decomposition of the heteroaryl 
boronate at room temperature over time (Table 15). A majority of the 2-heteroaryl 
pinacol boronate esters derived from nitrogen, oxygen and sulfur heterocycles remained 
in solution after 5 h, the approximate time of the catalytic reaction. The amount of 
decomposition of the nitrogen and sulfur heteroaryl boronates was approximately the 
same as that of phenyl pinacol boronate ester, showing the degree of increased stability of 
these 2-heteroaryl pinacol boronates over boronic acids and other esters. Similar 
experiments performed with 2,6-difluorophenyl pinacol boronate esters showed that 
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complete decomposition of these compounds occurred within 30 minutes at 50 °C. This 
greater lability explains the need to use a more active catalyst, such as the Pd-Q-phos 
catalyst, to achieve faster rates for the Suzuki-Miyaura coupling reaction with these 
boronates. 
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Table 14. Scope of Ir-catalyzed borylation/Pd-catalyzed cross coupling of 
polyfluorophenyl derivatives with aryl bromides 
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Table 15. Decomposition of heteroaryl pinacol boronate esters with aqueous base at 
room temperature  
 
Entry Aryl Boronate 
%Ar-Bpin  
Remaining 
% ArB(OH)2 
Remaining 
1 
 
87% - 
2 
 
73%a <2% 
3 
 
72% 9% 
4 
 
88% 74% 
a The analogous reaction with the corresponding 
indolylboronic ester left 87% of the ArBpin unreacted 
This greater stability of pinacolboronate esters is only beneficial if transmetallation, 
which is commonly proposed to be the turnover-limiting step in the Suzuki coupling 
reaction,8a of the esters is faster than the decomposition of the organoboron compound. 
The palladium hydroxo complex was shown recently to be the palladium species that 
reacts with the boron reagents in the transmetallation step.8 Thus, to assess the relative 
rates of transmetallation of the heteroaryl and fluoroaryl boronic esters, we conducted a 
series of competition experiments involving the reaction of an arylpalladium(II) 
hydroxide complex with 5 equiv of a 2-heteroaryl pinacol boronate ester and 5 equiv of 
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phenyl pinacol boronate ester. These reactions formed, almost exclusively (>90%), the 
coupled product derived from the 2-heteroaryl pinacol boronate ester (Table 16); 
negligible amounts of product from coupling of the phenyl boronate ester (<5%) was 
observed. This result indicates that transmetallation of the 2-heteroaryl pinacol boronate 
esters is significantly faster than transmetallation of standard aryl pinacol boronate esters. 
This rapid transmetallation could result from hydrogen bonding between the heterocycle 
and the palladium intermediate or coordination of the electron-rich alkene of the 
heteroarenes to the palladium complex before transmetallation. 
Similar competition experiments between 2,6-difluorophenyl pinacol boronates and 
the parent phenyl pinacol boronate ester showed that the 2,6-difluorophenylboronic ester 
reacts faster than the phenylboronic ester. The competition reaction yielded almost 
exclusively product from the 2,6-difluorophenyl pinacol boronate ester (Scheme 46).15 
These competition experiments, in combination with the data on the stability of the 
boronic esters, indicate that the high yields for coupling of 2-heteroaryl pinacol boronate 
esters and 2,6-difluoroaryl pinacol boronate esters result from the combination of their 
stability under aqueous basic conditions, and rapid transmetallation. 
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Table 16. Competition experiments between 2-heteroaryl and phenyl pinacol boronate 
esters  
Entry Heteroaryl Bpin Yield of A Yield of B 
1 
 
93% 5% 
2 
 
>98% 1% 
3 
 
>98% 1% 
 
Scheme 46. Competition experiments between 2,6-difluoroaryl and phenyl pinacol 
boronate esters 
 
4.4 Conclusion and Outlook 
In summary, 2-heteroaryl and polyfluoroaryl pinacol boronate esters form in good 
yield by Ir-catalyzed C-H borylation, and Suzuki-Miyaura cross coupling of these 
boronates generated in situ occurs with simple palladium catalysts. Although useful as 
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formed in situ, the pinacol boronate esters are isolable and stable in air at room 
temperature, as opposed to the corresponding boronic acids, which require cold, 
anaerobic storage. Suzuki-Miyaura coupling of 2-heteroaryl and polyfluoroaryl pinacol 
boronates generated in situ also occurs with aryl halides with easily accessible catalysts.  
Because of its generality, this methodology should be useful for the preparation of 
heteroaryl and fluoroaryl compounds with diverse applications. 
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4.5 Experimental Information 
General Procedures. All reactions were conducted under a nitrogen atmosphere in 
flame-dried glassware or in an inert atmosphere glovebox. Dry and degassed solvents 
were used unless otherwise noted. The water used as co-solvent was deionized and 
degassed by bubbling N2 gas for 10 minutes. Column chromatography was performed 
with a Teledyne Isco Combiflash® Rf system with RediSep Rf columns.  Analytical thin-
layer chromatography was performed on glass plates coated with silica gel (Silicycle, 60 
A pore size, 40-64 um particle size) impregnated with a fluorescent indicator (254 nm). 
TLC plates were visualized by ultraviolet light and staining solution of p-anisaldehyde or 
KMnO4. 
Materials.  [Ir(cod)OMe]2 and Q-phos (1,2,3,4,5-Pentaphenyl-1'-(di-t-
butylphosphino)ferrocene) were obtained from Johnson Matthey and used as received. 
4,4’-Di-tert-butylbipyridine was obtained from Aldrich Chemicals and used as received. 
Bis(pinacolato)diboron (B2pin2) was obtained from Allychem and used as received.  
Arenes, heteroarenes, aryl halides, tri-o-tolylphosphine, sodium carbonate, potassium 
phosphate, and pinacolborane were obtained from Aldrich, Alfa Aesar, Acros, 
Combiblocks, Oakwood Chemicals or TCI America and used as received. Heteroaryl 
boronic acids and boronate esters were obtained from Combi-Blocks or Aldrich and used 
as received.  Pd(dba)2 was synthesized according to published procedures.16  Pd-
hydroxide complexes were prepared according to published procedures.8a,17 
Instruments.  1H NMR spectra were recorded on a 500 MHz Varian instrument (126 
MHz for 13C).  Chemical shifts are reported in parts per million relative to residual 
protiated solvent (7.26 ppm for CDCl3). The carbon bonded to boron in the arene and 
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heteroarene borylation products were not observed via 13C NMR spectroscopy. This is 
consistent with previous reports of borylated arenes and heteroarenes.18  GC-MS data 
were obtained on an Agilient 6890-N GC system containing an Alltech EC-1 capillary 
column and an Agilient 5973 mass selective detector.  GC analyses were obtained on an 
Agilent 6890 Gas Chromatograph equipped with an HP- 5 25 m x 0.20 mm ID x 0.33 μm 
capillary column (Agilent) and an FID detector. 
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Experimental Procedures 
General Procedure for the Borylation of Heteroarenes.  Inside a glove box, 
[Ir(cod)OMe]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 
0.0050 equiv), B2pin2 (127 mg, 0.500 mmol, 0.500 equiv) or HBpin (141 mg, 1.10 mmol, 
1.10 equiv), the heteroarene (1.00 mmol, 1.00 equiv), and THF (2 mL) were added 
consecutively to a dry vial with a magnetic stir bar. The vial was sealed and heated at 80 
C for 18 h.  The reaction mixture was cooled to room temperature, concentrated and 
purified by column chromatography to give the product. 
 
Borylation of Indole.  Prepared according to the general procedure with indole (117 mg, 
1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(10% EtOAc:90% hexanes) to give the product (175 mg, 72%).  1H NMR (499 MHz, 
CDCl3) δ 8.60 (s, 1H), 7.70 (d, J = 8.1 Hz, 1H), 7.40 (m, 1H), 7.25 (m, 1H), 7.13 (m, 2H), 
1.38 (s, 12H).  13C NMR (126 MHz, CDCl3) δ 138.48, 128.55, 123.87, 121.85, 120.03, 
114.12, 111.51, 84.40, 25.07.  Anal. Calcd for C14H17BNO2: C, 68.17; H, 7.46; N, 5.76.  
Found: C, 69.55; H, 7.42; N, 6.08. 
 
Borylation of ethyl 3-furoate.  Prepared according to the general procedure with ethyl 3-
furoate (140 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (172 mg, 65%).  1H NMR 
(500 MHz, CDCl3) δ 8.12 (s, 1H), 7.31 (s, 1H), 4.22 (q, J = 6.9 Hz, 2H), 1.24 (m, 15H). 
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13C NMR (126 MHz, CDCl3) δ 163.06, 151.99, 123.01, 120.45, 84.77, 60.65, 24.88, 
14.43. Anal. Calcd for C13H19BO5: C, 58.68; H, 7.20.  Found: C, 58.75; H, 7.12.  
 
Borylation of Benzofuran.  Prepared according to the general procedure with 
benzofuran (118 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (5% EtOAc:95% hexanes) to give the product (151 mg, 62%).  1H NMR 
(499 MHz, CDCl3) δ 7.64 (d, J = 7.7 Hz, 1H), 7.58 (d, J = 8.3 Hz, 1H), 7.42 (s, 1H), 7.35 
(t, J = 7.6 Hz, 1H), 7.23 (t, J = 7.5 Hz, 1H), 1.39 (s, 12H).  13C NMR (126 MHz, CDCl3) 
δ 157.77, 127.74, 126.18, 122.97, 122.13, 119.81, 112.18, 84.90, 25.01.  Anal. Calcd for 
C14H17BO3: C, 68.89; H, 7.02.  Found: C, 68.86; H, 7.37. 
 
Borylation of 2-Methylthiophene.  Prepared according to the general procedure with 2-
methylthiophene (98 mg, 1.0 mmol, 1.0 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (166 mg, 74%). 
1H NMR (499 MHz, CDCl3) δ 7.48 (d, J = 3.4 Hz, 1H), 6.86 (d, J = 3.3 Hz, 1H), 2.55 (s, 
3H), 1.35 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 147.73, 137.89, 127.24, 84.08, 24.99, 
15.62.  Anal. Calcd for C11H17BO2S: C, 58.95; H, 7.65.  Found: C, 58.71; H, 7.40. 
General Procedure for the Borylation of Fluoroarenes.  Inside a glove box, 
[Ir(cod)OMe]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 
0.0050 equiv), B2pin2 (153 mg, 0.600 mmol, 0.600 equiv) or HBpin (141 mg, 1.10 mmol, 
1.10 equiv), the arene (1.00 mmol, 1.00 equiv), and THF (2 mL) were added 
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consecutively to a dry vial with a magnetic stir bar.  The vial was sealed and heated at 80 
C for 18 h.  The reaction mixture was cooled to room temperature and purified by 
column chromatography to give the product. 
 
Borylation of 2-chloro-4-fluorotoluene.  Prepared according to the general procedure 
with 2-chloro-4-fluorotoluene (144 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(223 mg, 83%).  1H NMR (499 MHz, CDCl3) δ 7.58 (d, J = 6.3 Hz, 1H), 7.07 (d, J = 8.9 
Hz, 1H), 2.33 (s, 3H), 1.37 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 165.46 (d, J = 252.9 
Hz), 138.45 (d, J = 8.7 Hz), 131.57 (d, J = 3.7 Hz), 116.52 (d, J = 5.3 Hz), 116.30 (d, J = 
5.1 Hz), 84.25 (s), 25.01 (s), 19.18 (s).  19F NMR (376 MHz, CDCl3) δ -106.11 (s). Anal. 
Calcd for C13H17BClFO2: C, 57.71; H, 6.33.  Found: C, 58.04; H, 6.14. 
 
Borylation of Methyl 3,4-difluorobenzoate.  Prepared according to the general 
procedure with methyl 3,4-difluorobenzoate (172 mg, 1.0 mmol, 1.0 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (217 mg, 73%).  1H NMR (499 MHz, CDCl3) δ 8.16 (dd, J = 4.1, 2.0 Hz, 1H), 
7.88 (ddd, J = 10.2, 7.6, 2.2 Hz, 1H), 3.90 (s, 3H), 1.35 (s, 12H). 13C NMR (126 MHz, 
CDCl3) δ 165.40 (d, J = 2.3 Hz), 157.71 (dd, J = 260.6, 12.0 Hz), 150.25 (dd, J = 250.5, 
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14.9 Hz), 133.244 (dd, J = 7.9 Hz, 3.7 Hz), 126.83 (t, J = 4.4Hz), 121.491 (dd, J = 18.8 
Hz, 2.3 Hz),  84.73 (s), 52.58 (s), 24.99 (s). 19F NMR (376 MHz, CDCl3) δ -121.44 (dd, J 
= 4.1, 21.3), -137.78 (dd, J = 10.5, 21.2). Anal. Calcd for C14H17BF2O4: C, 56.41; H, 5.75.  
Found: C, 56.30; H, 5.68. 
 
 
Borylation of Methyl 3,5-difluorobenzoate.  Prepared according to the general 
procedure with methyl 3,5-difluorobenzoate (172 mg, 1.0 mmol, 1.0 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (202 mg, 68%).  1H NMR (499 MHz, CDCl3) δ 7.48 (m, 2H), 3.91 (s, 3H), 1.37 
(s, 12H). 13C NMR (126 MHz, CDCl3) δ 166.36 (dd, J = 251.3, 12.8 Hz), 165.03 (t, J = 
3.4 Hz), 135.25 (t, J = 9.9 Hz), 112.35 (m), 84.88 (s), 52.82 (s), 24.91 (s). 19F NMR (376 
MHz, CDCl3) δ -100.06 (d, J = 6.5). Anal. Calcd for C14H17BF2O4: C, 56.41; H, 5.75.  
Found: C, 56.15; H, 6.01. 
 
Borylation of 3,5-difluoroanisole.  Prepared according to the general procedure with 
3,5-difluoroanisole (144 mg, 1.0 mmol, 1.0 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (200 mg, 74%).  
1H NMR (499 MHz, CDCl3) δ 6.38 (d, J = 9.5 Hz, 2H), 3.78 (s, 3H), 1.35 (s, 12H). 13C 
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NMR (126 MHz, CDCl3) δ 168.19 (dd, J = 249.8, 16.6 Hz), 164.11 (t, J = 14.7 Hz), 
97.92 (m), 83.94 (s), 55.94 (s), 24.94 (s). 19F NMR (376 MHz, CDCl3) δ -99.53 (d, J = 
8.2). Anal. Calcd for C13H17BF2O3: C, 57.81; H, 6.34.  Found: C, 57.82; H, 6.24. 
General Procedure for one-pot C-H Borylation and Suzuki-Miyaura cross-coupling 
of heteroarenes with aryl bromides.  Inside a glove box, [Ir(cod)OMe]2 (2.0 mg, 0.0030 
mmol, 0.0030 equiv), dtbpy (1.6 mg, 0.0060 mmol, 0.0060 equiv), B2pin2 (153 mg, 0.600 
mmol, 0.600 equiv), the heteroarene (1.20 mmol, 1.20 equiv), and THF (2 mL) were 
added consecutively to a dry vial with a magnetic stir bar.  The vial was sealed and 
heated at 80 C for 18 h.  The reaction mixture was cooled to room temperature, and the 
volatile materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 
equiv), tri-o-tolylphosphine (6.1 mg, 0.020 mmol, 0.02 equiv), Na2CO3 (424 mg, 4.00 
mmol, 4.00 equiv), the aryl halide (1.00 mmol, 1.00 equiv), THF (3 mL) and degassed 
H2O (0.3 mL) were added consecutively to the reaction mixture.  The reaction mixture 
was sealed and stirred at room temperature for 18 h.  The reaction mixture was filtered 
through silica gel, washing with EtOAc, and concentrated under vacuum.  The reaction 
mixture was purified by column chromatography to give the product. 
 
 
Arylation of indole with 4-bromotoluene.  Prepared according to the general procedure 
with indole (141 mg, 1.20 mmol, 1.20 equiv) and 4-bromotoluene (171 mg, 1.00 mmol, 
1.00 equiv).  The mixture was purified by flash column chromatography (10% 
181 
EtOAc:90% hexanes) to give the product (174 mg, 84%).  1H NMR (500 MHz, CDCl3) δ 
8.30 (s, 1H), 7.66 (d, J = 7.8 Hz, 1H), 7.57 (d, J = 8.1 Hz, 2H), 7.40 (d, J = 7.8 Hz, 1H), 
7.27 (d, J = 7.8 Hz, 2H), 7.22 (m, 1H), 7.16 (t, J = 7.5 Hz, 1H), 6.82 (s, 1H), 2.43 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 138.32, 137.89, 136.95, 129.96, 128.69, 125.32, 122.37, 
120.77, 120.45, 111.10, 102.85, 99.64, 21.51.  Anal. Calcd for C15H13N: C, 86.92; H, 
6.32; N, 6.76.  Found: C, 86.60; H, 6.29; N, 6.79. 
 
Arylation of indole with 4-bromoacetophenone.  Prepared according to the general 
procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and 4-bromoacetophenone (199 
mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(10% EtOAc:90% hexanes) to give the product (129 mg, 55%).  1H NMR (499 MHz, 
Acetone-d6) δ 10.88 (s, 1H), 8.06 (m, 2H), 7.99 (d, J = 8.3 Hz, 2H), 7.62 (d, J = 7.8 Hz, 
1H), 7.46 (d, J = 8.1 Hz, 1H), 7.18 (t, J = 7.6 Hz, 1H), 7.08 (d, J = 2.5 Hz, 2H), 2.60 (s, 
4H).  13C NMR (126 MHz, Acetone-d6) δ 196.56, 138.19, 137.01, 136.84, 136.01, 129.21, 
125.01, 122.86, 120.90, 120.16, 111.63, 101.37, 26.02.  Anal. Calcd for C16H13NO: C, 
81.68; H, 5.57; N, 5.95.  Found: C, 81.78; H, 5.59; N, 5.95. 
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Arylation of indole with ethyl 4-bromobenzoate.  Prepared according to the general 
procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and ethyl 4-bromobenzoate (229 
mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(15% EtOAc:85% hexanes) to give the product (231 mg, 87%).  1H NMR (500 MHz, 
CDCl3) δ 8.51 (s, 1H), 8.04 (s, 1H), 8.00 (s, 1H), 7.52 (d, J = 8.5 Hz, 2H), 7.36 (d, J = 8.4 
Hz, 2H), 7.20 (t, J = 2.8 Hz, 1H), 6.92 (s, 1H), 6.58 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.40 
(t, J = 7.1 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 163.94, 157.04, 146.34, 135.95, 
128.26, 125.55, 122.36, 121.38, 119.07, 116.88, 111.76, 103.27, 102.79, 60.79, 14.61. 
Anal. Calcd for C17H15NO2: C, 76.48; H, 5.21; N, 5.47. C, 76.10; H, 5.46; N, 5.29. 
 
Arylation of 5-chloroindole with 4-bromotoluene.  Prepared according to the general 
procedure with 5-chloroindole (182 mg, 1.20 mmol, 1.20 equiv) and 4-bromotoluene 
(171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (10% EtOAc:90% hexanes) to give the product (189 mg, 78%).  1H 
NMR (500 MHz, CDCl3) δ 8.34 (s, 1H), 7.57 (d, J = 2.0 Hz, 1H), 7.54 (d, J = 8.0 Hz, 
2H), 7.30 (d, J = 8.6 Hz, 1H), 7.26 (m, 2H), 7.12 (dd, J = 8.5, 2.0 Hz, 1H), 6.72 (s, 1H), 
2.40 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 139.68, 138.36, 135.20, 130.61, 130.01, 
129.25, 125.97, 125.35, 122.53, 120.05, 111.97, 99.19, 21.52. Anal. Calcd for C15H12ClN: 
C, 74.53; H, 5.00; N, 5.79.  Found: C, 74.22; H, 4.78; N, 5.74. 
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Arylation of indole with 2-bromotoluene.  Prepared according to the general procedure 
with indole (141 mg, 1.20 mmol, 1.20 equiv) and 2-bromotoluene (171 mg, 1.00 mmol, 
1.00 equiv).  The mixture was purified by flash column chromatography (10% 
EtOAc:90% hexanes) to give the product (151 mg, 73%).  1H NMR (499 MHz, CDCl3) δ 
8.07 (s, 1H), 7.79 (d, J = 7.7 Hz, 1H), 7.54 (m, 2H), 7.46 (d, J = 8.1 Hz, 1H), 7.41 (m, 
2H), 7.34 (m, 1H), 7.29 (m, 1H), 6.74 (s, 1H), 2.60 (s, 3H).  13C NMR (126 MHz, CDCl3) 
δ 137.79, 136.51, 136.42, 132.96, 131.40, 129.34, 129.20, 128.30, 126.41, 122.39, 120.88, 
120.40, 111.16, 103.29, 21.43.  Anal. Calcd for C15H13N: C, 86.92; H, 6.32; N, 6.76.  
Found: C, 86.76; H, 6.16; N, 6.76. 
 
Arylation of indole with 3-bromothiophene.  Prepared according to the general 
procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and 3-bromothiophene (163 mg, 
1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(10% EtOAc:90% hexanes) to give the product (148 mg, 74%).  1H NMR (499 MHz, 
CDCl3) δ 8.24 (s, 1H), 7.63 (dd, J = 7.9, 1.0 Hz, 1H), 7.43 (s, 3H), 7.39 (m, 1H), 7.21 
(ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.14 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 6.73 (m, 1H). 13C 
NMR (126 MHz, CDCl3) δ 136.65, 134.37, 134.18, 129.33, 126.88, 125.94, 122.51, 
184 
120.81, 120.51, 119.31, 110.97, 100.21.  Anal. Calcd for C12H9NS: C, 72.33; H, 4.55; N, 
7.03.  Found: C, 72.39; H, 4.56; N, 7.03. 
 
Arylation of indole with 2,6-dimethylbromobenzene.  Prepared according to the 
general procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and 2,6-
dimethylbromobenzene (185 mg, 1.00 mmol, 1.00 equiv) and the Suzuki coupling step at 
50 °C.  The mixture was purified by flash column chromatography (10% EtOAc:90% 
hexanes) to give the product (159 mg, 72%).  1H NMR (499 MHz, CDCl3) δ 7.89 (s, 1H), 
7.72 (d, J = 7.6 Hz, 1H), 7.43 (m, 1H), 7.27 (m, 3H), 7.20 (m, 2H), 6.46 (s, 1H), 2.24 (s, 
6H).  13C NMR (126 MHz, CDCl3) δ 138.64, 136.44, 136.18, 133.32, 129.06, 128.77, 
127.62, 121.78, 120.67, 120.06, 110.98, 102.78, 20.87. Anal. Calcd for C16H15N: C, 
86.84; H, 6.83; N, 6.33.  Found: C, 86.59; H, 6.76; N, 6.09. 
 
Arylation of benzofuran with 2,6-dimethylbromobenzene.  Prepared according to the 
general procedure with benzofuran (142 mg, 1.20 mmol, 1.20 equiv) and 2,6-
dimethylbromobenzene (185 mg, 1.00 mmol, 1.00 equiv) and the Suzuki coupling step at 
50 °C.  The mixture was purified by flash column chromatography (5% EtOAc:95% 
hexanes) to give the product (159 mg, 72%).  1H NMR (500 MHz, CDCl3) δ 7.71 (m, 1H), 
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7.61 (m, 1H), 7.36 (m, 3H), 7.23 (m, 2H), 6.75 (s, 1H), 2.36 (s, 6H).  13C NMR (126 
MHz, CDCl3) δ 155.14, 155.06, 138.84, 130.91, 129.48, 129.08, 127.88, 124.11, 122.97, 
121.09, 111.51, 106.42, 20.93.  Anal. Calcd for C16H14O: C, 86.45; H, 6.35.  Found: C, 
86.41; H, 6.17. 
 
Arylation of indole with 1-Bromo-3,4-(methylenedioxy)benzene.  Prepared according 
to the general procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and 1-Bromo-3,4-
(methylenedioxy)benzene (201 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified 
by flash column chromatography (10% EtOAc:90% hexanes) to give the product (199 mg, 
84%).  1H NMR (499 MHz, Acetone-d6) δ 9.74 (s, 1H), 6.76 (dd, J = 7.8, 1.0 Hz, 1H), 
6.59 (m, 3H), 6.30 (ddd, J = 8.1, 7.0, 1.2 Hz, 1H), 6.23 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 
6.15 (d, J = 8.5 Hz, 1H), 6.01 (m, 1H), 5.27 (s, 2H). 13C NMR (126 MHz, Acetone) δ 
148.63, 147.50, 138.21, 137.55, 129.63, 127.33, 121.69, 120.20, 119.75, 118.99, 111.18, 
108.78, 105.84, 101.59, 98.61. Anal. Calcd for C15H11NO2: C, 75.94; H, 4.67; N, 5.90.  
Found: C, 75.68; H, 4.37; N, 5.63. 
 
Arylation of methyl 2-methyl-3-furancarboxylate with ethyl 4-bromobenzoate.  
Prepared according to the general procedure with methyl 2-methyl-3-furancarboxylate 
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(168 mg, 1.20 mmol, 1.20 equiv) and ethyl 4-bromobenzoate (229 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (15% EtOAc:85% 
hexanes) to give the product (280 mg, 97%).  1H NMR (499 MHz, CDCl3) δ 7.97 (d, J = 
8.5 Hz, 2H), 7.58 (d, J = 8.6 Hz, 2H), 6.91 (s, 1H), 4.33 (q, J = 7.1 Hz, 2H), 3.79 (s, 3H), 
2.59 (s, 3H), 1.35 (t, J = 7.5 Hz 3H).  13C NMR (126 MHz, CDCl3) δ 166.26, 164.20, 
159.80, 150.84, 133.91, 130.20, 129.31, 123.30, 115.64, 107.77, 61.15, 51.60, 14.52, 
14.05.  Anal. Calcd for C16H16O5: C, 66.66; H, 5.59.  Found: C, 66.28; H, 5.50. 
 
Arylation of 2-acetylfuran with 4-bromotoluene.  Prepared according to the general 
procedure with 2-acetylfuran (132 mg, 1.20 mmol, 1.20 equiv) and 4-bromotoluene (171 
mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(5% EtOAc:95% hexanes) to give the product (138 mg, 69%).  1H NMR (499 MHz, 
CDCl3) δ 7.75 (d, J = 3.4 Hz, 1H), 7.27 (m, 4H), 6.67 (d, J = 3.7 Hz, 1H), 2.54 (s, 3H), 
2.52 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 186.74, 157.76, 151.93, 135.90, 131.69, 
129.31, 128.16, 126.43, 111.02, 26.23, 22.02. Anal. Calcd for C13H12O2: C, 77.98; H, 
6.04.  Found: C, 77.97; H, 5.92. 
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Arylation of ethyl 3-furoate with 5-bromoindole.  Prepared according to the general 
procedure with ethyl 3-furoate (168 mg, 1.20 mmol, 1.20 equiv) and 5-bromoindole (196 
mg, 1.00 mmol, 1.00 equiv) and the Suzuki coupling step at 50 °C.  The mixture was 
purified by flash column chromatography (15% EtOAc:85% hexanes) to give the product 
(225 mg, 88%).  1H NMR (500 MHz, CDCl3) δ 8.51 (s, 1H), 8.04 (s, 1H), 7.52 (m, 1H), 
7.40 (s, 1H), 7.38 (s, 1H), 7.21 (t, J = 2.8 Hz, 1H), 6.93 (s, 1H), 6.59 (d, J = 3.0 Hz, 1H), 
4.36 (q, J = 7.1 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 163.94, 
157.04, 146.34, 135.95, 128.26, 125.55, 122.36, 121.38, 119.07, 116.88, 111.76, 103.27, 
102.79, 60.79, 14.61.  Anal. Calcd for C15H13NO3: C, 70.58; H, 5.13; N, 5.49.  Found: C, 
70.40; H, 5.13; N, 5.42. 
 
Arylation of ethyl 3-furoate with 4-bromochlorobenzene.  Prepared according to the 
general procedure with ethyl 3-furoate (168 mg, 1.20 mmol, 1.20 equiv) and 4-
bromochlorobenzene (192 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (10% EtOAc:90% hexanes) to give the product (223 mg, 
89%).  1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 0.8 Hz, 1H), 7.58 (d, J = 8.6 Hz, 2H), 
7.36 (d, J = 8.6 Hz, 2H), 6.95 (s, 1H), 4.32 (q, J = 7.1 Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 163.15, 154.24, 147.10, 134.12, 129.24, 128.55, 125.46, 
121.65, 105.18, 60.85, 14.56.  Anal. Calcd for C13H11ClO3: C, 62.29; H, 4.42.  Found: C, 
61.94; H, 4.25. 
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Arylation of ethyl 3-furoate with 4-bromophenyl pivalate.  Prepared according to the 
general procedure with ethyl 3-furoate (168 mg, 1.20 mmol, 1.20 equiv) and 4-
bromophenyl pivalate (257 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (10% EtOAc:90% hexanes) to give the product (253 mg, 
80%).  1H NMR (499 MHz, CDCl3) δ 8.00 (s, 1H), 7.66 (d, J = 8.6 Hz, 2H), 7.10 (d, J = 
8.6 Hz, 2H), 6.94 (s, 1H), 4.32 (q, J = 7.1 Hz, 2H), 1.37 (m, 12H).  13C NMR (126 MHz, 
CDCl3) δ 177.10, 163.24, 154.68, 151.14, 146.95, 127.65, 125.31, 122.21, 121.58, 104.71, 
60.77, 39.33, 27.34, 14.57.  Anal. Calcd for C18H20O5: C, 68.34; H, 6.37.  Found: C, 
67.96; H, 6.41. 
 
Arylation of methyl 2-furoate with 3-bromoquinoline.  Prepared according to the 
general procedure with methyl 2-furoate (151 mg, 1.20 mmol, 1.20 equiv) and 3-
bromoquinoline (208 mg, 1.00 mmol, 1.00 equiv) and the Suzuki coupling step at 50 °C.  
The mixture was purified by flash column chromatography (20% EtOAc:80% hexanes) 
to give the product (243 mg, 96%).  1H NMR (499 MHz, CDCl3) δ 9.12 (d, J = 2.3 Hz, 
1H), 8.40 (d, J = 2.2 Hz, 1H), 8.01 (d, J = 8.4 Hz, 1H), 7.74 (d, J = 1.8 Hz, 1H), 7.62 (m, 
1H), 7.48 (m, 1H), 7.20 (d, J = 3.6 Hz, 1H), 6.84 (d, J = 3.6 Hz, 1H), 3.87 (s, 3H).  13C 
NMR (126 MHz, CDCl3) δ 159.13, 154.91, 147.72, 147.05, 144.61, 131.17, 130.30, 
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129.38, 128.41, 127.69, 127.66, 122.80, 120.13, 108.48, 52.21.  Anal. Calcd for 
C15H11NO3: C, 71.14; H, 4.38; N, 5.53.  Found: C, 71.18; H, 4.32; N, 5.45. 
 
Arylation of benzofuran with 4-bromochlorobenzene.  Prepared according to the 
general procedure with benzofuran (142 mg, 1.20 mmol, 1.20 equiv) and 4-
bromochlorobenzene (192 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (194 mg, 
85%).  1H NMR (499 MHz, CDCl3) δ 7.79 (d, J = 8.5 Hz, 2H), 7.61 (s, 1H), 7.57 (d, J = 
8.1 Hz, 1H), 7.44 (d, J = 8.6 Hz, 2H), 7.35 (d, J = 7.0 Hz, 1H), 7.30 (m, 1H), 7.00 (s, 1H).  
13C NMR (126 MHz, CDCl3) δ 155.16, 155.01, 134.56, 129.35, 129.28, 129.21, 126.37, 
124.85, 123.39, 121.31, 111.49, 102.04.  Anal. Calcd for C14H9ClO: C, 73.53; H, 3.97.  
Found: C, 73.72; H, 3.91. 
 
Arylation of 2-methylthiophene with 4-bromotoluene.  Prepared according to the 
general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 1.20 equiv) and 4-
bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (171 mg, 91%).  
1H NMR (499 MHz, CDCl3) δ 7.57 (d, J = 8.1 Hz, 2H), 7.26 (d, J = 7.8 Hz, 2H), 7.17 (d, 
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J = 3.5 Hz, 1H), 6.82 (s, 1H), 2.60 (s, 3H), 2.46 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
142.50, 139.18, 137.08, 132.33, 129.81, 126.43, 125.75, 122.68, 21.46, 15.73.  Anal. 
Calcd for C12H12S: C, 76.55; H, 6.42.  Found: C, 76.37; H, 6.47. 
 
Arylation of 2-methylthiophene with 4-bromoanisole.  Prepared according to the 
general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 1.20 equiv) and 4-
bromoanisole (187 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (172 mg, 84%).  
1H NMR (499 MHz, CDCl3) δ 7.54 (d, J = 8.7 Hz, 2H), 7.05 (d, J = 3.5 Hz, 1H), 6.95 (d, 
J = 8.7 Hz, 2H), 6.76 (m, 1H), 3.86 (s, 3H), 2.55 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
159.15, 142.20, 138.69, 127.95, 127.03, 126.35, 122.11, 114.51, 55.57, 15.67.  Anal. 
Calcd for C12H12OS: C, 70.55; H, 5.92.  Found: C, 70.36; H, 6.00. 
 
Arylation of 2-methylthiophene with 4-bromoacetophenone.  Prepared according to 
the general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 1.20 equiv) and 4-
bromoacetophenone (199 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (195 mg, 90%).  
1H NMR (499 MHz, CDCl3) δ 7.92 (d, J = 8.4 Hz, 2H), 7.59 (d, J = 8.5 Hz, 2H), 7.21 (d, 
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J = 3.6 Hz, 1H), 6.75 (d, J = 4.6 Hz, 1H), 2.58 (s, 3H), 2.51 (s, 3H).  13C NMR (126 MHz, 
CDCl3) δ 197.48, 141.73, 140.67, 139.28, 135.46, 129.31, 126.94, 125.25, 124.86, 26.75, 
15.79.  Anal. Calcd for C13H12OS: C, 72.19; H, 5.59.  Found: C, 72.50; H, 5.70. 
 
Arylation of 2-methylthiophene with 4-bromobenzaldehyde.  Prepared according to 
the general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 1.20 equiv) and 4-
bromobenzaldehyde (185 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (188 mg, 93%).  
1H NMR (499 MHz, CDCl3) δ 9.95 (s, 1H), 7.82 (d, J = 8.3 Hz, 2H), 7.65 (d, J = 8.3 Hz, 
2H), 7.24 (d, J = 3.6 Hz, 1H), 6.76 (s, 1H), 2.51 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
191.65, 142.30, 140.59, 140.44, 134.86, 130.66, 127.09, 125.61, 125.35, 15.82. Anal. 
Calcd for C12H10OS: C, 71.25; H, 4.98.  Found: C, 71.28; H, 4.86. 
 
Arylation of 2-methylthiophene with 1-bromo-4-(methoxymethoxy)benzene.  
Prepared according to the general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 
1.20 equiv) and 1-bromo-4-(methoxymethoxy)benzene (217 mg, 1.00 mmol, 1.00 equiv).  
The mixture was purified by flash column chromatography (5% EtOAc:95% hexanes) to 
give the product (197 mg, 84%).  1H NMR (499 MHz, CDCl3) δ 7.59 (d, J = 8.3 Hz, 2H), 
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7.39 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 3.5 Hz, 1H), 6.77 (d, J = 3.5, 1H), 4.77 (s, 2H), 4.64 
(s, 2H), 3.47 (s, 3H), 2.55 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 141.95, 139.76, 
136.91, 134.45, 128.69, 126.51, 125.75, 123.22, 95.92, 69.11, 55.62, 15.72.  Anal. Calcd 
for C14H16O2S: C, 67.71; H, 6.49.  Found: C, 68.01; H, 6.53. 
 
Arylation of 2-chlorothiophene with 4-bromotoluene.  Prepared according to the 
general procedure with 2-chlorothiophene (143 mg, 1.20 mmol, 1.20 equiv) and 4-
bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (192 mg, 92%).  
1H NMR (500 MHz, CDCl3) δ 7.44 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H), 7.05 (d, 
J = 3.9 Hz, 1H), 6.91 (d, J = 3.8 Hz, 1H), 2.41 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
143.41, 138.04, 131.20, 129.95, 128.76, 127.31, 125.71, 121.96, 21.48.  Anal. Calcd for 
C11H9ClS: C, 63.30; H, 4.35.  Found: C, 63.35; H, 4.44. 
 
Arylation of 2-chlorothiophene with 4-bromo-N,N-dimethylaniline.  Prepared 
according to the general procedure with 2-chlorothiophene (143 mg, 1.20 mmol, 1.20 
equiv) and 4-bromo-N,N-dimethylaniline (200 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
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product (185 mg, 78%).  1H NMR (499 MHz, Acetone) δ 7.43 (d, J = 8.8 Hz, 2H), 7.06 
(d, J = 3.8 Hz, 1H), 6.96 (d, J = 3.9 Hz, 1H), 6.77 (d, J = 8.8 Hz, 2H), 2.99 (s, 6H).  13C 
NMR (126 MHz, Acetone) δ 150.77, 129.19, 128.61, 127.70, 126.45, 121.66, 120.22, 
112.66, 39.72.  Anal. Calcd for C12H12ClNS: C, 60.62; H, 5.09; N, 5.89.  Found: C, 60.68; 
H, 4.96; N, 5.76. 
 
Arylation of 2-chlorothiophene with 4-bromobenzonitrile.  Prepared according to the 
general procedure with 2-chlorothiophene (143 mg, 1.20 mmol, 1.20 equiv) and 4-
bromobenzonitrile (182 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (10% EtOAc:90% hexanes) to give the product (187 mg, 85%).  
1H NMR (499 MHz, CDCl3) δ 7.63 (m, 2H), 7.56 (m, 2H), 7.18 (d, J = 3.9 Hz, 1H), 6.93 
(d, J = 4.0 Hz, 1H).  13C NMR (126 MHz, CDCl3) δ 140.65, 137.95, 133.05, 131.97, 
127.94, 125.84, 124.68, 118.89, 111.14.  Anal. Calcd for C11H6ClNS: C, 60.14; H, 2.75; 
N, 6.38.  Found: C, 59.97; H, 2.64; N, 6.14. 
 
Arylation of methyl thiophene-3-carboxylate with 4-bromobenzaldehyde.  Prepared 
according to the general procedure with methyl thiophene-3-carboxylate (171 mg, 1.20 
mmol, 1.20 equiv) and 4-bromobenzaldehyde (185 mg, 1.00 mmol, 1.00 equiv).  The 
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mixture was purified by flash column chromatography (10% EtOAc:90% hexanes) to 
give the product (204 mg, 83%).  1H NMR (500 MHz, CDCl3) δ 9.94 (s, 1H), 8.04 (s, 
1H), 7.82 (d, J = 8.3 Hz, 2H), 7.76 (s, 1H), 7.67 (d, J = 8.2 Hz, 2H), 3.84 (s, 3H).  13C 
NMR (126 MHz, CDCl3) δ 191.49, 162.96, 143.41, 139.11, 135.74, 134.75, 133.46, 
130.67, 126.20, 125.44, 52.22.  Anal. Calcd for C13H10O3S: C, 63.40; H, 4.09.  Found: C, 
63.11; H, 3.98. 
 
Arylation of methyl thiophene-3-carboxylate with 4-bromotoluene.  Prepared 
according to the general procedure with methyl thiophene-3-carboxylate (171 mg, 1.20 
mmol, 1.20 equiv) and 4-bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (221 mg, 95%).  1H NMR (499 MHz, CDCl3) δ 8.00 (s, 1H), 7.69 (s, 1H), 7.50 (d, 
J = 8.1 Hz, 2H), 7.20 (d, J = 7.8 Hz, 2H), 3.90 (s, 3H), 2.38 (s, 3H).  13C NMR (126 MHz, 
CDCl3) δ 163.41, 145.46, 138.30, 134.34, 131.46, 130.96, 129.91, 126.03, 123.03, 52.03, 
21.42.  Anal. Calcd for C13H12O2S: C, 67.22; H, 5.21.  Found: C, 67.53; H, 5.23. 
 
Arylation of methyl thiophene-3-carboxylate with (4-bromophenoxy)(tert-
butyl)dimethylsilane.  Prepared according to the general procedure with methyl 
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thiophene-3-carboxylate (171 mg, 1.20 mmol, 1.20 equiv) and (4-bromophenoxy)(tert-
butyl)dimethylsilane (288 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (10% EtOAc:90% hexanes) to give the product (335 mg, 
96%).  1H NMR (500 MHz, CDCl3) δ 7.94 (d, J = 1.3 Hz, 1H), 7.59 (d, J = 1.3 Hz, 1H), 
7.46 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 3.86 (s, 3H), 1.00 (s, 9H), 0.22 (s, 6H).  
13C NMR (126 MHz, CDCl3) δ 163.40, 156.10, 145.25, 134.27, 131.10, 127.36, 127.09, 
122.53, 120.80, 52.00, 25.91, 18.47, -4.16.  Anal. Calcd for C18H24O3SSi: C, 62.03; H, 
6.94.  Found: C, 61.97; H, 6.78. 
 
Arylation of 2-methylthiophene with 2-bromotoluene.  Prepared according to the 
general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 1.20 equiv) and 2-
bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (181 mg, 96%).  
1H NMR (499 MHz, CDCl3) δ 7.51 (m, 1H), 7.33 (m, 3H), 6.97 (d, J = 3.4 Hz, 1H), 6.85 
(d, J = 3.3 Hz, 1H), 2.63 (s, 3H), 2.56 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 141.18, 
139.91, 136.21, 134.86, 131.06, 130.60, 127.80, 126.60, 126.21, 125.64, 21.57, 15.58.  
Anal. Calcd for C12H12S: C, 76.55; H, 6.42.  Found: C, 76.87; H, 6.43. 
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Arylation of 2-acetylthiophene with 4-bromotoluene.  Prepared according to the 
general procedure with 2-acetylthiophene (152 mg, 1.20 mmol, 1.20 equiv) and 4-
bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (195 mg, 90%).  
1H NMR (499 MHz, CDCl3) δ 7.61 (d, J = 4.0 Hz, 1H), 7.52 (d, J = 8.1 Hz, 2H), 7.24 (d, 
J = 3.9 Hz, 1H), 7.19 (d, J = 7.8 Hz, 2H), 2.53 (s, 3H), 2.36 (s, 3H).  13C NMR (126 MHz, 
CDCl3) δ 190.66, 153.22, 142.78, 139.43, 133.79, 130.79, 130.02, 126.34, 123.63, 26.70, 
21.51.  Anal. Calcd for C13H12OS: C, 72.19; H, 5.59.  Found: C, 72.52; H, 5.56. 
 
Arylation of 2-acetylthiophene with 3-bromonitrobenzene.  Prepared according to the 
general procedure with 2-acetylthiophene (152 mg, 1.20 mmol, 1.20 equiv) and 3-
bromonitrobenzene (202 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (205 mg, 83%).  
1H NMR (499 MHz, CDCl3) δ 8.43 (s, 1H), 8.16 (m, 1H), 7.92 (m, 1H), 7.68 (d, J = 3.9 
Hz, 1H), 7.59 (t, J = 8.0 Hz, 1H), 7.43 (d, J = 3.9 Hz, 1H), 2.57 (s, 3H).  13C NMR (126 
MHz, CDCl3) δ 190.81, 149.33, 148.91, 144.83, 135.17, 133.67, 132.12, 130.48, 125.75, 
123.53, 121.00, 25.04.  Anal. Calcd for C12H9NO3S: C, 58.29; H, 3.67; N, 5.66.  Found: 
C, 58.37; H, 3.83; N, 5.43. 
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Arylation of 2-methylthiophene with 5-bromopyrimidine.  Prepared according to the 
general procedure with 2-methylthiophene (118 mg, 1.20 mmol, 1.20 equiv) and 5-
bromopyrimidine (159 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (15% EtOAc:85% hexanes) to give the product (139 mg, 79%).  
1H NMR (500 MHz, CDCl3) δ 9.02 (s, 1H), 8.83 (d, J = 2.2 Hz, 2H), 7.17 (t, J = 2.7 Hz, 
1H), 6.76 (s, 1H), 2.50 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 156.95, 153.11, 142.56, 
133.91, 129.05, 127.03, 125.42, 15.69.  Anal. Calcd for C9H8N2S: C, 61.34; H, 4.58; N, 
15.90.  Found: C, 61.24; H, 4.55; N, 15.56. 
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Arylation of methyl pyrrole-2-carboxylate with 4-fluorobromobenzene.  Prepared 
according to the general procedure with methyl pyrrole-2-carboxylate (150 mg, 1.20 
mmol, 1.20 equiv) and 4-fluorobromobenzene (175 mg, 1.00 mmol, 1.00 equiv).  The 
mixture was purified by flash column chromatography (15% EtOAc:85% hexanes) to 
give the product (199 mg, 91%).  1H NMR (500 MHz, CDCl3) δ 9.87 (s, 1H), 7.59 (dd, J 
= 8.8, 5.2 Hz, 2H), 7.09 (t, J = 8.6 Hz, 2H), 6.96 (dd, J = 3.8, 2.4 Hz, 1H), 6.48 (dd, J = 
3.8, 2.7 Hz, 1H), 3.87 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 162.58 (d, J = 248.5 Hz), 
162.14 (s), 136.56 (s), 128.01 (d, J = 3.3 Hz), 126.96 (d, J = 8.0 Hz), 123.25 (s), 117.26 
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(s), 116.16 (d, J = 21.8 Hz), 108.17 (s), 51.88 (s). 19F NMR (376 MHz, CDCl3) δ -114.20 
(s). Anal. Calcd for C12H10FNO2: C, 65.75; H, 4.60; N, 6.39.  Found: C, 65.49; H, 4.40; N, 
6.17. 
 
Arylation of 2-acetylpyrrole with 4-fluorobromobenzene.  Prepared according to the 
general procedure with 2-acetylpyrrole (131 mg, 1.20 mmol, 1.20 equiv) and 4-
fluorobromobenzene (175 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (15% EtOAc:85% hexanes) to give the product (152 mg, 
75%).  1H NMR (500 MHz, CDCl3) δ 10.47 (s, 1H), 7.69 (d, J = 5.4 Hz, 2H), 7.10 (m, 
2H), 6.97 (d, J = 2.5 Hz, 1H), 6.50 (m, 1H), 2.46 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
188.10 (s), 162.81 (d, J = 248.2 Hz), 138.33 (s), 132.94 (s), 127.40 (d, J = 8.1 Hz), 
119.05 (s), 116.12 (d, J = 21.9 Hz), 110.82 (s), 108.41 (s), 25.56 (s). 19F NMR (376 MHz, 
CDCl3) δ -113.57 (s). Anal. Calcd for C12H10FNO: C, 70.93; H, 4.96; N, 6.89.  Found: C, 
70.58; H, 4.87; N, 6.83. 
O
+
Br
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC O
2) Pd(dba)2 (1%),
P(o-tol)3 (2%), ArBr,
Na2CO3, THF/H2O (10:1), rt
Me Me
Me
Me
O
Me Me
O
 
Arylation of 2,3-dimethylfuran with 4-bromoacetophenone.  Prepared according to 
the general procedure with 2,3-dimethylfuran (116 mg, 1.20 mmol, 1.20 equiv) and 4-
bromoacetophenone (199 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
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column chromatography (10% EtOAc:90% hexanes) to give the product (204 mg, 95%).  
1H NMR (499 MHz, CDCl3) δ 7.89 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.0 Hz, 2H), 6.56 (s, 
1H), 2.55 (s, 3H), 2.26 (s, 3H), 1.96 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 197.62, 
149.95, 149.28, 135.46, 134.95, 129.14, 122.96, 117.10, 111.37, 26.62, 11.79, 10.09. 
Anal. Calcd for C14H14O2: C, 78.48; H, 6.59.  Found: C, 78.48; H, 6.63. 
General Procedure for one-pot C-H Borylation and Suzuki-Miyaura cross-coupling 
of ortho-fluoroarenes with aryl bromides.  Inside a glove box, [Ir(cod)OMe]2 (2.0 mg, 
0.0030 mmol, 0.0030 equiv), dtbpy (1.6 mg, 0.0060 mmol, 0.0060 equiv), B2pin2 (183 
mg, 0.720 mmol, 0.720 equiv), the heteroarene (1.20 mmol, 1.20 equiv), and THF (2 mL) 
were added consecutively to a dry vial with a magnetic stir bar.  The vial was sealed and 
heated at 80 C for 18 h.  The reaction mixture was cooled to room temperature, and the 
volatile materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 
equiv), tri-o-tolylphosphine (6.1 mg, 0.020 mmol, 0.02 equiv), Na2CO3 (424 mg, 4.00 
mmol, 4.00 equiv), the aryl halide (1.00 mmol, 1.00 equiv), THF (3 mL) and degassed 
H2O (0.3 mL) were added consecutively to the reaction mixture.  The reaction mixture 
was sealed and stirred at room temperature for 18 h.  The reaction mixture was filtered 
through silica gel, washing with EtOAc, and concentrated under vacuum.  The reaction 
mixture was purified by column chromatography to give the product. 
 
Arylation of 2-chloro-4-fluorotoluene with 4-chlorobromobenzene.  Prepared 
according to the general procedure with 2-chloro-4-fluorotoluene (174 mg, 1.20 mmol, 
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1.20 equiv) and 4-chlorobromobenzene (192 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (5% EtOAc:95% hexanes) to give the 
product (245 mg, 96%). 1H NMR (499 MHz, CDCl3) δ 7.44 (m, 4H), 7.27 (d, J = 8.2 Hz, 
1H), 7.20 (d, J = 10.1 Hz, 1H), 2.40 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 157.77 (d, J 
= 249.2 Hz), 134.22, 134.16, 133.59 (d, J = 1.7 Hz), 132.48 (d, J = 3.9 Hz), 132.17 (d, J 
= 3.8 Hz), 130.35 (d, J = 3.0 Hz), 128.97, 126.50 (d, J = 13.2 Hz), 117.22 (d, J = 26.2 
Hz), 19.57. 19F NMR (376 MHz, CDCl3) δ -120.64. Anal. Calcd for C13H9Cl2F: C, 61.20; 
H, 3.56.  Found: C, 61.01; H, 3.54. 
+
Br
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC
2) Pd(dba)2 (1%),
P(o-tol)3 (2%), ArBr,
Na2CO3, THF/H2O (10:1), rt
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Arylation of 2-chloro-4-fluorotoluene with 4-bromoacetophenone.  Prepared 
according to the general procedure with 2-chloro-4-fluorotoluene (174 mg, 1.20 mmol, 
1.20 equiv) and 4-bromoacetophenone (199 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (222 mg, 85%). 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 2H), 7.57 (d, 
J = 8.4 Hz, 2H), 7.27 (d, J = 8.1 Hz, 1H), 7.15 (d, J = 10.1 Hz, 1H), 2.60 (s, 3H), 2.35 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 197.74, 157.80 (d, J = 249.9 Hz), 139.79 (d, J = 1.7 
Hz), 136.40, 134.76 (d, J = 10.2 Hz), 132.58 (d, J = 3.8 Hz), 132.22 (d, J = 3.6 Hz), 
129.20 (d, J = 3.2 Hz), 128.72 , 126.45 (d, J = 13.1 Hz), 117.26 (d, J = 26.1 Hz), 26.85, 
19.53. 19F NMR (376 MHz, CDCl3) δ -120.24. Anal. Calcd for C15H12ClFO: C, 68.58; H, 
4.60.  Found: C, 68.61; H, 4.79. 
201 
 
Arylation of 2-chloro-4-fluorotoluene with ethyl 4-bromobenzoate.  Prepared 
according to the general procedure with 2-chloro-4-fluorotoluene (174 mg, 1.20 mmol, 
1.20 equiv) and ethyl 4-bromobenzoate (229 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (237 mg, 81%). 1H NMR (499 MHz, CDCl3) δ 8.10 (d, J = 8.4 Hz, 2H), 7.56 (dd, 
J = 8.4, 1.7 Hz, 2H), 7.28 (d, J = 8.2 Hz, 1H), 7.17 (d, J = 10.1 Hz, 1H), 4.41 (q, J = 7.1 
Hz, 2H), 2.37 (s, 3H), 1.42 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 166.44, 
157.84 (d, J = 249.8 Hz), 139.56 (d, J = 1.7 Hz), 134.65 (d, J = 10.2 Hz), 132.50 (d, J = 
3.9 Hz), 132.27 (d, J = 3.7 Hz), 130.02, 129.91, 128.97 (d, J = 3.1 Hz), 126.66 (d, J = 
13.0 Hz), 117.24 (d, J = 26.1 Hz), 61.25, 19.49, 14.56. 19F NMR (376 MHz, CDCl3) δ -
120.26. Anal. Calcd for C16H14ClFO2: C, 65.65; H, 4.82.  Found: C, 65.51; H, 4.97. 
 
Arylation of 2-chloro-4-fluorotoluene with 4-bromoveratrole.  Prepared according to 
the general procedure with 2-chloro-4-fluorotoluene (174 mg, 1.20 mmol, 1.20 equiv) 
and 4-bromoveratrole (217 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (5% EtOAc:95% hexanes) to give the product (278 mg, 
99%). 1H NMR (499 MHz, CDCl3) δ 7.26 (dd, J = 8.2, 0.8 Hz, 1H), 7.14 (d, J = 10.2 Hz, 
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1H), 7.07 (t, J = 1.8 Hz, 1H), 7.05 (t, J = 1.5 Hz, 1H), 6.92 (d, J = 8.1 Hz, 1H), 3.92 (s, 
3H), 3.91 (s, 3H), 2.36 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 157.79 (d, J = 247.9 Hz), 
149.08 (d, J = 7.5 Hz), 133.22 (d, J = 10.1 Hz), 132.19 (d, J = 3.8 Hz), 132.15, 127.81, 
127.50 (d, J = 13.2 Hz), 121.58 (d, J = 2.9 Hz), 117.14, 116.92, 112.33 (d, J = 3.2 Hz), 
111.38, 56.16, 56.11, 19.52. 19F NMR (376 MHz, CDCl3) δ -120.64. Anal. Calcd for 
C15H14ClFO2: C, 64.18; H, 5.03.  Found: C, 64.18; H, 5.16. 
 
Arylation of 2,4-dichlorofluorobenzene with ethyl 4-bromobenzoate.  Prepared 
according to the general procedure with 2,4-dichlorofluorobenzene (198 mg, 1.20 mmol, 
1.20 equiv) and 4-bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (5% EtOAc:95% hexanes) to give the product 
(243 mg, 95%). 1H NMR (499 MHz, CDCl3) δ 7.43 (dd, J = 8.1, 1.8 Hz, 2H), 7.39 (dd, J 
= 5.9, 2.6 Hz, 1H), 7.34 (dd, J = 6.0, 2.7 Hz, 1H), 7.31 (d, J = 7.9 Hz, 2H), 2.45 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 154.29 (d, J = 249.9 Hz), 138.95, 131.98 (d, J = 15.1 Hz), 
131.10, 129.67, 129.52 (d, J = 4.5 Hz), 129.02 (d, J = 3.1 Hz), 128.97 (d, J = 3.2 Hz), 
128.90, 122.95 (d, J = 20.5 Hz), 21.49. 19F NMR (376 MHz, CDCl3) δ -122.63. Anal. 
Calcd for C13H9Cl2F: C, 61.20; H, 3.56.  Found: C, 60.80; H, 3.44. 
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Arylation of indole with 4-bromotoluene on 5 mmol scale.  Inside a glove box, 
[Ir(cod)OMe]2 (0.9 mg, 0.001 mmol, 0.0003 equiv), dtbpy (0.8 mg, 0.002 mmol, 0.0005 
equiv), B2pin2 (667 mg, 2.63 mmol, 0.525 equiv), indole (615 mg, 5.25 mmol, 1.05 
equiv), and THF (10 mL) were added to a dry vial with a magnetic stir bar.  The vial was 
sealed and heated at 80 C for 18 h.  The reaction mixture was cooled to room 
temperature and the volatile materials were removed under vacuum.  Pd(dba)2 (14.4 mg, 
0.025 mmol, 0.0050 equiv), tri-o-tolylphosphine (15.2 mg, 0.050 mmol, 0.010 equiv), 4-
bromotoluene (855 mg, 5.00 mmol, 1.00 equiv), Na2CO3 (2.12 mg, 20.0 mmol, 20.0 
equiv), THF (15 mL) and degassed H2O (1.5 mL) were added to the reaction mixture.  
The reaction mixture was sealed and stirred at room temperature for 18 h.  The reaction 
mixture was filtered through silica gel washing with EtOAc, and concentrated under 
vacuum.  The reaction mixture was purified by column chromatography (15% 
EtOAc:85% hexanes) to give the product (859 mg, 83%). Spectral data matched that 
obtained for the reaction conducted on 1 mmol scale. 
General Procedure for one-pot C-H Borylation and Suzuki-Miyaura cross-coupling 
of heteroarenes with aryl chlorides.  Inside a glove box, [Ir(cod)OMe]2 (2.0 mg, 0.003 
mmol, 0.003 equiv), dtbpy (1.6 mg, 0.0060 mmol, 0.0060 equiv), B2pin2 (153 mg, 0.600 
mmol, 0.600 equiv), the heteroarene (1.20 mmol, 1.20 equiv), and THF (2 mL) were 
added to a dry vial with a magnetic stir bar.  The vial was sealed and heated at 80 C for 
18 h.  The reaction mixture was cooled to room temperature and the volatile materials 
were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.01 mmol, 0.01 equiv), Q-phos (7.1 mg, 
0.010 mmol, 0.010 equiv), the aryl chloride (1.00 mmol, 1.00 equiv), K3PO4 (849 mg, 
4.00 mmol, 4.00 equiv), 1,4-dioxane (3 mL) and degassed H2O (0.3 mL) were added to 
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the reaction mixture.  The reaction mixture was sealed and stirred at 40 °C for 18 h.  The 
reaction mixture was filtered through silica gel washing with EtOAc, and concentrated 
under vacuum.  The reaction mixture was purified by column chromatography to give the 
product. 
S
+
Cl
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC S
2) Pd(dba)2 (1%),
Q-phos (1%), ArCl,
K3PO4, 1,4-dioxane/H2O (10:1), 40 oC
Me Me
NC
CN
 
Arylation of 2-methylthiophene with 4-chlorobenzonitrile.  Prepared according to the 
general procedure with 2-methylthiophene (152 mg, 1.20 mmol, 1.20 equiv) and 4-
chlorobenzonitrile (138 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (10% EtOAc:90% hexanes) to give the product (157 mg, 79%).  
1H NMR (499 MHz, CDCl3) δ 7.59 (s, 4H), 7.21 (d, J = 3.5 Hz, 1H), 6.78 (s, 1H), 2.53 (s, 
3H).  13C NMR (126 MHz, CDCl3) δ 142.45, 139.78, 139.12, 132.85, 127.10, 125.69, 
125.39, 119.21, 110.11, 15.79.  Anal. Calcd for C12H9NS: C, 72.33; H, 4.55; N, 7.03.  
Found: C, 72.47; H, 4.58; N, 6.73. 
 
Arylation of 2-methylthiophene with 4-chloronitrobenzene.  Prepared according to the 
general procedure with 2-methylthiophene (152 mg, 1.20 mmol, 1.20 equiv) and 4-
chloronitrobenzene (158 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (10% EtOAc:90% hexanes) to give the product (178 mg, 79%).  
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1H NMR (499 MHz, CDCl3) δ 8.17 (d, J = 8.8 Hz, 2H), 7.62 (d, J = 8.8 Hz, 2H), 7.27 (d, 
J = 3.7 Hz, 1H), 6.79 (s, 1H), 2.54 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 146.39, 
143.24, 141.07, 139.32, 127.29, 126.04, 125.53, 124.57, 15.81.  Anal. Calcd for 
C11H9NO2S: C, 60.26; H, 4.14; N, 6.39.  Found: C, 60.35; H, 4.07; N, 6.52. 
O
+
Cl
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC O
2) Pd(dba)2 (1%),
Q-phos (1%), ArCl,
K3PO4, 1,4-dioxane/H2O (10:1), 40 oC
NC
CN
MeO
O
MeO
O
 
Arylation of methyl 2-furoate with 4-chlorobenzonitrile.  Prepared according to the 
general procedure with methyl 2-furoate (151 mg, 1.20 mmol, 1.20 equiv) and 4-
chlorobenzonitrile (138 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (15% EtOAc:85% hexanes) to give the product (218 mg, 96%).  
1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.4 Hz, 2H), 7.26 (d, 
J = 3.6 Hz, 1H), 6.88 (d, J = 3.7 Hz, 1H), 3.92 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
159.07, 155.25, 145.08, 133.47, 132.89, 125.28, 120.08, 118.74, 112.23, 109.73, 52.34. 
Anal. Calcd for C13H9NO3: C, 68.72; H, 3.99; N, 6.16.  Found: C, 68.56; H, 3.87; N, 6.46. 
S
+
Cl
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC S
2) Pd(dba)2 (1%),
Q-phos (1%), ArCl,
K3PO4, 1,4-dioxane/H2O (10:1), 40 oC
OHC
CHO
O O
 
Arylation of 2-acetylthiophene with 4-chlorobenzaldehyde.  Prepared according to the 
general procedure with 2-acetylthiophene (152 mg, 1.20 mmol, 1.20 equiv) and 4-
chlorobenzaldehyde (141 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (10% EtOAc:90% hexanes) to give the product (210 mg, 91%).  
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1H NMR (500 MHz, CDCl3) δ 9.99 (s, 1H), 7.90 (d, J = 7.7 Hz, 2H), 7.76 (d, J = 7.8 Hz, 
2H), 7.66 (d, J = 3.9 Hz, 1H), 7.42 (d, J = 3.8 Hz, 1H), 2.55 (s, 3H).  13C NMR (126 MHz, 
CDCl3) δ 191.57, 190.84, 150.60, 144.90, 138.99, 136.34, 133.68, 130.71, 126.80, 125.88, 
25.04.  Anal. Calcd for C13H10O2S: C, 67.80; H, 4.38.  Found: C, 67.86; H, 4.38. 
 
Arylation of indole with 3-chlorobenzotrifluoride.  Prepared according to the general 
procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and 3-chlorobenzotrifluoride 
(181 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column 
chromatography (15% EtOAc:85% hexanes) to give the product (235 mg, 90%).  1H 
NMR (500 MHz, CDCl3) δ 8.31 (s, 1H), 7.89 (s, 1H), 7.80 (d, J = 7.4 Hz, 1H), 7.70 (d, J 
= 7.8 Hz, 1H), 7.57 (m, 2H), 7.42 (d, J = 8.0 Hz, 1H), 7.26 (m, 1H), 7.19 (dd, J = 8.0, 1.0 
Hz, 1H), 6.91 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 137.33 (s), 136.48 (s), 133.41 (s), 
131.70 (q, J = 32.4 Hz), 129.76 (s), 129.31 (s), 128.47 (s), 124.37 (q, J = 3.7 Hz), 124.32 
(q, J = 272 Hz), 123.27 (s), 121.97 (q, J = 3.8 Hz), 121.22 (s), 120.86 (s), 111.39 (s), 
101.48 (s). 19F NMR (376 MHz, CDCl3) δ -63.28 (s). Anal. Calcd for C15H10F3N: C, 
68.96; H, 3.86; N, 5.36.  Found: C, 69.26; H, 3.91; N, 5.29. 
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Arylation of methyl 2-methyl-3-furancarboxylate with 4-chloroanisole.  Prepared 
according to the general procedure with methyl 2-methyl-3-furancarboxylate (168 mg, 
1.20 mmol, 1.20 equiv) and 4-chloroanisole (143 mg, 1.00 mmol, 1.00 equiv).  The 
mixture was purified by flash column chromatography (10% EtOAc:90% hexanes) to 
give the product (133 mg, 54%).  1H NMR (499 MHz, CDCl3) δ 7.57 (s, 2H), 6.91 (s, 
1H), 6.74 (s, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 2.64 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
164.78, 159.49, 158.32, 152.08, 125.34, 123.29, 115.21, 114.39, 103.96, 55.51, 51.54, 
14.04.  Anal. Calcd for C14H14O4: C, 68.28; H, 5.73.  Found: C, 68.64; H, 5.80. 
O
+
Cl
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC O
2) Pd(dba)2 (1%),
Q-phos (1%), ArCl,
K3PO4, 1,4-dioxane/H2O (10:1), 40 oC
EtO2C EtO2C OHC
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Arylation of ethyl 3-furoate with 2-chlorobenzaldehyde.  Prepared according to the 
general procedure with ethyl 3-furoate (168 mg, 1.20 mmol, 1.20 equiv) and 2-
chlorobenzaldehyde (141 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (10% EtOAc:90% hexanes) to give the product (144 mg, 59%).  
1H NMR (500 MHz, CDCl3) δ 10.31 (d, J = 0.8 Hz, 1H), 8.13 (d, J = 0.8 Hz, 1H), 7.95 (d, 
J = 1.3 Hz, 1H), 7.63 (m, 2H), 7.47 (m, 1H), 6.94 (d, J = 0.8 Hz, 1H), 4.32 (q, J = 7.1 Hz, 
2H), 1.35 (t, J = 7.1 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 191.74, 162.85, 152.37, 
148.48, 133.91, 133.51, 132.33, 129.11, 128.90, 128.49, 121.79, 110.86, 60.99, 14.55.  
Anal. Calcd for C14H12O4: C, 68.85; H, 4.95.  Found: C, 68.59; H, 4.82. 
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1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
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Arylation of methyl 2-methyl-3-furancarboxylate with 3-chlorotoluene.  Prepared 
according to the general procedure with methyl 2-methyl-3-furancarboxylate (168 mg, 
1.20 mmol, 1.20 equiv) and 3-chlorotoluene (127 mg, 1.00 mmol, 1.00 equiv).  The 
mixture was purified by flash column chromatography (10% EtOAc:90% hexanes) to 
give the product (133 mg, 58%).  1H NMR (500 MHz, CDCl3) δ 7.46 (s, 1H), 7.44 (d, J = 
8.1 Hz, 1H), 7.27 (t, J = 7.6 Hz, 1H), 7.09 (d, J = 7.5 Hz, 1H), 6.86 (s, 1H), 3.85 (s, 3H), 
2.65 (s, 3H), 2.38 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 164.71, 158.85, 152.15, 
138.56, 130.15, 128.85, 128.69, 124.47, 121.04, 115.28, 105.50, 51.58, 21.69, 14.09.  
Anal. Calcd for C14H14O3: C, 73.03; H, 6.13.  Found: C, 72.79; H, 6.13. 
O
+
Cl
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC O
2) Pd(dba)2 (1%),
Q-phos (1%), ArCl,
K3PO4, 1,4-dioxane/H2O (10:1), 40 oC
Me Me
MeO2C MeO2C NC
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Arylation of methyl 2-methyl-3-furancarboxylate with 2-chlorobenzonitrile.  
Prepared according to the general procedure with methyl 2-methyl-3-furancarboxylate 
(168 mg, 1.20 mmol, 1.20 equiv) and 2-chlorobenzonitrile (138 mg, 1.00 mmol, 1.00 
equiv).  The mixture was purified by flash column chromatography (20% EtOAc:80% 
hexanes) to give the product (193 mg, 80%).  1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 
8.1 Hz, 1H), 7.65 (m, 1H), 7.57 (td, J = 7.8, 1.4 Hz, 1H), 7.43 (s, 1H), 7.30 (m, 1H), 3.82 
(s, 3H), 2.64 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 164.08, 160.22, 147.70, 134.40, 
209 
133.15, 132.45, 127.64, 125.92, 118.80, 115.85, 110.95, 106.95, 51.71, 14.01.  Anal. 
Calcd for C14H11NO3: C, 69.70; H, 4.60; N, 5.81.  Found: C, 69.46; H, 4.47; N, 5.74. 
 
Arylation of indole with 2-fluorochlorobenzene.  Prepared according to the general 
procedure with indole (141 mg, 1.20 mmol, 1.20 equiv) and 2-fluorochlorobenzene (131 
mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash column chromatography 
(15% EtOAc:85% hexanes) to give the product (127 mg, 60%).  1H NMR (499 MHz, 
CDCl3) δ 8.90 (s, 1H), 7.82 (dd, J = 8.8, 6.9 Hz, 1H), 7.75 (d, J = 7.9 Hz, 1H), 7.47 (d, J 
= 8.1 Hz, 1H), 7.27 (m, 5H), 7.03 (d, J = 2.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 
159.60 (d, J = 246.4 Hz), 136.93 (d, J = 1.6 Hz), 132.89 (d, J = 2.4 Hz), 129.10 (d, J = 
8.9 Hz), 128.49 (s), 128.25 (d, J = 4.0 Hz), 125.09 (d, J = 3.1 Hz), 122.99 (s), 120.99 (s), 
120.55 (s), 120.24 (s), 116.80 (d, J = 23.0 Hz), 111.36 (s), 101.97 (d, J = 3.2 Hz). 19F 
NMR (376 MHz, CDCl3) δ -117.86 (s). Anal. Calcd for C14H10FN: C, 79.60; H, 4.77; N, 
6.63.  Found: C, 79.22; H, 4.72; N, 6.42. 
O
+
Cl
1) [Ir(cod)OMe]2 (0.25%)
dtbpy (0.5%), B2pin2 (0.5 equiv),
THF, 80 oC O
2) Pd(dba)2 (1%),
Q-phos (1%), ArCl,
K3PO4, 1,4-dioxane/H2O (10:1), 40 oC
Me Me
Me
MeO2C
Me
CO2Me
 
Arylation of 2,3-dimethylfuran with methyl 4-chlorobenzoate.  Prepared according to 
the general procedure with 2,3-dimethylfuran (116 mg, 1.20 mmol, 1.20 equiv) and 
methyl 4-chlorobenzoate (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
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flash column chromatography (10% EtOAc:90% hexanes) to give the product (184 mg, 
80%).  1H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 8.5 Hz, 2H), 7.61 (d, J = 8.5 Hz, 2H), 
6.55 (s, 1H), 3.89 (s, 3H), 2.27 (s, 3H), 1.97 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 
167.16, 150.04, 149.05, 135.35, 130.25, 127.83, 122.85, 116.98, 111.06, 52.20, 11.77, 
10.10. Anal. Calcd for C14H14O3: C, 73.03; H, 6.13.  Found: C, 72.93; H, 6.28. 
General Procedure for one-pot C-H Borylation and Suzuki-Miyaura cross-coupling 
of 3,5-difluoroarenes with aryl bromides.  Inside a glove box, [Ir(cod)OMe]2 (2.0 mg, 
0.003 mmol, 0.003 equiv), dtbpy (1.6 mg, 0.0060 mmol, 0.0060 equiv), B2pin2 (183 mg, 
0.720 mmol, 0.720 equiv), the arene (1.20 mmol, 1.20 equiv), and THF (2 mL) were 
added consecutively to a dry vial with a magnetic stir bar.  The vial was sealed and 
heated at 80 C for 18 h.  The reaction mixture was cooled to room temperature and the 
volatile materials were removed under vacuum.  Pd(dba)2 (5.8 mg, 0.010 mmol, 0.010 
equiv), Q-phos (7.1 mg, 0.010 mmol, 0.010 equiv), the aryl bromide (1.00 mmol, 1.00 
equiv), K3PO4 (849 mg, 4.00 mmol, 4.00 equiv), 1,4-dioxane (3 mL) and degassed H2O 
(0.3 mL) were added consecutively to the reaction mixture.  The reaction mixture was 
sealed and stirred at 50 °C for 18 h.  The reaction mixture was filtered through silica gel 
washing with EtOAc, and concentrated under vacuum.  The reaction mixture was purified 
by column chromatography to give the product. 
 
Arylation of 3,5-difluoroanisole with 4-bromotoluene.  Prepared according to the 
general procedure with 3,5-difluoroanisole (173 mg, 1.20 mmol, 1.20 equiv) and 4-
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bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (180 mg, 77%).  
1H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 7.7 Hz, 2H), 6.59 (d, 
J = 9.3 Hz, 2H), 3.84 (s, 3H), 2.45 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.94 (dd, J 
= 246.96 Hz, 10.46 Hz), 160.094 (t, J = 14.24 Hz), 137.85 (s), 130.45 (s), 129.24 (s), 
126.57 (s), 111.21 (t, J = 19.6 Hz), 98.39 (m), 55.96 (s), 21.50 (s). 19F NMR (376 MHz, 
CDCl3) δ -114.24 (s). Anal. Calcd for C14H12F2O: C, 71.79; H, 5.16.  Found: C, 71.87; H, 
5.24. 
 
Arylation of 3,5-difluoroanisole with 4-bromoanisole.  Prepared according to the 
general procedure with 3,5-difluoroanisole (173 mg, 1.20 mmol, 1.20 equiv) and 4-
bromoanisole (187 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (185 mg, 74%).  
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 8.8 Hz, 2H), 7.00 (d, J = 8.8 Hz, 2H), 6.56 (d, 
J = 9.5 Hz, 2H), 3.86 (s, 3H), 3.82 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.91 (dd, J 
= 245.70 Hz, 10.46 Hz), 159.901 (t, J = 14.24 Hz), 159.42 (s), 131.70 (s), 121.71 (s), 
114.00 (s), 110.88 (t, J = 19.4 Hz), 98.37 (m), 55.95 (s), 55.45 (s).  19F NMR (376 MHz, 
CDCl3) δ -114.35 (s). Anal. Calcd for C14H12F2O2: C, 67.20; H, 4.83.  Found: C, 67.52; H, 
4.66. 
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Arylation of 3,5-difluoroanisole with 4-bromo-N,N-dimethylaniline.  Prepared 
according to the general procedure with 3,5-difluoroanisole (173 mg, 1.20 mmol, 1.20 
equiv) and 4-bromo-N,N-dimethylaniline (200 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (192 mg, 73%).  1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 8.9 Hz, 2H), 6.84 (d, 
J = 8.8 Hz, 2H), 6.57 (d, J = 9.5 Hz, 2H), 3.83 (s, 3H), 3.03 (s, 6H).  13C NMR (126 MHz, 
CDCl3) δ 161.00 (dd, J = 245.2, 10.6 Hz), 159.39 (t, J = 14.2 Hz), 150.19 (s), 131.25 (s), 
117.03 (s), 112.31 (s), 111.44 (t, J = 19.5 Hz), 98.34 (m), 55.97 (s), 40.67 (s).19F NMR 
(376 MHz, CDCl3) δ -114.36 (s).  Anal. Calcd for C15H15F2NO: C, 68.43; H, 5.74; N, 
5.32.  Found: C, 68.80; H, 5.80; N, 5.14. 
 
Arylation of 3,5-difluoroanisole with 2-bromotoluene.  Prepared according to the 
general procedure with 3,5-difluoroanisole (173 mg, 1.20 mmol, 1.20 equiv) and 2-
bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (164 mg, 70%).  
1H NMR (500 MHz, CDCl3) δ 7.34 (s, 2H), 7.28 (m, 3H), 6.59 (d, J = 9.1 Hz, 1H), 3.85 
(s, 3H), 2.23 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.87 (dd, J = 245.83, 10.96), 
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160.55 (t, J = 13.8 Hz), 137.96 (s), 131.27 (s), 130.29 (s), 129.17 (s), 128.66 (s), 125.79 
(s), 110.63 (t, J = 22.1 Hz), 98.13 (m), 56.00 (s), 20.03 (s). 19F NMR (376 MHz, CDCl3) 
δ -112.03 (s).  Anal. Calcd for C14H15F2O: C, 71.78; H, 5.16.  Found: C, 72.00; H, 5.00. 
 
Arylation of 3,5-difluoroanisole with 3-bromobenzotrifluoride.  Prepared according to 
the general procedure with 3,5-difluoroanisole (173 mg, 1.20 mmol, 1.20 equiv) and 4-
bromotoluene (225 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (5% EtOAc:95% hexanes) to give the product (259 mg, 90%).  
1H NMR (499 MHz, CDCl3) δ 7.76 (s, 1H), 7.66 (d, J = 7.4 Hz, 2H), 7.57 (m, 1H), 6.60 
(d, J = 9.7 Hz, 2H), 3.84 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.91 (t, J = 14.2 Hz), 
160.78 (dd, J = 248.22 Hz, 10.08 Hz), 133.93 (s), 130.94 (q, J = 32.3 Hz), 130.49 (s), 
128.92 (s), 127.38 (dt, J = 3.9, 2.1 Hz), 124.72 (q, J = 3.8 Hz), 124.36 (q, J = 273 Hz), 
109.69 (t, J = 18.9 Hz), 98.56 (m), 55.99 (s). 19F NMR (376 MHz, CDCl3) δ -63.13 (s), -
114.33 (s). Anal. Calcd for C14H9F5O: C, 58.34; H, 3.15.  Found: C, 58.61; H, 3.43. 
 
Arylation of methyl 3,5-difluorobenzoate with ethyl 4-bromobenzoate.  Prepared 
according to the general procedure with methyl 3,5-difluorobenzoate (207 mg, 1.20 mmol, 
1.20 equiv) and ethyl 4-bromobenzoate (229 mg, 1.00 mmol, 1.00 equiv).  The mixture 
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was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (269 mg, 84%).  1H NMR (500 MHz, CDCl3) δ 8.11 (d, J = 8.3 Hz, 2H), 7.63 (d, 
J = 7.5 Hz, 2H), 7.53 (d, J = 8.4 Hz, 2H), 4.38 (q, J = 7.1 Hz, 2H), 3.92 (s, 3H), 1.38 (t, J 
= 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 166.21 (s), 164.81 (t, J = 3.2 Hz), 159.79 
(dd, J = 250.8, 6.8 Hz), 132.92 (s), 131.97 (t, J = 9.6 Hz), 130.95 (s), 130.41 (s), 129.68 
(s), 122.14 (t, J = 18.5 Hz), 113.26 (m), 61.36 (s), 52.91 (s), 14.51 (s). 19F NMR (376 
MHz, CDCl3) δ -113.08 (s). Anal. Calcd for C17H14F2O4: C, 63.75; H, 4.41.  Found: C, 
63.86; H, 4.37. 
 
Arylation of 3,5-difluoropropiophenone with 3-bromoanisole.  Prepared according to 
the general procedure with 3,5-difluoropropiophenone (204 mg, 1.20 mmol, 1.20 equiv) 
and 3-bromoanisole (187 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by flash 
column chromatography (10% EtOAc:90% hexanes) to give the product (199 mg, 72%).  
1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.0 Hz, 2H), 7.39 (t, J = 8.0 Hz, 1H), 7.06 (m, 
1H), 7.02 (d, J = 1.3 Hz, 1H), 6.98 (m, 1H), 3.83 (s, 3H), 2.97 (q, J = 7.2 Hz, 2H), 1.24 (t, 
J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 198.07 (s), 160.23 (dd, J = 245.70 Hz, 
6.80 Hz), 159.68 (s), 137.80 (t, J = 7.8 Hz), 129.63 (s), 123.05 (s), 122.90 (s), 122.72 (s), 
116.03 (s), 114.67 (s), 111.51 (m), 55.51 (s), 32.13 (s), 8.23 (s). 19F NMR (376 MHz, 
CDCl3) δ -112.67 (s). Anal. Calcd for C16H14F2O2: C, 69.56; H, 5.11.  Found: C, 69.59; H, 
5.08. 
215 
 
Arylation of 3,5-difluoropropiophenone with 4-bromoveratrole.  Prepared according 
to the general procedure with 3,5-difluoropropiophenone (204 mg, 1.20 mmol, 1.20 equiv) 
and 4-bromoveratrole (217 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified by 
flash column chromatography (10% EtOAc:90% hexanes) to give the product (187 mg, 
61%).  1H NMR (499 MHz, CDCl3) δ 7.53 (d, J = 7.7 Hz, 2H), 7.05 (d, J = 8.1 Hz, 1H), 
6.99 (s, 1H), 6.95 (d, J = 8.3 Hz, 1H), 3.91 (s, 3H), 3.88 (s, 3H), 2.94 (m, 2H), 1.22 (t, J = 
7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 198.03 (s), 160.22 (dd, J = 249.8, 6.9 Hz), 
149.78 (s), 148.97 (s), 137.25 (t, J = 7.8 Hz), 123.31 (s), 122.84 (t, J = 18.6 Hz), 120.70 
(s), 113.54 (s), 111.50 (m), 111.21 (s), 56.18 (s), 56.08 (s), 32.06 (s), 8.23 (s). 19F NMR 
(376 MHz, CDCl3) δ -113.05 (s). Anal. Calcd for C20H20F2O3: C, 69.35; H, 5.82.  Found: 
C, 69.20; H, 5.62. 
 
Arylation of 3,5-difluoropropiophenone with 4-chlorobromobenzene.  Prepared 
according to the general procedure with 3,5-difluoropropiophenone (204 mg, 1.20 mmol, 
1.20 equiv) and 4-chlorobromobenzene (192 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (185 mg, 66%).  1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.7 Hz, 2H), 7.42 (d, 
J = 3.2 Hz, 4H), 2.97 (q, J = 7.6 Hz, 2H), 1.23 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, 
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CDCl3) δ 197.98 (s), 160.11 (dd, J = 251.0, 6.7 Hz), 138.04 (t, J = 7.81 Hz), 135.27 (s), 
131.72 (s), 128.95 (s), 126.85 (s), 121.82 (t, J = 18.7 Hz), 111.60 (m), 32.17 (s), 8.24 (s). 
19F NMR (376 MHz, CDCl3) δ -113.11 (m). Anal. Calcd for C15H11ClF2O: C, 64.18; H, 
3.95.  Found: C, 64.29; H, 4.07.  
 
Arylation of 3,5-difluoropropiophenone with 4-bromophenyl pivalate.  Prepared 
according to the general procedure with 3,5-difluoropropiophenone (204 mg, 1.20 mmol, 
1.20 equiv) and 4-bromophenyl pivalate (257 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (194 mg, 56%).  1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.1 Hz, 2H), 7.51 (d, 
J = 8.7 Hz, 2H), 7.19 (d, J = 8.6 Hz, 2H), 3.00 (q, J = 7.2 Hz, 2H), 1.37 (s, 9H), 1.26 (t, J 
= 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 198.05 (s), 177.02 (s), 160.22 (dd, J = 
250.8, 6.8 Hz), 151.71 (s), 137.81 (t, J = 7.8 Hz), 132.57 (s), 131.53 (s), 125.72 (s), 
121.80 (s), 111.55 (m), 39.38 (s), 32.14 (s), 27.33 (s), 8.25 (s). 19F NMR (376 MHz, 
CDCl3) δ -112.99 (s). Anal. Calcd for C17H16F2O3: C, 66.66; H, 5.26.  Found: C, 66.45; H, 
5.07. 
 
Arylation of 3,5-difluorochlorobenzene with 4-bromobenzonitrile.  Prepared 
according to the general procedure with 3,5-difluorochlorobenzene (179 mg, 1.20 mmol, 
217 
1.20 equiv) and 4-bromobenzonitrile (182 mg, 1.00 mmol, 1.00 equiv).  The mixture was 
purified by flash column chromatography (10% EtOAc:90% hexanes) to give the product 
(192 mg, 77%).  1H NMR (499 MHz, CDCl3) δ 7.75 (d, J = 8.4 Hz, 2H), 7.57 (m, 2H), 
7.07 (d, J = 7.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 159.85 (dd, J = 252.6, 7.9 Hz), 
135.63 (t, J = 13.4 Hz), 133.28 (s), 132.30 (s), 131.19 (s), 118.58 (s), 115.82 (t, J = 18.6 
Hz), 113.36 (m), 112.71 (s). 19F NMR (376 MHz, CDCl3) δ -112.95 (s). Anal. Calcd for 
C13H6ClF2N: C, 62.54; H, 2.42; N, 5.61.  Found: C, 62.34; H, 2.36; N, 5.42. 
 
Arylation of 3,5-difluorochlorobenzene with 3-bromobenzotrifluoride.  Prepared 
according to the general procedure with 3,5-difluorochlorobenzene (179 mg, 1.20 mmol, 
1.20 equiv) and 3-bromobenzotrifluoride (225 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (196 mg, 67%).  1H NMR (499 MHz, CDCl3) δ 7.74 (s, 1H), 7.70 (d, J = 7.0 Hz, 
1H), 7.64 (m, 1H), 7.60 (m, 1H), 7.08 (d, J = 7.3 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 
160.00 (dd, J = 252.1, 8.3 Hz), 135.03 (t, J = 13.4 Hz), 133.75 (s), 131.20 (q, J = 32.5 
Hz), 129.29 (s), 129.14 (s), 127.24 (m), 125.56 (q, J = 3.7 Hz), 124.16 (q, J = 273 Hz), 
116.19 (t, J = 18.6 Hz), 113.27 (m). 19F NMR (376 MHz, CDCl3) δ -63.20 (s), -113.16 (s). 
Anal. Calcd for C13H6ClF5: C, 53.36; H, 2.07.  Found: C, 53.09; H, 2.35. 
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Arylation of 3,5-difluoro-N,N-dimethylaniline with 2-bromotoluene.  Prepared 
according to the general procedure with 3,5-difluoro-N,N-dimethylaniline (189 mg, 1.20 
mmol, 1.20 equiv) and 2-bromotoluene (182 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (232 mg, 94%).  1H NMR (499 MHz, CDCl3) δ 7.38 (m, 3H), 7.34 (s, 1H), 6.37 
(d, J = 10.9 Hz, 2H), 3.03 (s, 6H), 2.31 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 161.28 
(dd, J = 242.3, 11.6 Hz), 151.34 (t, J = 13.4 Hz), 138.26 (s), 131.63 (s), 130.26 (s), 
130.06 (s), 128.29 (s), 125.73 (s), 105.53 (t, J = 22.4 Hz), 95.20 (m), 40.44 (s), 20.21 (s). 
19F NMR (376 MHz, CDCl3) δ -113.47 (s). Anal. Calcd for C15H15F2N: C, 72.86; H, 6.11; 
N, 5.66.  Found: C, 73.06; H, 6.20; N, 5.66. 
 
Arylation of methyl 3,5-difluorobenzoate with 2-bromo-5-fluorotoluene.  Prepared 
according to the general procedure with methyl 3,5-difluorobenzoate (207 mg, 1.20 mmol, 
1.20 equiv) and 2-bromo-5-fluorotoluene (189 mg, 1.00 mmol, 1.00 equiv).  The mixture 
was purified by flash column chromatography (10% EtOAc:90% hexanes) to give the 
product (163 mg, 58%).  1H NMR (499 MHz, CDCl3) δ 7.68 (d, J = 7.4 Hz, 2H), 7.28 (m, 
1H), 7.07 (td, J = 8.4, 2.8 Hz, 1H), 6.96 (dd, J = 9.0, 2.7 Hz, 1H), 3.97 (s, 3H), 2.13 (s, 
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3H). 13C NMR (126 MHz, CDCl3) δ 165.01 (t, J = 3.4 Hz), 160.89 (d, J = 245.32 Hz), 
159.92 (dd, J = 250.74 Hz, 7.2 Hz), 133.04 (d, J = 3.4 Hz), 132.29 (t, J = 9.5 Hz), 131.78 
(d, J = 7.9 Hz), 129.65 (d, J = 8.2 Hz), 121.91 (t, J = 21.4 Hz), 117.28 (d, J = 22.3 Hz), 
116.14 (d, J = 20.6 Hz), 113.03 (m), 52.94 (s), 19.10 (s). 19F NMR (376 MHz, CDCl3) δ -
111.12 (s), -118.26 (s). Anal. Calcd for C15H11F3O2: C, 64.29; H, 3.96.  Found: C, 64.30; 
H, 3.82. 
 
Arylation of 3,5-difluoro-N,N-dimethylaniline with 4-bromobenzaldehyde.  Prepared 
according to the general procedure with 3,5-difluoro-N,N-dimethylaniline (189 mg, 1.20 
mmol, 1.20 equiv) and 4-bromobenzaldehyde (185 mg, 1.00 mmol, 1.00 equiv).  The 
mixture was purified by flash column chromatography (10% EtOAc:90% hexanes) to 
give the product (186 mg, 71%).  1H NMR (499 MHz, CDCl3) δ 10.03 (s, 1H), 7.90 (s, 
2H), 7.63 (s, 2H), 6.27 (s, 2H), 2.99 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 192.11 (s), 
161.17 (dd, J = 244.9, 10.8 Hz), 151.60 (t, J = 13.8 Hz), 137.23 (s), 134.97 (s), 131.05 (t, 
J = 2.6 Hz), 129.62 (s), 104.47 (t, J = 18.7 Hz), 95.45 (m), 40.26 (s). 19F NMR (376 MHz, 
CDCl3) δ -115.20 (s). Anal. Calcd for C15H13F2NO: C, 68.96; H, 5.02; N, 5.36.  Found: C, 
68.65; H, 4.89; N, 5.09. 
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Arylation of 3,5-difluoro-N,N-dimethylaniline with 1-Bromo-3,4-
(methylenedioxy)benzene.  Prepared according to the general procedure with 3,5-
difluoro-N,N-dimethylaniline (189 mg, 1.20 mmol, 1.20 equiv) and 1-Bromo-3,4-
(methylenedioxy)benzene (201 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified 
by flash column chromatography (10% EtOAc:90% hexanes) to give the product (177 mg, 
64%). 1H NMR (500 MHz, CDCl3) δ 6.92 (m, 2H), 6.87 (m, 1H), 6.27 (d, J = 11.5 Hz, 
2H), 5.99 (s, 2H), 2.97 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 161.16 (dd, J = 243.0, 
10.8 Hz), 150.75 (t, J = 13.5 Hz), 147.59 (s), 146.90 (s), 124.17 (s), 123.78 (s), 111.08 (s), 
108.36 (s), 105.61 (t, J = 19.9 Hz), 101.24 (s), 95.47 (m), 40.40 (s). 19F NMR (376 MHz, 
CDCl3) δ -115.56 (m). . Calcd for C15H13F2NO2: C, 64.98; H, 4.73; N, 5.05. Found: C, 
64.97; H, 4.59; N, 4.82. 
 
Arylation of methyl 3,4-difluorobenzoate with 4-bromotoluene.  Prepared according 
to the general procedure with methyl 3,4-difluorobenzoate (207 mg, 1.20 mmol, 1.20 
equiv) and 4-bromotoluene (171 mg, 1.00 mmol, 1.00 equiv).  The mixture was purified 
by flash column chromatography (10% EtOAc:90% hexanes) to give the product (231 mg, 
88%). 1H NMR (500 MHz, CDCl3) δ 7.95 (m, 1H), 7.80 (m, 1H), 7.46 (dd, J = 8.1, 1.6 
Hz, 2H), 7.28 (m, 2H), 3.93 (s, 3H), 2.42 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 165.49 
(d, J = 2.6 Hz), 151.20 (dd, J = 250.74, 6.43 Hz), 150.93 (dd, J = 248.72, 12.85 Hz), 
138.88, 131.50 (d, J = 11.0 Hz), 131.00 (d, J = 2.6 Hz), 129.66 , 128.97 (d, J = 3.1 Hz), 
127.26 (t, J = 3.2 Hz), 126.63 (dd, J = 6.6, 4.2 Hz), 117.15 (m), 52.72, 21.45. 19F NMR 
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(376 MHz, CDCl3) δ -136.27 (d, J = 20.0 Hz), -136.70 (dd, J = 20.6, 10.4 Hz). Anal. 
Calcd for C15H12F2O2: C, 68.70; H, 4.61.  Found: C, 68.73; H, 4.56. 
 
General Procedure for (hetero)aryl Bpin stability studies.  Into a vial with a magnetic 
stir bar were added the (hetero)aryl Bpin (0.1 mmol), THF (0.3 mL), 2M aqueous 
Na2CO3 and 1,3,5-trimethoxybenzene (10 mg).  The vial was sealed and was allowed to 
stir at room temperature for 5 hours.  At this time, a sample was removed and analyzed 
using gas chromatography.  The conversion of the (hetero)aryl Bpin was determined by 
comparison to the internal standard. 
 
 
General Procedure for competition experiments between heteroaryl pinacol 
boronate esters and phenyl pinacol boronate.  Inside a glove box, Pd complex 1 (9.6 
mg, 0.010 mmol, 1.0 equiv), heteroaryl Bpin (0.100 mmol, 10.0 equiv), PhBpin (20.4 mg, 
0.100 mmol, 10.0 equiv), PPh3 (15.9 mg, 0.0600 mmol, 6.00 equiv), THF (0.25 mL), 
H2O (0.025 mL), and 1,3,5-trimethoxybenzene (10 mg) were added to a dry vial 
equipped with a magnetic stir bar.  The reaction mixture was sealed and stirred at room 
temperature for 5 h.  At this time, a sample was removed and the yields of the 2-aryl-
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heteroarene and 4-fluorobiphenyl were determined using gas chromatography by 
comparison to the internal standard. 
 
General Procedure for competition experiments between 2,6-difluoroaryl pinacol 
boronate esters and phenyl pinacol boronate.  Inside a glove box, Pd(dba)2 (2.3 mg, 
0.0040 mmol, 0.10 equiv), Q-phos (2.9 mg, 0.0040, 0.10 equiv), 2,6-difluoroaryl Bpin 
(0.200 mmol, 5.00 equiv), PhBpin (40.8 mg, 0.200 mmol, 5.00 equiv), 1-bromo-4-
fluorobenzene (7.0 mg, 0.040 mmol, 1.0 equiv), K3PO4 (170 mg, 0.80 mmol, 20 equiv), 
1,4-dioxane (0.5 mL), H2O (0.05 mL), and 1,3,5-trimethoxybenzene (10 mg) were added 
to a dry vial equipped with a magnetic stir bar.  The reaction mixture was sealed and 
stirred at 50 °C for 2 h.  At this time, a sample was removed and the yields of the 2,6-
difluorobiaryl and 4-fluorobiphenyl were determined using gas chromatography by 
comparison to the internal standard. 
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 Chapter 5. Iridium-Catalyzed, Silyl-Directed C-H Borylation of Nitrogen-
Containing Heterocycles 
5.1 Introduction 
Nitrogen-containing heterocycles constitute core structures in many molecules of 
tremendous importance, including electronic materials, natural products and 
pharmaceutical molecules with a wide range of biological activity (Scheme 47).  Because 
of their importance, many methods for the synthesis and functionalization of this class of 
molecules have been developed.1  Selective methods for the direct functionalization of 
nitrogen heterocycles could lead to rapid access to materials that are cumbersome to 
prepare by classical methods. To develop these selective and direct functionalization 
methods, transition metal catalysis presents a promising approach for the introduction of 
a variety of functionality with control of the site-selectivity of heteroarenes 
functionalization. 
 
Scheme 47. Important nitrogen-containing heterocycles with biological activity 
5.2 Background 
Although progress has been made,1a,1b few systems selectively functionalization the 
benzo-fused aromatic ring of indoles and related heterocycles due to the greater reactivity 
of the azole ring (Scheme 48),2 and the selective functionalization of other biologically 
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important nitrogen-containing heterocycles, such as carbazoles and tetrahydroquinolines,3 
has been less studied. Some chloroperoxidases form 7-chloroindoles, but these reactions 
have not been reported on a synthetic scale or with a scope beyond tryptophan4 or the 
parent indole.5  
 
Scheme 48. Site-selectivity for borylation and metallation of heteroarenes 
Selective functionalization of the 7-position of an indole by chemical methods typically 
requires a substituent at the 2-position to block reactivity at this site (Scheme 49). The 
borylation of indoles at the 7-position would create a method to prepare a variety of 7-
indole derivatives by exploiting the reactivity of the heteroarylboronate products. 
Because the 2-position of indole is inherently the most reactive site for metallation,6 the 
existing direct borylations of indoles at the 7-position7 or indirect borylations by initial 7-
lithiation of N-carbamoyl indoles have been conducted with 2-substituted derivatives.8 
Here, we report the application of our recently disclosed hydrosilyl directing group for C-
H borylation9 to alter the inherent selectivity for the reactions of nitrogen heterocycles. 
This change in selectivity leads to the 7-borylation of indoles lacking any substituent at 
the 2-position, as well as the borylation of the analogous sites of benzo-fused nitrogen 
heterocycles containing an N-H bond. 
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Scheme 49. Borylation of indole at the 7-position with a blocking group at the 2-position 
5.3 Results and Discussion 
To assess the ability of a hydrosilyl group to affect the selectivity of the 
borylation of nitrogen heterocycles, we evaluated the borylation of 1-diethylsilylindole 
with bis-pinacolatodiboron (B2pin2) in the presence of the combination of [Ir(COD)Cl]2 
and 4,4’-di-tert-butylbipyridine (dtbpy).10 The borylation of this indole derivative 
occurred with complete selectivity for the borylation at the 7-position in good yield 
(Equation 5). In contrast, the undirected borylation of indole gives 2- or 2,7-
functionalized products depending on the equivalents of the boron reagent (Equation 5). 
Thus, the hydrosilyl group completely overrides the inherent site-selectivity for the 
borylation of indole at the 2-position. We envision that this directing effect results from 
temporary docking of the catalyst on the silyl group by reversible reaction of 
[Ir(dtbpy)(Bpin)3] with the Si-H bond to release HBpin and form an intermediate silyl 
complex. The selectivity for borylation at the 7-position would then result from formation 
of a five-membered metallacycle from C-H bond cleavage at the 7-position, as shown in 
Equation 5, versus formation of a four-membered metalacycle from C-H bond cleavage 
at the 2-position. 
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With this result in hand, we sought to develop a one-pot protocol for indole 
borylations by installation of the silyl group, directed borylation, and desilylation. To do 
so, we first sought conditions for the generation of N-hydrosilyl indoles from indole and 
dihydrosilanes by dehydrogenative coupling under neutral conditions. Studies of several 
potential catalysts for this reaction showed that [Ru(p-cymene)Cl2]2 formed the N-
hydrosilyl indole from diethylsilane and indole at room temperature. Indole derivatives 
that could not be silylated in this fashion were silylated with dimethylchlorosilane and 
triethylamine as base.  
After evaporation of the solvent, the combination of [Ir(cod)Cl]2 and di-tert-butyl 
bipyridine (dtbpy) catalyzed the subsequent borylation of the resulting hydrosilyl indole 
at the 7-position without interference from the residual ruthenium. Full conversion of the 
silyl indole occurred after 4 h at 80 °C in the presence of just 0.25% [Ir(cod)Cl]2. 
Reactions with a catalyst loading of 0.1% [Ir(cod)Cl]2 also occurred in high yield, but a 
longer reaction time was needed and a second portion of catalyst was often required to 
achieve full conversion of the silyl indole. Workup with 3 M aqueous NaOAc released 
the silyl group to give the free 7-borylindole. 
229 
N
H
1) [Ru(p-cymene)Cl2]2 (1 mol%),
Et2SiH2, PhMe, r.t.
2) solvent removal
N
H
Bpin
3) [Ir(cod)Cl]2 (0.25 mol%),
dtbpy (0.5 mol%), B2pin2 (1 equiv.)
HBpin (5 mol%), 80 oC, THF
4) 3M aq. NaOAc
N
H
Br
N
H
I
N
H
MeO
55% 60%57%Bpin Bpin Bpin
N
H
BnO
53%Bpin
N
H
Cl
64%Bpin
N
H
Bpin 66%
N
H
Me
61%Bpin
N
H
Bpin
Ph
44%
N
H
Bpin
Me
61%a
N
H
Bpin 64%
N
H
Bpin
CN
45%
N
H
48 %
OTBS
Bpin
(45% without
a silyl group)
 
Table 17. Substrate scope of indole borylation at the 7-position  
Studies of the scope of the silyl-directed borylation of substituted indoles are 
summarized in Table 17. The directed borylation reaction tolerates a variety of 
substituents at the 3-,4-, and 5-positions of the indole framework. Reactions of indoles 
containing halogens, cyano groups, and alkoxy and benzyloxy groups all occurred to 
form exclusively the 7-boryl indole, as determined by GC/MS analysis. The isolated 
yields shown correspond to those for the full reaction sequence starting from the N-H 
indole. 
The borylation of 3-methylindole reveals the striking effect of the N-silyl group. 
Most iridium-catalyzed borylations of arenes with B2pin2 are strongly disfavored at 
positions ortho to substituents, but borylations of 3-substituted indoles give 2-boryl 
indoles in the absence of a directing group. For example, the borylation of 3-
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methylindole with B2pin2 catalyzed by [Ir(cod)Cl]2 and dtbpy gave a ~2:1 mixture of 2-
boryl- and 2,7-diboryl-3-methylindole, whereas the borylation of 3-methyl-N-
diethylhydrosilylindole occurred exclusively at the 7-position in good yield.  
The silyl group also directs borylation exclusively to the indole 7-position in the 
presence of other aryl C-H bonds. The borylation of 3-phenyl indole forms a mixture of 
at least three products, whereas the borylation of 3-phenyl-N-diethylsilyl indole formed 
7-boryl-3-phenylindole without borylation of the phenyl substituent. Moreover, the 
borylation of N-silylindole in a THF solution containing 6 equiv of added benzene led to 
exclusive borylation of the indole, as assayed by GC-MS. Conversely, the borylation of 
indole in the presence of 6 equiv of benzene gave a mixture of 2-boryl-indole, 2,7-
diboryl-indole and Ph-Bpin. 
The hydrosilyl group accelerated not only the rates of the borylation of indoles 
lacking a 2-substituent, but the rates and yields of the borylations of 2-substituted indoles. 
The silyl-directed borylation of 1,2,3,4-tetrahydrocyclopentindole occurred at the 7-
position in 64% yield for the two-step silylation-borylation process after 8 h, whereas this 
reaction of indole lacking the silyl group occurred in only 45% yield after a longer 36 h.7  
The results of silyl-directed, Ir-catalyzed borylations of other nitrogen 
heterocycles containing N-H bonds are shown in Scheme 50. The borylation of carbazole, 
phenothiazines, and tetrahydroquinoline occurred to full conversion and in moderate to 
good yield in the presence of 1 mol % [Ir(cod)OMe]2 and 2 mol % dtbpy.  The lower 
yields observed in some cases were due to protodeborylation during cleavage of the silyl 
group. The borylation of 2-chlorophenothiazine underwent selective borylation at the less 
hindered ortho-C-H bond. Phenothiazine is the core of a number of neuroleptic 
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antipsychotic drugs, including chlorpromazine, fluphenazine, and prochlorperazine, and 
is contained within components of organic solar cells and photovoltaics.11 
 
Scheme 50. Ir-catalyzed, silyl-directed borylation of other nitrogen-containing 
heterocycles 
The conversion of 7-boryl indole to further functionalized materials is shown in 
Scheme 51. Suzuki-Miyaura coupling with bromobenzene in the presence of catalytic 
Pd(dba)2 and PPh3 and K3PO4 as base in DMF at 80 °C gave 7-phenylindole. Palladium-
catalyzed allylation with PdCl2, tri-2-furylphosphine, cinnamyl acetate and KF in MeOH 
gave 7-cinnamylindole.12  Halogenation using the protocol developed for the conversion 
of arylboronates gave 7-bromo- and 7-chloroindole.13 
N
H
Bpin
N
H
Br
N
H
Cl
CuBr2
CuCl2
75%
40%
N
H
Ph
N
H
Pd cat, PhBr
88%
Pd cat
cinnamyl
acetate
52%Ph  
Scheme 51. Functionalization of 7-borylindoles into other useful indole building blocks 
To further illustrate the potential of the silyl-directed, Ir-catalyzed borylation of 
indoles to facilitate the synthesis of biologically active compounds, we prepared the core 
of the pyrrolophenanthridone natural products that have shown promising antitumor and 
other biological activity. Previous syntheses of this class of natural products have utilized 
pre-functionalized starting materials,14 such as 7-bromoindole,15 and relied on blocking 
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groups at the C-2 position,8 and typically required several steps or harsh reaction 
conditions. In contrast, the Ir-catalyzed, silyl-directed, 7-borylation of indole, followed 
by Suzuki-Miyaura coupling of the desired ortho-bromobenzoate and lactamization in 
situ gave the pyrrolophenanthridone alkaloid core and the natural product Hippadine in a 
single, one-pot sequence in good yield (Equation 6). Because this approach begins with 
an indole, and a benzoate, this method should allow the modular introduction of groups 
on both the indole and arene units. 
 
5.4 Conclusion and Outlook 
In conclusion, a highly selective method has been developed for the Ir-catalyzed, 
silyl-directed C-H borylation of nitrogen heterocycles, including a general borylation of 
indole at the 7-position. This transformation occurs with a low catalyst loading in short 
reaction times under mild conditions. Furthermore, this reaction possess good functional 
group tolerance, can be extended to the directed borylation of other nitrogen-containing 
heterocycles, and creates a versatile intermediate for further functionalization. Studies on 
the origin of the regioselectivity and application of this approach to additional directed 
functionalizations are in progress. 
5.5 Experimental Information 
General Procedures.  All reactions were conducted under an argon or nitrogen 
atmosphere in flame-dried glassware or in an Innovative Technologies drybox.  Dry and 
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degassed solvents were used unless otherwise noted.  Column chromatography was 
performed using Silicycle silica gel.  Analytical thin-layer chromatography was 
performed on glass plates coated with silica gel (Silicycle, 60 A pore size, 40-64 um 
particle size) impregnated with a fluorescent indicator (254 nm). TLC plates were 
visualized by ultraviolet light and staining solution of p-anisaldehyde or KMNO4. 
Materials.  [Ru(p-cymene)Cl2]2 was obtained from Strem Chemicals and used as 
received.  [Ir(cod)Cl]2 and [Ir(cod)OMe]2 were obtained from Johnson Matthey and used 
as received.  4,4’-di-tert-butylbipyridine was obtained from Aldrich Chemicals and used 
as received.  B2pin2 was obtained from Allychem and used as received.  HBpin was 
obtained from Aldrich Chemicals and distilled before use.  Et2SiH2 was obtained from 
Aldrich Chemicals or Alfa Aesar and used as received.  Et3N was obtained from Fisher 
Scientific and used as received.  Dimethylchlorosilane was obtained from Gelest and 
used as received.  NaH was obtained as a 60% suspension in mineral oil and washed with 
pentane and dried before use.  All indoles and nitrogen heterocycles were obtained from 
Aldrich Chemicals, Alfa Aesar, TCI America or Acros and used as received.  Pd(dba)2 
was prepared using standard methods.  Bromobenzene, cinnamyl acetate, PPh3, K3PO4, 
CuCl2, CuBr2 and methyl 2-bromobenzoate were obtained from Aldrich and used as 
received.  KF was obtained from Acros and used as received.  Methyl 6-bromo-1,3-
benzodioxole-5-carboxylate was prepared from 6-bromopiperonal (purchased from 
Aldrich) using the method of McDonald, et. Al: McDonald, C.; Holcomb, H.; Kennedy, 
K.; Kirkpatrick, E.; Leathers, T.; Vanemon, P. J. Org. Chem. 1989, 54, 1213. 
Instruments.  1H NMR spectra were recorded on a 500 MHz Varian instrument (126 
MHz for 13C).  11B NMR spectra were recorded on a 300 MHz Varian instrument.  
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Chemical shifts are reported in parts per million relative to residual protiated solvent 
(7.26 ppm for CDCl3 and 7.15 for C6D6).  In general, the carbon bonded to boron the 
heterocycle borylation products could not be observed via 13C NMR spectroscopy.  This 
is consistent with previous reports of 7-borylindole compounds. GC-MS data were 
obtained on an Agilient 6890-N GC system containing an Alltech EC-1 capillary column 
and an Agilient 5973 mass selective detector.  Elemental analyses were conducted by the 
University of Illinois at Urbana-Champaign Microanalysis Laboratory or Robertson 
Microlit Laboratories (Madison, NJ, USA). 
General procedures for the silyl-directed borylation of indoles.   
Borylation of N-diethylsilylindoles (Procedure 1) 
Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 0.01 mmol, 0.01 equiv), the indole (1.00 
mmol, 1.00 equiv), diethylsilane (132 mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) 
were added to a dry vial.  The mixture was stirred for 2-12 h until GC analysis showed 
full conversion of the indole to the N-silylindole.  The volatile materials were removed 
under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 
mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 
mmol, 0.05 equiv), and THF (1 mL) were added to the vial, and the reaction mixture was 
heated at 80 °C.  GC analysis indicated full conversion of the N-diethylsilylindole after 4-
16 h.  The reaction mixture was cooled to room temperature.  The volatile materials were 
removed from the reaction mixture under high vacuum at 40 °C.  The reaction mixture 
was dissolved in 2 mL of THF, and 0.5 mL of 3 M NaOAc (aq) was added.  The mixture 
was stirred at room temperature for 4-6 h.  Upon complete desilylation, as assayed by GC, 
the reaction mixture was diluted with Et2O and H2O.  The aqueous layer was separated 
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and extracted with Et2O.  The combined organic layers were washed with brine.  The 
organic layer was dried with MgSO4, filtered and concentrated under vacuum.  Column 
chromatography eluting under the conditions described below for each example afforded 
pure product. 
Borylation of N-dimethylsilylindoles (Procedure 2) 
Inside a glove box, triethylamine (160 mg, 1.50 mmol, 1.50 equiv), the indole (1.00 
mmol, 1.00 equiv), dimethylchlorosilane (144 mg, 1.50 mmol, 1.50 equiv) and THF (2 
mL) were added to a dry vial.  The mixture was stirred at room temperature for 4-6 h 
until GC analysis showed full conversion of the indole to the N-silylindole.  The reaction 
mixture was filtered through Celite, and the volatile materials were removed under 
vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 
0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 
0.05 equiv), and THF (1 mL) were added to the vial, and the reaction mixture was heated 
at 80 °C.  GC analysis indicated full conversion of the N-dimethylsilylindole after 4-16 h.  
The reaction mixture was cooled to room temperature.  The volatile materials were 
removed from the reaction mixture under high vacuum at 40 °C.  The reaction mixture 
was dissolved in 2 mL of THF, and 1 mL of saturated NaHCO3 (aq) was added.  The 
mixture was stirred at room temperature for 6 h.  Upon complete desilylation as assayed 
using GC analysis, the reaction mixture was diluted with Et2O and H2O.  The aqueous 
layer was separated and extracted with Et2O.  The combined organic layers were washed 
with brine.  The organic layer was dried with MgSO4, filtered and concentrated under 
vacuum.  Column chromatography, eluting under the conditions described below for each 
example, afforded pure product. 
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Borylation of N-diethylsilylindoles without use of a glovebox (Procedure 3) 
[Ru(p-cymene)Cl2]2 (6.0 mg, 0.010 mmol, 0.010 equiv) and the indole (1.00 mmol, 1.00 
equiv) were added to a dry glass reaction vessel equipped with a side arm and a vacuum 
valve and sealed under N2.  The vessel was evacuated and filled with N2 three times.  
Under a positive flow of N2, a mixture of diethylsilane (132 mg, 1.50 mmol, 1.50 equiv) 
and toluene (0.5 mL) were added.  The vessel was sealed and stirred.for 2-12 h until GC 
analysis showed full conversion of the indole to the N-silylindole.  The volatile materials 
were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy 
(1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv) were 
added to the vessel.  The vessel was evacuated and refilled with N2 three times.  Under a 
positive flow of N2, a mixture of HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 
mL) was added to the reaction mixture.  The vessel was sealed and the reaction mixture 
was heated at 80 °C.  GC analysis indicated full conversion of the N-diethylsilylindole 
after 4-16 h.  The reaction mixture was cooled to room temperature.  The volatile 
materials were removed from the reaction mixture under high vacuum at 40 °C.  The 
reaction mixture was dissolved in 2 mL of THF, and 0.5 mL of 3 M NaOAc (aq) was 
added.  The mixture was stirred at room temperature for 4-6 h.  Upon complete 
desilylation, as assayed by GC, the reaction mixture was diluted with Et2O and H2O.  The 
aqueous layer was separated and extracted with Et2O.  The combined organic layers were 
washed with brine.  The organic layer was dried with MgSO4, filtered and concentrated 
under vacuum.  Column chromatography eluting under the conditions described below 
for each example afforded pure product. 
Specific Experimental Procedures for the Borylation of Indoles 
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Borylation of indole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 0.010 mmol, 
0.010 equiv), indole (117 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 mg, 1.50 mmol, 
1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture was stirred at 
room temperature for 2 h, at which time, GC analysis showed full conversion of the 
indole to the N-silylindole.  The volatile materials were removed under vacuum.  
[Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.005 
equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 
equiv), and THF (1 mL) were added to the vial, and the reaction mixture was heated at 
80 °C.  After 4 h, GC analysis indicated full conversion of the N-diethylsilylindole.  The 
reaction mixture was cooled to room temperature.  The volatile materials were removed 
from the reaction mixture under high vacuum at 40 °C.  The reaction mixture was 
dissolved in 2 mL of THF, and 0.5 mL of 3 M NaOAc (aq) was added.  The mixture was 
stirred at room temperature for 6 h.  Upon complete desilylation, the reaction mixture was 
diluted with Et2O and H2O.  The aqueous layer was separated and extracted with Et2O.  
The combined organic layers were washed with brine.  The organic layer was dried with 
MgSO4, filtered and concentrated under vacuum.  Column chromatography (85:15 
hexanes:ethyl acetate) afforded the known product2 judged to be pure by NMR 
spectroscopy (160 mg, 66%).  1H NMR (499 MHz, CDCl3) δ 9.27 (s, 1H), 7.80 (d, J = 
7.9, 1H), 7.68 (d, J = 7.0, 1H), 7.29 (t, J = 2.7, 1H), 7.16 (t, J = 7.4, 1H), 6.57 (m, 1H), 
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1.42 (s, 12H).  13C NMR (126 MHz, CDCl3) δ 141.20, 129.47, 127.02, 124.50, 124.30, 
119.55, 102.20, 83.95, 25.25.  11B NMR (300MHz, CDCl3): δ 31.3. 
N
H
1) [Ru(p-cymene)Cl2]2 (1 mol%),
Et2SiH2, PhMe, 80oC
2) solvent removal
3) [Ir(cod)Cl]2 (0.25 mol%),
dtbpy (0.5 mol%), B2pin2 (1 equiv)
HBpin (5 mol%), 80 oC, THF
4) 3 M aq NaOAc
N
H
Bpin
Me Me
 
Borylation of  3-methylindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 0.010 
mmol, 0.010 equiv), 3-methylindole (131 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 
mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture 
was stirred at 80 °C for 12 h, at which time  GC analysis showed full conversion of the 
indole.  The volatile materials were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 
mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 
mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) were 
added to the vial, and the reaction mixture was heated at 80 °C.  After 6 h, GC analysis 
indicated full conversion of the N-diethylsilylindole.  The reaction mixture was cooled to 
room temperature.  The volatile materials were removed from the reaction mixture under 
high vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of THF, and 0.5 mL 
of 3 M NaOAc (aq) was added.  The mixture was stirred at room temperature for 6 h.  
Upon complete desilylation, the reaction mixture was diluted with Et2O and H2O.  The 
aqueous layer was separated and extracted with Et2O.  The combined organic layers were 
washed with brine.  The organic layer was dried with MgSO4, filtered and concentrated 
under vacuum.  Column chromatography (90:10 hexanes:ethyl acetate) afforded 
analytically pure product (156 mg, 61%).  1H NMR (500 MHz, CDCl3) δ 8.99 (s, 1H), 
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7.74 (d, J = 7.8, 1H), 7.68 (dd, J = 0.9, 7.1, 1H), 7.17 (dd, J = 7.1, 7.8, 1H), 7.05 (d, J = 
0.9, 1H), 2.38 (s, 3H), 1.42 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 141.68, 129.34, 
127.43, 122.61, 121.75, 118.78, 111.28, 83.96, 25.25, 9.93.  11B NMR (300MHz, CDCl3): 
δ 31.6.  Anal Calcd. for C15H20BNO2: C, 70.0; H, 7.84; N, 5.45; found: C, 69.6; H, 7.96; 
N, 5.48. 
 
Borylation of 5-methylindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 0.010 
mmol, 0.010 equiv), 5-methylindole (131 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 
mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture 
was stirred at 80 °C for.  After 12 h, at which time, GC analysis indicated that the indole 
was fully conversion of the indole to N-diethylsilylindole.  The volatile materials were 
removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 
mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 
mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) were added to the vial, and the reaction 
mixture was heated at 80 °C.  After 4 h, GC analysis indicated full conversion of the N-
diethylsilylindole.  The reaction mixture was cooled to room temperature.  The volatile 
materials were removed from the reaction mixture under high vacuum at 40 °C.  The 
reaction mixture was dissolved in 2 mL of THF, and 0.5 mL of 3 M NaOAc (aq) was 
added.  The mixture was stirred at room temperature for 4 h.  Upon complete desilylation, 
the reaction mixture was diluted with Et2O and H2O.  The aqueous layer was separated 
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and extracted with Et2O.  The combined organic layers were washed with brine.  The 
organic layer was dried with MgSO4, filtered and concentrated under vacuum.  Column 
chromatography (90:10 hexanes:ethyl acetate) afforded analytically pure product (156 
mg, 61%).  1H NMR (500 MHz, CDCl3) δ 9.20 (s, 1H), 7.64 (s, 1H), 7.58 (s, 1H), 7.28 (t, 
J = 2.7, 1H), 6.54 (d, J = 2.7, 1H), 2.53 (s, 3H), 1.46 (s, 12H). 13C NMR (126 MHz, 
CDCl3) δ 139.69, 130.87, 128.59, 127.47, 124.47, 124.41, 101.71, 84.06, 25.28, 21.56.  
11B NMR (300MHz, CDCl3): δ 31.8.  Anal Calcd. for C15H20BNO2: C, 70.0; H, 7.84; N, 
5.45; found: C, 70.2; H, 8.02; N, 5.49. 
N
H
1) [Ru(p-cymene)Cl2]2 (2 mol%),
Et2SiH2, PhMe, 80oC
2) solvent removal
3) [Ir(cod)Cl]2 (0.5 mol%),
dtbpy (1 mol%), B2pin2 (1 equiv.)
HBpin (5 mol%), 80 oC, THF
4) 3 M aq NaOAc
N
H
Bpin
Ph Ph
 
Borylation of  3-phenylindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (12 mg, 0.020 
mmol, 0.020 equiv), 3-phenylindole (197 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 
mg, 1.50 mmol) and toluene (0.5 mL) were added to a dry vial.  The mixture was stirred 
at 80 °C for 16 h, at which time GC-MS analysis showed full conversion of 3-
phenylindole.  The volatile materials were removed under vacuum.  [Ir(cod)Cl]2 (3.4 mg, 
0.0050 mmol, 0.050 equiv), dtbpy (2.7 mg, 0.010 mmol, 0.010 equiv), B2pin2 (254 mg, 
1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (2.0 mL) 
were added to the vial, and the reaction mixture was heated at 80 °C.  After 12 h, GC-MS 
analysis indicated full conversion of the N-diethylsilyl-3-phenylindole.  The reaction 
mixture was cooled to room temperature.  The volatile materials were removed from the 
reaction mixture under high vacuum at 40 °C.  The reaction mixture was dissolved in 2 
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mL of THF, and 0.5 mL of 3 M NaOAc (aq) was added.  The mixture was stirred at room 
temperature for 4 h.  Upon complete desilylation, the reaction mixture was diluted with 
Et2O and H2O.  The aqueous layer was separated and extracted with Et2O.  The combined 
organic layers were washed with brine.  The organic layer was dried with MgSO4, filtered 
and concentrated under vacuum.  Column chromatography (90:10 hexanes:ethyl acetate) 
afforded analytically pure product (140 mg, 44%).   1H NMR (500 MHz, CDCl3) δ 9.41 
(s, 1H), 8.13 (d, J = 8.0, 1H), 7.77 (d, J = 7.0, 1H), 7.73 (d, J = 7.5, 2H), 7.49 (m, 3H), 
7.33 (t, J = 7.4, 1H), 7.27 (t, J = 7.5, 1H), 1.45 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 
142.11, 136.09, 129.93, 129.02, 127.76, 126.09, 124.97, 123.64, 122.04, 120.09, 118.06, 
84.18, 25.28.  11B NMR (300MHz, CDCl3): δ 31.6.  Anal Calcd. for C20H22BNO2: C, 
75.25; H, 6.95; N, 4.39; found: C, 75.29; H, 6.70; N, 4.16. 
 
Borylation of  5-methoxyindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 
0.010 mmol, 0.010 equiv), 5-methoxyindole (148 mg, 1.00 mmol, 1.00 equiv), 
diethylsilane (132 mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry 
vial.  The mixture was stirred at room temperature for 6 h, at which time GC analysis 
showed full conversion of the indole.  The volatile materials were removed under vacuum.  
[Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 
equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 
equiv), and THF (1 mL) were added to the vial, and the reaction mixture was heated at 
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80 °C.  After 6 h, GC analysis indicated full conversion of the N-diethylsilylindole.  The 
reaction mixture was cooled to room temperature.  The volatile materials were removed 
from the reaction mixture under high vacuum at 40 °C.  The reaction mixture was 
dissolved in 2 mL of THF, and 0.5 mL of 3 M NaOAc (aq) was added.  The mixture was 
stirred at room temperature for 4 h.  Upon complete desilylation, the reaction mixture was 
diluted with Et2O and H2O.  The aqueous layer was separated and extracted with Et2O.  
The combined organic layers were washed with brine.  The organic layer was dried with 
MgSO4, filtered and concentrated under vacuum.  Column chromatography (85:15 
hexanes:ethyl acetate) afforded analytically pure product (160 mg, 60%). 1H NMR (500 
MHz, CDCl3) δ 9.15 (s, 1H), 7.36 (d, J = 2.4, 1H), 7.31 (d, J = 2.3, 1H), 7.28 (t, J = 2.7, 
1H), 6.51 (dd, J = 2.3, 2.9, 1H), 3.90 (s, 3H), 1.42 (s, 12H). 13C NMR (126 MHz, CDCl3) 
δ 154.03, 136.72, 127.87, 125.17, 118.05, 107.81, 101.77, 84.17, 56.48, 25.24.  11B NMR 
(300MHz, CDCl3): δ 31.8.  Anal Calcd. for C15H20BNO3: C, 65.96; H, 7.38; N, 5.13; 
found: C, 65.70; H, 7.63; N, 4.95. 
 
Borylation of  5-bromoindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 0.010 
mmol, 0.010 equiv), 5-bromoindole (197 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 
mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture 
was stirred at 50 °C for 12 h, at which time GC analysis showed full conversion of the 
indole.  The volatile materials were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 
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mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 
mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) were 
added to the vial, and the reaction mixture was heated at 80 °C.  After 6 h, GC analysis 
indicated full conversion of the N-diethylsilylindole.  The reaction mixture was cooled to 
room temperature.  The volatile materials were removed from the reaction mixture under 
high vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of THF, and 0.5 mL 
of 3 M NaOAc (aq) was added.  The mixture was stirred at room temperature for 4 h.  
Upon complete desilylation, the reaction mixture was diluted with Et2O and H2O.  The 
aqueous layer was separated and extracted with Et2O.  The combined organic layers were 
washed with brine.  The organic layer was dried with MgSO4, filtered and concentrated 
under vacuum.  Column chromatography (85:15 hexanes:ethyl acetate) afforded 
analytically pure product (175 mg, 55%).  1H NMR (500 MHz, CDCl3) δ 9.23 (s, 1H), 
7.88 (d, J = 1.7, 1H), 7.73 (d, J = 1.8, 1H), 7.27 (m, 1H), 6.49 (m, 1H), 1.40 (s, 12H).  13C 
NMR (126 MHz, CDCl3) δ 139.74, 131.61, 129.00, 126.66, 125.55, 113.15, 101.82, 
84.43, 25.22.  11B NMR (300MHz, CDCl3): δ 31.8.  Anal Calcd. for C14H17BBrNO2: C, 
52.22; H, 5.32; N, 4.35; found: C, 52.16; H, 5.52; N, 3.96.   
 
Borylation of  1,2,3,4-Tetrahydrocyclopentindole.  Inside a glove box, [Ru(p-
cymene)Cl2]2 (6.0 mg, 0.010 mmol, 0.010 equiv), 1,2,3,4-Tetrahydrocyclopentindole 
(158 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 mg, 1.50 mmol, 1.50 equiv) and 
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toluene (0.5 mL) were added to a dry vial.  The mixture was stirred at room temperature 
for 6 h, at which time  GC analysis showed full conversion of the indole.  The volatile 
materials were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 
equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 
equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) were added to the 
vial, and the reaction mixture was heated at 80 °C.  After 8 h, GC analysis indicated full 
conversion of the N-diethylsilylindole.  The reaction mixture was cooled to room 
temperature.  The volatile materials were removed from the reaction mixture under high 
vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of THF, and 0.5 mL of 3 
M NaOAc (aq) was added.  The mixture was stirred at room temperature for 4 h.  Upon 
complete desilylation, the reaction mixture was diluted with Et2O and H2O.  The aqueous 
layer was separated and extracted with Et2O.  The combined organic layers were washed 
with brine.  The organic layer was dried with MgSO4, filtered and concentrated under 
vacuum.  Column chromatography (90:10 hexanes:ethyl acetate) afforded the known 
product2 judged to be pure by NMR spectroscopy (179 mg, 64%).  1H NMR (500 MHz, 
CDCl3) δ 9.02 (s, 1H), 7.63 (d, J = 2.4, 1H), 7.62 (d, J = 1.3, 1H), 7.16 (t, J = 7.4, 1H), 
2.98 (t, J = 7.1, 2H), 2.90 (t, J = 6.9, 2H), 2.60 (m, 2H), 1.45 (s, 12H). 13C NMR (126 
MHz, CDCl3) δ 146.64, 144.00, 127.86, 123.93, 122.22, 119.30, 119.12, 84.00, 29.06, 
26.32, 25.27, 24.75.  11B NMR (300MHz, CDCl3): δ 31.8. 
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Borylation of  5-chloroindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (6.0 mg, 0.010 
mmol), 5-chloroindole (151 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 mg, 1.50 
mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture was 
stirred at 80 °C for 2 h, at which time  GC-MS analysis showed full conversion of 5-
chloroindole.  The volatile materials were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 
0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 
mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) 
were added to the vial, and the reaction mixture was heated at 80 °C.  After 4 h, GC 
analysis indicated full conversion of the N-diethylsilylindole.  The reaction mixture was 
cooled to room temperature.  The volatile materials were removed from the reaction 
mixture under high vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of 
THF, and 0.5 mL of 3 M NaOAc (aq) was added.  The mixture was stirred at room 
temperature for 4 h.  Upon complete desilylation, the reaction mixture was diluted with 
Et2O and H2O.  The aqueous layer was separated and extracted with Et2O.  The combined 
organic layers were washed with brine.  The organic layer was dried with MgSO4, filtered 
and concentrated under vacuum.  Column chromatography (90:10 hexanes:ethyl acetate) 
afforded analytically pure product (176 mg, 64%). 1H NMR (500 MHz, CDCl3) δ 9.24 (s, 
1H), 7.74 (d, J = 1.8, 1H), 7.63 (d, J = 1.9, 1H), 7.30 (m, 1H), 6.51 (m, 1H), 1.41 (s, 12H). 
13C NMR (126 MHz, CDCl3) δ 139.55, 129.08, 128.40, 125.75, 125.48, 123.62, 101.92, 
84.44, 25.23.  11B NMR (300MHz, CDCl3): δ 31.4.  Anal Calcd. for C14H17BClNO2: C, 
60.58; H, 6.17; N, 5.05; found: C, 60.53; H, 6.32; N, 4.97. 
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Borylation of  5-iodoindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (12.0 mg, 0.020 
mmol, 0.020 equiv), 5-iodoindole (243 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 
mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture 
was stirred at 50 °C for 2 h, at which time  GC-MS analysis showed full conversion of 5-
chloroindole.  The volatile materials were removed under vacuum.  .  [Ir(cod)Cl]2 (1.7 mg, 
0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 
mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) 
were added to the vial, and the reaction mixture was heated at 80 °C.  After 4 h, GC 
analysis indicated full conversion of the N-diethylsilylindole.  The reaction mixture was 
cooled to room temperature.  The volatile materials were removed from the reaction 
mixture under high vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of 
THF, and 0.5 mL of an aqueous solution of 3 M NaOAc was added.  The mixture was 
stirred at room temperature for 4 h.  Upon complete desilylation, the reaction mixture was 
diluted with Et2O and H2O.  The aqueous layer was separated and extracted with Et2O.  
The combined organic layers were washed with brine.  The organic layer was dried with 
MgSO4, filtered and concentrated under vacuum.  Column chromatography (90:10 
hexanes:ethyl acetate) afforded analytically pure product (210 mg, 57%).  1H NMR (500 
MHz, CDCl3) δ 9.25 (s, 1H), 8.12 (s, 1H), 7.93 (d, J = 1.5, 1H), 7.24 (m, 1H), 6.49 (m, 
1H), 1.41 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 140.15, 137.11, 132.90, 129.83, 
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129.48, 125.24, 101.59, 84.45, 25.25.  11B NMR (300MHz, CDCl3): δ 32.5.  Anal Calcd. 
for C14H17BINO2: C, 45.57; H, 4.64; N, 3.80; found: C, 45.28; H, 4.44; N, 3.88. 
 
Borylation of  4-cyanoindole.  Inside a glove box, triethylamine (160 mg, 1.50 mmol, 
1.50 equiv), 4-cyanoindole (142 mg, 1.00 mmol, 1.00 equiv), dimethylchlorosilane (144 
mg, 1.50 mmol, 1.50 equiv) and THF (2 mL) were added to a dry vial.  The mixture was 
stirred at room temperature for 6 h, at which time  GC analysis showed full conversion of 
the indole.  The reaction mixture was filtered through Celite and the volatile materials 
were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy 
(1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin 
(0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) were added to the vial, and the 
reaction mixture was heated at 80 °C.  After 16 h, GC analysis indicated full conversion 
of the N-dimethylsilylindole.  The reaction mixture was cooled to room temperature.  The 
volatile materials were removed from the reaction mixture under high vacuum at 40 °C.  
The reaction mixture was dissolved in 2 mL of THF, and 1 mL of saturated NaHCO3 (aq) 
was added.  The mixture was stirred at room temperature for 6 h.  Upon complete 
desilylation, the reaction mixture was diluted with Et2O and H2O.  The aqueous layer was 
separated and extracted with Et2O.  The combined organic layers were washed with brine.  
The organic layer was dried with MgSO4, filtered and concentrated under vacuum.  
Column chromatography (75:25 hexanes:ethyl acetate) afforded analytically pure product 
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(120 mg, 49%). 1H NMR (500 MHz, CDCl3) δ 9.49 (s, 1H), 7.65 (d, J = 7.3, 1H), 7.46 (d, 
J = 7.3, 1H), 7.44 (t, J = 2.7, 1H), 6.76 (m, 1H), 1.41 (s, 12H). 13C NMR (126 MHz, 
CDCl3) δ 140.86, 128.47, 128.27, 127.12, 124.45, 119.03, 105.81, 101.28, 84.77, 25.22.  
11B NMR (300MHz, CDCl3): δ 31.9.  Anal Calcd. for C15H17BN2O2: C, 67.19; H, 6.39; N, 
10.45; found: C, 67.14; H, 6.37; N, 10.05 
 
Borylation of  5-benzyloxylindole.  Inside a glove box, [Ru(p-cymene)Cl2]2 (30 mg, 
0.050 mmol, 0.05 equiv), 5-benzyloxyindole (223 mg, 1.00 mmol, 1.00 equiv), 
diethylsilane (132 mg, 1.50 mmol) and toluene (0.5 mL) were added to a dry vial.  The 
mixture was stirred at 80 °C for 12 h, at which time GC-MS analysis showed full 
conversion of 5-benzyloxyindole.  The volatile materials were removed under vacuum.  
[Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 
equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 
equiv), and THF (1.0 mL) were added to the vial, and the reaction mixture was heated at 
80 °C.  After 6 h, GC-MS analysis indicated full conversion of the N-diethylsilyl-5-
benzyloxyindole.  The reaction mixture was cooled to room temperature.  The volatile 
materials were removed from the reaction mixture under high vacuum at 40 °C.  The 
reaction mixture was dissolved in 2 mL of THF, and 0.5 mL of 3 M NaOAc (aq) was 
added.  The mixture was stirred at room temperature for 4 h.  Upon complete desilylation, 
the reaction mixture was diluted with Et2O and H2O.  The aqueous layer was separated 
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and extracted with Et2O.  The combined organic layers were washed with brine.  The 
organic layer was dried with MgSO4, filtered and concentrated under vacuum.  Column 
chromatography (90:10 hexanes:ethyl acetate) afforded analytically pure product (183 
mg, 53%).  1H NMR (500 MHz, CDCl3) δ 9.14 (s, 1H), 7.51 (d, J = 7.5, 3H), 7.47 (d, J = 
2.4, 1H), 7.41 (t, J = 7.5, 3H), 7.37 (d, J = 2.4, 1H), 7.35 (d, J = 7.3, 1H), 7.27 (t, J = 2.7, 
1H), 6.50 (dd, J = 2.3, 3.0, 1H), 5.16 (s, 2H), 1.42 (s, 12H).  13C NMR (126 MHz, CDCl3) 
δ 153.22, 138.16, 136.85, 128.76, 127.87, 127.81, 127.70, 125.14, 119.20, 109.20, 101.88, 
84.31, 71.42, 25.26.  11B NMR (300MHz, CDCl3): δ 31.6.  Anal Calcd. for C21H24BNO3: 
C, 72.2; H, 6.9; N, 4.0; found: C, 72.0; H, 6.5; N, 3.7. 
N
H
1) [Ru(p-cymene)Cl2]2 (1 mol%),
Et2SiH2, PhMe, 50 oC
2) solvent removal
3) [Ir(cod)Cl]2 (0.25 mol%),
dtbpy (0.5 mol%), B2pin2 (1 equiv)
HBpin (5 mol%), 80 oC, THF
4) 3 M aq NaOAc
N
H
Bpin
OTBS OTBS
 
Borylation of 3-(2-(tert-butyldimethylsilyloxy)ethyl)indole. Inside a glove box, [Ru(p-
cymene)Cl2]2 (6.0 mg, 0.010 mmol, 0.010 equiv), 3-(2-(tert-
butyldimethylsilyloxy)ethyl)indole (275 mg, 1.00 mmol, 1.00 equiv), diethylsilane (132 
mg, 1.50 mmol, 1.50 equiv) and toluene (0.5 mL) were added to a dry vial.  The mixture 
was stirred at 50 °C for 12 h, at which time  GC-MS analysis showed full conversion of 
3-(2-(tert-butyldimethylsilyloxy)ethyl)indole.  The volatile materials were removed under 
vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 
0.0050 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 
0.05 equiv), and THF (1.0 mL) were added to the vial, and the reaction mixture was 
heated at 80 °C.  After 6 h, GC-MS analysis indicated full conversion of the N-
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diethylsilyl-3-(2-(tert-butyldimethylsilyloxy)ethyl)indole.  The reaction mixture was 
cooled to room temperature.  The volatile materials were removed from the reaction 
mixture under high vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of 
THF, and 0.5 mL of 3 M NaOAc (aq) was added.  The mixture was stirred at room 
temperature for 4 h.  Upon complete desilylation, the reaction mixture was diluted with 
Et2O and H2O.  The aqueous layer was separated and extracted with Et2O.  The combined 
organic layers were washed with brine.  The organic layer was dried with MgSO4, filtered 
and concentrated under vacuum.  Column chromatography (90:10 hexanes:ethyl acetate) 
afforded analytically pure product (193 mg, 48%).  1H NMR (499 MHz, CDCl3) δ 9.10 (s, 
1H), 7.80 (d, J = 7.8, 1H), 7.71 (d, J = 6.9, 1H), 7.19 (t, J = 7.4, 1H), 7.15 (s, 1H), 3.94 (t, 
J = 7.4, 2H), 3.07 (t, J = 7.4, 2H), 1.44 (s, 12H), 0.98 (s, 9H), 0.11 (s, 6H). 13C NMR (126 
MHz, CDCl3) δ 141.58, 129.44, 126.93, 122.72, 122.24, 118.97, 112.82, 84.00, 64.38, 
29.37, 26.30, 25.26, 18.67, -4.96.  11B NMR (300MHz, CDCl3): δ 32.5.  Anal Calcd. for 
C16H20BNO4: C, 65.82; H, 9.04; N, 3.49; found: C, 65.86; H, 9.18; N, 3.47. 
Specific Experimental Procedures for Functionalization of 7-borylindoles 
 
 
Suzuki-Miyaura Coupling of 7-borylindole with bromobenzene.  7-borylindole (243 
mg, 1.00 mmol, 1.00 equiv), Pd(dba)2 (28.8 mg, 0.050 mmol, 0.050 equiv), PPh3 (52.4 
mg, 0.200 mmol, 0.200 equiv), K3PO4 (640 mg, 3.00 mmol, 3.00 equiv), bromobenzene 
(220 mg, 1.40 mmol, 1.40 equiv) and DMF (4 mL) were added to a dry vial.  The 
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reaction mixture was heated at 80 °C for 10 h.  The reaction mixture was cooled to room 
temperature, filtered through Celite, washing with Et2O.  The filtrate was concentrated.  
Column chromatography (80:20 hexanes:ethyl acetate) afforded the known product 
judged to be pure by NMR spectroscopy (169 mg, 88%).  1H NMR (499 MHz, CDCl3): δ 
8.48 (s, 1H), 7.77 (dd, J = 4.1, 4.7, 1H), 7.73 (d, J = 8.2, 2H), 7.60 (t, J = 7.6, 2H), 7.51 (t, 
J = 7.4, 1H), 7.34 (t, J = 5.0, 2H), 7.21 (d, J = 2.0, 1H), 6.73 (d, J = 4.3, 1H). 13C NMR 
(126 MHz, CDCl3) δ 139.64, 134.05, 129.47, 128.66, 128.54, 127.73, 125.97, 124.81, 
122.23, 120.64, 120.39, 103.31. 
 
Chlorination of 7-borylindole.  7-borylindole (243 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in MeOH (12 mL).  CuCl2 (404 mg, 3.00 mmol, 3.00 equiv) was dissolved in 
H2O (12 mL).  The aqueous CuCl2 solution was added to the MeOH solution, and the 
mixture was heated at 80 C for 4 h.  The reaction mixture was cooled to room 
temperature and diluted with Et2O.  The layers were separated, and the aqueous layer was 
extracted with Et2O.  The combined organic layers were washed with brine, dried with 
MgSO4, filtered and concentrated under vacuum.  Column chromatography (80:20 
hexanes:ethyl acetate) afforded the known product judged to be pure by NMR 
spectroscopy (113 mg, 75%). 1H NMR (500 MHz, CDCl3) δ 8.37 (s, 1H), 7.56 (d, J = 7.9, 
1H), 7.26 (d, J = 2.5, 1H), 7.21 (d, J = 7.6, 1H), 7.07 (t, J = 7.8, 1H), 6.61 (d, J = 4.3, 1H). 
13C NMR (126 MHz, CDCl3) δ 133.38, 129.54, 124.98, 121.56, 120.81, 119.58, 116.81, 
103.92. 
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Bromination of 7-borylindole.  7-borylindole (243 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in MeOH (12 mL).  CuBr2 (670 mg, 3.00 mmol, 3.00 equiv) was dissolved in 
H2O (12 mL).  The aqueous CuBr2 solution was added to the MeOH solution and the 
mixture was heated at 80 C for 4 h.  The reactions mixture was cooled to room 
temperature and diluted with Et2O.  The layers were separated, and the aqueous layer was 
extracted with Et2O.  The combined organic layers were washed with brine, dried with 
MgSO4, filtered and concentrated under vacuum.  Column chromatography (80:20 
hexanes:ethyl acetate) afforded the known product judged to be pure by NMR 
spectroscopy (78 mg, 40%).  1H NMR (499 MHz, CDCl3) δ 8.34 (s, 1H), 7.63 (d, J = 7.9, 
1H), 7.40 (d, J = 7.6, 1H), 7.26 (m, 1H), 7.05 (t, J = 7.7, 1H), 6.70 (m, 1H).  13C NMR 
(126 MHz, CDCl3) δ 134.84, 129.26, 124.96, 124.59, 121.26, 120.22, 104.91, 104.11. 
 
Allylation of 7-borylindole.  PdCl2 (7.0 mg, 0.039 mmol, 0.05 equiv), tri-2-
furylphosphine (18 mg, 0.078 mmol, 0.10 equiv), 7-borylindole (243 mg, 1.00 mmol, 
1.30 equiv), cinnamyl acetate (136 mg, 0.770 mmol, 1.00 equiv), KF (118 mg, 2.00 
mmol, 2.6 equiv), and MeOH (4 mL) were added to a dry vial.  The reaction was stirred 
at room temperature.  After 24 h, GC analysis indicated full consumption of cinnamyl 
acetate.  The reaction mixture was diluted with EtOAc and filtered through silica gel.  
The reaction mixture was concentrated under vacuum.  Column chromatography (95:5 
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hexanes:ethyl acetate) afforded analytically pure product (121 mg, 52%).  1H NMR (499 
MHz, CDCl3) δ 8.23 (s, 1H), 7.67 (d, J = 7.7, 1H), 7.43 (d, J = 7.7, 2H), 7.38 (t, J = 7.6, 
2H), 7.31 (t, J = 7.2, 1H), 7.18 (dt, J = 7.3, 17.1, 3H), 6.66 (dd, J = 6.2, 9.4, 2H), 6.58 – 
6.45 (m, 1H), 3.86 (d, J = 6.5, 2H). 13C NMR (126 MHz, CDCl3) δ 137.32, 135.47, 
131.61, 128.91, 128.65, 128.29, 127.69, 126.48, 124.42, 122.51, 122.44, 120.34, 119.58, 
103.16, 36.19.  Anal Calcd. for C17H15N: C, 87.52; H, 6.48; N, 6.00; found: C, 87.27; H, 
6.28; N, 5.93.
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Specific Experimental Procedures for Borylation of other Nitrogen-Containing 
Heterocycles 
 
Borylation of 1,2,3,4-tetrahydroquinoline.  Inside a glove box, triethylamine (160 mg, 
1.50 mmol, 1.50 equiv), 1,2,3,4-tetrahydroquinoline (133 mg, 1.00 mmol, 1.00 equiv), 
dimethylchlorosilane (144 mg, 1.50 mmol, 1.50 equiv) and THF (2 mL) were added to a 
dry vial.  The mixture was stirred at room temperature for 6 h, at which time GC analysis 
showed full conversion of the 1,2,3,4-tetrahydroquinoline.  The reaction mixture was 
filtered through Celite, and the volatile materials were removed under vacuum.  
[Ir(cod)OMe]2 (6.8 mg, 0.010 mmol, 0.010 equiv), dtbpy (5.6 mg, 0.020 mmol, 0.020 
equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 
equiv), and THF (1 mL) were added to the vial, and the reaction mixture was heated at 
80 °C.  GC analysis indicated full conversion of the N-dimethylsilyltetrahydroquinoline.  
The reaction mixture was cooled to room temperature.  The volatile materials were 
removed from the reaction mixture under high vacuum at 40 °C.  The reaction mixture 
was dissolved in 2 mL of THF, and 1 mL of saturated NaHCO3 (aq) was added.  The 
mixture was stirred at room temperature for 6 h.  Upon complete desilylation, the reaction 
mixture was diluted with Et2O and H2O.  The aqueous layer was separated and extracted 
with Et2O.  The combined organic layers were washed with brine.  The organic layer was 
dried with MgSO4, filtered, and concentrated under vacuum.  Column chromatography 
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(90:10 hexanes:ethyl acetate) afforded analytically pure product (64 mg, 40%). 1H NMR 
(499 MHz, CDCl3) δ 7.44 (d, J = 7.4, 1H), 6.99 (d, J = 7.2, 1H), 6.50 (t, J = 7.3, 1H), 5.84 
(s, 1H), 3.36 (m, 2H), 2.75 (t, J = 6.4, 2H), 1.91 (m, 2H), 1.32 (s, 12H). 13C NMR (126 
MHz, CDCl3) δ 151.58, 135.15, 133.08, 120.46, 115.11, 83.58, 41.81, 27.79, 25.11, 
21.80.  11B NMR (300MHz, CDCl3): δ 33.3.  Anal Calcd. for C15H22BNO2: C, 69.52; H, 
8.56; N, 5.40; found: C, 69.50; H, 8.68; N, 5.13. 
 
Borylation of carbazole.  Inside a glove box, carbazole (168 mg, 1.00 mmol, 1.00 equiv), 
NaH (27 mg, 1.1 mmol, 1.1 equiv), and THF (2 mL) were added to a dry vial.  The 
mixture was stirred at room temperature for 2 h.  Dimethylchlorosilane (144 mg, 1.50 
mmol, 1.50 equiv) was added.  The mixture was stirred at room temperature for 10 h, at 
which time  GC analysis showed full conversion of the carbazole.  The reaction mixture 
was filtered through Celite, and the volatile materials were removed under vacuum.  
[Ir(cod)OMe]2 (6.8 mg, 0.010 mmol, 0.010 equiv), dtbpy (5.6 mg, 0.020 mmol, 0.020 
equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 
equiv), and THF (1 mL) were added to the vial, and the reaction mixture was heated at 
80 °C.  GC analysis indicated full conversion of the N-dimethylsilylcarbazole.  The 
reaction mixture was cooled to room temperature.  The volatile materials were removed 
from the reaction mixture under high vacuum at 40 °C.  The reaction mixture was 
dissolved in 2 mL of THF, and 1 mL of saturated NaHCO3 (aq) was added.  The mixture 
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was stirred at room temperature for 6 h.  Upon complete desilylation, the reaction mixture 
was diluted with Et2O and H2O.  The aqueous layer was separated and extracted with 
Et2O.  The combined organic layers were washed with brine.  The organic layer was 
dried with MgSO4, filtered, and concentrated under vacuum.  Column chromatography 
(90:10 hexanes:ethyl acetate) afforded analytically pure product (138 mg, 47%).  1H 
NMR (500 MHz, CDCl3) δ 9.20 (s, 1H), 8.23 (d, J = 7.5, 1H), 8.12 (t, J = 7.0, 2H), 7.91 
(d, J = 7.0, 1H), 7.55 (d, J = 8.0, 1H), 7.50 – 7.37 (m, 2H), 7.28 (dd, J = 7.3, 14.7, 3H), 
1.47 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 145.30, 139.57, 133.08, 125.98, 123.94, 
123.14, 122.53, 120.54, 119.39, 118.98, 110.82, 84.27, 25.30. Anal Calcd. for 
C18H20BNO2: C, 73.74; H, 6.88; N, 4.78; found: C, 73.66; H, 7.10; N, 4.78. 
 
Borylation of phenothiazine. Inside a glove box, phenothiazine (199 mg, 1.00 mmol, 
1.00 equiv), NaH (27 mg, 1.1 mmol, 1.1 equiv), and THF (2 mL) were added to a dry vial.  
The mixture was stirred at room temperature for 2 h.  Dimethylchlorosilane (144 mg, 
1.50 mmol, 1.50 equiv) was added, and the mixture was stirred at room temperature for 
10 h.  The reaction mixture was filtered and concentrated, washing with Et2O. 
[Ir(cod)OMe]2 (6.8 mg, 0.010 mmol, 0.010 equiv), dtbpy (5.6 mg, 0.020 mmol, 0.020 
equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 
equiv), and THF (1 mL) were added to the vial..  The reaction mixture was heated at 
80 °C for 24 h, at which time GC analysis indicated full conversion of the N-
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dimethylsilyl-phenothiazine.  The reaction mixture was cooled to room temperature.  The 
volatile materials were removed from the reaction mixture under high vacuum at 40 °C.  
Column chromatography (90:10 hexanes:ethyl acetate) afforded analytically pure product 
(208 mg, 64%).  1H NMR (499 MHz, CDCl3) δ 8.22 (s, 1H), 7.48 (d, 1H), 7.09 (d, J = 7.5, 
1H), 7.01 (m, 2H), 6.82 (ddd, J = 4.6, 9.1, 10.5, 2H), 6.58 (d, J = 7.8, 1H), 1.41 (s, J = 1.6, 
12H). 13C NMR (126 MHz, CDCl3) δ 148.95, 142.23, 135.02, 130.42, 127.49, 126.86, 
122.71, 121.72, 118.55, 118.27, 115.01, 84.48, 25.21.  11B NMR (300MHz, CDCl3): δ 
31.7.  Anal Calcd. for C18H20BNO2S: C, 66.47; H, 6.20; N, 4.31; found: C, 66.22; H, 6.19; 
N, 4.38.  
 
Borylation of 2-chlorophenothiazine. Inside a glove box, 2-chlorophenothiazine (234 
mg, 1.00 mmol, 1.00 equiv), NaH (27 mg, 1.1 mmol, 1.1 equiv), and THF (2 mL) were 
added to a dry vial.  The mixture was stirred at room temperature for 2 h.  
Dimethylchlorosilane (144 mg, 1.50 mmol, 1.50 equiv) was added, and the mixture was 
stirred at room temperature for 10 h.  The reaction mixture was filtered and concentrated, 
washing with Et2O. [Ir(cod)OMe]2 (6.8 mg, 0.010 mmol, 0.010 equiv), dtbpy (5.6 mg, 
0.020 mmol, 0.020 equiv), B2pin2 (254 mg, 1.00 mmol, 1.00 equiv), HBpin (0.008 mL, 
0.05 mmol, 0.05 equiv), and THF (1 mL) were added to the vial.. The reaction mixture 
was heated at 80 °C for 24 h, at which time GC analysis indicated full conversion of the 
N-dimethylsilyl-2-chlorophenothiazine.  The reaction mixture was cooled to room 
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temperature.  The volatile materials were removed from the reaction mixture under high 
vacuum at 40 °C.  The reaction mixture was dissolved in 2 mL of THF, and 1 mL of 
saturated NaHCO3 (aq) was added.  The mixture was stirred at room temperature for 6 h.  
Upon complete desilylation, the reaction mixture was diluted with Et2O and H2O.  The 
aqueous layer was separated and extracted with Et2O.  The combined organic layers were 
washed with brine.  The organic layer was dried with MgSO4, filtered and concentrated 
under vacuum.  Column chromatography (90:10 hexanes:ethyl acetate) afforded 
analytically pure product (314 mg, 87%).  1H NMR (500 MHz, CDCl3) δ 8.18 (s, 1H), 
7.46 (dd, J = 1.2, 7.4, 1H), 7.04 (d, J = 8.4, 1H), 6.80 (m, 3H), 6.50 (d, J = 1.9, 1H), 1.39 
(s, 12H). 13C NMR (126 MHz, CDCl3) δ 148.04, 143.30, 135.15, 132.96, 130.39, 127.47, 
122.41, 122.21, 117.86, 117.11, 114.81, 84.64, 25.19.  11B NMR (300MHz, CDCl3): δ 
31.8. Anal Calcd. for C18H19BNO2SCl: C, 60.11; H, 5.632 N, 3.89 found: C, 60.34; H, 
5.49; N, 4.10. 
Specific Experimental Procedures for Synthesis of Pyrrolophenanthridone 
Alkaloids 
 
Synthesis of core of pyrrolophenanthridone alkaloids.  Inside a glove box, 
triethylamine (160 mg, 1.50 mmol, 1.50 equiv), indole (117 mg, 1.00 mmol, 1.00 equiv), 
dimethylchlorosilane (144 mg, 1.50 mmol, 1.50 equiv) and THF (2 mL) were added to a 
dry vial.  The mixture was stirred at room temperature for 6 h, at which time GC analysis 
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showed full conversion of the indole.  The reaction mixture was filtered through Celite, 
and the volatile materials were removed under vacuum.  [Ir(cod)Cl]2 (1.7 mg, 0.0025 
mmol, 0.0025 equiv), dtbpy (1.4 mg, 0.0050 mmol, 0.0050 equiv), B2pin2 (254 mg, 1.00 
mmol, 1.00 equiv), HBpin (0.008 mL, 0.05 mmol, 0.05 equiv), and THF (1 mL) were 
added to the vial..  The reaction mixture was heated at 80 °C for 6 h, at which time GC 
analysis indicated full conversion of the N-dimethylsilylindole.  The reaction mixture was 
cooled to room temperature.  The volatile materials were removed from the reaction 
mixture under high vacuum.  Pd(dba)2 (30 mg, 0.050 mmol, 0.050 equiv), PPh3 (52 mg, 
0.20 mmol, 0.20 equiv), methyl 2-bromobenzoate (255 mg, 1.20 mmol, 1.20 equiv), 
K3PO4 (638 mg, 3.00 mmol, 3.00 equiv) and DMF (4 mL) were added to the reaction 
mixture.  The reaction mixture was heated to 80 oC for 24 h.  The reaction was filtered 
through Celite, washed with EtOAc, and concentrated under vacuum.  Column 
chromatography (80:20 hexanes:ethyl acetate) afforded the known product judged to be 
pure by NMR spectroscopy  (130 mg, 60%).  1H NMR (499 MHz, CDCl3) δ 8.58 (d, J = 
8.0, 1H), 8.22 (d, J = 7.9, 1H), 8.03 (d, J = 3.6, 1H), 7.97 (d, J = 7.7, 1H), 7.75 (m, 2H), 
7.58 (t, J = 7.6, 1H), 7.44 (t, J = 7.7, 1H), 6.89 (d, J = 3.6, 1H). 13C NMR (126 MHz, 
CDCl3) δ 158.93, 134.65, 133.28, 131.64, 129.73, 128.65, 128.29, 127.22, 124.26, 123.59, 
123.12, 122.83, 118.77, 116.80, 111.27.  
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Synthesis of Hippadine.  Inside a glove box, triethylamine (37 mg, 0.36 mmol, 1.5 
equiv), indole (28 mg, 0.24 mmol, 1 equiv), dimethylchlorosilane (34 mg, 0.36 mmol, 1.5 
equiv) and THF (0.5 mL) were added to a dry vial.  The mixture was stirred at room 
temperature for 6 h, at which time GC analysis showed full conversion of the indole.  The 
reaction mixture was filtered through Celite, and the volatile materials were removed 
under vacuum.  [Ir(cod)Cl]2 (0.4 mg, 0.0006 mmol, 0.003 equiv), dtbpy (0.3 mg, 0.001 
mmol, 0.005 equiv), B2pin2 (61 mg, 0.24 mmol, 1.0 equiv), HBpin (0.001 mL, 0.01 mmol, 
0.05 equiv), and THF (0.4 mL) were added to the vial.  The reaction mixture was heated 
at 80 °C for 6 h, at which time GC analysis indicated full conversion of the N-
dimethylsilylindole.  The reaction mixture was cooled to room temperature.  The volatile 
materials were removed from the reaction mixture under high vacuum.  Pd(dba)2 (7.2 mg, 
0.012 mmol, 0.05 equiv), PPh3 (12.4 mg, 0.048 mmol, 0.20 equiv), methyl 6-bromo-1,3-
benzodioxole-5-carboxylate (68 mg, 0.26 mmol, 1.10 equiv), K3PO4 (153 mg, 0.717 
mmol, 3.00 equiv) and DMF (1 mL) were added to the reaction mixture.  The reaction 
mixture was heated at 80 °C for 24 h.  The reaction was filtered through Celite, washed 
with EtOAc, and concentrated under vacuum.  Column chromatography (80:20 
hexanes:ethyl acetate) afforded the known product judged to be pure by NMR 
spectroscopy (30 mg, 48%).  1H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 3.5, 1H), 7.94 (s, 
1H), 7.87 (d, J = 7.6, 1H), 7.73 (d, J = 7.6, 1H), 7.60 (s, 1H), 7.45 (t, J = 7.7, 1H), 6.88 (d, 
J = 3.5, 1H), 6.15 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 158.35, 152.73, 148.72, 131.69, 
131.10, 128.69, 124.15, 123.69, 122.84, 122.64, 118.54, 116.76, 110.98, 108.15, 102.57, 
101.86. 
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Chapter 6. A Simple, Multidimensional Approach to High-Throughput Discovery of 
Catalytic Reactions 
6.1 Introduction 
Transition metal complexes catalyze many important reactions used in medicine, 
materials science and energy production. Most approaches to the design and discovery of 
new transition metal-catalyzed reactions begins with two or more substrates each 
containing a functional group (Figure 3). The substrates are generally chosen because it is 
hypothesized that they can undergo a reaction based on mechanistic insight, or because 
the product of their reaction would be of particular value. Another approach to the 
discovery of new chemical reactions and new transition metal catalysts is to expose two 
or more substrates each with a unique functional group to a transition metal catalyst, and 
to then perform an assay to identify reaction products. Although high-throughput 
methods for catalyst discovery that would mirror related approaches for the discovery of 
medicinally active compounds have been the focus of much attention, these methods 
have not been sufficiently general or accessible to typical synthetic laboratories to be 
adopted widely. 
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Figure 3. General approaches to the discovery of new chemical reactions and new 
catalysts 
6.2 Background 
Mechanistic data often provide the foundation for catalyst development and 
optimization. However, many reactions were discovered serendipitously while seeking a 
different synthetic transformation.1 The advent of combinatorial methods for the 
discovery of new drug candidates and new enzymes for organic synthesis has raised the 
prospect of applying analogous high-throughput experimental methods to the discovery 
of catalytic transformations. Many studies on this topic have been published over the past 
two decades.2 Although the experimental designs that have been reported all have merit, 
few, have been used by laboratories beyond those disclosing the original studies. Many of 
these approaches require cationic intermediates2i,2j,2m,2n acidic products,3 substrates with 
colorimetric tags, serial optimization of portions of modular ligands,4 the attachment of 
reactants to DNA fragments and PCR amplification to identify the product, or robotic 
equipment having a cost that is prohibitory to most laboratories. Thus, to apply 
combinatorial methods to catalyst discovery in a general fashion, new methods are 
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needed that require equipment commonly available in a synthetic laboratory or obtainable 
at a comparable cost.   
Most published methods for the high-throughput discovery of catalysts evaluate 
one of the two catalyst-reactant dimensions. In other words, these methods have 
examined either many catalysts for a single class of reaction or a single catalyst for many 
reactions. A two-dimensional approach in which many catalysts for many catalytic 
reactions are tested simultaneously would create a more efficient discovery platform, if 
the reactants and products from such a system could be identified. Here, we disclose a 
method to discover catalytic reactions by conducting experiments in an x-y array on 
pools of substrates having similar masses, and analyzing combinations of these pools by 
mass spectroscopy. This format evaluates thousands of reactions at one time and 
pinpoints with just a few mass spectral measurements the coordinates of the metal and 
ligand that effect a reaction between two or more substrates. Using this method, we 
discovered a copper-catalyzed alkyne hydroamination and two nickel-catalyzed 
hydroarylation reactions, each of which displays excellent functional group tolerance. 
6.3 Results and Discussion 
For the study described here, the core experiment was conducted with a set of 17 
organic reactants, each of which contains 10 to 13 heavy atoms (C, N, O, F, S) and 
possesses a single functional group (Figure 4). To facilitate implementation of this 
reaction discovery approach without the need to time-intensive synthesis of starting 
materials, we selected substrates which, with the exception of 1-butylindole, are 
commercially available. A reaction between two of these substrates would produce a 
product with a mass that would lie outside of the range of masses of the reactants. We 
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obtained mass spectral data by a combination of gas chromatography/mass spectrometry 
(GC/MS) to measure the masses of non-polar products and electrospray ionization mass 
spectrometry (ESI-MS) to measure the masses of polar products. Previously, custom 
mass spectrometers have been used to analyze by tandem MS-MS methods the activity of 
charged catalysts for reactions conducted in the gas phase. These examples have focused 
on comparing several catalysts for a single reaction, and require mass spectrometry 
instrumentation which is not available to most synthetic laboratories.2m The mass of 
potential products from joining two substrates is easily calculated from the masses of the 
reactants, including the masses of potential products formed with concomitant loss of 
common small molecules, such as H2O, NH3, H2, and HCN, or common leaving groups, 
such as halides. Several additional design elements were used`, including the placement 
of different substituents on aryl groups to discriminate between them by their distinct 
mass spectral fragmentation patterns.  
 
Figure 4. The combination of 17 substrates was placed into each reaction well.   
A standardized method was devised to enable the simultaneous screening of 
substrates, metal catalyst precursors and ligands. Twelve ligands were dispensed, one into 
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each well of a column, and eight metal catalyst precursors were dispensed, one into each 
well of a row.  The plate was sealed and heated at 100 °C for 18 h.  After this time, the 
contents of the wells in the plate were analyzed by mass spectrometry.  The number of 
substrates is arbitrary; the 17 substrates contain a representative set, not a comprehensive 
set, of typical organic functional groups. A group of catalysts derived from Mn, Fe, Cr, 
Co, Cu, Ni, and W was chosen due to their abundance and low cost.  In addition, we 
examined catalysts derived from Ru, Mo becuause these metals are inexpensive, Yb as a 
representative f-block metal, and Au because of its wide range of reactivity uncovered 
recently. The ligands we combined with these metals included common phosphines and 
amines, as well as less explored phosphine oxides, phosphine sulfides and amidinates 
(Table 18).  Excess of the metal complexes were used in this system to alleviate 
poisoning all of the potential catalysts by one substrate. Reactions discovered in such a 
system would be rendered catalytic after initial identification of the transformation and 
metal-ligand combination that induces the transformation. The 17 substrates, in 
combination with catalysts derived from 15 metal centers and 23 ligands or the absence 
of a ligand, corresponds to more than 50,000 reactions. These reactions were conducted 
in a few days, after developing our protocol. 
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Table 18. Metal catalyst precursors and ligands used for the high-throughput reaction 
discovery protocol. 
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The catalyst components for the initial implementation of this strategy were 
chosen to identify earth-abundant metals that catalyze reactions previously induced by 
precious metal complexes. Although progress has been made toward the goal of 
catalyzing reactions using first-row transition metals, the smaller body of mechanistic 
information on reactions catalyzed by such systems makes high-throughput discovery 
methods to evaluate particularly appealing. The exact metals and ligands used in these 
experiments are depicted in Table 18. The reactions identified in this format would 
necessarily have the high degree of functional-group tolerance most often needed to 
prepare natural products and medicinally important compounds because they were 
identified in a medium containing a wide range of additional functional groups. 
To minimize the number of mass spectra, in anticipation of conducting such 
studies on a large format, we analyzed reaction products by creating eight samples 
containing a portion of the contents of each row and twelve samples containing a portion 
of the contents of each column of a 96-well plate. By this method, only 20 mass spectra 
on each 96-well plate are needed to identify the x-y coordinates of the metal-ligand 
combination that gives rise to a reaction product. These coordinates correspond to the 
pooled samples of the row and column containing the same reaction product. In some 
cases, the product (and therefore the reaction partners) would be difficult to determine 
from the mass spectrum alone. Therefore, we devised an additional protocol to identify 
the product within a particular well by running a small set of additional experiments (vide 
infra).  
Our design was implemented by conducting experiments in which the 17 reagents 
were combined in each of 384 wells (of a 16 x 24 array), all but one well containing one 
270 
metal precursor (15 total + one negative control containing no metal) and one ligand (23 
ligands + one negative control containing no ligand). In this experiment, we included the 
substrates, metal-catalyst precursors, and ligands for three known reactions as positive 
controls. These reactions were the Ni-catalyzed carbocyanation of an alkyne,5 the Cu-
catalyzed oxidative coupling of an aromatic amine and an aryl boronic acid,6 and the Ru-
catalyzed alkylation of a sulfonamide with an alcohol (Figure 5-7).7 The product from 
each of these three reactions was observed among the more than 50,000 possible catalytic 
reactions [(17•16/2 cross combinations of substrates + 17 homo-coupling of substrates) x 
15 metal catalyst precursors x 24 ligands]. The GC-MS trace from the row containing 
Ni(cod)2 revealed the product from carbocyanation of 5-decyne with 2-cyanonaphthalene, 
which eluted at 18.1 minutes and showed a molecular ion with an m/z value of 291 
(Figure 5). The GC-MS trace from the row containing Cu(OAc)2 revealed the 
diarylamine obtained from oxidative coupling of 4-tert-butylphenylboronic acid with 4-
butylaniline, which eluted at 17.9 minutes and showed a molecular ion with an m/z value 
of 281 (Figure 6). Finally, the ESI-MS for the row containing [Ru(p-cymene)Cl2]2 
contained peaks corresponding to the mono-and dialkylation of p-toluenesulfonamide 
with 1-dodecanol (Figure 7) with m/z = 339 and m/z = 507. These positive control 
experiments showed that discrete transition metal-catalyzed reactions could be identified 
from a pool of substrates that could undergo thousands of possible binary reactions. 
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Figure 5. GC-MS of the combination of reactions in the row containing Ni(cod)2 as a 
metal catalyst precursor. The product from Ni-catalyzed alkyne carbocyanation was also 
detected in the GC/MS for the column with PBu3, indicating that the combination of 
Ni(cod)2 and PBu3 catalyzes the reaction. The peak at 18.1 minutes corresponds to 
material with an m/z = 291, which is the mass of the alkyne carbocyanation product.   
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Figure 6.  GC-MS of the combination of reactions in the row containing Cu(OAc)2 as a 
metal catalyst precursor. The product from Cu-catalyzed oxidative coupling was 
observed. The peak at 17.9 minutes corresponds to material with an m/z = 281, which is 
the mass of the amination product. 
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Figure 7. ESI-MS of the combination of reactions in the row containing [Ru(p-
cymene)Cl2]2 as a metal catalyst precursor. The peaks at m/z = 339 and m/z = 507 
correspond to the products from Ru-catalyzed sulfonamide monoalkylation and 
dialkylation, respectively. 
In addition to the products of these positive control reactions, we observed the 
products from a reaction catalyzed by a first-row metal complex without ligand and a 
reaction catalyzed by a first-row metal complex containing a phosphine ligand. The GC-
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MS of the solutions in the two rows containing CuCl and Cu(OAc)2 consisted of a peak 
with a molecular ion having m/z = 315 (Figure 8). This product corresponds to that from 
coupling of 1-dodecyne with 4-butylaniline. This peak also appeared in the GC-mass 
spectra of the contents of the rows corresponding to reactions containing PBu3 (C), the β-
diketiminate ligand (L), and tri-p-tolylphosphite (S), as well as the row corresponding to 
reactions containing no ligand (T), indicating that the reaction occurs with the copper 
precursors alone and with the combination of the precursors and two of the phosphine 
ligands or the β-diketiminate ligand. 
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Figure 8. GC-MS of the combination of reactions in the row containing Cu(OAc)2 as a 
metal catalyst precursor. The product of Cu-catalyzed alkyne hydroamination with an 
aromatic amine is observed. This product was also observed in the GC-MS of the 
combination of reactions in the columns containing P(nBu)3, the nacnac-type ligand, tri-
p-tolylphosphite and the column with no ligand. The peak at 17.8 minutes corresponds to 
material with an m/z = 315, which is the mass of the imine product. The same peak is 
observed for the row with CuCl as the metal catalyst precursor. 
Separate experiments with the amine, alkyne, and catalyst components alone 
demonstrated that the reaction of the aromatic amine with the alkyne catalyzed by CuCl 
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and Cu(OAc)2 leads to the Markovnikov addition of the amine to the alkyne, followed by 
tautomerization to the corresponding imine (Scheme 52).8 The products of these reaction 
could be isolated as the secondary amine following reduction with NaBH3CN. Reactions 
catalyzed by CuCl occurred in higher yield than those catalyzed by Cu(OAc)2. Reactions 
catalyzed by Cu(OAc)2 yielded substantial product from Glaser coupling of the alkynes 
to form a diyne. Although this reaction occurs in the presence of three of the ligands 
identified in the combinatorial format, the reaction also proceeded rapidly in the absence 
of ligand. This copper-catalyzed reaction represents a rare hydroamination of an alkyne 
catalyzed by a first-row metal. 9 Intermolecular hydroamination of an alkyne has been 
reported with complexes of Group IV metals that are air sensitive and generally suffer 
from poor functional group compatibility, and it has been catalyzed by complexes of the 
precious metals palladium, rhodium and gold.8c  Classical additions of amines to alkynes 
are conducted with toxic mercury compounds. 
Scheme 52.  Cu-catalyzed alkyne hydroamination with 4-nBu-aniline 
As shown by data in Table 19, this process occurs under conditions with 25 
mol % of the inexpensive CuCl in good yield and tolerates an array of potentially reactive 
functional groups, such as nitriles, esters, ketones with enolizable hydrogens and 
unprotected alcohols, vindicating a core hypothesis of our experimental design. 
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Table 19.  Selected copper-catalyzed alkyne hydroaminations with aromatic amines 
NH2
C6H13+
CuCl N
C6H13
THF, 100 oC
R
R
 
Entry R Catalyst Loading Yield*
1 4-nBu 10 mol% 57% 
2 4-OH 25 mol% 80% 
3 4-CN 25 mol% 51% 
4 4-CO2Me 25 mol% 68% 
5 3-Br 25 mol% 84% 
6 4-acetyl 25 mol% 60% 
7 2,6-di-isopropyl 25 mol% 70% 
* Yield determined by using gas chromatography with 1,3,5-trimethoxybenzene as an 
internal standard after hydrolysis with 1 M HCl at room temperature to 2-octanone 
 
The GC-MS analysis from our experiment also revealed a reaction product eluting 
at 18.6 minutes with an apparent molecular ion having an m/z = 312. This peak was 
observed in the traces of the wells containing the combination of Ni(cod)2 or NiCl2-dme 
(Figure 9). This product was also observed in the GC-MS of the combination of reactions 
in the columns containing PPh3, P(nBu)3, PCy3, dppf, dtbpy, Monophos, and SiPr, 
indicating that the reaction is catalyzed by the combination of a Ni precatalyst and these 
ligands.  The peak at 18.6 minutes corresponds to material with an m/z = 312, which is 
the mass of the product from alkyne hydroarylation. Because the identity of this product 
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was not obvious from the mass spectrum, we devised a deconvolution strategy to 
determine the reactants that formed it.  
 
 
Figure 9. GC-MS of the combination of reactions in the row containing Ni(cod)2 as a 
metal catalyst precursor. The product of Ni-catalyzed alkyne hydroarylation with an aryl 
boronic acid was observed.  
For this strategy, the potential reactants (in this case 17) were first divided into a 
small number of subsets, in this case three sets of 4 potential reactants and one set of five 
potential reactants (Figure 10; see Experimental Information for more details). The 
reactants in each of these sets were combined to create four pools of reactants.  The pool 
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of reactants in one set was then allowed to react with the three other pools in the presence 
of the metal catalyst precursor and ligand that had been shown to form the unidentified 
product. These binary combinations of the four sets of substrates corresponded to just six 
reactions. In addition, to assess whether the coupling of two of the reactants requires a 
third component that could act as a ligand or promoter, three of the substrate sets were 
also allowed, in parallel, to react in a similar manner, for a total of ten reactions. This set 
of ten reactions identified the two sets that contained the reactants that formed the 
unknown product. The components of these two sets were then divided into four sets, 
each containing two substrates. In a similar manner, ten reactions were conducted in 
parallel with the metal catalyst precursor and ligand, and the two sets that yielded the 
desired product were identified. The four individual components of these sets were then 
allowed to react with each other in binary and ternary combinations. From these reactions, 
the two reactants that formed the unknown product were identified. 
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Figure 10.  Deconvolution strategy to identify coupling partners for products observed in 
high-throughput reaction discovery 
This short series of 3 x 10 reactions showed that the unknown product with m/z = 
312 corresponded to the hydroarylation of diphenylacetylene with 4-tert-
butylphenylboronic acid to yield a triarylalkene product. A similar strategy showed that 
an additional product in the wells containing Ni(cod)2 and P(nBu)3 that eluted at 16.6 min 
with a molecular ion of m/z = 292 (Figure 11) corresponded to a triarylalkene product 
from hydroarylation of diphenylacetylene with the haloarene 4-bromo-1,2-
difluorobenzene. Examination of the combinations of Ni(cod)2 and NiCl2-dme with the 
ligands identified from the initial catalyst screening showed that Ni(cod)2 and PPh3 
catalyzed the hydroarylation of diphenylacetylene with phenylboronic acid to yield 
triphenylethylene in good yield (Scheme 53). The reaction catalyzed by Ni(cod)2 without 
added ligand formed just 15% yield of triphenylethylene. When the hydroarylation of 
diphenylacetylene was conducted with bromobenzene and the combination of Ni(cod)2 
and P(nBu)3 as the catalyst, triphenylethylene was formed in less than 10% yield, but the 
same reaction with triethylsilane as a third component to act as a reducing agent 
furnished triphenylethylene in 71% yield (Scheme 53).This transformation of arylboronic 
acids has been reported most commonly with rhodium10 and palladium11 catalysts,12 
which contain costly precious metals. 
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Figure 11. GC-MS of the combination of reactions in the row containing Ni(cod)2 as a 
metal catalyst precursor. The product of Ni-catalyzed alkyne hydroarylation with an aryl 
bromide was observed. 
 
Scheme 53.  Ni-catalyzed hydroarylation of diphenylacetylene with phenylboronic acid 
and bromobenzene 
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The synthesis of stereochemically defined trisubstituted alkenes is a challenging 
problem.13 Such products are often prepared by stereo-controlled additions to alkynes, 
but fewer reactions give anti-addition products than give syn-addition products, and 
hydroarylations that give anti addition products are unknown. In contrast to this 
precedent, the major products of the two types of nickel-catalyzed hydroarylation 
discovered here result from anti addition to the alkyne in most cases. Likewise, the 
products from nickel catalyzed hydroarylation of an alkyne with the aryl halide and silane 
gave predominantly the anti-addition product. Moreover, the ligand affects the E/Z ratio 
from reaction of the arylboronic acid. The hydroarylation of diphenylacetylene with 4-
tert-butylphenylboronic acid gave the addition product with an 8.7:1 ratio when the 
catalyst contained PPh3, while reactions conducted with the catalyst generated from PCy3 
gave the addition product in a 1:3.8 ratio favoring the stereoisomer from syn addition. 
These stereochemical outcomes were unexpected and show the ability to use the 
discovery platform to identify reactions that occur with different selectivities, presumably, 
from mechanisms not followed by prior catalysts. 
A survey of this nickel-catalyzed hydroarylation of alkynes with various boronic 
acids (Scheme 54) showed that this reaction, like the hydroamination we identified, 
tolerates a broad range of functional groups. The nickel-catalyzed hydroarylation of 
alkynes with aromatic boronic acids containing esters, nitriles, ketones with enolizable 
hydrogens, aryl chlorides, and aldehydes formed trisubstituted alkenes in good yield with 
generally good selectivity for the Z over E alkene geometry. High Z:E ratios were 
generally observed for arylboronic acids bearing electron-withdrawing groups, while aryl 
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boronic acids containing electron-donating substituents at the 4-position give ~1:1 
mixtures of stereoisomers. 
 2-Heteroaryl boronic acids, which are unstable in many reactions,14 also 
underwent this process to form the corresponding product from trans 
hydroheteroarylation of diphenylacetylene. Reaction of a heteroaryl boronic acid with an 
internal alkyne possessing alkyl substituents also formed the product of 
hydroheteroarylation. 
B(OH)2
+
Ni(cod)2 (20 mol%),
PPh3 (40 mol%),
THF, 100 oCR2 R2
R2
R1 R1
Ph
X
X = CF3; 91%; 8.3:1
X = CHO; 76%; 11.8:1
X = CN; 62%; >20:1
X = C(O)Me; 73%; 3.6:1
X = CO2Me; 90%; 3.2:1
X = Cl; 83%; 11.3:1
X
O
X = Ph; 95%; >20:1
X = C2H5; 55%;
Ph
S
89%
2.9:1
R2
Ph X Ph
 
Scheme 54.  Nickel-catalyzed alkyne hydroarylation with aryl and heteroaryl boronic 
acids.  The ratio given is cis:trans (Z:E) olefin geometry.  
Selected examples of the second type of alkyne hydroarylation we discovered 
involving aryl halides and triethylsilane are shown in Scheme 55. Although further 
studies are needed to identify the most effective combination of catalyst and reducing 
agent, our current studies show that the reactions of aryl halides containing potentially 
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reactive functional groups, as well as heteroaryl halides, form the trisubstituted alkenes 
with good to moderate selectivity for the product from formal trans addition. While the 
hydroarylation product could be observed in the reaction of diphenylacetylene with 
iodoarenes and chloroarenes, the yield for these reactions was lower than the reaction 
conducted with bromobenzene as the aryl halide. However, this result indicates that the 
scope of this reaction can be extended to other aryl halides. 
 
Scheme 55.  Nickel-catalyzed alkyne hydroarylation with aryl and heteroaryl bromides.  
The ratio given is cis:trans (Z:E) olefin geometry. 
6.4 Conclusion and Outlook 
This approach to reaction discovery holds significant potential to be used for 
purposes beyond those revealed in the current work. For example, this system could be 
used to explore reactions with additives, such as oxidants, reductants, acids, and bases 
and to explore reactions of two substrates with a third component, such as carbon 
monoxide or carbon dioxide. It could also be used to examine the reactivity of a single 
class of ligand with various organic substrates and transition-metal catalyst precursors. 
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Other current plans are to examine dual-metal catalyst systems for their ability to bring 
about new avenues to chemical reactivity, and to use this general approach to conduct 
more directed catalyst screening, such as focusing on reactive and highly valuable 
nitrogen heterocycles to examine their potential for reactivity with a wide range of 
organic substrates. While we have focused on the discovery of transition metal catalysts, 
because of the simplicity and generality of this approach, this system for 
multidimensional reaction discovery should be applicable to discovery of other catalyst 
types, such as heterogeneous catalysts, organocatalysts and biocatalysts. Thus, we 
anticipate that this approach to reaction discovery will provide a general and adaptable 
platform suitable for use by a wide range of laboratories for the discovery of a variety of 
catalytic reactions. 
 Following publication of our work, several other examples of similar approaches 
to the discovery of new reactions or new catalysts have been reported. MacMillan and co-
workers have reported a method, which was termed “accelerated serendipity,” in which a 
large number of random, binary combinations of substrates are mixed with various 
transition metal catalysts.15 To facilitate this process, an automated workflow is utilized 
with the aid of robotic equipment. Each of the reactions is then assayed by GC-MS to 
identify new reactions. With this approach to high-throughput reaction discovery, 
MacMillan and co-workers found a C-H arylation reaction at the α–position of amines 
with electron-deficient aryl nitriles catalyzed by an iridium photoredox catalyst and 
visible light.  
Taran and co-workers have utilized a sandwich immunoassay in which binary 
combinations of tagged substrates are mixed and exposed to a transition metal catalyst.16 
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The immunoassay is then used to pull out reactive combinations and to identify the 
substrates undergoing reaction. Application of this system allowed for the discovery of a 
copper-catalyzed coupling of thioureas and phenols to yield isoureas and a copper-
mediated cyclization of alkynes and N-hydroxythioureas to form thiazole derivatives. 
While this system requires initial synthesis of a library of substrates, its high-throughput 
capability allows for efficient examination of catalysts. 
A collaboration between Bellomo, Houk and the process chemistry division of 
Merck Research Laboratories has developed a method to use microscale parallel 
screening to discover a new method for the synthesis of pyrimidinones.17 Pyrimidinones 
constitute the core structure of an important class of HIV integrase inhibitors. The goal of 
this investigation was to develop and apply a microscale screening platform to discover a 
catalyst for the synthesis of pyrimidinones from a linear, N-hydroxyamidine precursor. 
The platform that was developed enabled a single scientist to assemble and analyze 475 
reactions in a single day. With this approach, the team discovered a new copper catalyst 
for the synthesis of pyrimidinones with low catalyst loading under mild conditions, 
whereas the previous methods for the synthesis of this structure required heating at very 
high temperatures. This approach demonstrates how high-throughput experimentation 
can be used to rapidly improve a single reaction without a need for detailed mechanistic 
insight. However, this approach to reaction discovery and improvement relies upon 
access to specialized equipment and the availability of large libraries of metal catalysts, 
ligands, and various additives. 
 As the recent development of several methods for high-throughput reaction 
discovery demonstrates, this approach to the discovery of new reactions and catalysts will 
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likely be a topic of future investigation. The development of better screening approaches 
and more rapid analysis techniques will prove crucial in the improvement of this 
approach to catalyst discovery. Many of the catalysts and reaction discovered using these 
approaches will address unmet synthetic challenges and eventually find use in targeted 
small molecule synthesis. 
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6.5 Experimental Information 
Methods 
All reactions were conducted under an argon or nitrogen atmosphere in flame-dried 
glassware or in an Innovative Technologies drybox. Dry and degassed solvents were used 
unless otherwise noted. Column chromatography was performed with a Teledyne Isco 
Combiflash® Rf system with RediSep Rf columns. 
Materials. Fe(acac)2, MoCl5, CuCl, FeCl3, NiCl2-dme Mn(acac)2, (benzene)Cr(CO)3, 
Co(OAc)2, Yb(OAc)3, W(CO)3(MeCN)3, PPh3, PnBu3, PCy3, 2-aminocyclohexanol HCl, 
ethanolamine, 2-picolinic acid, 4,4’-di-tert-butylbipyridine, TMEDA, trans-1,2-
diaminocyclohexane, BINOL, cis,cis-1,5-cyclooctadiene (cod), 2,2,6,6-
tetramethylheptane-3,5-dione, diphenylphosphine oxide, L-proline, dodecane, 1-
dodecene, 1-dodecanol, 1-dodecylamine, p-toluenesulfonamide, 4-bromo-1,2-
difluorobenzene, 4-pentylphenol, 2-cyanonaphthalene, diphenylacetylene, triethylsilane, 
triethylamine, NaOtBu, 1-octyne, NaBH3CN, AcOH, DMF, indole and 1-iodobutane 
were purchased from Aldrich Chemicals and used as received.  Ni(cod)2, [Ru(p-
cymene)Cl2]2, Cu(OAc)2 (anhydrous), Mo(CO)3(EtCN)3, AuCl, 1,1’-
Bis(diphenylphosphino)ferrocene, and Monophos were purchased from Strem Chemicals 
and used as received. 1-dodecyne, decanonitrile, n-pentylbenzene, 2-vinylnaphthalene, 
and 5-decyne were purchased from Alfa Aesar and used as received. 4-n-Bu-aniline was 
purchased from TCI America and used as received.  Aryl and heteroaryl boronic acids 
were purchased from CombiBlocks and used as received. N-((Z)-4-(phenylamino)pent-3-
en-2-ylidene)aniline,(47) Methylenebis(diphenylphosphine oxide)(48), and 
Methylenebis(diphenylphosphine sulfide)(49) were prepared by literature methods. NaH 
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was purchased from Aldrich Chemicals as a 60% dispersion in mineral oil, washed with 
pentane and dried under vacuum before use.  Z-1,2-diphenylethenyl tosylates was 
prepared according to a literature report.(50)  
Instruments. GC-MS data were obtained on an Agilient 6890-N GC system containing 
an Alltech EC-1 capillary column and an Agilient 5973 mass selective detector. ESI-MS 
data were obtained with a Waters ZMD Quadropole Instrument with a photomultiplier 
detection system and a 1:1 MeCN:H2O mobile phase. 
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 Experimental Procedures and Information 
 
Synthesis of N-Bu-indole. Inside a glovebox, indole (1.17 g, 10.0 mmol, 1.00 equiv), 
NaH (240 mg, 10.0 mmol, 1.00 equiv) and dry DMF (10 mL) were mixed in a dry vial at 
room temperature for 2 h. After 2 h, 1-iodobutane (2.03 g, 11.0 mmol, 1.10 equiv) was 
added, and the vial was heated at 100 °C for 2 h. After 2 h, the mixture was cooled to 
room temperature, filtered through silica gel washing with EtOAc, and the resulting 
solution was concentrated under vacuum. The residue was purified by flash column 
chromatography (0-5% EtOAc in hexanes) to give pure N-Bu-indole (951 mg, 55%). 
Spectral properties matched those of previous reports containing the preparation of this 
compound. 
Assembly of 96-well plates for high-throughput discovery. An aluminum 96-well plate 
(see Picture 1 and Picture 2 below) was filled with ~ 1 mL glass tubes (Kimble Reusable 
Borosilicate Glass Tubes with Plain End O.D. x L: 6 x 50mm; available from Fisher 
Scientific), dried in an oven and brought into a nitrogen-filled glovebox. Stock solutions 
of each metal catalyst precursor were prepared with the following masses of each metal 
and 1.2 or 2.4 mL of THF. 
Metal Catalyst Precursor Mass per Well (mg) Total Mass (mg) 
1) Fe(acac)2 3.8 45.8 
2) MoCl5 4.0 48 
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3) Ni(cod)2 4.2 49.6 
4) [Ru(p-cymene)Cl2]2 4.6 55.2 
5) CuCl 1.6 19.2 
6) Cu(OAc)2 2.8 32.8 
7) FeCl3 4.6 56.2 
8) NiCl2-dme 3.3 39.6 
9) Mn(acac)2 3.8 45.6 
10) Co(OAc)2 2.7 31.9 
11) AuCl 3.5 41.9 
12) (benzene)Cr(CO)3 3.3 38.5 
13) W(CO)3(MeCN)3 5.9 70.4 
14) Yb(OAc)3 5.3 63.1 
15) Mo(CO)3(EtCN)3 5.2 62.2 
16) None - - 
 
The metal catalyst precursors were then added to the tubes in the plate by adding 0.1 mL 
(1.2 mL stock solution) or 0.2 mL (2.4 mL stock solution) to each tube of the appropriate 
row. Metal catalyst precursors (3, 5-8, 10, 14) that were not soluble were added 
individually to the appropriate tubes. 
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Stock solutions of each ligand (see table below for structures) were prepared with 0.8 mL 
or 1.6 mL of THF and the masses of the ligands shown below. 
Ligand Mass per Well (mg) Total Mass (mg) 
A) PPh3 7.8 62.8 
B) PCy3 8.4 67.2 
C) PnBu3 6.1 48.8 
D) dppf 8.4 67.2 
E) 2-aminocyclohexanol HCl 2.2 18.2 
F) Ethanolamine 1.0 8.0 
G) 2-picolinic acid* 1.8 14.8 
H) N,N'-diphenylbenzimidamide* 4.1 32.8 
I) Trans-1,2-diaminocyclohexane 1.8 14.4 
J) TMEDA 1.8 14.4 
K) Tetramethylheptanedione* 2.8 22.4 
L) N-((Z)-4-(phenylamino)pent-3-en-2-
ylidene)aniline* 
3.8 30.4 
M) L-proline* 1.8 14.4 
N) Methylenebis(diphenylphosphine 
oxide)* 
6.3 50.4 
O) Methylenebis(diphenylphosphine 
sulfide)* 
6.8 54.4 
P) Diphenylphosphine oxide 6.1 48.8 
Q) SIpr-HCl* 6.4 51.2 
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R) Cod 3.2 25.6 
S) P(O-p-tol)3 10.6 84.8 
T) None - - 
U) Monophos [(3,5-Dioxa-4-phospha-
cyclohepta[2,1-a;3,4-a']dinaphthalen-4-
yl) 
dimethylamine) 
5.4 43.2 
V) BINOL 4.2 34.4 
W) 4,4’-di-tert-butylbipyridine 4.0 32 
X) (N,N'E,N,N'E)-N,N'-(ethane-1,2-
diylidene)bis(2,6-diisopropylaniline) 
5.6 45.2 
 
The ligands were then added to the tubes in the plate by adding 0.1 mL (0.8 mL stock 
solution) or 0.2 mL (1.6 mL stock solution) to each tube of the appropriate row. Ligands 
(D, E, G, M, N, O, Q) that were not soluble were added individually to the appropriate 
tubes (To the tubes containing ligand precursors that were activated with base (*), 2 mg 
of NaOt-Bu was added as a solution in dry THF. 
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The plate with the tubes containing the metal catalyst precursors and ligands were then 
heated at 40-50 °C inside the glove box to evaporate the solvent. 
To an oven-dried 25 mL volumetric flask was added the following masses of each 
substrate. 
 
Substrate Total Mass (mg) 
Mass per Well (mg) after 
dispensing the stock solution
Dodecane 245 2.6 
1-dodecene 242 2.5 
1-dodecyne 240 2.5 
1-dodecanol 268 2.8 
1-dodecylamine 267 2.8 
Decanonitrile 221 2.3 
4-bromo-1,2-difluorobenzene 278 2.9 
2-vinylnaphthalene 222 2.3 
p-toluenesulfonamide 247 2.6 
Diphenylacetylene 257 2.7 
4-n-pentylphenol 237 2.5 
2-cyanonaphthalene 221 2.3 
4-tert-butylphenylboronic acid 257 2.7 
5-decyne 200 2.1 
n-pentylbenzene 214 2.2 
4-n-Bu-aniline 215 2.2 
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N-Bu-indole 250 2.6 
 
Following addition of the substrates to the volumetric flask, the mixture was diluted with 
dry THF to a volume of 25 mL. This solution was then transferred to a separate dry glass 
container, and the volumetric flask was washed with an additional 4 mL of THF for a 
total volume of 29 mL. A 0.3 mL aliquot of this solution was then added to each of the 96 
tubes in the plate (29 mL/96 wells = 0.30 mL/well). The plate containing the glass tubes 
was then heated at 40-50 °C inside the glove box to evaporate the solvent.  
After evaporation of the solvent, the well plate was sealed by placing a sheet of Teflon® 
over the glass tubes and placing a smooth metal plate on top of the well plate. The top 
plate was fixed into place with bolts tightened with a torque wrench. This sealed well 
plate was then heated on a standard heating plate for 18 h at 100 °C (See Picture 3 below). 
Following heating, the reaction assembly was removed from the heating plate and cooled 
to room temperature. After cooling, the assembly was removed from the glove box. A set 
of eight 4 mL vials was labeled A, B, C, D, E, F, G, and H for each of the 8 rows in the 
well plate. A set of 12 4 mL vials was labeled 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 for 
each of the columns in the well plate, making a total of 20 vials. 0.5 mL of CH2Cl2 was 
added to each of the 96 glass tubes, and 2 samples were removed from each glass tube: 
one sample was placed in the 4 mL vial corresponding to the row and one sample was 
placed in the 4 mL vial corresponding to the column. For example, a sample from tube 
A1 was placed in both vial A and vial 1. After this distribution of aliquots was completed 
for each of the 96 glass tubes, the contents of the 20 4 mL vials labeled A-H and 1-12 
was filtered through a plug of Celite in a pipette into a GC vial, washing with ethyl 
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acetate. These vials were analyzed by GC-MS. A sample was removed from each of the 
samples for GC-MS analysis, placed into a separate GC vial, and diluted with MeOH. 
These samples were analyzed by ESI-MS. 
Following analysis of each of these samples by GC-MS and ESI-MS, the mass spectral 
data were analyzed. In each of the GC-MS chromatograms, the organic substrates eluted 
between 0 and 13.5 minutes. The masses of peaks for material eluting between 13.5 
minutes and the end of the GC-MS method were determined. In the ESI-mass spectra, 
significant peaks in the appropriate mass range for the reaction of two of the organic 
substrates were identified. After the mass(es) of product(s) had been determined, a 
spreadsheet (see spreadsheet below) containing potential product masses was used to 
identify the possible combinations of substrates that could form a product with the 
observed mass. To use this spreadsheet efficiently, a search for the product mass was 
conducted with Microsoft Excel. When two potential reactive substrates were identified, 
two independent reactions were conducted: one reaction with the two substrates (0.05 
mmol each), the metal catalyst precursor (0.05 mmol) and THF (0.1 mL) and one 
reaction with the two substrates (0.05 mmol each), the metal catalyst precursor (0.05 
mmol), the ligand (0.05 mmol) and THF (0.1 mL). These independent reactions were 
then assayed by GC-MS or ESI-MS to confirm the assignment of the reaction 
components leading to the observed product. 
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Reaction Deconvolution Scheme for identification of the product of the 
hydroarylation of diphenylacetylene with 4-tert-butylphenylboronic acid. To 
determine the two substrates that led to the observed reaction product when we were 
unable to identify the product from the mass spectrum, the following deconvolution 
scheme was followed. This scheme could be used generally to find the two reactants that 
lead to an observed product. First, the 17 substrates used in the high-throughput reaction 
discovery system were divided into 4 groups, as shown below. 
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A set of 10 reactions was then assembled. Ni(cod)2 (6.9 mg, 0.025 mmol), PPh3 (13.1 mg, 
0.05 mmol), the substrates (the masses are shown in the table below) and THF (0.2 mL) 
were added to a dry vial containing a magnetic stir bar. The vial was sealed, removed 
from the glove box, and heated at 100 °C for 18 h. After heating, the reaction mixture 
was cooled to room temperature and analyzed by GC-MS. Each reaction was then 
evaluated to determine if it contained the product observed during the catalyst screening. 
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Reaction # Substrate Groups Product Detected by GC-MS? 
1 1,2 No 
2 1,3 Yes 
3 1,4 No 
4 2,3 No 
5 2,4 No 
6 3,4 No 
7 1,2,3 Yes 
8 1,2,4 No 
9 1,3,4 Yes 
10 2,3,4 No 
 
From these results, it was determined that the reaction occurred between a substrate from 
Group 1 and a substrate from Group 3. The substrates in Group 1 and Group 3 were then 
divided into 4 2nd generation groups shown below. 
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The same set of reactions with the same catalyst loading, temperature and time was then 
performed with these substrate groups. The results are shown in the following table. 
Reaction # Substrate Groups Product Detected by GC-MS? 
1 1,2 No 
2 1,3 No 
3 1,4 No 
4 2,3 No 
5 2,4 No 
6 3,4 Yes 
7 1,2,3 No 
8 1,2,4 No 
9 1,3,4 Yes 
10 2,3,4 Yes 
 
From these results, it was determined that the reaction occurred between a substrate from 
Group 3 and a substrate from Group 4. The substrates in Group 3 and Group 4 were then 
divided into four groups shown below. 
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3rd Generation Groups
Group 1 Group 2
Group 3 Group 4
NH2
9
9.3 mg
Ph Ph 9 mg
C5H11
7.4 mg
B(OH)2
tBu
8.9 mg
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The same set of reactions with the same catalyst loading, temperature and time was then 
performed with all binary and ternary combinations of the four substrates in the two 
second generation groups that led to product. The results are shown in the following table. 
 
Reaction # Reactant Product Detected by GC-MS? 
1 1,2 No 
2 1,3 No 
3 1,4 No 
4 2,3 No 
5 2,4 No 
6 3,4 Yes 
7 1,2,3 No 
8 1,2,4 No 
9 1,3,4 Yes 
10 2,3,4 Yes 
 
From these results, it was determined that the product was formed from Reactant 3 
(diphenylacetylene), and Reactant 4 (4-tert-butylphenylboronic acid). An independent 
reaction with phenylboronic acid and diphenylacetylene catalyzed by 20% Ni(cod)2 and 
40% PPh3 in THF formed triphenylethylene in 78% yield, as determined by GC and GC-
MS, confirming the assignment of reactants leading to the product. 
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NH3
C6H13+
CuCl (25 mol%)
nBu
N
C6H13
nBu
THF, 100 oC
NaBH3CN,
HN
C6H13
nBu
AcOH, THF, rt
 
One-pot alkyne hydroamination and reduction with 4-n-Bu-aniline and 1-octyne. 
Inside a glove box, CuCl (24.9 mg, 0.250 mmol, 0.250 equiv), 4-nBu-aniline (224 mg, 
1.50 mmol, 1.50 equiv), 1-octyne (110 mg, 1.00 mmol, 1.00 equiv), and dry THF (2 mL) 
were added to a dry vial containing a magnetic stir bar. The vial was sealed, removed 
from the glove box, and heated at 100 °C for 16 h. After heating, the reaction mixture 
was cooled to room temperature and analyzed by GC-MS. After full conversion of the 
alkyne was observed, NaBH3CN (189 mg, 3.00 mmol, 3.00 equiv) and 2 mL THF were 
added to the reaction mixture. The reaction mixture was cooled to 0 °C with an ice bath. 
AcOH (0.6 mL, 10 mmol, 10 equiv) was added dropwise to the reaction mixture. The ice 
bath was removed, and the reaction was allowed to warm gradually to room temperature. 
GC-MS analysis after 4 h indicated full conversion to the secondary amine. The reaction 
mixture was neutralized with aq. Na2CO3, extracted with EtOAc, washed with brine, 
dried with MgSO4, filtered and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography (0-15% EtOAc in hexanes) to give the 
secondary amine product (177 mg, 68%). 1H NMR (499 MHz, CDCl3) δ 7.07 (d, J = 8.3, 
2H), 6.61 (d, J = 8.4, 2H), 3.51 (dd, J = 6.1, 12.3, 1H), 3.27 (s, 1H), 2.60 (m, 2H), 1.65 
(m, 4H), 1.45 (m, 11H), 1.25 (d, J = 6.3, 4H), 1.01 (dt, J = 7.2, 14.4, 3H). 13C NMR (126 
MHz, CDCl3) δ 145.94, 131.48, 129.38, 113.45, 49.03, 37.62, 34.99, 34.31, 32.14, 29.68, 
26.45, 22.92, 22.64, 21.14, 14.36, 14.27. 
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NH2
Ph+
CuCl (25 mol%)
nBu
N
Ph
nBu
THF, 100 oC
NaBH3CN,
HN
Ph
nBu
AcOH, THF, rt
 
One-pot alkyne hydroamination and reduction with 4-n-Bu-aniline and 
phenylacetylene. Inside a glove box, CuCl (24.9 mg, 0.250 mmol, 0.250 equiv), 4-nBu-
aniline (224 mg, 1.50 mmol, 1.50 equiv), phenylacetylene (102 mg, 1.00 mmol, 1.00 
equiv), and dry THF (2 mL) were added to a dry vial containing a magnetic stir bar. The 
vial was sealed, removed from the glove box, and heated at 100 °C for 16 h. After heating, 
the reaction mixture was cooled to room temperature and analyzed by GC-MS. After full 
conversion of the alkyne was observed, NaBH3CN (189 mg, 3.00 mmol, 3.00 equiv) and 
2 mL THF were added to the reaction mixture. The reaction mixture was cooled to 0 °C 
with an ice bath. AcOH (0.6 mL, 10 mmol, 10 equiv) was added dropwise to the reaction 
mixture. The ice bath was removed, and the reaction was allowed to warm gradually to 
room temperature. GC-MS analysis after 4 h indicated full conversion to the secondary 
amine. The reaction mixture was neutralized with aq. Na2CO3, extracted with EtOAc, 
washed with brine, dried with MgSO4, filtered and concentrated under reduced pressure. 
The crude product was purified by flash column chromatography (0-15% EtOAc in 
hexanes) to give the secondary amine product (138 mg, 55%). 1H NMR (500 MHz, 
CDCl3) δ 7.46 (d, J = 7.1, 2H), 7.40 (t, J = 7.6, 2H), 7.31 (t, J = 7.3, 1H), 7.00 (d, J = 8.4, 
2H), 6.54 (d, J = 8.4, 2H), 4.54 (q, J = 6.7, 1H), 3.99 (s, 1H), 2.55 (m, 2H), 1.60 (m, 6H), 
1.41 (dq, J = 7.4, 14.8, 2H), 0.99 (t, J = 7.3, 3H). 13C NMR (126 MHz, CDCl3) δ 145.82, 
145.55, 131.92, 129.28, 128.92, 127.14, 126.18, 113.59, 54.03, 35.02, 34.30, 25.43, 22.68, 
14.34. 
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NH2
C6H13+
CuCl N
C6H13
THF, 100 oC
R
R
1 M HCl, rt O
C6H13  
 
General procedure for copper-catalyzed alkyne hydroamination. Inside a glove box, 
CuCl (12.4 mg, 0.125 mmol, 0.250 equiv), an aromatic amine (0.75 mmol, 1.5 equiv), 1-
octyne (56 mg, 0.50 mmol, 1.0 equiv), trimethoxybenzene, and dry THF (1 mL) were 
added to a dry vial containing a magnetic stir bar. The vial was sealed, removed from the 
glove box, and heated at 100 °C for 16-18 h. After heating, the reaction mixture was 
cooled to room temperature and analyzed by GC-MS. When full conversion of the alkyne 
was observed, 0.25 mL of 1 M HCl in H2O was added to the reaction mixture and the 
mixture was stirred at room temperature for 4 h. After 4 h, the reaction mixture was 
analyzed by GC, and the yield of 2-octanone was determined by comparison to 
trimethoxybenzene, the internal standard, correcting for the response factor of the ketone 
to the standard. 
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Masses of aromatic amines and yields for copper-catalyzed alkyne hydroamination 
and hydrolysis. 
Aromatic Amine Mass of Aromatic Amine (mg) GC Yield of Ketone after 
Hydrolysis 
4-nBu 112 77% 
4-OH 82 80% 
4-CN 89 51% 
4-CO2Me 114 68% 
3-Br 129 84% 
4-acetyl 102 60% 
2,6-di-isopropyl 133 70% 
 
B(OH)2
+
Ni(cod)2 (20%), 
PPh3 (40%),
THF, 100 oC
 
Nickel-catalyzed hydroarylation of diphenylacetylene with phenylboronic acid. 
Inside a glove box, Ni(cod)2 (5.5 mg, 0.020 mmol, 0.20 equiv), PPh3 (10.5 mg, 0.040 
mmol, 0.40 equiv), diphenylacetylene (17.8 mg, 0.100 mmol, 1.00 equiv), phenylboronic 
acid (36.6 mg, 0.300 mmol, 3.00 equiv) and THF (0.4 mL) were added to a dry vial 
containing a magnetic stir bar. The vial was sealed, removed from the glove box, and 
heated at 100 °C for 18 h. After heating, the reaction mixture was cooled to room 
temperature and analyzed by GC. The yield of triphenylethylene was determined by 
comparison to 1,3,5-trimethoxybenzene, the internal standard. 
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B(OH)2
+
Ni(cod)2 (20%), 
PPh3 (40%),
THF, 100 oCR2 R2
R2
R1 R1R2  
 
General Procedure for nickel-catalyzed hydroarylation of alkynes with aryl or 
heteroaryl boronic acids. Inside a glove box, Ni(cod)2 (16.5 mg, 0.06 mmol, 0.2 equiv), 
PPh3 (31.5 mg, 0.12 mmol, 0.4 equiv), alkyne (0.300 mmol, 1.00 equiv), arylboronic acid 
or heteroarylboronic acid (0.900 mmol, 3.00 equiv) and THF (1.2 mL) were added to a 
dry vial containing a magnetic stir bar. The vial was sealed, removed from the glove box, 
and heated at 100 °C for 18 h. After heating, the reaction mixture was cooled to room 
temperature, filtered through silica gel washing with EtOAc, and concentrated under 
vacuum. The reaction mixture was then purified by column chromatography to give the 
product.  The isomeric ratio (Z:E) was determined by comparison of GC peak areas. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with 4-(trifluoromethyl)-
phenylboronic acid. Reaction performed according to the general procedure with 4-
(trifluoromethyl)phenylboronic acid (171 mg) and diphenylacetylene (53.4 mg) to 
provide 88 mg of the product (91%) as a colorless oil.  Column chromatography was 
performed with 5:95 ethyl acetate:hexanes.  Z:E = 8.3:1. 1H NMR (499 MHz, CDCl3) δ 
7.62 (d, J = 8.3, 2H), 7.35 (m, 7H), 7.20 (m, 4H), 7.06 (m, 2H). 13C NMR (126 MHz, 
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CDCl3) δ 144.54, 142.94, 141.49, 137.07, 131.17, 130.49, 129.79, 129.64, 129.12, 128.94, 
128.65, 128.43, 128.12, 127.89, 127.43, 126.77, 125.82, 125.79. 
+
OHC
B(OH)2
Ni(cod)2,
PPh3, THF
CHO  
Nickel-catalyzed hydroarylation of diphenylacetylene with 4-formylphenylboronic 
acid. The reaction was performed according to the general procedure with 4-
formylphenylboronic acid (135 mg) and diphenylacetylene (53.4 mg) to provide the 65 
mg of the product (76%) as a colorless oil.  Column chromatography was performed with 
5:95 ethyl acetate:hexanes.  Z:E = 11.8:1.   1H NMR (500 MHz, CDCl3) δ 10.04 (s, 1H), 
7.85 (d, J = 8.1, 2H), 7.40 (d, J = 8.0, 2H), 7.31 (dt, J = 14.0, 22.6, 4H), 7.16 (dd, J = 5.9, 
10.4, 4H), 7.04 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 192.22, 147.50, 142.81, 141.69, 
136.98, 135.58, 131.54, 130.51, 130.26, 129.84, 129.80, 129.17, 128.66, 128.41, 128.15, 
127.91, 127.49. 
+
NC
B(OH)2
Ni(cod)2,
PPh3, THF
CN  
Nickel-catalyzed hydroarylation of diphenylacetylene with 4-cyanophenylboronic 
acid. The reaction was performed according to the general procedure with 4-
cyanophenylboronic acid (135 mg) and diphenylacetylene (53.4 mg) to provide 52 mg of 
the product (62%) as a yellow solid.  Column chromatography was performed with 10:90 
ethyl acetate:hexanes.  Z:E = >20:1.  1H NMR (499 MHz, CDCl3) δ 7.62 (m, 2H), 7.34 
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(m, 4H), 7.27 (m, 2H), 7.18 (dt, J = 3.1, 6.2, 4H), 7.04 (m, 3H). 13C NMR (126 MHz, 
CDCl3) δ 145.83, 142.51, 141.16, 136.75, 132.61, 131.66, 130.16, 129.76, 128.72, 128.49, 
128.28, 127.90, 127.63, 119.12, 111.40. 
+
B(OH)2
Ni(cod)2,
PPh3, THF
Me
O
OMe  
Nickel-catalyzed hydroarylation of diphenylacetylene with 4-acetylphenylboronic 
acid. The reaction was performed according to the general procedure with 4-
acetylphenylboronic acid (148 mg) and diphenylacetylene (53.4 mg) to provide 65 mg of 
the product (73%) as a white solid.  Column chromatography was performed with 10:90 
ethyl acetate:hexanes.  Z:E = 3.6:1.  1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 8.2, 2H), 
7.32 (m, 6H), 7.16 (dd, J = 5.0, 9.5, 2H), 7.05 (m, 5H), 2.63 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 198.08, 145.97, 142.97, 141.86, 137.09, 136.27, 131.04, 129.78, 129.51, 128.90, 
128.59, 128.37, 128.05, 127.87, 127.36, 26.79.  
+
B(OH)2
Ni(cod)2,
PPh3, THF
MeO
O
OMeO  
Nickel-catalyzed hydroarylation of diphenylacetylene with 4-methoxycarbonyl-
phenylboronic acid. The reaction was performed according to the general procedure 
with 4-methoxycarbonylphenylboronic acid (162 mg) and diphenylacetylene (53.4 mg) to 
provide 85 mg of the product (90%) as a white solid.  Column chromatography was 
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performed with 10:90 ethyl acetate:hexanes.  Z:E = 3.2:1.  1H NMR (500 MHz, CDCl3) δ 
8.02 (m, 3H), 7.37 (m, 6H), 7.19 (m, 3H), 7.06 (m, 3H), 3.95 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 167.31, 145.79, 142.99, 137.11, 133.17, 132.10, 130.86, 130.16, 129.94, 
129.08, 128.59, 128.04, 127.87, 127.35, 115.49, 52.39. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with 4-chlorophenylboronic 
acid. The reaction was performed according to the general procedure with 4-
chlorophenylboronic acid (141 mg) and diphenylacetylene (53.4 mg) to provide 72 mg of 
the product (83%) as a white solid.  Column chromatography was performed with 5:95 
ethyl acetate:hexanes.  Z:E = 11.3:1.  1H NMR (500 MHz, CDCl3) δ 7.53 (m, 1H), 7.32 
(m, 5H), 7.16 (m, 5H), 7.04 (m, 3H), 6.98 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 143.29, 
141.59, 139.04, 137.27, 132.21, 129.75, 129.12, 128.99, 128.54, 128.35, 127.96, 127.87, 
127.22, 126.75. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with benzofuran-2-boronic 
acid. The reaction was performed according to the general procedure with benzofuran-2-
boronic acid (146 mg) and diphenylacetylene (53.4 mg) to provide 84 mg of the product 
(95%) as a white solid.  Column chromatography was performed with 5:95 ethyl 
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acetate:hexanes.  Z:E = >20:1.   1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 9.0, 17.1, 
2H), 7.48 (m, 3H), 7.42 (m, 2H), 7.33 (m, 2H), 7.29 (m, 2H), 7.22 (t, J = 7.4, 1H), 7.18 
(m, 2H), 7.09 (dd, J = 6.7, 12.0, 1H), 6.27 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 158.18, 
155.27, 137.76, 136.48, 132.75, 131.76, 130.26, 129.99, 129.22, 128.35, 128.32, 127.58, 
127.56, 124.96, 123.10, 121.17, 111.19, 106.41. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with thiophene-2-boronic acid. 
The reaction was performed according to the general procedure with thiophene-2-boronic 
acid (116 mg) and diphenylacetylene (53.4 mg) to provide 70 mg of the product (89%) as 
a colorless oil.  Column chromatography was performed with 5:95 ethyl acetate:hexanes.  
Z:E = 2.9:1.  1H NMR (499 MHz, CDCl3) δ 7.47 (m, 1H), 7.44 (m, 2H), 7.37 (m, 2H), 
7.26 (m, 2H), 7.16 (m, 3H), 7.03 (dd, J = 2.2, 5.7, 1H), 6.99 (dd, J = 3.7, 5.0, 1H), 6.95 
(dd, J = 0.8, 3.4, 1H), 6.79 (d, J = 3.5, 1H). 13C NMR (126 MHz, CDCl3) δ 148.22, 
139.72, 136.91, 130.73, 129.72, 129.08, 128.49, 128.28, 128.12, 127.75, 127.11, 126.63, 
126.38, 125.01. 
 
Nickel-catalyzed hydroarylation of 3-hexyne with benzofuran-2-boronic acid. The 
reaction was performed according to the general procedure with benzofuran-2-boronic 
acid (146 mg) and 3-hexyne (24.7 mg) to provide 33 mg of the product (55%) as a 
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colorless oil.  Column chromatography was performed with 5:95 ethyl acetate:hexanes.  
Z:E = 3.7:1.  1H NMR (499 MHz, CDCl3) δ 7.53 (d, J = 7.6, 1H), 7.45 (d, J = 8.1, 1H), 
7.22 (m, 2H), 6.59 (s, 1H), 5.66 (t, J = 7.1, 1H), 2.49 (dd, J = 7.6, 15.2, 2H), 2.31 (m, 2H), 
1.15 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 157.66, 154.77, 133.52, 130.89, 129.58, 
124.02, 122.74, 120.72, 110.94, 101.07, 21.50, 21.47, 14.52, 14.47. 
Br
+
Ni(cod)2 (20%), 
P(nBu)3 (40%),
Et3SiH (2 equiv)
THF, 100 oC
 
Nickel-catalyzed hydroarylation of diphenylacetylene with bromobenzene. Inside a 
glove box, Ni(cod)2 (5.5 mg, 0.020 mmol, 0.20 equiv), P(nBu)3 (8.1 mg, 0.040 mmol, 
0.40 equiv), diphenylacetylene (35.6 mg, 0.200 mmol, 2.00 equiv), bromobenzene (15.7 
mg, 0.100 mmol, 1.00 equiv), triethylsilane (24 mg, 0.20 mmol, 2.0 equiv) and THF (0.2 
mL) were added to a dry vial containing a magnetic stir bar. The vial was sealed, 
removed from the glove box, and heated at 100 °C for 18 h. After heating, the reaction 
mixture was cooled to room temperature and analyzed by GC. The yield of 
triphenylethylene was determined by comparison to 1,3,5-trimethoxybenzene, the 
internal standard. 
Ni(cod)2 (20%), 
P(nBu)3 (40%),Br
+ R2 R2R1
Et3SiH (2 equiv),
THF, 100 oC
R2
R1R2
 
General procedure for nickel-catalyzed hydroarylation of diphenylacetylene with 
aryl or heteroaryl bromides. Inside a glove box, Ni(cod)2 (16.5 mg, 0.06 mmol, 0.2 
equiv), P(nBu)3 (24.3 mg, 0.12 mmol, 0.4 equiv), diphenylacetylene (107 mg, 0.600 
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mmol, 2.00 equiv), arylbromide or heteroarylbromide (0.300 mmol, 3.00 equiv), 
triethylsilane (70 mg, 0.60 mmol, 2.0 equiv) and THF (0.6 mL) were added to a dry vial 
containing a magnetic stir bar. The vial was sealed, removed from the glove box, and 
heated at 100 °C for 18 h. After heating, the reaction mixture was cooled to room 
temperature, filtered through silica gel washing with EtOAc, and concentrated under 
vacuum. The reaction mixture was purified by column chromatography to give the 
product.  The isomeric ratio (Z:E) was determined by comparison of GC peak areas. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with 2-bromotoluene. Reaction 
performed according to the general procedure with 2-bromotoluene (51.3 mg) to provide 
44 mg of the product (54%) as a yellow oil.  Column chromatography was performed 
with 5:95 ethyl acetate:hexanes.  Z:E = 17.5:1.   1H NMR (500 MHz, CDCl3) δ 7.36 (m, 
2H), 7.33 (m, 2H), 7.29 (m, 2H), 7.24 (m, 2H), 7.15 (m, 2H), 7.11 (s, 1H), 6.99 (dd, J = 
1.6, 7.8, 2H), 2.08 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 142.56, 141.62, 139.90, 
137.57, 136.87, 130.78, 130.43, 129.27, 128.94, 128.48, 128.35, 127.93, 127.63, 127.15, 
126.84, 126.63, 19.92. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with methyl 2-bromobenzoate. 
Reaction performed according to the general procedure with methyl 2-bromobenzoate 
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(64.5 mg) to provide 50 mg of the product (53%) as a yellow oil.  Column 
chromatography was performed with 10:90 ethyl acetate:hexanes.  Z:E = 4.2:1. 1H NMR 
(499 MHz, CDCl3) δ 7.98 (d, J = 7.6, 1H), 7.65 (m, 1H), 7.44 (m, 3H), 7.25 (m, 5H), 7.12 
(m, 3H), 6.98 (m, 2H), 3.58 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 167.70, 143.07, 
142.61, 141.62, 137.51, 132.54, 132.48, 131.03, 130.22, 129.59, 128.43, 128.24, 127.88, 
127.83, 127.57, 127.04, 126.96, 52.08. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with 5-bromobenzofuran. 
Reaction performed according to the general procedure with 5-bromobenzofuran (59.1 
mg) to provide 61 mg of the product (69%) as a colorless oil.  Column chromatography 
was performed with 10:90 ethyl acetate:hexanes.  Z:E = 1.1:1.  1H NMR (499 MHz, 
CDCl3) δ 7.65 (m, 1H), 7.56 (d, J = 1.6, 1H), 7.49 (m, 2H), 7.36 (m, 5H), 7.28 (m, 3H), 
7.08 (m, 2H), 7.04 (s, 1H), 6.74 (d, J = 8.0, 1H). 13C NMR (126 MHz, CDCl3) δ 154.87, 
145.74, 143.13, 141.08, 137.82, 135.25, 130.72, 129.75, 128.88, 128.24, 127.94, 127.19, 
126.85, 124.67, 123.24, 120.75, 111.89, 107.06. 
 
Nickel-catalyzed hydroarylation of diphenylacetylene with 2-bromothiophene. 
Reaction performed according to the general procedure with 2-bromothiophene (49.0 mg) 
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to provide 30 mg of the product (38%) as a colorless oil.  Column chromatography was 
performed with 5:95 ethyl acetate:hexanes.  Z:E = 5.4:1.  1H NMR (499 MHz, CDCl3) δ 
7.55 (d, J = 7.3, 1H), 7.41 (m, 3H), 7.31 (m, 3H), 7.22 (m, 2H), 7.12 (m, 2H), 6.98 (m, 
2H), 6.75 (d, J = 3.6, 1H). 13C NMR (126 MHz, CDCl3) δ 148.18, 139.67, 137.56, 136.86, 
136.50, 130.14, 129.67, 129.03, 128.93, 128.23, 127.86, 126.75, 126.58, 124.96. 
 
Ph
Ph
B
O
O
+ R
Br
Pd(dba)2 (5%), 
P(o-tol)3 (10%),
Na2CO3 (4 equiv), 
THF/H2O, 50 oC
Ph
Ph
R
 
Determination of olefin stereochemistry. Inside a glove box, Pd(dba)2 (1.4 mg, 0.0025 
mmol, 0.050 equiv), P(o-tol)3 (1.5 mg, 0.0050 mmol, 0.050 equiv), cis-stilbeneboronic 
acid pinacol ester (15.3 mg, 0.0500 mmol, 1.00 equiv), aryl bromide (11.3 mg, 0.0500 
mmol, 1.00 equiv), sodium carbonate (22 mg, 0.20 mmol, 4.0 equiv), THF (0.2 mL) and 
degassed H2O (0.04 mL) were added to a dry vial containing a magnetic stir bar. The vial 
was sealed, removed from the glove box, and heated at 50 °C for 18 h. After heating, the 
reaction mixture was cooled to room temperature and analyzed by GC-MS. The GC-MS 
retention times of the product from this Suzuki-Miyaura coupling reaction, which is the E 
alkene product, and the products from the alkyne hydroarylation were then compared.  
The GC-MS retention time of the triarylalkene product observed from this Suzuki-
Miyaura coupling matched the minor product of the alkyne hydroarylation reactions.  
Therefore, the minor product of the hydroarylation was assigned as the E alkene product. 
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Inside a glove box, Pd(dba)2 (1.4 mg, 0.0025 mmol, 0.050 equiv), P(o-tol)3 (1.5 mg, 
0.0050 mmol, 0.050 equiv), Z-1,2-diphenylethenyl tosylate (17.5 mg, 0.0500 mmol, 1.00 
equiv), aryl boronic acid (0.0750 mmol, 1.50 equiv), sodium carbonate (22 mg, 0.20 
mmol, 4.0 equiv), THF (0.2 mL) and degassed H2O (0.04 mL) were added to a dry vial 
containing a magnetic stir bar. The vial was sealed, removed from the glove box, and 
heated at 50 °C for 18 h. After heating, the reaction mixture was cooled to room 
temperature and analyzed by GC-MS.  The GC-MS retention times of the product from 
this Suzuki-Miyaura coupling reaction, which is the Z alkene product, and the products 
from the alkyne hydroarylation were then compared.  The GC-MS retention time of the 
triarylalkene product observed from this Suzuki-Miyaura coupling matched the major 
product of the alkyne hydroarylation reactions.  Therefore, the major product of the 
hydroarylation was assigned as the Z alkene product. 
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Picture 1 – Top View of Aluminum Well Plate with Glass Tubes used for Catalyst 
Screening 
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Picture 2 - Side View of Aluminum Well Plate with Glass Tubes used for Catalyst 
Screening 
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Picture 3 - Aluminum Well Plate used for Catalyst Screening with Top and Bottom 
Plates in place 
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